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Abstract  
 
Disorders of cartilage and tendon account for a high incidence of disability and are 
highly prevalent co-morbidities within the ageing population; therefore, 
musculoskeletal disorders represent a major public health policy issue.  Despite 
considerable efforts to characterise biochemical and biomechanical cues that 
promote a stable differentiated cartilage or tendon phenotype in vitro the 
benchmarks by which progress is measured are limited.   Common regenerative 
interventions, such as autologous cartilage implantation, have a required period of 
monolayer expansion that induces a loss of the functional phenotype, termed 
dedifferentiation.  Dedifferentiation has no definitive mechanism yet is widely 
described in both regenerative and degenerative contexts; in addition to stem cell 
transplantation and cell-seeding in three-dimensional scaffolds, dedifferentiation 
represents the third approach to the development of regenerative mechanisms for 
mammalian tissue repair.   
Cartilage and tendon show a number of common features in structure, develop, 
disease, and repair.  The extracellular matrix is a dynamic and complex structure 
that confers the functional mechanical properties of cartilage and tendon.  
Dysregulation of production and degradation are critical to the pathophysiology of 
musculoskeletal disorders, therefore, reparative interventions require a stable, 
functional phenotype from the outset.  Cartilage and tendon demonstrate a 
commonality in terms of function defining structure both being sparsely cellular 
with a preponderance of collagenous matrix.  Parity of functionality with the pre-
injury state after healing is rarely achieved for cartilage and tendon.  Cartilage and 
tendon also share common embryological origins.  Common mesenchymal 
progenitor cells differentiate into many musculoskeletal tissues with diverse 
functions.  Specialist sub-populations of tendon and cartilage progenitors enable 
formation of transitional zones between these developing tissues.  The 
development of musculoskeletal structures does not occur in isolation, however, 
cartilage and tendon have not previously been considered together in a systems 
context.  An integrated understanding of the differentiation of these tissues should 
inform regenerative therapies and tissue engineering strategies.  
Systems biology is paradigm shift in scientific thinking where traditional 
reductionist strategies to complex biological problems have been superseded by a 
holistic philosophy seeking to understand the emergent behavior of a system by 
the integrative and predictive modeling of all elements of that system.  Whole 
transcriptome and proteome profiling studies are used to collect quantitative data 
about a system, which may then be exploited by systems biology methodologies 
including the analysis of gene and protein networks.  Gene-gene co-expression 
relationships, which are core regulatory mechanisms in biology, are often not part 
of a comprehensive gene expression analysis. Many biological networks are sparse 
and have a scale-free topology, which generally indicates that the majority of genes 
have very few connections, whilst certain key regulators, or ‘hubs’, are highly 
interconnected.  Co-expression networks may be used to define regulatory sub-
networks and ‘hubs’ that have phenotypic associations.  This approach allows all 
quantitative data to be used and makes no a priori assumptions about relationships 
in the system and, therefore, can facilitate the exploration of emergent behavior in 
the system and the generation of novel hypotheses.     
The ultimate goal of tissue engineering is the replacement of lost or damaged cells, 
and in vitro, to develop biomimetic (organotypic) structures to serve as 
experimental models.  Tissues, and the strategies to functionally replicate them ex 
vivo, are complex and require an integrated, multi-disciplinary approach.  Systems 
biology approaches, using data arising from multiple-levels of the biological 
hierarchy, can facilitate the development of predictive models for bioengineered 
tissue.  The iterative refinement, quantification, and perturbation of these models 
may expedite the translation of well-validated organotypic systems, through legal 
regulatory frameworks, into regenerative strategies for musculoskeletal disorders in 
humans.     
In this thesis the systems under consideration are the major cell populations of 
cartilage and tendon (chondrocytes and tenocytes, respectively).  They are 
described in three environmental conditions: native tissue, monolayer (two-
dimensional), or three-dimensional models.  There has been no systematic 
investigate of the global gene and protein profiles of cartilage and tendon in their 
native state relative to monolayer or three-dimensional cultures.  There is no clear 
mechanistic description of the impact of in vitro environmental perturbations on 
the system or indeed the adequacy of these models as proxies for cartilage and 
tendon.  
A discovery approach using transcriptomic and proteomic profiling is undertaken 
to define a robust and consistent gene and protein profile for each condition.  
Differentially expressed elements are functionally annotated and pathway topology 
approaches employed to predict major signalling pathways associated with the 
observed phenotype.  This study defines dedifferentiated chondrocytes and 
tenocytes in monolayer culture as expressing markers of musculoskeletal 
development, including scleraxis (Scx) and Mohawk (Mkx).  Furthermore, there is 
reproducible synthetic profile convergence in monolayer culture between cartilage 
and tendon cells.  Standard three-dimensional culture systems for chondrocyte and 
tenocytes fail to replicate the gene expression profile of cartilage and tendon.  The 
PI-3K/Akt signaling pathway is predicted to be the predominant canonical 
pathway associated with de- and re-differentiation in vitro.   
Using novel, and publically available, transcriptomic data sets a meta-analysis of 
microarray gene expression profiles is performed using weighted gene co-
expression network analysis. This is employed for transcriptome network 
decomposition to isolate highly correlated and interconnected gene-sets (modules) 
from gene expression profiles of cartilage and tendon cells in different 
environmental conditions.  Sub-networks strongly associated with de- and re-
differentiation phenotypes are defined. Comparison of global transcriptome 
network architecture was performed to define the conservation of network 
modules between a model species (rat) and human data.  In addition to the 
annotation of an osteoarthritis-associated module in the rat a class-prediction 
analysis defined a minimal gene signature for the prediction of three-dimensional 
cultures from standard monolayer culture.  Finally, proteomic and transcriptomic 
data sets are integrated by defining common upstream regulators (TGFB and 
PDGF BB) and unified mechanistic networks are generated for de- and re-
differentiation. 
The studies collected in this thesis contribute to a wider understanding of cartilage 
and tendon tissue engineering and organotypic culture development. A clear 
mechanistic understanding of the regulatory networks controlling differentiation 
of cartilage and tendon progenitor cells is required in order to develop improved in 
vitro models and bio-engineered tissue that are physiologically relevant.  The 
findings presented here provide practical outputs and testable hypotheses to drive 
future evidence-based research in organotypic culture development for 
musculoskeletal tissues.        
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1.1: Opening statement 
In this introduction an overview is provided of cartilage and tendon anatomy and 
physiology.  The pathophysiological mechanisms of cartilage and tendon degeneration 
are summarized and the population impact is reported. Current regeneration strategies 
are presented with explanations of the growth in tissue-engineering research and use of 
musculoskeletal progenitor cells.  The motivations and project objectives are defined 
relative to this current understanding.  Firstly, the philosophy of systems biology and 
common tools are outlined with view to applying these to quantitative transcriptomic 
and proteomic data from cartilage and tendon studies.   
1.2: Philosophy of Systems Biology  
 
1.2.1: Systems Biology: a paradigm shift in science 
To understand the philosophy of systems biology its origins should be considered. 
Ambiguity and difficulties in finding an adequate definition of systems biology are in 
part due to the historical development of the discipline.  Systems biology is either 
considered a natural evolution of earlier scientific disciplines e.g. biophysics, and the 
work of pioneers such as Turing (Turing 1952), or considered a paradigm shift (Marcum 
2009, Bard 2013) in scientific thinking.  Definitions are also confounded by the 
complexity of the strategies a systems biology approach encompasses – methods as 
diverse as, and not restricted to, whole-genome sequencing and ‘omics’ studies 
(proteomics, transcriptomics, metabolomics), single-cell microfluidics (Breslauer, Lee et 
al. 2006), in silico modeling, machine learning, and other bioinformatics methods.  
1 :  Genera l  Int roduct ion  
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Advocates would present systems biology as a Kuhnian paradigm shift, or revolutionary 
step, in science.  According to Kuhn a paradigm shift in science occurs where the 
recognition of an anomaly in fundamental understanding results in a crises so profound 
that it propagates a revolution in thinking; this results in a shift in a paradigm toward a 
competitor (Kuhn 2012).  The catalyst for this shift, it has been suggested, was the wave 
of data generated by the completion of the Human Genome project (Ideker, Galitski et 
al. 2001, Marcum 2009, Conesa and Mortazavi 2014).  Proponents would suggest that 
traditional reductionist strategies in biology fail to account for the complexity of 
biological phenomena. Critics, in contrast, would suggest that systems biology 
represents an evolutionary extension of molecular biology and it certainly builds on the 
successes of a reductionist methodology (Bard 2013).        
Two comprehensive definitions of systems biology, below, give some indication as to 
the central tenets of a systems approach:  
 “Systems biology is a discipline seeking to understand the emergent 
behavior of a biological system by integrative modeling of the 
interactions of (all) the molecular elements”.  (Wang and Levchenko 
2009); 
and,  
 “The goal of systems biology is a predictive understanding of the whole.  
If the whole is more than the sum of its parts, it follows that acquiring a 
catalogue of all the parts is not necessarily the first order of business”. 
(Szallasia, Stelling et al. 2010).   
 
1.2.2: The systems biology approach 
To define the systems biology approach the ultimate objectives must be considered.  
Systems biology should be considered as having two goals, firstly to describe how 
proteins in complex networks work (as proteins drive biological networks) and 
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secondly, to integrate with the functional or organismal phenotype the molecular and 
network data (Bard 2013).   
In general terms the systems biology approach consists of an iterative series of 
comprehensive perturbations and systematic quantifications to measure, temporally, 
elements from all the distinct levels of a biological system.  In an attempt to recapitulate 
the behavior of the system under investigation all the quantitative data must be 
integrated into a network model.  This mathematical model is reconciled against the 
observed responses then a new hypothesis is formulated and tested experimentally.  The 
model is cyclically refined and perturbed with new findings being incorporated as they 
arise (Ideker, Galitski et al. 2001, Wang and Levchenko 2009).   Systems may be 
perturbed in a number of ways including high-throughput genetic manipulation, e.g. 
gene overexpression, systematic gene mutations, RNA interference, small molecule 
(drug) libraries, and growth hormones.  The concomitant response to these 
perturbations is then quantified as before.   
Individual elements of the biological system are not under consideration; rather the 
relationships between all elements within the system are investigated dynamically.  
Consequently, systems biology considers all biology as an information science.  
Discovery investigations (or global profiling studies) are common and these are not 
necessarily hypothesis-driven at the outset, however, the integration of hypothesis- and 
discovery-driven approaches is a hallmark of systems biology (Ideker, Galitski et al. 
2001).  The tools that make systems biology possible include: genomic reference 
sequences of model organisms, comprehensive gathering of information at all levels of 
the biological hierarchy, high-throughput, massively parallel and automated 
methodologies, improved computational power, curated databases, open-source 
software and multi-disciplinary teams.    
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What does not constitute a systems biology approach is as relevant as the definitions 
above.  Some researchers do not consider that global data gathering, perturbation of 
that system and integration of that data alone constitutes systems biology, rather the 
mathematical modeling of biological systems represents a true systems approach.  
Sequencing of transcripts from samples in a discovery study does not represent a 
systems biology approach, however, studies following changes in gene expression in a 
temporal manner, or in response to siRNAs, may be considered a systems biology 
methodology (Conesa and Mortazavi 2014).   
Complexity in biological systems 
Biological phenomena, e.g. development, physiological homeostasis, neoplasia, are 
complex.  The behavior of these phenomena cannot be reduced to a linear 
representation comprising the sum of the components parts.   By extension biological 
data is complex for several reasons – a) organization operates on multiple, hierarchical 
levels; b) it is derived from integrated networks; c) these networks are robust to multiple 
perturbations; d) key target nodes within the network, when perturbed, may have 
profound effects.  Causality is distributed throughout the system and operates in a 
bidirectional manner between, and within, levels.  Furthermore, systems biology 
assumes that no biological level has preferred status.  (Ideker, Galitski et al. 2001, Bard 
2013).   Complexity is also associated with the fact that data will always be missing, for 
example failure to identify peptides in mass-spectra or measuring in vivo states (rate 
constants) (Bard 2013), or redundancy in the system, or that biological processes occur 
over vastly differing time scales.  A systems biology approach does not, however, need 
to include large numbers of elements or data sets and may represent small-scale 
quantitative modeling, e.g. in yeast studies (Klipp, Liebermeister et al. 2009).   
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Kitano (2002) defined that a systems-level understanding would require analysis four 
properties of a biological system, a) the system structure (e.g. the network of gene 
interactions), b) system dynamics (behavior over time), c) the control method (define 
the mechanisms that control the state of the cell and modulate them), and d) the design 
method (principles of design and simulation to modify biological systems to having 
desired properties) (Kitano 2002) 
1.2.3: Systems biology tools 
As stated earlier a number of methodologies may be used in a system approach and two 
of these are described below.  Further discussions on quantitative data integration 
techniques are explored in Chapters 5 and 7.   
Tools of interpretation in systems biology I: Co-expression network analysis  
With the reduction in the cost of microarrays many studies have published lists of 
differentially expressed genes or gene sets.  Prioritised lists, whilst useful reference tools, 
provide only single gene-specific measurements at the expense of all the data points that 
did not meet the threshold criteria.  Furthermore, it does not consider the interactions 
of the elements of the system.  A systems approach does not make a priori assumptions 
about elements of a system, rather it is explored in a holistic manner. Covariance, a 
measure of how much two random variables change relative to each other, may be used 
to establish gene-gene co-expression relationships and may be used to infer patterns in 
the expression data and create networks of highly interconnected genes (Conesa and 
Mortazavi 2014).  Established systems approaches, such as weighted gene co-expression 
network analysis (WGCNA), can be applied to many biological contexts to define 
modules of highly co-expressed genes and derive phenotypic associations from them 
(Langfelder and Horvath 2008, Gaiteri, Ding et al. 2014).  This will be explored further 
in Chapters 4 and 5. 
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Tools of interpretation in systems biology: Pathway Analysis  
Pathways are graphical representations of models encoding the interactions between 
genes, proteins and metabolites within cells, tissues and organisms – pathway topology 
is the overall arrangement of the elements of this model.  The production of lists of 
differentially expressed genes between two conditions has now become relatively 
routine, however, predicting the phenomena that drive a phenotype is still challenging.  
It has been suggested that the ability to infer, correctly and consistently, the pathway 
perturbations promoting a phenotype from a list of genes may be what translates vast 
data gathering exercises into meaningful biological knowledge (Mitrea, Taghavi et al. 
2013).  
In order to make inferences about networks the properties of the system, mechanistic 
and structural, must be mapped.  These networks have a complex topology, which, 
although likely to be biologically relevant, may be difficult to interpret in terms of 
cellular function (Conesa and Mortazavi 2014).  Furthermore, causality in biological 
systems is bidirectional within, and between, hierarchical levels (Marcum 2009, Bard 
2013), therefore profiling only gene expression is not consistent with a systems 
approach.   
Long lists of differential abundance provides no mechanistic insight into the system 
under investigation (Khatri, Sirota et al. 2012).  Pathway analysis is a group of 
methodologies that seeks to gather cohorts, or sets, of genes that function within the 
same pathways; achieving this reduces the complexity of the data from thousands of 
genes to scores of pathways. Rather than producing a list of pathways this type of 
analysis should define the activity status of pathways thereby improving our ability to 
explain the data.   
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The term ‘pathway’ is often misappropriated, for example, gene ontology terms do not 
describe a pathway, nor do protein-protein interaction networks (Khatri, Sirota et al. 
2012).  Most pathway analysis is driven through the use of a pathway knowledge base, 
which describes a process, structure, or components.  Gene expression patterns for the 
condition under review are correlated with information within a pathway knowledge 
base.  Numerous techniques are available, though most are derivative and use 
overlapping resources.  The most widely used and accessible method is ‘over-
representation analysis’ (ORA) where the statistical evaluation of a subset of genes 
within a differential expression list matching to a particular pathway is considered. 
Over-representation analysis assumes each gene, or pathway, is an independent entity, 
contrary to the understanding of the complex interactions that exist between them, and 
so limits any insight into the pathways.   
Functional class scoring (FCS) techniques, such as Gene Set Enrichment Analysis 
(Broad Institute, http://www.broadinstitute.org/gsea), try to address some of these 
issues by not having arbitrary thresholds, using molecular measurements, and consider 
coordinated changes between genes.  However, pathways are still considered 
independently and many methods may rank and discard genes in a particular pathway.  
For both methods, described above, as only the number of genes or co-expression of 
those genes is used to define significant pathways were these pathways to be redrawn 
with entirely different links between the genes both ORA and FCS would produce the 
same results.  As lists of genes, or ‘gene-sets’ do not include any additional information 
on a pathway they cannot be considered pathway analysis (Tarca, Draghici et al. 2009, 
Mitrea, Taghavi et al. 2013).   
Pathway topology methods use many of the same steps as functional-class scoring, 
however, the gene-level statistic is calculated on pathway topology.  Pathway topology 
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makes use of the previously collected knowledge about the structure of a pathway, in 
addition to the molecular measurements. An impact factor analytic approach is a more 
recent development; this takes into account not only the changes in gene expression, 
but also the positions of genes in pathways and types of interactions.  The impact factor 
of a pathway is the sum of perturbation factors for all the genes in a pathway. In 
Chapter 2 this methodology, implemented through the SPIA algorithm (Tarca, 
Draghici et al. 2009) was employed to predict the activation status of KEGG canonical 
pathways based upon the Illumina gene expression data sets.  This method is becoming 
more widely used (Balbin, Prensner et al. 2013, Nance, Smith et al. 2014, Nouailles, 
Dorhoi et al. 2014), however, is already likely to have been superseded by a number of 
new methods using several curated databases, implementing multivariate analysis and 
incorporating multi-dimensional genomics data (Vaske, Benz et al. 2010, Mitrea, 
Taghavi et al. 2013). However, many are limited by their ease of implementation.   
Working definition of systems biology 
In the context of this thesis a systems biology approach is understood to be the 
collection of methodological steps, which together aim to generate novel and testable 
hypotheses about the system under investigation.  Initially, hypothesis-free discovery 
projects survey and quantify global transcriptome and proteome profiles for a series of 
conditions using cartilage and tendon.  This data is curated and integrated with 
functional in vivo and in vitro phenotypes at the network level to define emergent 
properties of the system.  Protein-protein interaction networks arising from these 
relationships are used to generate a hypothesis about regulatory units driving the 
phenotype of interest with the intention of perturbing these units in future and feeding 
into computational models.  
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1.3: Structure & Function of Cartilage and Tendon 
 
1.3.1: The musculoskeletal system: an introduction 
The musculoskeletal system consists of a diverse group of tissues that are 
developmentally, anatomically, and functionally inter-related.  Bone confers the 
structural rigidity required for locomotion; muscle contraction generates force, tendon 
transfers that force, whilst cartilage provides a smooth surface for unimpeded angular 
movements at joints. Contributing to this mechanical system are ligaments, synovial 
tissue that lines joints and provides lubricating fluid, and complex extracellular matrices.    
Of these tissues cartilage and tendon are the focus of the studies presented in this thesis.  
To demonstrate the common ontogeny, disease pathophysiology, and regeneration 
strategies for cartilage and tendon three sections provide an overview: i) structure and 
function; ii) disease and development; and iii) repair and regeneration.  In each of these 
the key issues highlighted and how they inform and influence the motivations for the 
series of studies presented in this thesis.  A final section clarifies the core objectives of 
the thesis and the novelty of the study design.   
It is not possible within the constraints of this thesis to fully survey the literature 
pertaining to development, anatomy, pathophysiology, regeneration and therapeutics for 
each tissue and these disciplines will be considered in general terms. Where points of 
interest are expanded upon elsewhere in the thesis these will be referenced in the text.   
1.4: The extra-cellular matrix 
As the majority of both cartilage and tendon consists of specialised extra-cellular matrix 
(ECM), and contribute to a loss of function in disease, an overview is provided.  
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Although the ECM is not the principal focus of this thesis it is fundamental to an 
understanding of the goals of musculoskeletal regeneration strategies.  The ECM in 
crude terms is often considered the filler between cells in all tissues, but in reality 
represents both a physical scaffold and a transducer of biochemical and biomechanical 
cues with roles in morphogenesis, differentiation, homeostasis and is implicated in 
variety of disorders related to age, injury, or neoplasia (Frantz, Stewart et al. 2010).  
Although the fundamental components are comparable across many tissues the 
proportional composition is functionally related and unique to each tissue; it also exists 
as the interface between tissues and between cell populations within a tissue.  
The ECM is a dynamic structure involved with sequestration and release of growth 
factors. It undergoes constant remodeling, and interacts with the resident cells through 
integrins, syndecans, and discoidin domain receptors.  Excluding water, the ECM 
components are proteins, glycoproteins or proteoglycans.  The former are, in various 
proportions: fibrous collagens, elastins, laminins, fibrillins, thrombospondins, fibulins, 
tenascins and fibronectin (Halper and Kjaer 2014).  The latter, proteoglycans, consist of 
glycosaminoglycans (GAGs) with a covalent link to a core protein; this core protein is 
not present in hyaluronan.  The composition of these structures may classify 
proteoglycans into: cell surface-associated (syndecans, glypicans), small leucine-rich 
proteoglycans or SLRPs (decorin, lumican), or modular (aggrecan, versican, perlecan).  
In general, proteoglycans are highly hydrophilic, linear molecules that confer the 
resistance to compressive forces through the formation of hydrogels (Schaefer and 
Schaefer 2010).  Furthermore, each proteoglycan group has relevance to signalling 
modulation, cell adhesion, migration and proliferation (Frantz, Stewart et al. 2010, 
Schaefer and Schaefer 2010).    
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The CCN-family of proteins is of particularly relevance to ECM function.  The six 
secreted CCN proteins (CYR61, CNN2/CTGF, CNN3/NOV and WISP 1-3) have 
specific ECM associations with roles as adaptor molecules linking the intracellular state 
and the ECM signalling through integrins and proteoglycans.  They are induced by 
growth factors and cytokines including TGF-β and are also implicated in cell 
differentiation, chondrogenesis, proliferation and migration (Leask and Abraham 2006).   
1.4.1: Collagens  
Collagens represent one third of the human proteome (Frantz, Stewart et al. 2010, 
Ricard-Blum 2011, Chang, Shefelbine et al. 2012) and collagen alpha-helical chains, 
which represent the fundamental unit of the ECM, intertwine with other collagen 
helices to form homo- or hetero-trimeric collagen helices contributing to the structural 
integrity of tissues.  Each collagen chain contains repeating glycine (Gly,G)-X-Y triplets, 
of which X and Y are usually proline (Pro,P) or hydroxyproline (Hyp,O) (van der Rest 
and Garrone 1991, Ricard-Blum 2011).   Triple-helical collagenous domains are flanked 
by non-collagenous regions; these often containing recognisable domains found in other 
matricellular proteins. Collagens may be loosely grouped into: fibrillar, fibril-associated, 
network-forming, transmembranous, endostatin-precursors, or within a miscellaneous 
group (Gordon and Hahn 2010).  For the purposes of this introduction only the fibrillar 
collagens will be considered.   
The fibrillar collagens are types I (the must abundant in tendon), II (the most abundant 
in cartilage), III, V and XI. Collagen type I principally exists as a hetero-trimer 
consisting of two alpha-1 and one alpha-2 collagen chains; homo-trimeric forms of 
collagen type I, three alpha-1 chains, exist in foetal tissue, musculoskeletal disorders 
(Dupuytren’s contracture and osteogenesis imperfecta) and neoplastic stroma with 
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altered structural and mechanical properties (Chang, Shefelbine et al. 2012).  In contrast, 
collagen type II exists only as a homo-trimeric molecule (Gordon and Hahn 2010).  
Pro-collagen biosynthesis  
Pro-collagen units are the precursors of collagen and undergo conversion, complex 
post-translational modifications and trafficking through an intra-cellular secretory 
pathway to ultimately result in the deposition of collagen fibrils into the ECM.   In the 
pro-form triple helices are flanked by N- and C-terminus pro-peptide globular 
extensions, which undergo proteolytic cleavage by N- and C-proteinases respectively 
(Kadler, Baldock et al. 2007).  The removal of the pro-peptides permits the aggregation 
of collagen triple helical molecules into fibrils.   
Pro-collagen chain biosynthesis occurs in the endoplasmic reticulum (ER) and 
nucleation of three pro-collagen monomers into the triple helix occurs at the C-pro-
peptide under the influence of various enzymes with resultant post-translational 
modifications (PTM) (Banos, Thomas et al. 2008).  For example, the conversion of 
proline residues (in the Gly-X-Y repeating triplets of the collagen chains) to 
hydroxyproline is performed by prolyly-4-hydroxylase, with ascorbic acid (Vitamin C) as 
an essential co-factor (Canty and Kadler 2005).  Trafficking covers the transition of 
collagen triple helices from the ER to the plasma membrane, via the Golgi, for secretion 
from the cell.  Vesicular transport clusters transport pro-collagen to the cis-Golgi after 
budding directly from the ER membrane (Banos, Thomas et al. 2008).  In this model 
the cleavage of the C- and N-globular domains occurs intracellularly; this is the final 
PTM and creates the highly insoluble tropocollagen rods that may spontaneously self-
assemble to form fibrils (Banos, Thomas et al. 2008).  Proteinase activity is specifically 
mediated by C- and N-propeptide tolloid and ADAMTS family enzymes respectively 
(Canty and Kadler 2005), although these have other substrates additionally.   
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1.4.2: Integrins coordinate chondrocyte communication with the ECM 
The chondrocyte is isolated within the general ECM and peri-cellular matrix (see 
Chapter 3), lacking cell-to-cell contacts and is supremely sensitive to changes in the 
microenvironment – it is connected to it by integrins and these influence chondrocyte 
responses (Demoor, Ollitrault et al. 2014), i.e. ‘integrating’ the extracellular matrix, 
cytoskeletal components and signalling pathways. Integrins are heterodimeric 
transmembrane proteins consisting of α and β subunits that have extracellular domains 
defining the matrix ligands (Loeser 2014).  Of the 24 integrin heterodimers described 
chondrocytes express seven (α1β1, α3β1, α5β1, α10β1, αVβ1, αVβ3, and αVβ5) in 
physiological circumstances, with elevated levels of α1β1 and α3β1 and novel 
heterodimer expression (α2β1, α4β1) evident in osteoarthritis (Almonte-Becerril, Costell 
et al. 2014, Loeser 2014).  Integrins can recognize distinct collagen subgroups, for 
example α10β1 is collagen, type II binding and is limited to cartilage (Heino 2014). 
Integrins function to mediate cell-adhesion to ECM proteins in a substrate-restricted 
manner, e.g. fibronectin, collagen type II.  Binding stimulates ‘outside-in’ signalling 
networks that converge on mitogen-activated protein (MAP) kinase family of proteins 
(ERK, JNK, p38) to influence down-stream transcription of genes through NF-κB and 
AP-1 (Fos-Jun dimer).  Canonical integrin signalling results in the rapid increase in levels 
of phosphatidylinositol lipid messengers (PI-3K/Akt signalling, see Chapter 3) and 
receptor tyrosine kinase-mediated phosphorylation of proteins including focal adhesion 
kinase (FAK) and Rho/Rac activation (Heino 2014, Loeser 2014).  In general, the 
activity of integrins has been shown to include: mechano-transduction, survival, 
differentiation, and proliferation.  Additionally, matrix fragments, especially fibronectin, 
influence the catabolic signalling through RGD motif binding by integrins including 
α5β1, resulting in a signalling cascade promoting increased expression of MMPs, pro-
inflammatory cytokines (PGE2/COX2), reactive oxygen species (ROS) and other 
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degradative enzymes (ADAMTS5).  The generation of further matrix protein fragments 
can perpetuate a cycle of degenerative effects on cartilage (Loeser 2014).    
Summary  
The ECM is a dynamic and complex structure that confers the functional mechanical 
properties of cartilage and tendon.  Dysregulation of its production and degradation are 
critical to the pathophysiology of musculoskeletal disorders.   
1.5 Cartilage 
 
“Where-ever the Motion of one Bone upon another is requisite, 
there we find an excellent Apparatus for rendering that Motion 
safe and free.” (Hunter 1743) 
 
1.5.1: General anatomy 
Having defined the principal structural components of cartilage and tendon each tissue 
will be considered in turn with regard to the general anatomy and function.   
Adaptations of cartilage may be found wherever, in the axial or appendicular skeleton, 
two surfaces are required to move over one another without impedance.  Cartilage may 
be described as: fibro-cartilage, elastic, fibro-elastic or hyaline (Eyre 2002). Articular 
cartilage, a smooth, load-bearing surface that allows frictionless motion of a joint, is a 
form of hyaline cartilage.  In the healthy adult articular cartilage is devoid of blood and 
lymph vessels, and is aneural.  The only cell-type is the chondrocyte, which is 
responsible for the synthesis of extracellular matrix and maintenance of the cartilage 
architecture.  These critical cells only account for 1-5% of the cartilage structure.  
Nutrition is conferred by diffusion and chondrocytes have no cell-to-cell contacts (see 
integrins, below).  The physiological environment is considered to be hypoxic as a result 
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of the low oxygen tension at the level of the chondrocyte; consequently anaerobic 
glycolysis is the main mechanism for ATP generation (Demoor, Ollitrault et al. 2014).    
As wet weight, over two-thirds of cartilage is water; this accounts for the load-
dependent deformation.  Collagens represent a further 10-20% of cartilage volume, of 
which collagen type II is the most prevalent. The principal collagens in mammalian 
cartilage (types II, IX and XI) exist as cross-linked collagen hetero-polymers to form, at 
the ultra-structural level, a random network of fibrils, in contrast to tendon (see below). 
Other collagens, type III, VI and X are also present, with type X restricted to the 
calcified cartilage interface with the sub-chondral bone (Eyre 2002, Bhosale and 
Richardson 2008, Demoor, Ollitrault et al. 2014).  Four zones are apparent in articular 
cartilage by light microscopy.  Passing deep to the articular surface these are: 
superficial/tangential, intermediate/transitional, deep/radial and calcified.  These layers 
differ in their collagen fibril orientation, which, along with the extensive collagen cross-
linking ensures the material strength of cartilage (Eyre 2002). 
Non-collagenous matrix and proteoglycans 
Protein polysaccharides, proteoglycans (mainly aggrecan), account for an additional 10-
20% of cartilage volume and contribute to the compressive strength of cartilage.  In 
addition to aggrecan other aggregating proteoglycans, such as versican, form large multi-
molecular complexes with hyaluronan, an interaction that is stabilised by hyaluronan 
link protein (HAPLN1).  Small leucine-rich proteins (biglycan, decorin, lumican, 
fibromodulin), which interact with fibrillar collagens, and miscellaneous proteoglycans 
(perlecan, lubricin/PRG4) are also components of the cartilage ECM (Roughley 2001).  
Of the non-collagenous proteins a number of structural components are present 
including: cartilage oligomeric matrix protein (COMP), matrilin-1/cartilage matrix 
protein (MATN1), thrombospondins (THBS1, 3, 4), fibronectin (FN), chondroadherin 
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(CHAD), elastin (ELN) and fibrillin (FBLN). Disruption of these matrix components, 
either through congenital mutations, for example COMP in skeletal dysplasias (Hecht, 
Hayes et al. 2005), or acquired mechanisms, e.g. proteolytic activity (Mort and Billington 
2001), can contribute to the degradation of cartilage and loss of function.     
1.6: Tendon 
 
1.6.1: General anatomy 
Tendons are the functional link between the static and dynamic parts of the 
musculoskeletal system transferring the forces generated by muscular contraction to the 
skeleton and, thus, facilitating motion.  Following injury this function is impaired.  
Parity of functionality with the pre-injury state after healing is rarely achieved; the final 
tensile strength of healed tendon has been reported as being reduced by up to thirty 
percent (Müller, Todorov et al. 2013).   
Comprising dense bundles of parallel collagen fibres in close apposition confers tendons 
with specialist mechano-transducive properties of high tensile strength.  Elasticity is a 
function of the elastin molecule tropoelastin, which aggregates and is stabilized by 
cross-links in a lysyl-oxidase-dependent manner (Scott 2003). As a caveat to the 
statements above tendons may also exist as ‘intramuscular tendons’, facilitating 
pennation of muscle bellies, or as ‘intermediate tendons’ connecting two muscle bellies 
(Benjamin, Kaiser et al. 2008).  Furthermore, although in general tendons act to transmit 
tensile forces derived from skeletal muscle in some anatomical locations forces of 
compression and shear are also applied, for example, where tendons pass over a curved 
region of bone and act as a pulley.  Other tendons, such as the highly developed equine 
superficial digital flexor tendon, have the capacity to store elastic energy for efficient 
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locomotion (Thorpe, Udeze et al. 2012).  Some anatomical features are defined by the 
presence of calcified structures or areas within the tendon including distal limb and 
pedal sesamoid bones in the horse and man, and areas of fibro-cartilaginous adaptation 
at tendon insertions (Benjamin, Kaiser et al. 2008).  
The canonical tendon structure, as described by Kastelic and co-workers (1978) 
(Kastelic, Galeski et al. 1978) consists of hierarchically organized structural units of 
insoluble collagen type I molecules aggregated to form collagen fibrils; subsequently 
these are collected to form ‘fibres’ – the basic functional unit of the tendon.  Primary, 
secondary and tertiary fibre bundles form from sequential aggregation.  Combined 
tertiary bundles form the tendon, which is surrounded by the epitenon connective 
tissue, blood vessels and nerves (Kannus 2000).   
Tenocytes, or tendon fibroblasts, are the majority cell type in an otherwise sparsely 
cellular tissue, and are responsible for the production and secretion of ECM and 
collagen turnover.  As dry weight, tendon is predominantly comprised of collagen of 
which type I collagen represents 95% with the remainder consisting of type III, V, XII 
and XIV (Müller, Todorov et al. 2013, Thorpe, Birch et al. 2013).  Within each level of 
the tendon hierarchy small amounts of non-collagenous matrix are present (Kastelic, 
Galeski et al. 1978), which has been relatively ill-defined.    The tendon non-collagenous 
matrix (NCM) comprises glycoproteins including COMP, lubricin and tenascin-C and 
other proteoglycans, mainly SLRPs, with decorin the most abundant.  The relative 
abundance of the NCM is associated with the functional requirements of the tendon 
with areas of high compressive load requiring higher concentrations of NCM, whilst 
areas with high tensile loads are sparse by comparison (Thorpe, Birch et al. 2013).  
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Summary  
These cursory reviews of tendon and cartilage anatomy and structure demonstrate a 
commonality in terms of function defining structure, sparse cellularity, and a 
preponderance of collagenous matrix and varying proportions of non-collagenous 
matrix.  This commonality extends to the morphogenesis of each tissue as outlined in in 
the following section.     
1.7: Disease & Development  
 
1.7.1: Common origins: models of musculoskeletal development  
 
Cartilage and tendon progenitors 
An understanding of cartilage and tendon morphogenesis, through the limb bud 
developmental paradigm, provides a conceptual framework within which an 
understanding of the regulatory elements and networks driving pathophysiological and 
regenerative mechanisms may be developed.  
Whereas muscle progenitors arise from the myotome, cartilage, bone, tendon and 
ligament all arise from undifferentiated cells within the sclerotome, lateral plate 
mesoderm or neural crest (Sugimoto, Takimoto et al. 2013).  For the limbs, progenitors 
are derived from the lateral plate mesoderm.  At appropriate topographical regions, 
encoded by homeobox (Hox) genes (Zakany and Duboule 2007), the progenitors 
displace from the lateral plate mesoderm and assemble beneath ectodermal pockets 
forming dome-like structures called ‘limb buds’.  As these buds rapidly grow invasion by 
the primitive muscle and vasculature cells occurs.  In the classical model proximo-distal 
outgrowth of the limb bud is promoted by the apical ectodermal ridge (AER), which is 
relevant to our understanding of musculoskeletal morphogenesis because it produces a 
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number of signals relevant to specification of mesenchymal progenitors, particularly 
fibroblast growth factor (FGF) family members (Zeller, López-Ríos et al. 2009).   The 
ultimate fate of skeletal progenitors is defined by sequential, modular signals generally 
consisting of the bone morphogenetic proteins (BMP), transforming growth factor beta 
(TGF-β), fibroblast growth factor (FGF) and Wingless/Wnt and Hedgehog family of 
growth factors (Lorda-Diez, Montero et al. 2014) through the generation of dynamic 
spatial and temporal morphogen gradients (Dekanty and Milan 2011).  It is these local 
signals that drive the divergent differentiation of mesenchyme to cartilage and tendon.  
It is proposed that as the limb bud proliferates the distal most mesenchymal cells remain 
in an undifferentiated state whilst core mesenchyme, no longer under the influence of 
defined morphogen gradients, activate SRY-box containing-9 (Sox9) expression to 
initiate chondrogenic differentiation.  
Summary 
Common mesenchymal progenitor cells differentiate into many musculoskeletal tissues 
with diverse functions.  Growth factor gradients and homeodomain genes coordinate 
and spatially restrict development of nascent cartilage and tendon structures.  An 
understanding of developmental ontogeny is critical to understanding directed 
differentiation in regenerative therapies and biomimetic cultures.   
1.7.2: Chondrogenesis, articular cartilage and joint development 
The condensation of mesenchymal progenitors to form discrete, self-organising cartilage 
templates (anlagen) is the initial process in skeletogenesis.  Associated with this 
transition is a move from expression of collagen types I, III, and V to cartilage-
associated collagens II, IX, and XI.  Proliferating chondrocytes express collagen VI and 
matrilin-1 (MATN1) under the control of the PTHrP/Ihh axis (Goldring 2012).  
Cartilage determinism, and the prevention of differentiation towards an osteogenic 
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lineage, is under the control of a number of signalling pathways and transcriptional 
regulators. Activation of chondrogenic pattern formation may be under the influence of 
TGF-β signalling, possibly via a reaction-diffusion mechanism (Turing 1952, Miura and 
Shiota 2000, Christley, Alber et al. 2007).  Complex interplay between TGF-β, BMP-
(Pizette and Niswander 2000, Yoon, Ovchinnikov et al. 2005) and Wnt-(Day, Guo et al. 
2005, Hill, Später et al. 2005) signalling all contribute to the balance between osteo- and 
chondro-genesis.   The major transcriptional regulators are RUNX2 and SOX9 for 
osteogenesis and chondrogenesis respectively (Goldring 2012).  SOX9, with the 
addition of SOX5 and SOX6, are a triad of transcriptional controllers that cooperatively 
activate collagen type II expression (Lefebvre, Li et al. 1998, Lefebvre, Behringer et al. 
2001).   
More is understood about the regulatory elements involved in chondrogenic 
determinism in skeletogenesis than definition of articular cartilage formation.  The 
complex three-dimensional architecture of joints and the compound nature of the 
tissues that comprise them (cartilage, ligament, synovium, meniscus, tendon) are not 
well described in terms of the pool of progenitors from which they arise. Decker, et al 
(2014) have proposed a model for the emergence of joints, and formation of articular 
cartilage, from undifferentiated mesenchyme based upon a review of a number of 
genetic cell lineage tracing studies (Decker, Koyama et al. 2014).  The authors proposed 
that SOX9/COL2A1/doublecortin-positive cells within the cartilaginous anlagen, which 
is linear and uninterrupted in early embryogenesis, becomes segmented by unknown 
mechanisms; GDF5+ cells, which define the avascular mesenchymal ‘interzone’ that 
interrupts the adjacent cartilaginous elements, together with migrating cells give rise to 
the articular cartilage, synovial lining and intra-joint ligaments.  Matrillin 1-expressing 
chondrocytes residing within the anlagen diverge to undergo endochondral ossification, 
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whilst matrillin-1 negative cells with COL2A1-expression history go on to differentiate 
into articular chondrocytes.  Furthermore, TGF-βR2-expressing cells would emerge as 
slow-cycling, reserve progenitor cell population.       
1.7.3: Tendon development  
The development of the embryonic tendon demonstrates heterotypic induction through 
the intimate association with the developing structures of the limb, in particular the 
developing muscle (Aslan, Kimelman-Bleich et al. 2008), but also developing cartilage 
(Schweitzer, Zelzer et al. 2010).  These complex interactions are required to ensure the 
robust anchoring of tendon to muscle at the myotendinous junction and to bone at 
insertional entheses without which force transduction would not be possible.  There is 
evidence that axial tendons arise from a different embryonic lineage than the 
developmental mechanisms that promote appendicular, or limb, tenogenesis thus 
further complicating our understanding of potential regenerative processes (Brown, 
Finley et al. 2014).    
Regulators of tendon differentiation 
The development of tendon repair mechanisms is partly limited by our understanding of 
tendon development, the paucity of data on tendon differentiation cues, and evidence of 
the role of biomechanics in development.  Some lineage-restricted transcription factors 
have been implicated in tendon formation in a time-restricted manner with scleraxis and 
SOX9 associated with the emergence of progenitors, whilst Mohawk (MKX) 
(Anderson, Arredondo et al. 2006, Anderson, Beres et al. 2009) and early growth 
response proteins EGR1 and 2 (Lejard, Blais et al. 2011, Guerquin, Charvet et al. 2013) 
are associated with differentiation and maturation stages (Liu, Zhu et al. 2014).  
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The most notable of the tendon-specific mediators is scleraxis (SCX), a basic helix-loop-
helix (bHLH) transcription factor, which was detected in mouse embryos from 9.5 days 
post coitus (d.p.c.) with high levels demonstrable in cartilage, tendon and ligaments 
(Cserjesi, Brown et al. 1995, Schweitzer, Zelzer et al. 2010).  For axial tendon 
development tendon-progenitor cells are defined by the expression of SCX, in early 
developmental stages, within the syndetome compartment arising from the interaction 
of the somitic compartments of the sclerotome and the myotome (Brent, Schweitzer et 
al. 2003).  The former giving rise to the dorsal dermis and axial skeleton, whilst the latter 
to skeletal muscle.  Fibroblast growth factor signalling from the adjacent myotome 
induces and propagates development of the SCX-positive cells.     In comparison, the 
SCX+ cells in the developing limbs arise from superficial dorsal and ventral aspects of 
the limb bud mesenchyme without the compartmentalization described for axial tendon 
(Brown, Finley et al. 2014).  Here interactions between bone morphogenetic proteins, 
and the BMP antagonist Noggin, were reported to influence the domain of SCX+ cells 
(Schweitzer, Chyung et al. 2001).    
In general the molecular targets considered for neotendon formation have arisen from 
our understanding of tendon development, but largely consider the tendon in isolation 
belaying what is clear from tendon ontogeny, that tendon development relies on the 
cross-talk of muscle, bone and cartilage (Schweitzer, Zelzer et al. 2010).  Additionally, 
evidence for the tenogenic effects of these targets is limited.  Putative targets for tendon 
regeneration include SIX1 and SIX2, SMAD8, TGF-β and BMP-family members 
including GDF5, GDF6 and GDF7 (Aslan, Kimelman-Bleich et al. 2008).  
In additional to soluble factors, such as the role of TGF-β signalling in the recruitment 
and maintenance of tendon progenitors (Hasson 2011), mechanical factors are known 
to have roles in the development and homeostasis of tendon function.  Tissue 
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engineering studies have considered how best to utilize mechanical cues, such as 
substrate stiffness (elastic modulus) or to provide guides for scaffolds and bioreactors.  
Studies considering the mechano-activity of developing embryonic cells have been few 
and conflicting in their conclusions.  Using various forms of neuromuscular blockade 
several studies have demonstrated the impact of altered skeletal muscle contraction on 
the developing tendon with reduced, degenerative, or inhibited tendon structure 
formation, and reductions in the expression of tenascin-C or numbers of SCX+ cells 
(Schiele, Marturano et al. 2013).  In the absence of muscle, early tendon progenitor 
distribution and tenogenic induction is not inhibited in the developing avian limb, 
however further progress is retarded at the development and maturation stages and 
primitive tendons degenerate (Kardon 1998).    For the developing axial tendon there is 
no muscle-independent stage documented (Brown, Finley et al. 2014).  Whether this 
muscle dependence is derived from mechanical cues, soluble factors from muscle, or a 
combination of both, still requires further study (Schiele, Marturano et al. 2013).    
Summary 
The induction of tendon development does not occur in isolation and requires 
coordinated interactions including muscle and cartilage.  Key regulators of tendon 
development included SCX, MKX and SOX9.  Any consideration of the development 
of tendon regeneration strategies should also consider an integrated understanding of 
musculoskeletal development.    
1.7.4: Defining cartilage and tendon progenitors   
Cartilage and tendon progenitors in the limb have been defined principally by the 
differential expression of the key regulators SOX9 and SCX respectively. This assertion 
that scleraxis-positive cells alone form tendons in the limb bud has been based upon the 
continued expression of SCX rather than the absolute tracing of SCX-positive cells 
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from common progenitors to functional tissue. In early mouse studies the close 
temporal and spatial relationship of SCX and SOX9 was found in mesenchymal 
progenitor cells; these cells diverged at E11.5 d.p.c. into cells with restricted expression 
to form tendon and cartilage respectively (Asou, Nifuji et al. 2002).  
More recent studies, however, suggest that cell-fate determination on the basis of 
categorical expression of either SCX or SOX9 is insufficient. Takimoto, et al (2012) 
demonstrated the direct conversion of tenomodulin (TNMD)-expressing tenocytes into 
chondrocytes by the forced expression of SOX9 alone (Takimoto, Oro et al. 2012). 
Further work demonstrated that tenocytes are derived from both SCX+/SOX9+ and 
SCX+/SOX9- cells; the proportion of the former expression profile increased the closer 
the tenocytes came to the nascent cartilage (Sugimoto, Takimoto et al. 2013).  
Conditional inactivation of SOX9 in SCX+/SOX9+ resulted in the defective formation 
of the junction between tendon and cartilage.  The role of a specialist population of 
SCX+/SOX9+ in forming the enthesis, the junction between bone and tendon, has also 
been demonstrated (Blitz, Sharir et al. 2013).    In lineage tracing studies SOX9+ cells 
were indicative of precursors for articular and growth plate cartilage, in addition to 
ligament and tendon (Soeda, Deng et al. 2010).  The results from this study, suggested 
the authors, were consistent with part of the nascent tendon cells arising from a 
contribution by SOX9+ cells of the condensed mesenchymal cells of the cartilage 
primordia.   
Summary   
Recent evidence points toward specialist sub-populations of tendon and cartilage 
progenitors that enable formation of transitional zones between developing tissue, 
furthermore, it is clear that chondrogenic cells make some contribution to the 
developing tendon.  An understanding of the common origin and intimate spatial 
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development of cartilage, tendon, and muscle is valuable to the development of 
organotypic models and bioengineered tissue.     
1.7.5: Musculoskeletal disease: population impact 
Disorders of the musculoskeletal system are highly prevalent comorbidities of aging 
populations in contemporary society (Siebens 2007, van Dijk, Veenhof et al. 2008).  
Debilitating in their own right musculoskeletal disorders contribute significantly to the 
global burden of disease, the fourth most prevalent (Murray, Vos et al. 2012), have a 
wider impact on rehabilitation of parallel pathologies (obesity, strokes, cardiovascular 
disease) and so represent a major health policy issue.  Despite this population impact 
musculoskeletal research and clinical trials are not necessarily proportionately funded or 
investigated (Bourne, Whittle et al. 2014, Rankin, Sprowson et al. 2014).  Medical 
interventions aimed at management of musculoskeletal tissues vary from physiotherapy, 
arthroscopy, anti-inflammatories, immunomodulation and numerous ‘regenerative’ 
therapies, how there is no treatment for conditions such as osteoarthritis.  The basis for 
complex musculoskeletal diseases, such as osteoarthritis, is multifactorial.  Although 
heritable factors account for 50% of an individual’s risk of developing osteoarthritis 
only 16 disease risk loci have been consistently identified (Panoutsopoulou and Zeggini 
2013).  
1.7.6: Cartilage Disease Pathogenesis 
 
“If we consult the standard Chirurgical Writers from 
Hippocrates down to the present Age, we shall find that 
ulcerated Cartilage is universally allowed to be a very 
troublesome Disease…and that, when destroyed, it is never 
recovered.” (Hunter 1743) 
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This statement, above, by the 18th century surgeon William Hunter was prescient in its 
forecasting.  Over 250 years later the therapeutic strategies available to treat 
osteoarthritis (OA) range from benign neglect and anti-inflammatories to total joint 
replacement.  As discussed earlier the inherent capacity of cartilage to respond to injury 
is limited.  Globally, osteoarthritis of the hip and knee joints is one of the leading causes 
of disability and a highly prevalent comorbidity of the ageing society alongside Type II 
diabetes and neurological conditions.  Of the 291 conditions surveyed in the Global 
Burden of Disease Study (2010) hip and knee OA ranked as the 11th highest contributor 
to disability (Cross, Smith et al. 2014), accounting for 6.8% of the total disease burden 
(Murray, Vos et al. 2012).  Adjusted for age, the global prevalence of osteoarthritis was 
3.8% and 0.85% for the knee and hip respectively (Cross, Smith et al. 2014).  This places 
musculoskeletal disorders high on the ranking of major health policy issues, however, 
funding levels and research activity globally lag behind other fields (Bourne, Whittle et al. 
2014, Rankin, Sprowson et al. 2014) 
Osteoarthritis cannot be considered a single disease with a linear narrative to describe 
the pathogenesis, rather it is a heterogenous condition with multiple causation, where 
joint failure represents the common end-point (Cicuttini and Wluka 2014).  Where the 
adage ‘abnormal wear on normal cartilage; normal wear on abnormal cartilage’ is a useful 
lay description of the pathogenesis in reality there are a myriad of risk factors 
contributing to chondral damage.  It is beyond the scope of this review to cover the 
plethora of disorders arising from, and associated with, degenerative and inflammatory 
conditions of cartilage.  In Chapter 5 a review of recent studies of the genetic 
associations with osteoarthritis will be presented.  
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Cartilage degeneration: balance of anabolic and catabolic process  
The chondrocyte is solely responsible for the turnover of cartilage ECM, however, 
articular chondrocytes are post-mitotic in the adult and turn-over is very slow – 
chondrocytes therefore regulate the synthesis and degradation of ECM molecules 
through the fine balance of catabolic (matrix metalloproteinases, aggrecanases, IL-6) and 
anabolic (IGF-1, BMP, TGF-β, TIMPs, PDGF) components (Demoor, Ollitrault et al. 
2014).  Degeneration of cartilage in OA is defined by the degradation of the ECM by a 
variety of catabolic enzymes including matrix metalloproteinases (MMPs) and 
aggrecanases in response to elevated levels of interleukin-1β (IL-1β) or tumour necrosis 
factor-α (TNF-α).  These pro-inflammatory factors establish an intra-articular and intra-
cellular milieu that disrupts the narrow homeostatic range chondrocytes try to preserve 
(Demoor, Ollitrault et al. 2014).  This establishes chondrocyte dedifferentiation, the loss 
of the functional phenotypic hallmarks, through the elevated expression of type I 
collagen (Young, Smith et al. 2005).   
1.7.7: Tendon disorders  
Within the Global Burden of Disease 2010 study disorders relating to tendon were 
considered within ‘other musculoskeletal disorders’ as sequelae to injury of tendon and 
ligaments are not often part of long-term data capture (Smith, Hoy et al. 2014).  As this 
analysis also included a variety of rheumatoid and musculoskeletal conditions an 
accurate estimate of the burden of disease attributable to tendon and ligament injury is 
not possible.  If the incidence of acute trauma alone is considered 130,000 patient per 
annum are presented in the USA with injuries related to the Achilles tendon, rotator 
cuff of the shoulder, or patellar tendon (Sakabe and Sakai 2011); elsewhere a total 
incidence for tendon-associated injuries of 52.1 – 166.6/100,000 per year, for men and 
women respectively, has been reported  (Clayton and Court-Brown 2008).  It is evident 
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that a lack of contemporary epidemiological data is available to represent the true 
incidence of tendon and ligament associated disorders.     
Tendon healing 
The sub-optimal mechanical integrity of the repaired tendon is a key issue in the return 
to athletic function.  In the acute injury scenario healing of tendon may be organized 
into distinct phases, which in total may require several months before normal 
physiological loading may be introduced.  Immediately following trauma, bleeding and 
clotting in the tendon defines the ‘haemorrhagic state’.  Initial platelet degranulation, 
releasing cytokines and growth factors, is succeeded by the infiltration of the injury site 
with neutrophils and macrophages.  In the following week a ‘proliferative stage’ 
consisting of the migration and proliferation of extrinsic (peritendinous soft tissue, 
fascia, periosteum) and intrinsic (epitenon, endotenon) cells at the site of injury form a 
delicate granulation tissue comprising mainly type III collagen.  Approximately one 
month after acute injury the ‘formative phase’ consists of the active resorption and 
production of collagen by intrinsic fibroblasts mainly from the epitenon.  As this 
nascent tissue matures there is a gradual reorientation of fibres longitudinally in 
accordance with the prevailing tensional forces.  The ‘remodelling phase’ is defined by 
the return to physiological loading imparted by the maturing tissue reaching maximal 
biomechanical strength.  The collagen fibres become more organized in the longitudinal 
plane, and there is more cross-linking.  The type III collagen from the formative phase 
is slowly replaced by the more mechanically resistant type I collagen, however, this 
healed tendon callus remains hypercellular, with a greater proportion of type III 
collagen fibres relative to the uninjured state and with thinner collagen fibres (Voleti, 
Buckley et al. 2012, Connizzo, Yannascoli et al. 2013, Müller, Todorov et al. 2013).  This 
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failure to recapitulate the native state may account for the high morbidity seen with 
tendon injury.   
Conflict in pathophysiology of tendon disorders  
Tendon disorders encompasses a range of clinical presentations from acute rupture to 
chronic degenerative tendinopathy.  Strain-induced injury in energy-storing tendons (e.g. 
Achilles and patellar tendons) is the most common form of tendon injury in athletic 
humans.  Unlike positional tendons, energy-storing tendons serve to transmit forces 
generated by muscles and store elastic energy as a mechanism for the conservation of 
energy (Thorpe, Udeze et al. 2012).  Both age and level of athleticism have a strong 
association with the incidence of strain-induced tendinopathies (Smith, Birch et al. 
2002).  The underlying pathophysiological mechanism has been subject to some debate 
– the historical definition of tendon damage resulting from an inflammatory process 
alone (‘tendinitis’) gave way to the degenerative model (‘tendinopathy’) following 
evidence of a dearth of inflammatory cells in damaged tendons (Järvinen, Józsa et al. 
1997, Riley 2008) and became the prevailing paradigm for chronic tendon injury (Rees, 
Stride et al. 2014). Understanding of the model is complicated by the rise in 
inflammatory mediators (e.g. IL-6) (Andersen, Pingel et al. 2011) and promotion of 
collagen synthesis in the peritendinous region in response to physiological mechanical 
loading and evidence of very low rates of tendon remodeling (Kjaer, Bayer et al. 2013).   
Recent evidence has revisited inflammation as a contributing factor to the cumulative 
damage model or vascular insufficiency model associated with tendinopathy, however 
there is still a lack of clarity.  In paired samples from normal and painful Achilles tendon 
Pingel et al (2013) found that expression of inflammatory markers were significantly 
lower in tendinopathic regions as compared to healthy tendon after acute exercise 
(Pingel, Fredberg et al. 2013).  Evidence from rat upper-extremity overuse models, in 
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contrast, demonstrated higher expression of pro-inflammatory serum cytokines and 
greater inflammatory changes (macrophages and CCN2/CTGF+ fibroblasts) within the 
supraspinatus tendon of aged rats compared to young controls (Kietrys, Barr-Gillespie 
et al. 2012).  The same group, using a high repetition/low force model, demonstrated 
inflammatory changes within the forearm long flexor digitorum with elevated serum and 
tissue levels of TNF-alpha and IL-6, in addition to elevated serum levels of fibrogenic 
proteins, TGF-β1, CCN2/CTGF, PDGF-BB AND PDGF-AB (Gao, Fisher et al. 
2013).  Considering loss of function in the tendon may require reconsidering active 
infiltration of inflammatory cells into the tissue resembling the current understanding in 
osteoarthritis (Rees, Stride et al. 2014).   
Summary 
In summary, cartilage and tendon share a limited capacity to respond to injury with 
repair failing to reach functional equivalence with the uninjured state.  Morbidity 
associated with musculoskeletal disease is significant, but knowledge of the true 
incidence of chronic, degenerative disorders of cartilage and tendon may be 
underestimated.  Furthermore, time scales for development of clinical signs are often 
protracted complicating an understanding of the pathophysiology; in tendon 
pathophysiology of injury is not clear with degenerative and inflammatory components 
described.  Factors such as IL-6 appear to contribute to both de- and re-generative 
phenotypes.  The following section considers the current therapeutic approaches and 
organotypic culture models for both cartilage and tendon.   
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1.8: Repair & Regeneration 
 
1.8.1: Tissue engineering  
Tissue-engineering and regenerative medicine (TERM) seeks to develop and synthesise 
functional replacements for diseased and damaged tissue in a physiologically relevant 
way often by the differentiation of progenitor cells.  Tissues are complex, comprising 
multiple cells types, which may include luminal interfaces (lung), vascular and nervous 
tissue components, they are often multi-functional (liver), and have specialist 
biomechanical properties (cartilage, tendon).  Replacement is also confounded by the 
underlying pathophysiology.  Additionally, the use of synthetic biomaterials and 
biologically active factors are often also elements of bioengineered tissue (Atala, Kasper 
et al. 2012).  Tissue complexity, therefore, requires a comparable level of complexity in 
tissue-engineering strategies.  The goals and philosophies of systems biology are well-
placed to inform TERM through the modeling of cell signalling and behavioural 
phenotypes (Cosgrove, Griffith et al. 2008) especially as regenerative strategies often 
aim to recapitulate dynamic processes, e.g. tissue morphogenesis.  It is proposed that 
systems biology approaches (data integration, data mining, machine learning, network 
algorithms, pathway analysis) using multi-level data sources (transcriptomics, 
proteomics, functional annotations, and interaction networks) can facilitate the 
development of predictive models for bioengineered tissues to inform and refine these 
systems (Rajagopalan, Kasif et al. 2013).  Systems biology tools are applied in this thesis 
to explore novel approaches to inform TERM.    
Organotypic culture systems 
Tissue-specific environments are preserved contexts that confer function through 
biophysical, biochemical and biological signals.  Homeostasis and morphogenesis entail 
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dynamic dialogues between multiple cell types responding to cues coded in various 
forms on multiple hierarchical levels and within temporal and spatial scales of several 
orders of magnitude (Johnson, Leight et al. 2007). The restitution of tissue function ex 
vivo has been a common goal for biologists that has led to the development of diverse 
methods referred to as ‘three-dimensional’, ‘organotypic’, or ‘organoid’ culture (Shamir 
and Ewald 2014).  Organotypic cultures represent a sub-discipline of TERM and use 
bioengineering techniques to develop biomimetic environments for in vitro tissue models 
for research pursuits.   
Physiological relevance of in vitro culture 
Two dimensional, monolayer, in vitro culture systems have been a standard tool for 
biologists for over a century (Harrison, Greenman et al. 1907) facilitating manipulation 
of live cells ex vivo.  Contemporaries of Harrison (1902), the histologists Golgi and 
Ramon y Cajal, were awarded the Nobel Prize in Physiology and Medicine for their 
images of neural structures (De Carlos and Borrell 2007, Musumeci 2014).  Their 
drawings and histological images were considered representative of neural tissue 
organization in two-dimensions; these drawing alone were more complex renderings of 
the in vivo environment than monolayer culture. Although the simplicity of the 
monolayer system has aided reductionist biology it is self-evident that monolayer 
cultures in no way adequately recapitulate complex three-dimensional tissue architecture 
or the developmental or homeostatic conditions within which cells function (Baker and 
Chen 2012).  Yet monolayer culture is still the basis of most in vitro work in cartilage and 
tendon biology.    
Conventional in vitro studies grossly underestimate the complexity of the native 
environment by growing heterogenous cell populations on tissue culture plastics, under 
hyperoxic conditions, non-physiological concentrations of bio-active factors, and devoid 
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of mechanical stimulation.  Promotion of a proliferative profile and metabolic 
alterations compound phenotypic drift and senescence - as such, given the clear 
inadequacies of traditional methods, the question has been posed by Spanoudes, et al 
(2014), as to how much longer ‘physiologically irrelevant’ culture systems may be 
employed (Spanoudes, Gaspar et al. 2014).   
Summary 
The ultimate objective of in vitro tissue engineering, and so also organotypic cultures, is 
to comprehensively, consistently and consummately replicate the in vivo environment in 
surrogate tissue cultures, in a physiologically relevant manner.  Additionally, they serve 
as an opportunity to integrate disease models with rational therapeutic design in a 
dynamic setting. In reality, recreating the complex relationships in part, through a 
simple, cost-effective and reproducible model that does not compromise cellular 
behavior, would suffice (Johnson, Leight et al. 2007).  
1.8.2: Obstacles to development of organotypic cultures 
Progress in the development of organotypic cultures is related to difficulties in 
replicating the three-dimensional structures (e.g. highly axial structure in tendon), 
ensuring the major constituents and cell populations are in correct ratios, and harvesting 
sufficient number of cells for autologous therapies.  The general approaches to 
qualifying the progress from novel interventions in organotypic cultures and 
regenerative therapies has been histological and biomechanical properties and targeted, 
yet limited, gene and protein profiling.  
For clinically relevant cell-based therapies to be attained they require an integrated 
approach to prevent transdifferentiation of cells (towards an alternative cell phenotype) 
and commitment of the cell population to a stable, functional phenotype.  This would 
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require a concerted interaction of biophysical (topographical and mechanical contexts), 
biochemical environment cues (oxygen tension, pH, metabolic precursors) and dynamic 
biological signals (growth factors, cytokines, and co-cultures) with relevant temporal 
relationships and kinetics (Spanoudes, Gaspar et al. 2014).  As mentioned earlier in this 
section systems biology techniques are especially suited to this problem of complexity 
and integration.  
Spanoudes, et al (2014) cite a number of obstacles to the development of adequate 
organotypic culture models for tendon, although they have more general application to 
cartilage models too: a) a lack of standardised and commercially available products (e.g. 
fabricated scaffolds, bioreactor systems); b) a lack of protein and gene analysis tools of 
sufficient depth and common potential; c) little collaborative and inter-disciplinary 
analysis; d) continued use of mono-dimensional culture systems (Spanoudes, Gaspar et 
al. 2014).  Further, the authors describe that extrapolating definitive conclusions across 
studies is prohibited by an ad hoc approach to interventions (such as surface topology), a 
lack of agreement on differentiation markers and standardised read-outs (morphology, 
gene and protein expression), or uniform transparency of cell sourcing, harvesting and 
culture methods. In a review by Johnson, et al (2007), the authors note that many three-
dimensional culture systems incorporate multiple modifications simultaneously, often 
crudely defining the ECM components (Johnson, Leight et al. 2007).  This highlights 
the requirement for a clear understanding of simple organotypic systems rather than the 
development of increasingly more complex bio-engineered tissues.    
1.8.3: Repairing musculoskeletal tissues 
Intrinsically there is little scope for regeneration following injury, with insidious 
remodelling and matrix degradation prevailing (Steinert, Ghivizzani et al. 2007). 
Perturbations to matrix homeostasis are likely to be an early event in the onset of 
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osteoarthritis (Heinegard and Saxne 2011), however, pathogenesis and genetic 
predispositions are still subject to much discussion (Berenbaum 2013, Felson 2013, 
Reynard and Loughlin 2013). Tendon, for which there is a dearth of data, has similarly 
poor reparative responses for comparable reasons (Kannus 2000, Liu, Aschbacher-
Smith et al. 2011, Young 2012).   Medical interventions for the facilitation of healing 
and regeneration of cartilage and tendon, such as autologous cartilage implantation, or 
the use of bone-marrow or adipose-derived mesenchymal stem cells, to treat tendon 
injury inherently rely on the expansion of cells in monolayer culture prior to 
implantation.  These early interventions often had little or no validation in terms of the 
alterations that such a considerable change in environment has had on the global 
synthetic profile of these cells (Demoor, Maneix et al. 2012).  
Stem and progenitor cells  
Although not the focus of this thesis considerable reference is made to stem/progenitor 
cells in the context of tissue engineering and regenerative therapies and so these will be 
reviewed in brief.   
Stem cells are an autonomous population of self-renewing (clonogenic) cells with the 
capacity to differentiate into multiple tissue lineages in response to biological cues.  To 
understand the motivation of cellular regenerative strategies in musculoskeletal biology 
the most recent developments in stem cell research should be considered.  These cells 
hold particular value as they may be autologous and side-step the contentious use of 
embryonic-derived cells.   
It is widely accepted that a progenitor cell population, variably termed ‘adult-somatic 
stem cells’ or ‘tissue stem cells’, exist within variable niches in adult tissue (Fuchs and 
Horsley 2011).  Niches represent highly specialized environments that facilitate the 
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balance between self-renewal and differentiation (Moore and Lemischka 2006).  These 
cells are distinct from embryonic or induced pluripotent cells in that they have a 
reduced capacity to differentiate into different tissue lineages.  It is striking that 
progenitor cells from mesenchymal tissues (adipose, muscle, cartilage, bone) are shown 
reduced efficiency for multi-lineage differentiation as compared to their capacity to 
differentiate towards their tissue of origin (Pizzute, Lynch et al. 2015).  This suggests 
that progenitor cells derived from adult tissue have an inherently constrained plasticity, 
likely to be epigenetically regulated.  
Progenitor cells are often identified by a myriad of cell surface markers (CD90/THY1, 
CD166, SSEA-4, D146) or by gene expression (Oct4, Nanog, Ktf4), however, there is 
considerable transcriptomic and proteomic heterogeneity between studies and tissue 
sources and expression is not stable in vitro (Lv, Tuan et al. 2014).   
Musculoskeletal progenitor cells  
As presented in section 1.7.4 cartilage and tendon progenitors in the embryonic 
developing limb have been shown to express SCX and SOX9 in various combinations 
associated with anatomical location.  This does not, however, reflect the variety of 
markers in recent studies defining musculoskeletal progenitors.  Recently embryonic 
osteochondroreticular stem cells have been identified, by BMP-antagonist Grem1 
expression, that retain the capacity to differentiate into bone, cartilage and synovial cell 
phenotypes (Worthley, Churchill et al. 2015).  In cartilage research attention has also 
focused on migratory progenitor cells (Koelling, Kruegel et al. 2009).  In Schminke and 
Miosge (2014) chondrogenic progenitor cells with a migratory phenotype, under the 
influence of SOX9 and RUNX2, were shown to express stem cell surface markers 
(CD105, CD73, Stro-1) (Schminke and Miosge 2014), however this study mainly 
demonstrated cells with a fibroblastic phenotype arising from tissue explants in vitro.  
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Although transcriptome analysis by microarray has been undertaken for these cell 
populations there has been no comparison with normal tissue or other culture 
phenotypes.  Consequently, although potential sub-populations of progenitor cells have 
been defined in contemporary studies they still lead by assertion with populations 
defined by expression of a limited panel of markers and with no comparison to in vitro 
phenotypes.  In this thesis baseline gene and protein expression surveys serve to inform 
researchers of the synthetic profile of chondrocytes and tenocytes in different 
environments.          
Musculoskeletal tissue regeneration strategies  
Three principal strategies have been proposed to pursue regenerative potential in 
mammals: i) stem cell transplantation (physical implantation of cells), ii) cells seeding 
and embedding into scaffolds, iii) dedifferentiation of terminally differentiated cells 
(Odelberg 2002, Cai, Fu et al. 2007, Maden 2013).  The latter has been largely 
overlooked as a reparative approach in cartilage and tendon and is this is addressed in 
this thesis, Chapter 2.   A brief overview of alternative strategies for cartilage and 
tendon repair is provided below.   
Cartilage repair: autologous cartilage implantation 
Therapeutic interventions in OA range from arthroscopic interventions, such as micro-
fracture and autologous chondrocyte implantation (ACI), scaffold-based and scaffold-
free techniques (Makris, Gomoll et al. 2015) to total joint replacement. ACI requires the 
harvesting of normal, healthy cartilage from non-load-bearing hyaline cartilage of 
diseased joints to be implanted into early chondral lesions following expansion of 
isolated cells in monolayer culture (Brittberg, Lindahl et al. 1994).  As will be discussed 
further in Chapter 2 this deprives the resident cells of the complex three-dimensional 
environment and induces a state of dedifferentiation, in part mimicking aspects of 
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osteoarthritis (Demoor, Ollitrault et al. 2014).  Consequently, the treated chondral defect 
heals as fibrocartilage.  Three separate systematic Cochrane reviews (2002–2010) of ACI 
in the knee concluded that despite increasing and widespread use of the technique there 
was insufficient evidence to draw conclusions on the clinical impact (Wasiak and 
Villanueva 2002, Wasiak, Clar et al. 2006, Vasiliadis and Wasiak 2010). Central to this 
methodology is the assumption that the implanted chondrocytes retain functionality, are 
a homogenous population, are not senescent and will be viable when transferred from a 
hyperoxic culture environment into the hypoxic joint environment.  
1.8.4: Parallels in tendon healing and development 
The temporal expression of growth factors, cell proliferation, migration and ECM 
production in tendon healing parallels that of embryonic tendon development; as such, 
some strategies for tendon regeneration have focused on harnessing these similarities  
(Connizzo, Yannascoli et al. 2013).  Cytokine modulators of tendon healing include: 
basic FGF, TGF-β, PDGF, BMP family members, IGF and VEGF (Müller, Todorov et 
al. 2013).    
Methods for tendon repair and regeneration  
Excluding direct surgical intervention, anti-inflammatory and rehabilitative therapies 
(shock-wave therapy, therapeutic ultrasound) there are three principal, although not 
mutually exclusive, strategies being employed and researched to promote tendon healing.  
First, regenerative strategies based upon the application of soluble cues to facilitate 
tenogenic differentiation; second, tissue engineering techniques, incorporating 
mechanical cues and environmental factors into the development of replacement tissue; 
thirdly, cell-based therapies (Ho, Sawadkar et al. 2014).  
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To develop organo-typic structures the complex architecture of tendons would have to 
be recreated.  Principle amongst these would be: a) alignment of collagen fibres and 
fascicular structure; b) transitional properties, e.g. proteoglycan content, mineralization 
and collagen type that would be found at the myotendinous junction, bone insertion sites 
and areas of compression; c) the degree of collagen cross-linking, and d) the collagen 
fibre crimp pattern (Connizzo, Yannascoli et al. 2013).  In injuries such as anterior 
cruciate ligament rupture and rotator cuff injury there often little in the way of useful 
healthy tissue available for repair (Müller, Todorov et al. 2013) further complicating 
repair strategies.  
Soluble factors 
Understanding of the role of these soluble factors in development and healing have led 
to the use of autologous sources of growth factors, usually in the form of platelet-rich 
plasma (PRP); the alpha granules of platelets contain many of the growth factors and 
cytokines listed earlier.  Despite the attractive nature of an autologous source of growth 
factors, and their gaining popularity, the evidence for early intervention with PRP is not 
convincing. A recent well-controlled study (Kaniki, Willits et al. 2014) and systematic 
review (de Vos, van Veldhoven et al. 2010) have failed to demonstrate a clear benefit for 
the use of PRP in acute tendon injury or chronic tendinopathy. Another key growth 
factor undergoing active research for tendon and ligament repair is platelet-derived 
growth factor BB (PDGF-BB) (Thomopoulos, Das et al. 2009, Shah, Bendele et al. 
2013) with which there is some evidence for improved functional repair over PRP or 
corticosteroids (Solchaga, Bendele et al. 2014).  The relevance of PDGF BB to 
differentiation of tenocytes is considered further in Chapter 7.     
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Cell-therapies  
A variety of cell sources have been used for cell replacement therapy studies including, 
bone-marrow or adipose-derived MSCs and autologous fibroblasts/tenocytes (Ho, 
Sawadkar et al. 2014).  Tendon-derived stem cells (Bi, Ehirchiou et al. 2007) may be an 
alternative source of autologous cells for tendon repair (Lui and Chan 2011).  The 
definition of the differentiated status of tenocytes varies between studies.  Many studies 
considering the development of regenerative tendon models use a narrow definition of 
tendon differentiated status, for example, the expression of type-I collagen, and/or the 
expression of the differentiation marker TNMD. For example, Tan, et al (2014) recently 
reported improved repair of a window injury model of the rat patellar tendon using 
SCX-transduced tendon-derived stem cells (Tan, Lui et al. 2014).  Using a fibrin scaffold 
containing a high density of late-passage cells fibrin constructs were placed into the 
injured patellar window.  The authors report improved histological scoring and repair, 
higher expression of COL1A1 by immunohistochemistry (IHC), and higher levels of 
expression of tenogenic markers by qPCR.  Changes between the controls and 
transduced constructs, however, appeared equivocal by eight weeks post-implant.  In 
Chapters 2 and 3 the synthetic profiles of tenocytes in fibrin cultures are defined.  
Scaffolds  
Artificial scaffolds have been a focus of keen research and strong commercialization.  
Scaffolds attempt to provide a microenvironment that may support damaged tissue 
biomechanically and stimulate cell proliferation and growth.  As host tendon is often 
damaged, tendon allografts and xenografts have found popularity for the repair of large 
tendon and ligament defects.  These may be biological, decellularised extra-cellular 
matrices derived from animal or human connective tissue (e.g. porcine small intestinal 
submucosa), or synthetic, chemically-derived products (e.g. polyester, polypropylene). 
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Additionally, most studies concerning commercial products are retrospective or small 
case studies, limiting any insight into the benefits of these products (Chen, Xu et al. 
2009).   
Summary 
The plethora of regenerative interventions that have developed for cartilage and tendon 
repair suggest that few have been universally successful.  Systematic evaluation of the 
interactions between cells, biomaterials, bio-active factors and other environmental 
variables is required.  This development of standardised biomimetic culture systems 
would aid the validation of developments in tissue engineering.   
1.8.5: Musculoskeletal organotypic/three-dimensional models 
The provision of normal human tissue for musculoskeletal research is often a limiting 
factor for achieving adequately powered studies. Standardised organotypic, three-
dimensional culture systems would ideally limit the requirement of healthy tissue, or in 
vivo models, for predictive and prognostic assays, and preclinical therapeutic testing for 
genome editing and therapeutics.  The approach to three-dimensional culture 
development for musculoskeletal tissues has often followed a deconstructed approach, 
i.e. considering one tissue in isolation or using one mechanism (mechanical or biological 
cues) to optimize a system. Pertinent research relating to two common in vitro models 
for cartilage and tendon, the focus in this thesis, is outlined below.   
Alginate-Encapsulated chondrocyte cultures 
Alginate-encapsulated chondrocytes have been widely used as a three-dimensional 
culture system for the re-differentiation of monolayer-expanded chondrocytes, Figure 
1.1.  Alginic acid is a naturally occurring polysaccharide derived from seaweed and is 
especially attractive for tissue engineering as it is considered to have excellent 
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biocompatibility (it is an Food and Drug Administration (FDA)-approved polymer), 
may be processed in a number of ways, may be utilized for drug or cell delivery and may 
be modified chemically and physically to reflect the application (Sun and Tan 2013).   
Benya and Schaffer (1982) described the use of agarose, another polysaccharide 
polymer, to promote a chondrogenic synthetic profile from dedifferentiated 
chondrocytes (Benya and Shaffer 1982).  Transfer to agarose suspension cultures from 
monolayer and a reversion to the differentiated phenotype initially resulted in reduced 
rates of collagen, proteoglycan, DNA and protein synthesis, with approximately 80% of 
cells surviving the transition.  Although DNA and protein synthesis did not reach the 
levels at culture initiation proteoglycan and collagen synthesis (with α1(II)-chains 
showing elevated levels within two days of culture) increase significantly over a period 
of 14 days.  
Almqvist et al (2001) reported that chondrocytes proliferate in alginate cultures by 
showing out-growth of collagen type II-positive cells into a cell-free fibrin gel 
surrounding the alginate beads and pronounced increases in DNA and aggrecan 
synthesis (Almqvist, Wang et al. 2001). However, other reports contradict the 
proliferative capacity of chondrocytes in alginate: Müller, et al (2008) found introduction 
to alginate cultures retarded proliferative activity relative to monolayer, but also that a 
small, rapidly proliferating cell population was present after eight days in culture (Müller, 
John et al. 2008). Extended population doubling times relative to monolayer have also 
been presented elsewhere (Baghaban Eslaminejad, Taghiyar et al. 2009).  Jonitz, et al 
(2011) found that dedifferentiated chondrocytes in unstimulated alginate cultures 
showed a significant reduction in DNA synthesis over 35 days in culture relative to 
alginate cultures in pro-chondrogenic media containing TGF-β1 and IGF-1 (Jonitz, 
Lochner et al. 2011).  Notably, this study demonstrated the increased expression of 
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MSC-associated cell-surface markers (CD104, CD44, CD166 and CD29) in monolayer-
expanded chondrocytes.  A stimulation of re-differentiation by TGF-β1 was also shown 
in a study considering the effect of different sources of chondrocytes.  Relative to ear 
and nose chondrocytes, or BM-MSCs, articular chondrocytes demonstrated the highest 
chondrogenic potential in alginate cultures, but this was not reproduced in vivo 
(Pleumeekers, Nimeskern et al. 2014). Hypoxia has been demonstrated to improve the 
redifferentiation capacity of bovine articular chondrocytes in alginate cultures with a 5% 
oxygen tension showing elevated collagen type II production by Western blot (Domm, 
Schünke et al. 2002).  These studies are difficult to compare with a range of seeding 
densities used (5x105 – 5x106/mL), culture durations (7 days-2 months), varying oxygen 
tensions (5-21%), chondrocyte sources (articular, nasal septum, OA-derived) and the 
extent of dedifferentiation (period in monolayer culture) is not standardised.   
Notably, the synthetic profiles considered in the aforementioned studies have been 
limited.  In general expression of collagen type II and aggrecan are considered, in 
addition to the production of GAGs. More recent studies have included more diverse 
consideration of synthetic profiles. Caron, et al (2012) established in a study comparing 
human articular chondrocytes (HACS) in high-density monolayer culture to alginate 
bead or pellet cultures, that three-dimensional (3D) cultures resulted in higher 
expression of Col2a1 and Acan as expected, but also Sox9 (especially in alginate beads) 
(Caron, Emans et al. 2012).  Notably, protein levels of COL2A1 and SOX9 were not 
significantly different between 2D and 3D culture systems by quantitative immunoblots.  
Hypertrophic synthetic profiles, characterised by the higher expression of alkaline 
phosphatase, MMP13, COL10A1 and RUNX2, were associated with monolayer 
chondrocytes after 7 days in the same differentiation media.   Furthermore, 3D cultures 
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did not support cell proliferation to the same extent as monolayer culture, as defined by 
DNA synthesis.     
Tensional fibrin constructs associated with embryonic-like fibrillogenesis  
The presence of tension-dependent actin-rich fibripositors in embryonic chick tendon 
cells were found in an in vitro three-dimensional cell culture model (Kapacee, 
Richardson et al. 2008).  In this model embryonic tenocytes were seeded into fibrin gels 
held in culture wells, Figure 1.1.  Two anchor points, consisting of suture material 
secured in the wells by minutien pins, served to provide tension across the self-
contracting culture and allowed the formation of linear, tendon-like constructs.   Further 
work by Bayer, et al (2010) found that mature human tendon fibroblasts were able to 
recapitulate embryonic fibrillogenesis, using the same culture model, as defined by the 
presence of membrane-enclosed fibrils in fibripositors (Bayer, Yeung et al. 2010).  The 
authors concluded that mature tendon fibroblasts retained an intrinsic capacity for 
embryonic collagen fibril formation when cultured under tension, however, monolayer 
expansion of harvested cells up to passage five may have influenced the differentiation 
state of the mature cells.  Similarly, mesenchymal stromal cells in comparable fibrin-
constructs exhibited collagen fibril-containing fibripositors and the higher expression of 
phosphorylated SMAD2 under the influence of TGF-β signalling (Kapacee, Yeung et al. 
2010).  
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1.8.6: Summary statements 
For both tissue engineering and organotypic culture systems the ultimate aim is the 
development of physiologically relevant and/or functionally equivalent proxies for the 
tissue under investigation/repair.  Without validated in vitro organotypic models it is not 
possible to translate developments in regenerative medicine from the laboratory to the 
clinic in an expedient manner.  Furthermore, incremental advances in the biochemical 
and biomechanical properties of in vitro systems are not made with respect to a 
standardised baseline system or ‘worst model’, rather on an individual laboratory basis.  
In addition, the rapid development of complex combinations of progenitor cells, 
biomaterials, and bio-active compounds needs to be considered with respect to the 
Figure 1.1:  Three-dimensional culture systems are proposed to better replicate the 
native environment than two-dimensional monolayer culture.  Two standard techniques 
are represented: A) chondrocytes suspended in alginate beads; B) linear tendon 
construct (arrow) suspended between two pieces of  suture material pinned to base of  
six-well plate.   
A B 
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regulatory framework for safety and efficacy in the translation of engineered tissue into 
humans (Atala, Kasper et al. 2012).  The blind-pursuit of increasingly complex 
structures may ignore simple solutions, i.e. increasing complexity of a bio-engineered 
model does not mean that it is functionally more stable.  At present organotypic models 
have been insufficiently described in terms of their transcriptomic and proteomic 
profiles, let alone bio-engineered tissue.    
1.9: Closing statements 
 
1.9.1: Project motivation 
Cartilage and tendon repair strategies often have equivocal evidence for their 
application, with in vitro models and novel experimental interventions defined by a 
limited array of established gene expression markers or qualitative end-points.  There is 
a need for concerted community efforts to standardise methodologies, culture systems, 
interrogate global gene and protein expression, and establish common functional end-
points.   
Understanding of regulatory networks involved in cartilage and tendon morphogenesis, 
homeostasis, pathology and regeneration is largely incomplete and limits attempts to 
develop comprehensive systems models.  Deconstructed, ‘bottom-up’ approaches to 
defining these are limited in scope and potential and so integrated, holistic approaches 
are required if rational in vitro models or regenerative therapies are to be developed.  The 
common origins, structural components, integrated development, and functionality of 
cartilage and tendon should be considered when organotypic systems are developed.  
Establishing regulatory networks, through gene expression and protein abundance 
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profiling, which may influence the differentiation status of both cartilage and tendon 
would provide an evidence-based rational for developments in tissue engineering.   
A systems biology approach lends itself to this ‘top-down’ integration of multi-level data 
and this thesis employs such a methodology to define inform future tissue engineering 
strategies through the exploration of organotypic, three-dimensional culture systems. 
The genome may be considered a database of coded functions rather than a formal 
program for life.  This database of functions or subroutines (proliferation, apoptosis, 
etc) may be accessed in a cell-autonomous manner as required and used many times 
over (Bard 2013).  Whilst some of these subroutines are well-described de- and re-
differentiation in the adult mammalian cell have received little attention.    The potential 
for dedifferentiation as a regenerative mechanism has been alluded to in this 
introduction.  Using systems biology approaches it is possible to define highly co-
expressed sub-networks of genes with strong phenotypic associations that may reveal 
gene regulatory networks relevant to these processes.     
1.9.2: Project outline 
In this thesis the system under consideration are the major cell populations of cartilage 
tendon (chondrocytes and tenocytes, respectively) and they are described in three 
environmental conditions: native, monolayer (two-dimensional), or three-dimensional 
models, Figure 1.2.  There has been no systematic investigate of the global gene and 
protein profiles of cartilage and tendon in their native state relative to monolayer or 
three-dimensional cultures.  There is no clear mechanistic description of the impact that 
in vitro environmental perturbations have on the system or indeed the adequacy of these 
models as proxies for cartilage and tendon. Monolayer represents the most common in 
vitro model yet there is little evidence for validation of growth of cartilage or tendon cells 
in culture relative to their native tissues or model organotypic cultures.  
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A discovery approach using transcriptomic and proteomic profiling is undertaken in the 
first instance to define a robust and consistent gene and protein profile for each 
condition.  Differentially expressed elements are functionally annotated and pathway 
topology approaches employed to predict major signalling pathways associated with the 
observed phenotype 
Gene-gene co-expression network analysis is being increasingly used and a systems 
biology method to extract molecular networks from multi-dimensional data and 
describe multiple regulatory systems activities. They are also being used to generate 
novel hypotheses about complex disease mechanisms as they are not constrained by 
prior knowledge of molecular biology (Gaiteri, Ding et al. 2014).  This methodology is 
most commonly used to define gene ‘hubs’ with strong disease correlation, which may 
represent putative biomarkers.  However, this technique shows greater potential when 
employed to extract co-expression networks, which represent the underlying descriptors 
of the system and may be used to translate multi-scale data sets into testable predictions.   
In this thesis gene-gene co-expression network analysis is employed for transcriptome 
network decomposition to isolate highly correlated and interconnected gene-sets 
(modules) from gene expression profiles of cartilage and tendon cells in different 
environmental conditions in order to define sub-networks regulating de- and re-
differentiation.  Gene expression data from discovery studies and publically available 
transcriptomic data sets are integrated as part of a weighted gene co-expression network 
analysis (WGCNA).  Comparison of global transcriptome network architecture is 
performed to define the conservation of network modules between a model species (rat) 
and human data.  Finally, initial findings from the integration of gene and protein 
profiles are presented and mechanistic networks derived to described de- and re-
differentiation in chondrocytes and tenocytes.    
 49 
The studies collected in this thesis contribute to a wider understanding of cartilage and 
tendon tissue engineering and organotypic culture development. A clear mechanistic 
understanding of the regulatory networks controlling differentiation of cartilage and 
tendon progenitor cells is required in order to develop improved in vitro models and bio-
engineered tissue that are physiologically relevant.   
1.9.3: Project objectives 
This project was devised and executed with the intention of tackling one aspect of the 
present limitations of tissue engineering for cartilage and tendon, i.e. the dearth of in-
depth transcriptomic and proteomic profiling and integrate data to explore emerging 
relationships that may describe these organotypic systems.  Beyond the generation of 
reference data sets the project aimed to deliver three key objectives: 
• Objective 1: To define dedifferentiation and re-differentiation in terms of 
synthetic profile and mark-out the phenotypic boundaries within which cartilage 
and tendon cells function; 
• Objective 2: Define cross-species responses to homeostatic perturbations in 
cartilage and tendon through integration of gene-expression data from multiple 
gene expression studies;   
• Objective 3:  Integrate gene expression and protein abundance data to 
rationalize validation targets and derive mechanistic networks.  
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Cartilage and tendon structure, 
anatomy and physiolog y.  
Regeneration strategies and 
systems biology approaches. 
 
Hypothesis generation 
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Introduction  
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monolayer 
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Novel discovery studies 
Transcriptomic 
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three-dimensional culture systems 
Public repositories 
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Discussion  
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human cartilage and tendon gene expression profiles 
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Study objective: Explore ‘omics’ data integration 
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transcriptional regulators  
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Study objective:  Collect and collate comprehensive 
reference gene expression profiles for all conditions 
beyond what is available in the literature 
Dedifferentiation  
Native 
Redifferentiation  
Figure 1.2: Overview of  thesis structure by chapter 
(C).  Three conditions are profiled across two tissues 
reflecting the native, monolayer and three-
dimensional models by transcriptomic and 
proteomic approaches.  Novel discovery studies and 
public repository data sets contribute to co-
expression network analysis or omics integration 
analysis.  Major study objectives are outlined with 
regard to the hypotheses outlined in the introduction 
and subsequent chapters.  A general discussion 
unifies findings from all studies.    
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Abstract 
Dedifferentiation, a loss of cellular functionality, is a term with no definitive 
mechanism yet is used to described distinct and diverse biological contexts ranging 
from the histological features of neoplasia to regenerative responses in injury 
models.  Recent evidence also implicates the loss of differentiated status as a 
factor in degenerative and chronic disease.  In chondrocyte biology 
dedifferentiation is a well-recognised sequelae to expansion in monolayer culture.  
Regenerative therapeutics, such as autologous cartilage implantation, by necessity 
require periods of monolayer culture expansion. Consequently, exploration of 
mechanisms, which may contribute to degenerative phenotypes, could help 
elucidate points for therapeutic intervention in conditions such as osteoarthritis.   
Despite considerable efforts to characterise soluble factors and environmental and 
mechanical cues that may actively promote differentiation of permissive cells 
towards a chondrogenic or tenogenic lineage the benchmarks by which progress is 
measured are inconsistent and limited.  To date there is no available reference 
dataset against which progress in organo-typic culture techniques may be 
compared at a global transcriptomic level.  
In this study there gene expression profiles native, monolayer and standard three-
dimensional culture systems using chondrocytes and tenocytes are compared using 
2 :  Convergent  t ranscr ip tomic  
prof i l es  a r i se  f rom the  
ded i f ferent ia t ion  of  car t i l age  
and tendon ce l l s  in  monolayer  
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microarrays providing the first comparative data set of its kind. Results 
demonstrate an inadequate restitution of native tissue expression profiles by 
commonly used three-dimensional culture models. In addition, convergence of 
gene expression profiles in monolayer culture, and the expression of development-
associated genes in these cells, implicates dedifferentiation as a mechanism worthy 
of further investigation or de- and re-generation of musculoskeletal tissues.  In 
particular, the expression of a hind-limb development-associated homeobox gene, 
Pitx1, in monolayer chondrocytes is validated that suggests further investigation of 
homeobox genes in dedifferentiation is warranted.     
2.1: Introduction  
 
2.1.1: Plasticity of terminally differentiated cells 
Convention presents us with the linear narrative of development and 
differentiation of cells from the pluripotent state to the terminal, functional, 
differentiated state in adult tissue.  This trajectory follows binary cell-fate decisions 
implicit in the visual metaphor of Waddington’s epigenetic landscape (Zhou and 
Huang 2011, Ferrell 2012).  It is clear, through the use of somatic cell nuclear 
transfer (Campbell, McWhir et al. 1996) and induced-pluripotent stem cells 
(Takahashi and Yamanaka 2006), that the differentiated state is not an irreversible 
one and adult somatic cells may be phenotypically plastic in certain contexts.  It is 
suggested, however, that the more specialist the cellular function the more difficult 
it is to reverse that differentiated state (Holmberg and Perlmann 2012).  This is 
complemented by the concept of cells residing within an epigenetic landscape 
consisting of kinetic barriers and ‘sinks’ of attraction that ensure differentiated 
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states prevail in the adult (Enver, Pera et al. 2009, Huang 2009, Bhattacharya, 
Zhang et al. 2011).      
Contemporary studies utilise terms such as de-, trans-, and re-differentiation to 
represent alterations in the synthetic profile of adult somatic cells in response to 
injury, ageing or disease (Poss 2010, Jopling, Boue et al. 2011).  The mechanism of 
‘dedifferentiation’, an organised loss of differentiated function, has been 
investigated in multiple novel model species from Hydra to the zebrafish (Danio 
rerio) (Grafi 2004, Sugimoto, Gordon et al. 2011).  In addition to plant, amphibian, 
and fish models, mammalian models have been recently presented (Lehoczky, 
Robert et al. 2011, Nagoshi, Shibata et al. 2011, Porrello, Mahmoud et al. 2011). 
Dedifferentiation has also been considered as a target mechanism to separate the 
biological (functional) and chronological age of a cell (Rando and Chang 2012).  
However, the concept of dedifferentiation as an exclusive regenerative mechanism 
is conflicted by evidence supporting the presence of specialised populations of 
adult tissue stem cells as the principle effectors of regeneration (Sugimoto, 
Gordon et al. 2011).  To clarify, the presence, or absence, of dedifferentiation as a 
regenerative mechanism in vertebrates relies on how dedifferentiated a cell is 
considered to be, i.e. the degree of ‘stemness’. The extent of phenotypic plasticity 
in higher vertebrates is suggested to be much more restricted than would be 
expected of an embryonic stem cell.  As such dedifferentiation is an ambiguous 
term, without mechanistic definition, and is used permissively in several contexts. 
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2.1.2: Definition of dedifferentiation varies with context 
 
De-differentiation in cartilage biology 
To cartilage matrix biologists the concept of cartilage dedifferentiation is well 
recognised (Schulze-Tanzil 2009) and is a term used with impunity for several 
decades.  The morphological alteration from rounded chondrocytes in cartilage to 
a fibroblastoid phenotype is an inevitable response to two-dimensional monolayer 
culture (Von der Mark, Gauss et al. 1977, Benya and Shaffer 1982).  Under these 
conditions chondrocytes rapidly lose their rounded morphology and functional 
phenotype, characterised by the pronounced down-regulation of collagen type II, 
and aggrecan, hallmarks of cartilage tissue, with passage four considered a 
threshold to terminal dedifferentiation (Darling and Athanasiou 2005, Schulze-
Tanzil 2009).  In their seminal study Benya and Shaffer (1982) explicitly state that 
‘dedifferentiated’, relating to chondrocytes in monolayer, referred only to a loss of 
differentiated function and not evidence of a multipotent cell (Benya and Shaffer 
1982), although no evidence was provided to support this assertion.     
De-differentiation as a regenerative mechanism 
Dedifferentiation is also used to describe a response in adult cells to injury as 
demonstrated by regeneration models such as axolotl forelimb amputation.  In 
these models it is implicit that adult cells lose their functional gene expression 
profile, up-regulate expression of genes associated with an earlier developmental 
stage, re-enter the cell cycle and proliferate, before recapitulating development in a 
tissue lineage and position-specific manner (Kragl, Knapp et al. 2009).  Recently 
contrasting results indicated that dedifferentiated myofibres proximal to a forelimb 
amputation site made no contribution to the proliferating cell population in the 
regenerating limb of the axolotl, but made a significant contribution to 
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regeneration in the newt, in a cell tracing study (Sandoval-Guzmán, Wang et al. 
2014).  Further to this, a study by Tata, et al (2013) found that luminal epithelial 
secretory cells of mouse airways dedifferentiated to, and were indistinguishable 
from, basal stem cells, following conditional ablation of the resident progenitor 
population (Tata, Mou et al. 2013).         
De-differentiation as a pathological mechanism in chronic disease  
Insulin-secreting pancreatic beta (β) cells also dedifferentiate when expanded in 
culture and have been shown to return to a functional, insulin-secreting state in 
certain culture conditions (Russ, Sintov et al. 2011).  Recently dedifferentiation has 
been demonstrated in vivo as a mechanism for beta-cell failure in a model of Type 
II diabetes (Talchai, Xuan et al. 2012).  Evidence suggests that a transient period 
of dedifferentiation is necessary prior to proliferation in response to β-cell loss 
(El-Gohary, Tulachan et al. 2014).  
Dedifferentiation has been described in cardiomyocytes where it is characterised 
by a loss of electrophysiological properties, disassembly of the sarcomeric 
structure, proliferation, and expression of progenitor gene markers.  
Cardiomyocyte dedifferentiation is now well described in vitro (Zhang, Li et al. 
2010) and in vivo (Dispersyn, Mesotten et al. 2002, Jopling, Sleep et al. 2010, 
Porrello, Mahmoud et al. 2011) and more recently as a key feature of 
cardiomyocyte remodeling (Szibor, Pöling et al. 2014). Dedifferentiation also has a 
characterised association with chronic cardiac pathologies (Ausma, Wijffels et al. 
1997, Driesen, Verheyen et al. 2009).  
Common to these regenerative models are i) loss of functional markers, ii) periods 
of proliferation, iii) evidence of tissue-restricted progenitors, and iv) and function-
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restoring redifferentiation processes.  It is not illogical to suggest that cells that 
have dedifferentiated, no longer expressing the synthetic profile of the specialist 
cell, would fail to contribute to tissue function. Whether dedifferentiation 
contributes to chronic, degenerative disease in musculoskeletal tissues, or a 
regenerative response, has yet to be elucidated.    
Dedifferentiation in neoplasia 
Dedifferentiation in neoplasia is used to describe the histopathological changes 
associated with deregulated tumour masses.  It has been demonstrated that NF-ĸB 
modulation of Wnt-signalling can lead to the dedifferentiation of intestinal 
epithelial cells not of stem cell origin into cells with a crypt-progenitor phenotype, 
and subsequently into tumour-initiating cells (Schwitalla, Fingerle et al. 2013). 
Dedifferentiation of epithelial cells towards a tumourigenic status has also been 
described from neurons during glioma formation (Friedmann-Morvinski, Bushong 
et al. 2012), but is also used to describe the development of ‘cancer stem cells’ as a 
self-renewing source distinct from cancer cells derived through a Wnt-/β-catenin 
pathway (Debeb, Lacerda et al. 2012).  Signalling pathways associated with poorly 
differentiated cells in cancers may be relevant to an understanding of the 
underlying mechanisms involved in dedifferentiation.     
Summary 
Dedifferentiation of somatic cells in physiological conditions represents some loss 
of the functional characteristics of the differentiated cell.  In the adult mammal 
this is unlikely to represent a cell with multi-lineage potential as found in the 
amphibian.  As a term dedifferentiation is applied to regeneration, degeneration, 
and neoplasia, but it is not clear whether the same regulatory mechanism is in 
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place in these contexts.  Although dedifferentiation is recognised in cartilage 
biology there has been no systematic investigation of this process.  
2.1.3: Anatomical topography in development is encoded by 
homeobox genes 
Homeobox (Hox) genes contain homeobox DNA sequences and encode 
transcription factors that specify positional identity during embryonic 
development (Wang, Helms et al. 2009); the proteins contain the ‘homeodomain’. 
Positional identity has been likened to a Cartesian coordinate system or ‘genome 
GPS’ for cells, defined by the expression signatures of the ~300 homeobox genes 
(Chang 2009). Hox gene expression codes have been found to define fibroblast 
(Rinn, Bondre et al. 2006) and mesenchymal stem cell populations (Ackema and 
Charite 2008, Sagi, Maraghechi et al. 2012) based on the tissue and site of origin.  
Loss of cellular identity through alterations in Hox gene expression (Trivedi, 
Cappola et al. 2011) or cellular dedifferentiation to a progenitor-like state appears 
to result in aberrant cellular homeostasis and age-related functional deterioration. 
Hox gene-mediated transcriptional memory appears to limit stem cell-mediated 
tissue regeneration (Chang 2009). Whilst Hox gene function has been well studied 
during embryonic segmentation, there is limited information on gene expression 
patterns in adult tissues.   
Summary 
Given the relevance of Hox gene expression to differentiated status, and 
positioning during development, altered expression patterns may be evident 
between differentiated and dedifferentiated cells.    
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2.1.4: Study aims 
This study hypothesises that the gene expression profiles in de- and re-
differentiation of chondrocytes and tenocytes in monolayer and three-dimensional 
cultures are consistent with many of the criteria associated with dedifferentiation 
in the context of regeneration and disease models.   
In addition to a return to proliferation, which is a prerequisite of monolayer 
expansion, there is a) a loss of a broad range of differentiation markers, b) re-
expression of genes specifically associated with tissue development, c) evidence of 
positional identity, c) restricted potential, and d) recapitulation of development 
when dedifferentiated cells are placed in a supportive, three-dimensional 
environment.   
The study sought to develop the profile of known markers of differentiated status 
in cartilage and tendon; define a dedifferentiation profile; establish features of 
dedifferentiation that may be consistent with established markers of degeneration 
of cartilage and tendon; and compare the expression profile of three-dimensional 
culture systems relative to the native tissue they attempt to model.  Additionally, 
the expression profile of Hox genes in adult cartilage and tendon are defined to 
establish whether musculoskeletal tissue in the adult retains expression of markers 
of positional identity.   
This study sevidence of global transcriptomic changes associated with 
dedifferentiation, including expression of lineage-associated development markers 
and alteration in the expression of Hox genes, but also a failure of three-
dimensional culture systems to faithfully restore differentiated status.  These 
findings provide supportive evidence for the plasticity of dedifferentiated 
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musculoskeletal cells and the need for further exploration of dedifferentiation in 
organotypic culture systems.  
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Chapter 2 
Transcriptomic survey of  cartilage and tendon in de- and 
re-differentiation conditions 
2.2.3: Microarray analysis 
Biological samples = 40 
Native cartilage 
n=5 
Native tendon 
n=5 
Monolayer, passage 5 tenocytes|
chondrocytes|fibroblasts, n=19 
3D cultures, fibrin or 
alginate cultures, n=11 
2.2.6: Selection of   
endogenous  
controls 
2.2.6: qPCR  
validation  
2.2.7: Topography of   
HOX gene expression 
2.2.8: Immunohistochemistry  
Figure 2.1a:  Overview of  experimental design for results presented in Chapter 2.  Forty microarrays were 
used to interrogate samples derived from n=18 biological replicates.  Two tissue sources and three 
environmental conditions are shown – native, monolayer and three-dimensional cultures.  Relevant sections 
in the methods are provided.     
2.2.1: Sample Collection 
F344 male rats 
12 weeks old 
Whole tissue Isolated cells 
2.2.2: RNA extraction 
2.2.4: Differential gene 
expression lists.   
Selection of  candidate 
genes and proteins 
Data analysis workflow,  
Figure 2.1b  
Paraffin-embedded  
cartilage or tendon 
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Excluded arrays, 
n=4 
Microarray quality control 
Illumina RatRef  BeadChip v1, 
n=40 
Probe re-annotation 
Conditional comparisons and 
differential expression analysis,  
36 arrays 
Normalised matrix 
Native 
cartilage 
Native 
tendon 
Monolayer 
chondrocytes 
Monolayer 
tenocytes 
Monolayer 
fibroblasts 
Alginate 
chondrocytes 
Fibrin 
tenocytes 
beadarray 
Raw bead-level data  
imported into R 
Org.Rn.eg.db 
Background correction  
and normalisation RMA and Loess 
Limma 
Pathway  
Analysis 
Pathway topology: 
SPIA 
Ingenuity Pathway  
Analysis 
Functional 
Annotation 
Statistical filtering 
Gene  
Ontology:  
Gostats, ReviGO 
Prioritised gene lists  
Chapter 7 
Chapter 4 
Gene list ranking:  
RobustRankAggre 
Dimensionality 
Reduction 
Clustering: 
pca, huclust 
Figure 2.1b: Data analysis workflow (left column) and bioinformatics pipeline (right column) for data arising 
from Illumina microarrays.  Pairwise comparisons between conditions are shown within the pipeline with the 
direction of  the comparison indicated by the arrow.  R packages or functions used are also provided.       
Pairwise comparisons: 
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2.2:  Methods  
A graphical overview of the workflow employed in this chapter and sample 
sources is provided in Figure 2.1a and 2.1b.   
2.2.1:  Culture protocols 
 
Tissue 
Tissue was obtained from twelve week old, skeletally mature (Roach, Mehta et al. 
2003) male F344 rats (F344/IcoCR (Charles River, n=5) or F344/NCrHsd 
(Harlan Laboratories, Inc, n=13)), total n=18 (mean weight±s.d; 248 g ± 25.5). All 
rats were communally housed for seven days after transport and were humanely 
destroyed in compliance with the Animals (Scientific Procedures) Act 1986, 
Schedule I.  Tissue was harvested following a short delay post-mortem (3.5 hours ± 
1.4) (Marchuk, Sciore et al. 1998).  All cartilage and tendon tissue was harvested 
from the hind limbs. Cartilage was pooled from coxo-femoral (hip) and 
femorotibial (knee) joints; tendon was pooled from the tendon of the 
gastrocnemius (Achilles), tail and the deep flexor tendons of the hind limbs.  From 
the left flank an area of approximately 2 cm2 was obtained for isolation of dermal 
fibroblasts.  Cartilage was digested in 0.2 % collagenase type II (Worthington, 
Lakewood, NJ, USA) at 37 °C for 12-18 hours in 15 mL conical Falcon tubes 
(Falcon, BD Biosciences).  All cell culture reagents were from Gibco, (Life 
Technologies, Carlsband, CA, USA) unless otherwise stated. Tendon and dermis 
were pre-digested with 0.25 % (w/v) trypsin for 20 minutes, with further digestion 
as described for cartilage.  For primary culture, cells were seeded at 103 cells/cm2 
in 25 cm2 cell-culture flasks with low glucose Dulbecco’s Modified Eagle’s 
Medium (DMEM) with L-glutamine, with the addition of 10 % foetal calf serum 
(Sigma-Aldrich, St. Louis, MO, USA), 1 % penicillin (100 U/mL) and 
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streptomycin (100 µg/mL), and 0.2 % amphotericin B (2 µg/mL), which will be 
referred to as culture medium 1 (CM1). Cells were incubated at 37 °C in a 
humidified environment (5 % CO2: 21 % O2). Growth medium was changed every 
2-3 days to maintain active proliferation. Cells were grown to 80-90 % confluence.  
Prior to subculture the cell monolayer was washed with 10 mL of HBSS. For 
subculture cells were dissociated from flasks using a 0.05 % trypsin-EDTA 
solution (1 mL per 75 cm2), followed by a cell count using a modified Fuchs-
Rosenthal method and trypan-blue (0.4 %, Sigma-Aldrich) exclusion test on 10 µL 
samples. Over 90% of cells were viable at all passages. The first passage occurred 
once the primary cell culture reached confluence. For all subsequent subcultures 
cells were seeded at 104 cells/cm2.  Cells underwent subculture on four further 
occasions and were harvested at passage five.  Population doublings for each 
culture did not reach the limit defined by Hayflick (Hayflick 1961).    
Alginate beads cultures 
Passage five chondrocytes, or tenocytes, were released from monolayer culture, 
pelleted at 500 x g for 10 minutes and washed twice in sterile phosphate-buffered 
saline (PBS) after discarding the supernatant.  Cells were re-suspended at a density 
of 2x106 cells/mL in 1.2 % sterile-filtered alginic acid (alginate) solution (Sigma-
Aldrich, as before) adapted from de Ceunicnk, et al (2004) (De Ceuninck, Lesur et 
al. 2004).  CM1, with the addition of filter-sterilised L-ascorbic acid-2-phosphate at 
a final concentration of 200 µM (Sigma-Aldrich), is referred to as culture media 2 
(CM2).  Beads were incubated in 100 mm diameter Petri dishes in 25 mL of CM2 
for 14 days, as before, with media changed twice weekly.  A cell viability study 
defined the number of trypan-blue positive (dead) cells taken from individual 
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alginate beads on six occasions over fourteen days (n=4, triplicate counts for each 
replicate) for both chondrocytes and tenocytes.     
Fibrin constructs 
Fibrin culture systems were prepared using a previously described technique 
(Kapacee, Richardson et al. 2008).  The CM2 media for alginate beads was 
modified by the addition of aprotinin (20 µg/mL (Aprotinin from bovine lung, 
Sigma-Aldrich, A1153), after Ye, et al (2010), to inhibit fibrinolysis (Ye, Zünd et al. 
2000).  In each well, 7.5 x105 cells (using the modified cell number in (Kapacee, 
Yeung et al. 2010)) passage 5 tenocytes or chondrocytes were suspended in filter-
sterilised 20 mg/mL fibrinogen and 200 U/mL thrombin (Sigma-Aldrich) with 
modified CM2 to a final volume of 480 µL; this was added to each well and was 
rapidly agitated to ensure even coverage of the well.  Wells were left at 37 °C for 
five minutes to permit a thin fibrin layer to form before the addition of 5 mL of 
modified CM2.  The fibrin layer was scored circumferentially with sterile 10 µL 
pipette tip after 24 hours, and then scored centripetally every other day, to 
facilitate contraction of the developing construct.  Constructs were incubated, as 
before, until a robust linear construct was formed after 7-10 days.         
2.2.2: RNA extraction  
Monolayer cells were washed twice with HBSS then lysed using a choatropic agent 
(TRIzol®, Ambion, as before) and left for 10 minutes at room temperature. RNA 
isolation was then performed using an acid guanidinium thiocyanate–phenol–
chloroform extraction method (Chomczynski and Sacchi 2006).  Following co-
precipitation with glycogen and re-suspension with 75 % ethanol (v/v) RNA was 
transferred to spin-columns to undergo an on-column DNAse digest, wash and 
purification (Qiagen GmbH, Hilden, Germany) as per the manufacturer’s 
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instructions. Native tissue samples were minced in petri dishes and stored in ten 
volumes of RNAlater (Ambion, as before) and handled as per the manufacturer’s 
instructions.  For extraction, RNAlater was removed and the tissue snap-frozen in 
liquid nitrogen and pulverised using either a sterile mortar and pestle (tendon) or 
dismembrator (cartilage).  Pulverised tissue was then incubated at room 
temperature in TRIzol® before undergoing the RNA extraction protocol described 
above.  All samples were quality controlled and quantified using a 
spectrophotometer (Nanodrop, Thermo Scientific).  RNA was eluted in DEPC-
treated dH20 and stored at -80 °C until required. 
Cells were recovered from alginate beads by incubation with a depolymerising 
solution, to chelate calcium, (55 mM sodium citrate, 150 mM sodium chloride, pH 
6) in a shaking incubator at 37 °C for ten minutes.  The solution was centrifuged 
at 500 x g for ten minutes.  The supernatant was discarded and the cell pellet was 
washed twice in warmed PBS and centrifuged as before.  RNA extraction 
proceeded as described above on the isolated cell pellet.  For fibrin constructs 
media was aspirated and constructs washed twice in situ with warmed PBS.  
Constructs were sharply dissected from the two anchor points using a scalpel 
blade and transferred directly to a chaotropic agent.   
2.2.3: Microarray analysis 
Microarray samples were derived from several sources: a) native (whole tissue) 
cartilage or tendon, b) monolayer-expanded chondrocytes, tenocytes or dermal 
fibroblasts at passage five, or c) cells derived from alginate or fibrin three-
dimensional cultures. Forty microarrays were analysed, Table 2.1, using the 
Illumina RatRef-12 v1.0 BeadChip® array (Illumina, Inc., San Diego, California, 
USA) (Oliphant, Barker et al. 2002) following submission to The Genome Centre, 
 
83 
Barts and the London, Queen Mary, University of London. Twelve samples could 
be run in parallel on each array and were performed in three batches (native and 
monolayer in two batches, with three-dimensional cultures as a separate batch) on 
separate occasions. On each array there were 22,523 randomly distributed gene-
specific bead probes for the rat reference genome. RNA quality and quantity was 
assessed prior to amplification using the Agilent Bioanalyser RIN system (Agilent 
Technologies).  Samples with a RIN-value greater than 8 were considered to have 
passed quality control.  Labelling was undertaken using standard manufacturers 
protocols for RNA amplification based upon the technique by Van Gelder, et al 
(1990) (Van Gelder, von Zastrow et al. 1990).  Biotinylated cRNA was prepared 
with Illumina TotalPrep® RNA amplification kit (Ambion).  Hybridisation and 
image acquisition were performed using the manufacturer’s standard protocol for 
this array.  Raw data text files and un-normalised expression data were obtained 
from Illumina BeadStudio® software output and used at the input for data analysis, 
Figure 2.1b.   
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2.2.4: Data Analysis 
 
Quality control of microarray analysis 
General analysis of raw and normalised data was performed to assess systematic 
and individual array errors that may have arisen during the scanning protocol.  All 
analysis was performed using the R programming platform, R version 3.0.2 (2013, 
The R Foundation for Statistical Computing) through open-source packages made 
available via the Bioconductor network, (http://www.bioconductor.org 
(Gentleman, Carey et al. 2004)). Data was loess-normalised (Bolstad, Irizarry et al. 
2003) and log2-transformed after alternative techniques were investigated using the 
beadarray package, v2.6.0, (Dunning, Smith et al. 2007), implementing the 
Condition Replicates  Comments  
Cartilage 5(4) Pooled hip and knee cartilage, n=1 removed at quality 
control (QC) 
Tendon  5(5) Pooled Achilles, tail and deep flexor tendon  
Chondrocytes (monolayer 8(8) Passage 5 
Tenocytes (monolayer) 8(8) Passage 5 
Fibroblasts (monolayer 3(3) Passage 5 
Alginate (chondrocytes) 4(4) - 
 
Alginate (tenocytes) 1(0) Removed at QC 
Fibrin (tenocytes) 3(2) One array removed at QC 
Fibrin (chondrocytes) 3(2) Chondrocytes transferred to fibrin constructs.  One 
array removed at QC. 
Table 2.1: Table demonstrates source of  samples, biological replicates and the 
number of  arrays actually used for analysis in parentheses, total n=36.  For three-
dimensional cultures the component cell type is also given.  
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Figure 2.2: Plot of  proposed 
endogenous control genes 
re la t ive to the average 
expression stability value, M.  
Of  the those tested ATB5B 
and RPS20 were defined as 
the least variable across 
samples; it is not possible to 
rank the two most stable 
genes using this technique as 
it is based on the gene ratios.  
A l l n o r m a l i s a t i o n wa s 
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BASH algorithm to analyse spatial artifacts (Cairns, Dunning et al. 2008).  This 
data analysis included the removal of four arrays at quality control that were 
considered unsuitable for further analysis (remaining for analysis, n=36 arrays).  
Differential expression analysis 
Statistical analysis of differential gene expression was performed using the limma 
package (Smyth 2004).  Results for gene expression are presented as the log2 fold 
change (log2FC), false discovery rate (FDR, Benjamini-Hochberg correction) and 
log-odds ratio of expression (B statistic).  Pairwise comparisons are described such 
that the first term defines the baseline condition to which a comparison is made, 
for example, ‘native cartilage to monolayer chondrocytes’ defines native cartilage 
as the baseline. Complete differential expression lists for pairwise comparisons are 
available in supplementary data SD2.1-2.10.  Only differentially expressed genes 
passing a filtering threshold were used for bioinformatic analysis: log2 fold-change 
(log2FC≥0.5 (absolute fold-change =1.4); FDR <0.01; B statistic >0 (equivalent 
to a 50% likelihood of differential expression).  Illumina identifiers were re-
annotated using org.Rn.eg.db. (Pages H, Carlson M, Falcon S and Li N. 
AnnotationDbi: Annotation Database Interface. R package version 1.28.1). 
2.2.5: Bioinformatics  
All web-interface bioinformatics tools were last accessed in November 2014.   
 
Dimensionality reduction  
Principal component analysis (PCA) was undertaken using a co-variance matrix 
(Husson 2010) from filtered expression data from 36 arrays based upon the top 
500 most co-variant genes establish using WGCNA (Langfelder and Horvath 2008).  
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Hierarchical clustering using the was based upon the complete linkage method 
(Murtagh 1985) using the same gene expression matrix.   
Gene ontology function annotations 
Gene ontology (GO) (Ashburner, Ball et al. 2000) functional annotation 
enrichment was assessed using a strict hypergeometric analysis with the package 
GOstats (Falcon and Gentleman 2007).  Gene ontology analysis was also 
undertaken using DAVID (http://david.abcc.ncifcrf.gov) (Huang, Sherman et al. 
2008), with appropriate species and platform backgrounds, for validation.  Output 
GO lists were rationalised using ReviGO (http://revigo.irb.hr) (Supek, Bošnjak et 
al. 2011).  The ‘SimRel’ algorithm was used to calculate the semantic similarity 
score.  The UniProt Rattus norvegicus database (2013) was used to define the search 
space.  Only terms with a FDR<0.001 were used.  
Pathway Topology:  
Canonical signalling pathways were obtained from The Kyoto Encyclopedia of 
Genes and Genomes, KEGG (http://www.genome.jp/kegg/), for Rattus norvegicus 
(58 pathways used) in XML format (Kanehisa and Goto 2000).  Total, filtered 
differential expression lists consisting of Entrez gene identifiers and log2 fold-
changes were used as the input to the SPIA pathway topology package in R, 
version 2.14.0 (Tarca, Draghici et al. 2009).  For a pairwise comparison, for 
example native cartilage versus monolayer chondrocytes, positive log2 fold-
changes represented higher expression in native cartilage.    
Prioritised gene lists using rank aggregation 
These gene lists consisted of two sets of effect sizes, log2FC, arising from either 
cartilage or tendon.  In order to integrate differential expression results from 
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different comparisons into a meaningful prioritised gene list a rank aggregation 
method (Kolde, Laur et al. 2012) was employed. Ranked gene lists for each pair-
wise comparison were ordered by ascending adjusted p-value (FDR).  
Inference of Upstream Regulators of Gene Expression 
To infer upstream master regulators of gene expression the Ingenuity® Pathway 
Analysis (IPA®, Qiagen Bioinformatics, Redwood City, USA, www.ingenuity.com) 
knowledge base and software implementing causal analysis methods (Krämer, 
Green et al. 2014) were used under license.  Briefly, regulators with network 
connections to, and the direction of regulation within, the expression dataset were 
scored on their likelihood of occurring more frequently than in a random model.  
The top upstream regulators (including: transcription factors, small molecules, 
endogenous chemicals, miRNAs) were defined in this study as those with: i) the 
smallest ‘overlap p-value’ – a measure of enrichment of regulated genes within a 
dataset using a Fisher’s Exact Test (right-tailed), and ii) the highest ‘activation z-
score’ – the activation state of a regulator inferred from a test of the match in up- 
and down-regulation patterns.  To build on the mechanistic networks predicted 
through IPA, downstream targets of transcription factors were collected from the 
existing gene expression dataset.  Only those genes that were differentially 
expressed and had a direct relationship with the master regulators were chosen.  
2.2.6: Validation techniques 
 
Reverse transcription production of cDNA   
Random hexamers were annealed to 1 µg RNA with addition of 0.2 mM of each 
dNTP in a 25 µL reaction, with M-MLV reverse transcriptase and buffer, and 
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RNAse inhibitor in volumes prescribed by the manufacturers (all Promega, 
Madison, WI, USA).   
Determination of endogenous control genes for delta-Ct method of normalisation  
A series of endogenous control genes were selected from a review publication (de 
Jonge, Fehrmann et al. 2007) and commercially available multiplex qPCR 
endogenous control arrays.  These were cross-referenced with the mean log2 
fluorescence intensity from all Illumina arrays.  Genes with a coefficient of 
variation (CV) < 1% and a mean fold change < 2 across all tissues and culture 
conditions were chosen for the next round of validation.  Quantitative PCR was 
undertaken using three biological replicates with technical triplicates for each.  
Raw Ct values were exported into the R package NormqPCR (Perkins, Dawes et al. 
2012) which implements the geNorm algorithm (Vandesompele, De Preter et al. 
2002) to define the least variable gene pairs.  The ribosomal protein Rps20 was 
used for all normalisation; there was no evidence of differential expression of this 
gene in any pairwise comparisons.     
Quantitative polymerase chain reaction (qPCR) 
Primers were designed for qPCR using the NCBI PrimerBlast tool (Ye, Coulouris 
et al. 2012) (http://www.ncbi.nlm.nih.gov/tools/primer-blast) against the most 
recent mRNA records and spanning exon-exon boundaries where possible.  
Annealing temperature of all primer pairs was 60 °C ± 0.2 °C. All primers had 
efficiencies > 98% based upon six serial ten-fold dilutions.  Quantitative PCR was 
performed using a complete mix containing SYBR intercalating dye, ROX passive 
reference, UNG and dNTPs (MESA BLUE, Eurogentec, Germany) at the 
concentrations recommended by the manufacturer.   
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The standard protocol for all qPCR reactions performed using the 7300 ABI 
platform (Roche, Switzerland) consisted of: 50 °C (2 mins), 95 °C (10 mins) 
followed by 40 cycles of 95 °C (15 s) and 60 °C (1 min).   
Specificity of PCR products on validated primers was determined by melt-curve 
analysis. The predicted molecular weight of PCR products was verified by 
electrophoresis relative to a molecular weight marker on a 1% agarose gel 
impregnated with ethidium bromide and visualised under UV light. All details for 
primers are presented in SD2.11.  ‘No template’ and ‘no reverse transcriptase’ 
negative controls were also run in parallel for each sample.     
Validation of genes differentially expressed in microarray studies 
The baseline cycle threshold (Ct) for each qPCR run on 96-well plates was 
automatically generated using ABI software to ensure Ct threshold was within the 
linear phase of the exponential curve. cDNA was diluted 1:3 and 3 µL of cDNA 
was used for each reaction well to minimise pipetting errors. The comparative 
delta Ct method, as described by Schmittgen and Livak (Livak and Schmittgen 
2001, Schmittgen and Livak 2008), was used.  Technical triplicates for each of 
three biological replicates were averaged and were normalised to the means of 
technical replicates for Rps20 for the same biological replicate.    
Statistical analysis of qPCR data 
Normalised and linear transformed qPCR data (2^-dCt) was tested for deviation 
from a Guassian distribution using the Shapiro-Wilk test within R.  Analysis of 
variance (ANOVA) of group means was undertaken for qPCR validation data; post 
hoc Tukey multiple-comparison of means was performed with a 95% family-wise 
confidence level.       
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2.2.7: Expression of homeobox genes in adult cartilage and tendon 
Six, twelve week old, male outbred (Lewis) rats (Harlan, as before) were harvested 
for cartilage and tendon from discrete anatomical sites in both the fore- and hind-
limbs.  Specifically these were: scapulo-humeral joint (shoulder), fore- and hind-
digital flexor tendons, and the coxofemoral joint (hip).  Samples were prepared as 
described for native tissue.  Homeobox genes with established topographical 
and/or tissue-specific developmental expression in the literature were selected.  A 
panel of 19 homeobox genes were considered. For each independent biological 
replicate qPCR reactions (technical triplicates) were performed over four separate 
96-well plates with a standardised plate design.  The qPCR protocol used was 
consistent with the description above.  There were 2,304 data points in total. In 
order to deal with ‘non-detects’, or missing data cells, the following strategy was 
used to impute values from the available data cells for technical triplicates: a) 
where one technical triplicate was missing the mean of the remaining two was 
substituted; b) where the mean value of the remaining technical replicates was ≥ 35 
(considered the limits of real-time qPCR sensitivity), or c) where two or more 
technical replicates were missing, the missing data point was considered to 
represent no amplified product and Ct = 40 was the imputed value. Across plates 
the median absolute deviation (MAD), used in the beadarray package, was 
employed as a measure of central tendency and was calculated for the summary 
values from each biological replicate (n = 6).  A threshold of  ± 2.5*MAD defined 
outlier values to be removed (Leys, Ley et al. 2013).    As before, Rps20 was used 
as the endogenous control and means of technical triplicates were normalised to 
sample-matched Rps20 controls.  For each gene there were six summary 
observations (2^-dCt) for each of four tissues.  To account for the technical 
variation across 24 separate qPCR studies data was log2 transformed and 
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studentised such that the mean was equal to zero and the standard deviation equal 
to ± 1.  This generated a data matrix comprising ‘z-scores’ and was further 
analysed in R.   
Departures from a Guassian distribution were assessed using the Shapiro-Wilks 
test. Where outlier values were removed an alternative implementation of the 
ANOVA, using weighted means and type I sum of squares, was employed for 
unequal group sizes and post-hoc testing performed using the Games-Howell test, 
appropriate for unequal group sizes and heteroscedastic data.    
2.2.8: Histology and Immunohistochemistry 
Tendon tissue was harvested from 12 week old, male Lewis rats (Chapter 3) from 
the tendon of the gastrocnemius muscle (Achilles) and the deep flexor tendon.  
Achilles tendons were divided into proximal and distal sections, whilst the deep 
flexor tendons were sectioned in three parts (origin, mid-portion, and insertion).  
Where possible a small portion of skeletal muscle tissue was retained to act as an 
internal positive control.  Tissue samples were placed in fresh 4% para-
formaldehyde and stored at 4 °C for 7 days.  Tendon samples were paraffin-
embedded in a longitudinal orientation and 5 micron sections obtained.  
For analysis of cartilage, whole knee samples, consisting of the distal one third of 
the femur, femorotibial joint, and proximal one third of the tibia, were fixed as 
described and decalcified in 12.5% EDTA/1.25% NaOH (w/v, pH 7.4) for six 
weeks.  Embedding, sectioning and heamatoxylin and eosin (H&E) or Masson’s 
Trichrome staining was undertaken as a service by the Pathology Department of 
the School of Veterinary Science, University of Liverpool.  Special 
acknowledgement is extended to Ms. Valerie Tilston for this work.   
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For immunohistochemistry paraffin wax was removed through sequential ten-
minute baths in xylene and graded ethanol stages, followed by rehydration in 
deionized water.  All reagents were supplied by Sigma-Aldrich (catalogue numbers 
provided), as before, unless otherwise stated.  Antigen retrieval for both cartilage 
and tendon sections was undertaken with chondroitinase ABC (5 U/g) (#C2905) 
with 5 µL/mL in a Tris (50 mM)|sodium acetate (60 mM) buffer (pH 8 at romm 
temperature (RT)) according to the manufacturer’s guidelines and (Linhardt 2001).  
Each slide was incubated with 200 µL of the enzymatic solution for twenty 
minutes at 37 °C.  Subsequently, endogenous peroxidases were quenched in a 3% 
peroxide solution (v/v) for ten minutes, except for 3,3'-diaminobenzidine (DAB)-
only controls, and then washed in de-ionised water.    Alternative techniques 
employing pre-digestion with a topical solution of 0.05% trypsin from bovine 
pancreas (w/v, #T1426) in CaCl2 at pH 7.8 for 20 minutes were also attempted.     
Samples were washed in 1xTBS (pH 7.6 at 25 °C) with 0.1% TWEEN20 (v/v, 
TBST buffer). Sections were delimited using a hydrophobic pen, and blocked 
using 5% normal serum (v/v, diluted in TBST) specific to the species in which the 
secondary antibody was raised, either goat (#G9023) or donkey (#D9663), for one 
hour at 25 °C.   
Blocking buffer was removed and replaced with 100-200 µL of primary antibody 
diluted in the blocking buffer, Table 2.2, and incubated overnight (> 12 hours) at 
4 °C. Sections were washed three further times in TBST before the application of 
either: i) an anti-sheep HRP-polymer conjugated secondary antibody (GBI Labs 
Inc., Bothwell, USA, #D85-6) incubated for ten minutes following the application 
of an enhancer; or, ii) an anti-rabbit HRP-polymer (Zytomed Systems GmbH, 
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Berlin, Germany, #ZUC032-006) and incubated in a humidified atmosphere at 25 
°C for a further sixty minutes.   
Samples were washed twice in ultrapure dH20 for five minutes before the 
application of 3,3’-diaminobenzidine (DAB) (SIGMAFAST™ tablets, #D4293) 
and colour allowed to develop over five minutes. Sections were immersed in dH20 
for five minutes to retard any further colour development.  Sections were counter-
stained with hematoxylin solution according to Delafield (#03971) for ten seconds 
before being left under running tap water for five minutes.  Sections were 
dehydrated through graded ethanol and xylene, air-dried and mounted using DPX 
mountant (#06522).  Quadriceps muscle or myotendinous junction served as a 
positive tissue control for TNNI2; bone marrow canals and blood vessels in knee 
sections served as positive tissue controls for CRAMP.  Species-specific IgG 
isotype controls were concentration matched to test primary antibodies.  No 
primary antibody (secondary only) and a DAB only, for endogenous peroxidase 
activity, were also included.  
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Condition Replicates  Comments  
Cartilage 5(4) Pooled hip and knee cartilage, n=1 removed at quality 
control (QC) 
Tendon  5(5) Pooled Achilles, tail and deep flexor tendon  
Chondrocytes (monolayer 8(8) Passage 5 
Tenocytes (monolayer) 8(8) Passage 5 
Fibroblasts (monolayer 3(3) Passage 5 
Alginate (chondrocytes) 4(4) - 
 
Alginate (tenocytes) 1(0) Removed at QC 
Fibrin (tenocytes) 3(2) One array removed at QC 
Fibrin (chondrocytes) 3(2) Chondrocytes transferred to fibrin constructs.  One 
array removed at QC. 
Table 2.1: Table demonstrates source of  samples, biological replicates and the 
number of  arrays actually used for analysis in parentheses, total n=36.  For three-
dimensional cultures the component cell type is also given.  
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Figure 2.2: Plot of  proposed 
endogenous control genes 
re la t ive to the average 
expression stability value, M.  
Of  the those tested Atb5b 
and Rps20 were defined as the 
least variable across samples; 
it is not possible to rank the 
two most stable genes using 
this technique as it is based 
on the gene ratios.  All 
normalisation was undertaken 
using Rps20.     
Target Antibody 
Description 
Source Stock (Dilution) 
TNNI2, 
troponin 
Sheep, anti-rabbit 
polyclon l IgG  
Abcam, UK 
(ab97711)  
2 mg/mL (40 ug/mL)  
CRAMP/CAMP Rabbit, anti-mouse 
p lyclonal IgG 
Innovagen, Sweden 1 mg/mL (20 ug/mL) 
Sheep IgG Non-immune serum Santa Cruz 
Biotechnology 
(sc-2717) 
400 ug/mL (40 ug/mL) 
Rabbit IgG Non-immune serum Santa Cruz 
Biotechnology 
(sc-2027) 
400 ug/mL (20 ug/mL) 
Anti-sheep HRP-conjugated 
polymer (PoLink-2 
Plus) 
GBI Labs (D85-6) As per manufacturers instructions 
Anti-rabbit HRP-conjugated 
polymer 
Zytomed  Systems  As per manufacturers instructions  
Table 2.2: Antibody sources for immunohistochemistry studies 
 
95 
2.3: Results 
  
2.3.1:  Rps20 is a suitable endogenous control gene 
After global assessment of gene expression variation for all microarray Rps20 and 
Atb5b were found to be the most invariant, Figure 2.2. For normalisation of 
qPCR data across samples Rps20 was used.  Standard endogenous control genes, 
Gapdh and Actb, were differentially expressed between conditions and were not 
suitable candidates.    
2.3.2: Chondrocyte and tenocyte gene expression profiles converge in 
monolayer culture  
 
Principal Component Analysis (PCA) 
After filtering on the top 500 most covariant genes derived from a subset of highly 
variant genes (> 0.8) arrays could be clustered into four distinct groups, Figure 
2.3.  The first two components described 70.2% of the variation in the data.  
These groups consisted of: i) native cartilage; ii) native tendon; iii) monolayer 
cultured chondrocytes, tenocytes, and fibroblasts; iv) or three-dimensional culture 
systems, (alginate or fibrin cultures). It was not possible to discriminate between 
cell types for monolayer or three-dimensional culture conditions.  Native tendon 
and cartilage were strongly divergent from each other and cultured cells. 
Unsupervised PCA, without filtering of invariant genes, was poorly discriminatory 
(> 0.2, 43.9% described by the first two components); the overall relationships 
described were present with less stringent filtering, however, clustering of native 
samples was less robust.  Inclusion of a third component did not discriminate 
further between the groups.   
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The variation in the gene expression profile was suggestive of a convergence of 
expression profiles for cells in monolayer and a failure of chondrocytes or 
tenocytes in three-dimensional culture to recapitulate differentiation status to 
parity with native tissue.     
Hierarchical Clustering  
Unsupervised hierarchical clustering of the top 500 most co-variant genes 
concurred with principal component analysis and delineated the data into clades of 
cartilage, tendon, 3D culture systems and monolayer-expanded cells, Figure 2.4.  
The genes that comprise the top 500 most co-variant are listed in SD2.12. 
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Figure 2.3: Principal component analysis of  gene expression data from 36 Illumina arrays derived from three 
cell types (Cell type) and isolated from three environmental conditions (Condition) – native (cartilage or tendon 
matrix), monolayer (passage 5, dedifferentiated), or 3D (alginate or fibrin cultures). Plot presents the separation 
of  samples based upon the first two principal components (PC1, PC2), which together explain >70% of  the 
variation of  the data in the top 500 most covariant genes.  Although cartilage and tendon were highly divergent it 
was not possible to discriminate between cell types in monolayer and three-dimensional cultures, i.e. the plot 
reflects variation relating to the environmental conditions.   
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3D – alginate or fibrin 
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Cartilage 
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Condition  
Figure 2.4: Heatmap represents a matrix of  scaled gene expression values (rows) for the 500 
most covariant genes across 36 samples (columns), see figure legends. Dashed vertical line bisects 
clades into four groups (legend) for functional annotation – clades show general grouping with 
condition specific annotations in text and SD2.  Gene ontology based upon significant terms 
(p<0.05) in each group except D, which is too small for significant annotation.  
C: Translational elongation | ribonucleoprotein complex | structural constituent of  ribosome | 
cytoplasm | extracellular matrix  
B: Extracellular space | Response to external stimulus | Response to wounding | inflammatory 
response | developmental response | cell differentiation | cell migration  
A: Contractile fibre | muscle system process | actin binding | cytoskeletal protein biding |  actin 
filament-based process | immune system process | defense response | extra-cellular region | 
organ development | system development   
D: Lysosome* | chemical homeostasis* | extra-cellular matrix*   
Group annotations based on defined clades  
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2.3.3: Differential gene expression  
 
Overview 
For each of the conditions considered in this study selected pairwise comparisons 
were undertaken to determine the number of differentially expressed genes in 
each, Table 2.3.  The greatest number of differentially expressed genes were 
found between native tissues and their monolayer expanded equivalent, for 
example, a total of 2709 genes were up- and down-regulated between native 
cartilage and dedifferentiated chondrocytes.  In comparison, 2352 genes were 
differentially expressed between native cartilage and chondrocytes in alginate, but 
only 289 between dedifferentiated tenocytes and chondrocytes after statistical 
threshold filtering.  There were fewer differentially expressed genes between native 
tendon and tenocytes in monolayer or fibrin constructs than the equivalent 
comparisons for cartilage.  The fewest statistically significant differentially 
expressed genes were found between monolayer-expanded tenocytes and 
fibroblasts; a total of 270 were either up- or down-regulated.  
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Analysis of differential gene expression by cell type 
 
CHONDROCYTES 
In dedifferentiated chondrocytes (monolayer) the most highly expressed genes 
were matrix metalloproteinase 3 (Mmp3), transforming growth-factor beta 2 (Tgf-
β2) and thrombospondin 2 (Thbs2); compared to native cartilage the greatest 
reduction in expression is found in genes encoding heamaglobin alpha and beta 
chains, Hbb and Hbb-b, Hba1, defensin Defa5 and the cathelicidin-related 
antimicrobial peptide Cramp/Camp. Monolayer chondrocytes also demonstrated 
higher expression of mesenchymal markers Thy-1 and prion protein gene, Prnp, 
epithelial-mesenchymal transition regulator Snai1 and bHLH transcription factor 
Comparison n.C n.T d.C d.T d.F Alginate Fibrin 
n.C 823 1503 1244 
n.T 1142 964 649 
d.C 1206 154 522 
d.T 734 135 113 294 
d.F 157 
Alginate 1108 900 158 
Fibrin 580 627 265 
Lower expression 
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Table 2.3: Matrix of  up- and down-regulated genes for selected pairwise comparisons involving different 
environmental conditions for chondrocytes and tenocytes.  Values indicate the number of  up- or down- regulated 
genes with a log2FC >+/- 0.5, FDR <0.01 and a log-odds ratio of  expression >0.  Duplicate Entrez gene identifiers 
are removed.  Table Code: n.C – native cartilage; n.T – native tendon; d.C – dedifferentiated chondrocytes; d.T – 
dedifferentiated tenocytes; d.F – dedifferentiated fibroblasts; Alginate – chondrocytes in alginate beads; Fibrin – 
tenocytes in fibrin constructs.  The fewest differentially expressed genes were found between cultured cells.      
Figure 2.5: Euler diagram indicating the proportion of  overlap between different pair-wise comparisons.  All 
comparisons are made with respect to the native tissue and duplicate Entrez gene entries are removed.  For 
example, in the union between genes differentially expressed in cartilage vs. monolayer chondrocytes and tendon 
vs. monolayer tenocytes, 861 genes are differentially expressed in both comparisons.  A: native cartilage vs. 
chondrocytes; B: native tendon vs. tenocytes; C, native cartilage vs. alginate beads; D, native tendon vs. fibrin 
constructs.    
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Twist1.  The TGF-β signalling inhibitor Smad7, was also higher in monolayer 
culture.    
Native chondrocytes expressed higher levels of collagen type II (Col2a1), aggrecan 
(Acan), thrombospondin 4 (Thbs4), clusterin (Clu), dentin matrix acidic 
phosphoprotein (Dmp1), integrin-binding sialoprotein (Ibsp), and proteoglycan 2 
and 3 (Prg2/3) than monolayer-expanded chondrocytes.  Expression of CCN-
family genes, connective tissue growth factor (Ccn2/Ctgf) and Wnt1-inducible 
signalling pathway proteins Wisp1 and Wisp2, and Wnt-signalling gene frizzled 
family receptors Fzd1, Fzd2 and Fzd8 were all lower in native cartilage than 
monolayer.   
There was notable differential expression of homeobox genes across native 
cartilage and monolayer.  Monolayer was associated with higher expression of 
Pitx1, a hind-limb coding gene, and Prrx2, a differentiation-associated homeobox 
gene.  In native cartilage HOP homeobox (Hopx) and SATB homeobox 2 (Satb2) 
were more highly expressed.    
Relative to native cartilage, chondrocytes in alginate culture expressed the 
chemokine ligand 1 Cxcl1 most highly, followed by prostaglandin D2 synthase 
(Ptgds) and Mmp3.  The FBJ osteosarcoma oncogene Fos, Ccn3 (formerly 
nephroblastoma-overexpressed, Nov) and chitinase-3 like-1 (Chi3l1) were also 
more highly expressed in alginate beads relative to native cartilage.  In comparison 
to monolayer chondrocytes, alginate bead cultures expressed higher levels of 
interleukin 6 (Il-6), alarmin genes (S100a4, S100b) and prostaglandin-endoperoxide 
synthase 2 (Ptgs2/Cox2).  A number of chondrogenesis-associated genes were also 
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more highly expressed, Scrg1 (stimulator of chondrogenesis 1), inhibitor of DNA 
binding 1 (Id1), Bhlhb2 (basic helix loop helix transcription factor Dec1). 
TENOCYTES  
 
The most highly expressed genes in dedifferentiated tenocytes included 
phospholipase A2 (Pla2g7), integrin-α11 (Itga11), heme oxygenase 1 (Homx1) and 
secreted phosphoprotein 1 (Spp1).  The serine protease Serpine1 and the 
transcription factor Cebpb were also more highly expressed in monolayer relative to 
native tendon.  Monolayer tenocytes, in addition to expressing genes in common 
with chondrocytes (Thy1, Prnp, Twist1) also expressed elevated levels of biglycan 
(Bgn) and the homolog of slit (Drosophila), Slit3.    
Those genes most highly expressed in native tendon included troponins and 
myosins. Specifically troponin I type 2 (Tnni2), actin α1 (Acta1) and creatine kinase 
(Ckm) had higher expression in native tendon relative to monolayer.  The 
differentiation marker tenomodulin (Tnmd) and tendon-associated gene Mustang 
(Mustn1) had significantly lower expression in monolayer cultures.  Elastin (Eln), 
keratocan (Kera), lubricin (Prg4), dermatopontin (Dpt), apolipoprotein (ApoE) and 
bone morphogenetic protein encoding genes Bmp1 and Bmp7 were more highly 
expressed in native tendon than in monolayer.   
When compared to native tendon, tenocytes in fibrin cultures expressed higher 
levels of metallothionein 1a (Mt1a), the BMP-antagonist gremlin 1 (Grem1) and 
enolase 2 (Eno2), a neuron-associated enolase isoenzyme.  The tenasin N/W 
isoform, Tnn, was highly expressed in fibrin cultures. In addition to the 
chemokines found in alginate beads (Cxcl1, Ptgs2), hypoxia-inducible factor 1 
(Hif1a), RUNT transcription factor Runx1, and Gpnmb/osteoactivin were also 
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highly expressed. Relative to alginate beads, fibrin cultures exhibited higher 
expression of microfibrillar-associated protein 5 (Mfap5/Magp2), thrombospondin 
4 (Thbs4), and the Meox2 homeobox gene.  
Consensus genes by condition  
Principal component and differential expression analysis indicated that a number 
of genes were commonly expressed in native tissue, or monolayer and three-
dimensional cultures derived from either cartilage or tendon.  To describe 
common functions the consensus genes for different conditions were identified, 
Figure 2.5.  
NATIVE TISSUE TO MONOLAYER CULTURES 
 
There were 861 genes that were differentially expressed in both cartilage and 
tendon transitions to monolayer culture.  The top differentially expressed genes 
unique to tenocytes or chondrocytes are presented in Table 2.4a. Of the 
consensus genes for cartilage and tendon only 34 of 861 differed in the direction 
of the fold change.  Genes found to be differentially expressed in both tissues 
included lubricin (Prg4), the HOP homeobox gen (Hopx), osteocalcin (Bglap) and 
the troponin I, type 2 (Tnni2). The top five highest-ranked consensus genes for 
native cartilage and tendon were: Hba1, Hbb, transferrin (Tf), Hbb-b1, complement 
factor D (Cfd) and major histocompatibility complex gene RT1-Da.  Relative to 
monolayer culture 457 genes with lower expression in both cartilage and tendon 
with the highest ranking genes including: transgelin (Tagln), Had11b1 
(hydroxysteroid 11-beta dehydrogenase 1), collagen type VIII, alpha 1 subunit 
(Col8a1), C1qtnf5 (C1q and tumor necrosis factor related protein 5), Itga11 and 
Serpine1.  
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NATIVE TISSUE TO THREE-DIMENSIONAL CULTURES 
When differentially expressed genes in three-dimensional cultures are considered, 
Table 2.4b, 283 genes were found to be down-regulated in native tissue relative to 
both alginate and fibrin cultures.  In three-dimensional cultures AP-1 components 
Fos and Jun, the transmembrane glycoprotein osteoactivin gene Gpnmb, clusterin 
(Clu) and the bone morphogenetic protein receptor, type 1a (Bmpr1a) were all 
more highly expressed relative to native tissue. Top five ranked consensus genes in 
three-dimensional cultures were Errfi1 (ERBB receptor feedback inhibitor 1), 
Rasd1 (dexamethasone-induced Ras-related protein 1) and the serine peptidase 
inhibitor Serpina3n. Consensus gene lists are provided in SD2.13-2.14.  Genes 
found to be uniquely expressed in each condition are provided in SD2.15-SD2.18.
Comparison n.C n.T d.C d.T d.F Alginate Fibrin 
n.C 823 1503 1244 
n.T 1142 964 649 
d.C 1206 154 522 
d.T 734 135 113 294 
d.F 157 
Alginate 1108 900 158 
Fibrin 580 627 265 
Lower expression 
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Table 2.3: Matrix of  up- and down-regulated genes for selected pairwise comparisons involving different 
environmental conditions for chondrocytes and tenocytes.  Values indicate the number of  up- or down- regulated 
genes with a log2FC >+/- 0.5, FDR <0.01 and a log-odds ratio of  expression >0.  Duplicate Entrez gene identifiers 
are removed.  Table Code: n.C – native cartilage; n.T – native tendon; d.C – dedifferentiated chondrocytes; d.T – 
dedifferentiated tenocytes; d.F – dedifferentiated fibroblasts; Alginate – chondrocytes in alginate beads; Fibrin – 
tenocytes in fibrin constructs.  The fewest differentially expressed genes were found between cultured cells.      
Figure 2.5: Euler diagram indicating the proportion of  overlap between different pair-wise comparisons.  All 
comparisons are made with respect to the native tissue and duplicate Entrez gene entries are removed.  For 
example, in the union between genes differentially expressed in cartilage vs. monolayer chondrocytes and tendon 
vs. monolayer tenocytes, 861 genes are differentially expressed in both comparisons.  A: native cartilage vs. 
chondrocytes; B: native tendon vs. tenocytes; C, native cartilage vs. alginate beads; D, native tendon vs. fibrin 
constructs.    
A
B
C
D
Cartilage to Monolayer
Tendon to Monolayer
Cartilage to 3D
Tendon to 3D
Euler Diagram of Differentially Expressed Genes
2352 
2709 
1616 
1698 
1227 
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861 
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•"
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Gene Symbol log2FC FDR 
Myl1 
Tnnt3 
7.3 
6.8 
9.8e-19 
3.8e-18 
Mb 
Ttn 
5.6 
5.4 
6.5e-21 
3.0e-12 
Hfe2 
Pygm 
5.3 
5.2 
1.8e-15 
3.5e-15 
Des 
Cox8b 
5.2 
5.2 
4.1e-14 
3.2e-20 
Myot 
Pvalb 
4.9 
4.8 
2.7e-10 
6.1e-12 
Myh7 
Tnmd 
4.8 
4.7 
1.1e-10 
1.1e-08 
Gene Symbol log2FC FDR 
Np4 
Car2 
7.3 
6.8 
9.8e-19 
3.8e-18 
Prg2 
Ifitm6 
5.6 
5.4 
6.5e-21 
3.0e-12 
RGD1565970 
Retnlg 
5.3 
5.2 
1.8e-15 
3.5e-15 
Dmp1 
RGD1561694 
5.2 
5.2 
4.1e-14 
3.2e-20 
Ca1 
Ctsg 
4.9 
4.8 
2.7e-10 
6.1e-12 
Serpinb1a 
Mpo 
4.8 
4.7 
1.1e-10 
1.1e-08 
Gene Symbol Score 
Hba1 
Hbb 
6.7e-05 
1.3e-04 
Tf  
Hbb-b1 
4.6e-04 
8.7e-03 
Cfd 
RT1-DA 
1.1e-03 
1.3e-03 
Prg4 
Aif1 
1.3e-03 
2.1e-03 
Pla2g2a 
RGD1562323 
2.1e-03 
2.3e-03 
Gene Symbol Score 
Tagln 
Hsd11b1 
3.9e-04 
4.3e-04 
Col8a1 
Itga11 
4.6e-04 
7.0e-04 
C1qtnf5 
Serpine1 
8.7e-04 
1.1e-03 
Gpr176 
Nqo1 
1.6e-03 
1.7e-03 
Insig1 
Plod1 
1.9e-03 
2.3e-03 
Gene Symbol log2FC FDR 
Mmp3 
Abi3bp 
-5.4 
-4.4 
4.5e-07 
1.5e-10 
Prss23 
Nov 
-4.1 
-3.8 
9.9e-08 
1.0e-06 
Loxl2 
Bag3 
-3.7 
-3.6 
3.1e-11 
1.2e-10 
Pmp22 
Timp2 
-3.5 
-3.5 
9.6e-16 
6.3e-05 
Smoc1 
Aox1 
-3.4 
-3.3 
1.1e-13 
3.6e-08 
Nbl1 
Lgals1 
-3.3 
-3.2 
1.8e-11 
4.6e-06 
Gene Symbol log2FC FDR 
Pla2g7 
Spp1 
-3.6 
-3.4 
1.3e-09 
5.5e-06 
Prss35 
Gadd45a 
-3.2 
-2.9 
2.2e-08 
8.4e-08 
Fam198b 
Mgst2 
-2.8 
-2.7 
1.1e-05 
3.3e-08 
Mta1a 
Clec2d 
-2.6 
-2.5 
1.3e-05 
7.4e-10 
Col5a2 
Ddit3 
-2.3 
-2.2 
1.0e-04 
2.4e-05 
Smoc2 
Plod2 
-2.2 
-2.03 
3.9e-05 
8.8e-05 
Ranked consensus monolayer, down-regulated genes 
Ranked consensus native tissue, up-regulated genes 
Unique native cartilage vs.  
dedifferentiated chondrocytes 
Unique native tendon vs.  
dedifferentiated tenocytes 
H
igher expression 
Low
er expression 
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Table 2.4a: Differentially expressed genes and consensus comparisons described in Figure 2.5 considered in more detail for the transition from the 
native to monolayer condition.  Top genes unique to each pairwise comparison are presented with genes showing higher expression presented in the 
top frames and those showing lower expression in the bottom frames.  Consensus genes are presented as a prioritised gene list based upon a rank 
aggregation method using the adjusted p-value.  Standard gene symbols are presented, but not italicised.   
A B 
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Gene Symbol log2FC FDR 
Acta1 
Tnnc2 
8.6 
8.2 
1.3e-10 
8.0e-15 
Mylpf  
Myl1 
7.3 
7.3 
1.6e-15 
4.2e-14 
Tpm1 
Tnnt3 
6.9 
6.4 
1.4e-11 
5.3e-13 
Myoc 
Mb 
6.3 
5.7 
3.3e-19 
1.4e-16 
Tnmd 
Hfe2 
5.6 
5.3 
1.1e-06 
3.1e-11 
Pygm 
Ttn 
5.2 
5.2 
6.9e-11 
4.0e-07 
Gene Symbol Score 
Tf  
Fcer1g 
1.6e-3 
2.2e-3 
Hba1 
Hbb 
2.2e-3 
25.5e-3 
Pf4 
RT1-Da 
8.7e-3 
0.015 
Hbb-b1 
Coro1a 
0.018 
0.019 
Lyl1 
C1qc 
0.026 
0.031 
Gene Symbol Score 
Errfi1 
Rasd1 
5.5e-4 
1.2e-3 
Cp 
Serpin3n 
1.7e-3 
2.8e-3 
Usmg5 
Clu 
0.0107 
0.011 
Cfb 
LOC100364062 
0.012 
0.016 
Mtx1 
Rbbp7 
0.02 
0.03 
Gene Symbol log2FC FDR 
Mt1a 
Grem1 
-4.4 
-4.3 
4.2e-07 
2.7e-09 
Tnn 
Npy 
-3.5 
-3.3 
4.3e-06 
2.2e-03 
Prdx5 
Car9 
-3.2 
-3.2 
5.4e-06 
4.9e-07 
Mgst1 
Pla2g7 
-3.2 
-2.8 
1.2e-4 
2.6e-06 
Cthrc1 
LOC687649 
-2.8 
-2.7 
8.9e-05 
2.5e-11 
Enpp3 
Mmp11 
-2.6 
-2.6 
7.7e-05 
3.9e-05 
Gene Symbol log2FC FDR 
Defa5 
RatNP-3b 
8.1 
7.3 
1.5e-22 
1.1e-23 
Bglap 
Np4 
7.2 
6.7 
1.0e-11 
1.6e-25 
Car2 
Prg2 
6.4 
6.1 
7.1e-28 
1.6e-26 
Ifitm6 
Plac8 
5.9 
5.8 
2.4e-30 
4.8e-25 
Col2a1 
Retnlg 
5.7 
5.3 
7.5e-08 
5.8e-23 
Dmp1 
Arhgdib 
5.3 
5.2 
2.3e-23 
8.6e-26 
Gene Symbol log2FC FDR 
Ptgds 
MMP3 
-5.3 
-5.2 
4.7e-22 
9.1e-07 
Hsd11b1 
Aox1 
-5.2 
-4.7 
4.6e-12 
2.7e-11 
Nov 
Mlana 
-4.4 
-4.2 
1.1e-07 
1.2e-10 
Nbl1 
Fbln5 
-4.2 
-3.8 
4.1e-14 
1.0e-10 
Ier3 
Insig1 
-3.7 
-3.7 
7.2e-17 
1.7e-09 
Atf3 
Gdf15 
-3.6 
-3.5 
1.5e-24 
1.3e-16 
Ranked consensus 3D cultures, down-regulated genes 
Ranked consensus native tissue, up-regulated genes 
Unique native cartilage vs.  
alginate cultures 
Unique native tendon vs.  
fibrin constructs 
H
igher expression 
Low
er expression 
H
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Table 2.4b: Differentially expressed genes and consensus comparisons described in Figure 2.5 considered in more detail for the transition from 
the native to three-dimensional culture condition.  Top genes unique to each pairwise comparison are presented with genes showing higher 
expression presented in the top frames and those showing lower expression in the bottom frames.  Consensus genes are presented as a prioritised 
gene list based upon a rank aggregation method using the adjusted p-value.  Standard gene symbols are presented, but not italicised.   
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2.3.4: Gene Ontology Functional Annotation  
 
NATIVE TISSUE 
All terms reported are significantly enriched (p<0.001) after adjustment for 
multiple testing.  The genes most highly expressed in native cartilage were 
significantly associated with the gene ontology biological process terms ‘immune 
system process’, ‘immune response’, ‘cell cycle’ and ‘defense response’ using a 
hypergeometric analysis.  
For native tendon the most highly enriched terms were those relating to ‘muscle 
system process’, ‘muscle contraction’, and ‘immune system process’.  The gene 
expression profile was also associated with ‘skeletal muscle tissue development’ 
and ‘actin filament-based process’.  A full list is available in SD2.19-SD2.24. 
MONOLAYER 
Dedifferentiated (monolayer) chondrocytes and tenocytes demonstrated some 
overlap in the biological process gene ontology terms that were significantly 
enriched.  The terms ‘single-organism metabolic process’, ‘sterol biosynthetic 
process’ and ‘small molecule metabolic process’ were associated with genes more 
highly expressed in dedifferentiated cells.  The gene expression profile in 
monolayer cells was described by development associated terms ‘anatomical 
structure development’ and ‘developmental process’; terms associated with 
‘extracellular matrix organisation’ and ‘cell substrate adhesion’ were also enriched 
for both cell types.  In tenocytes ‘cell redox homeostasis’ was the most highly 
enriched term; in chondrocytes ‘oxidation-reduction process’ was enriched.   
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THREE-DIMENSIONAL CULTURE 
In the three-dimensional culture context genes more highly expressed in alginate 
beads containing chondrocytes were associated with biological processes terms 
related to: ‘single organism metabolic process’, ‘oxidation-reduction process’, 
‘oxoacid metabolic process’, ‘response to oxidative stress’ and ‘lipid metabolic 
process’.  The gene expression profile was also described by developmental terms 
relating to ‘vasculature development’, ‘cardiovascular development’, ‘post-
embryonic development’ and ‘regulation of anatomical structure morphogenesis’.    
Fibrin constructs containing tenocytes were enriched for biological process terms 
associated with ‘translation’, ‘metabolic process’, ‘collagen catabolic process’ and 
‘single-organism metabolic process’.  The terms ‘response to oxidative stress’ and 
‘apoptotic signaling pathway’ are common to both fibrin and alginate cultures. 
METABOLIC FUNCTIONS AND CELLULAR COMPARTMENTS 
To define the common metabolic functions and cellular locations of differentially 
expressed gene in different conditions functional annotations for ‘metabolic 
function’ and ‘cellular compartments’ for consensus genes were analysed.   
For consensus genes derived from the native tissue to monolayer comparison 
‘actin filament binding’, ‘integrin binding’ and ‘cytoskeletal protein binding’ were 
enriched.  For native to three-dimensional culture comparison ‘lipid particle 
binding’, ‘glycosaminoglycan binding’ and ‘carbohydrate binding’ were enriched 
metabolic functions.  The term ‘oxidoreductase activity’ was common to both 
analyses.  The cellular compartment annotations was described by the terms: 
‘cytoplasmic part’, ‘membrane-bound organelle’ and ‘cytoplasm’ in both analyses, 
SD2.23-SD2.24.     
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Differentially expressed genes were also functionally annotated using the 
Ingenuity® Pathway Analysis knowledge base to include further disease and 
physiology annotations.  The summary annotations for the three comparisons, 
native – monolayer – 3D, for cartilage (Table 2.5a) and tendon (Table 2.5b) are 
presented.  
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Comparison  IPA descriptors  
Native cartilage to monolayer  DD: Inflammatory response | Connective Tissue Disorders | Skeletal muscle disorders. 
MCF: Cell growth and proliferation | Cell movement | Cell death and survival  
PS: Immune Cell Trafficking | Hematological system development | Tissue morphology | Tissue 
development  
Monolayer to alginate  DD: Dermatological disease and conditions | Cancer | Cardiovascular disease | Neurological disease 
| Skeletal and muscular disorders 
MCF: Cell death and survival | Cell growth and proliferation | Cellular movement  
PS: Immune cell trafficking | Hematological system development and function | Cardiovascular 
system development and function | Organismal development  
Alginate to Native cartilage DD:  Inflammatory response | Connective tissue disorders | Inflammatory disease | Skeletal muscle 
disorders | Immunological disease; 
MCF:  Cellular movement | Cellular growth and proliferation | Cell death and survival | Cell-to-cell 
signalling and interaction  
PS:  Immune cell trafficking |  Hematological system development and function | Tissue morphology 
| Tissue development | Cardiovascular system development and function  
Table 2.5a: Functional descriptors of  differentially expressed gene lists derived using Ingenuity Pathway Analysis for chondrocyte comparisons.  
Legend: DD – Diseases and Disorders; MCF: Molecular and Cellular Function; PS: Physiological System Development and Function.  These 
give another level of  analysis of  the data; within each parent term lie numerous ‘child’ terms carrying their own p-values and activation z-scores.  
The comparison of  alginate to native cartilage uses three-dimensional cultures as the baseline condition consistent with pathway topology 
analysis figures.    
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Comparison  IPA descriptors  
Native tendon to monolayer  DD:  Neurological disease | Psychological disorders | Skeletal and muscular disorders | Hereditary 
disorder | Organismal injury and abnormalities   
MCF: Cell growth and proliferation | Cell death and survival | Cell morphology | Cellular movement 
PS: Organ morphology | Skeletal and muscular system development and function | Cardiovascular 
system development and function | Tissue morphology | Embryonic development  
Monolayer to fibrin  DD: Dermatological disease and conditions | Neurological disease|  Connective tissue disorders | 
Hereditary disorder | Opthalmic disease 
MCF: Protein synthesis | Cell death and survival | Cell growth and proliferation | Cellular movement 
| Cellular development  
PS: Skeletal and muscular system development | Cardiovascular system development and function | 
Organismal development | Tissue development | Connective tissue development and function  
Fibrin to native tendon DD:  Neurological disease | Cardiovascular disease | Skeletal and muscular disorders | Psychological 
disorders | Hereditary disorder  
MCF:  Cellular movement | Cellular growth and proliferation | Cell death and survival | Cell-to-cell 
signalling and interaction  
PS:  Organ morphology | Skeletal and muscular system development and function | Cardiovascular 
system development and function | Embryonic development | Organ development  
Table 2.5b: Functional descriptors of  differentially expressed gene lists derived using Ingenuity Pathway Analysis for tenocyte comparisons.  
Legend: DD – Diseases and Disorders; MCF: Molecular and Cellular Function; PS: Physiological System Development and Function.  These 
give another level of  analysis of  the data; within each parent term lie numerous ‘child’ terms carrying their own p-values and activation z-scores.   
The comparison of  fibrin cultures to native tendon uses three-dimensional cultures as the baseline condition consistent with pathway topology 
analysis figures.  
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2.3.5: Pathway topology - prediction of perturbed pathways  
A pathway topology technique was employed (SPIA), which makes use of both 
differentially expressed gene effect size and pathway topology to predict 
perturbations of KEGG canonical signalling pathways and predicts an activation 
state.  Both positive and negative log2-fold-changes from comparisons were used 
as inputs to SPIA to provide an adequate description of each transition. Ingenuity® 
Pathway Analysis canonical pathways, derived from over-representation analysis 
methods, were also assessed.  The most perturbed pathways are provided in 
SD2.25-2.26 with annotated HTML links to KEGG pathways.       
Native to monolayer transition 
Consistently the most significantly perturbed pathways for the native to monolayer 
transition for cartilage were ‘cell cycle’, ‘systemic lupus erythematosus’ and 
‘chemokine signalling pathway’, Figure 2.6.  For both cartilage and tendon native 
to monolayer comparisons the canonical pathways ‘rheumatoid arthritis’ and 
‘systemic lupus erythematosus’ were predicted to be activated.  Specifically in 
tendon to monolayer ‘focal adhesion’ and ‘complement and coagulation cascades’ 
were predicted to be activated, Figure 2.7, whilst the canonical pathway 
‘Parkinson’s disease’ was predicted to be inhibited.    
Monolayer to three-dimensional culture transition 
In the transition from monolayer to alginate cultures chondrocytes were predicted 
to have activation of the pathways ‘focal adhesion’, ‘PI-3K/Akt signalling 
pathway’ and ‘ECM-receptor interaction; ‘chemokine signalling pathway’ was the 
most significant pathway and this was predicted to be inhibited; this was also true 
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for the monolayer tenocyte to fibrin culture transition.  In the latter comparison 
the ‘HIF1-signalling pathway’ was predicted to be activated. 
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|KEGG   
+ Focal Adhesion    
+ PI3K-Akt signalling pathway   
+ ECM-receptor interaction   
 
- Chemokine signalling pathway 
- Huntington’s disease  
- Alzheimer’s disease 
|KEGG  
+ Systemic Lupus erythematosus  
+ Chemokine signalling pathway 
+ Rheumatoid arthritis  
-  Cell cycle 
-  Transcriptional misregulation in cancer 
-  HIF-1 signalling pathway 
|IPA  
•  Acute phase response signalling; 
•  LXR/RXR activation; 
•  Complement system 
•  IL-17a signalling in fibroblasts 
|IPA 
•  Integrin signalling 
•  Atherosclerosis signalling 
•  Leukocyte extravasation signalling 
 
Native chondrocytes 
Monolayer chondrocytes 
3D culture chondrocytes 
Legend 
Pairwise comparison  
Common upstream regulators  
TP53, TGFβ1, HRAS, 
lipopolysaccharide, TNF,  
IL6,MYC 
|IPA 
•  Mismatch repair in eukaryotes 
•  Heme biosynthesis II 
•  NRF2-mediated oxidative stress  
     response 
•  Granulocyte adhesion  
     and diapedesis  
|KEGG   
+ Cell cycle;  
+ Osteoclast differentiation; 
+ TNF signalling pathway.  
- Systemic Lupus erythematosus ; 
- Rheumatoid arthritis; 
- PPAR signalling pathway. 
Figure 2.6: Schematic Diagram: Using genes found to be differentially 
expressed in three pairwise comparisons, and their associated effect size 
(log2 fold-change), canonical KEGG pathway activation was inferred 
using a pathway topology approach.  Pathways are predicted to be 
activated (+) or inhibited (-) based upon global perturbation score and 
FDR-adjusted p-value.  Arrows indicate the direction of  the pairwise 
comparison. Predicted pathways from Ingenuity Pathway Analysis (IPA) 
are also shown, but do not use the pathway topology approach.  
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Native tenocytes 
Monolayer tenocytes 
3D culture tenocytes 
Legend 
Pairwise comparison  
Common upstream regulators  
Figure 2.7: Schematic Diagram: Using genes found to be differentially 
expressed in three pairwise comparisons, and their associated effect 
size (log2 fold-change), canonical KEGG pathway activation was 
inferred using a pathway topology approach.  Pathways are predicted 
to be activated (+) or inhibited (-) based upon global perturbation 
score and FDR-adjusted p-value.  Arrows indicate the direction of  the 
pairwise comparison.  Predicted pathways from Ingenuity Pathway 
Analysis (IPA) are also shown but do not use the pathway topology 
approach.     
|KEGG   
+HIF-1 signalling pathway  
- Chemokine signalling; 
|IPA 
•  EIF2 signalling pathway 
•  Glycolysis I 
•  Regulation of  eIF4 and p70S6K 
signalling 
•  Acute phase response signalling 
|IPA 
•  Glycolysis I 
•  Complement system 
•  Hepatic fibrosis/ 
     Hepatic stellate cell activation 
•  ILK signalling   
|KEGG   
+ HIF-1 signalling pathway 
+ Adipocyte signalling pathway 
- Systemic lupus erythematosus 
- Rheumatoid arthritis 
- Complement and coagulation cascades 
|KEGG   
+ Rheumatoid arthritis; 
+Systemic lupus erythematosus; 
+ Focal adhesion. 
- Parkinson’s disease; 
- MAPK signalling pathway; 
- Dilated cardiomyopathy 
|IPA 
•  Superpathway of  cholesterol 
biosynthesis 
•  Complement system 
•  Glycolysis I  
TGFβ1, MYC, (HIF1A, 
PDGF BB, TNF, TP53) 
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2.3.6: Inference of Upstream Regulators from Gene Expression Data  
Upstream regulators of genes defined as differentially expressed in comparisons 
were inferred using Ingenuity® Pathway Analysis (IPA).   
Top Scoring Upstream Regulators  
The top scoring upstream regulators were ordered by overlap p-value. In the 
cartilage to monolayer comparison the top upstream regulators were inferred to be 
Tp53, Tgf-β1, lipopolysaccharide (LPS), Hras, and Myc (p < 1.86e-18).  Of the two 
mechanistic networks generated from the top scoring regulators (z-scores) Tp53 (-
3.68, p = 9.01e-32, inhibited) contained 14 regulators with down-stream effects on 
435 dataset genes; Tgf-β1 (-2.6, p = 2.04e-26 inhibited) targeted 23 regulators with 
effects on 679 downstream genes represented in the differential gene expression 
analysis, Figure 2.8.  For the Tgf-β1 mechanistic network downstream targets of 
the root node included: Smad7, Smad3, Il-6, Jun, Fos, Cebpb, and Nf-κbia.  Of these 
Smad7 expression was down-regulated in dedifferentiated chondrocytes in culture.    
For native tendon compared to monolayer-expanded tenocytes the top scoring 
upstream regulators by overlap p-value were Tgf-β1, Hras, dexamethasone, Myc and 
Kras.  Only Kras (-2.3, p=1.2e-16, inhibited) had a predicted activation score above 
the threshold set by IPA and was predicted to be inhibited, however a Tgf-β1 
network was also predicted to be inhibited (-1.04, p=4e-23) as for chondrocytes. 
Only Myod1 was within the differential expression lists (log2FC=1.67) and 
predicted to be activated (2.45, p=1.04e-12).  This regulator was upstream of 14 
core regulators and effected 237 genes within the expression dataset, Figure 2.9.
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Figure 2.8: Ingenuity mechanistic network formed from Illumina data for native cartilage to monolayer transition.  Up-stream 
master regulator predicted as Tgf-β1 with downstream targets predicted from Ingenuity knowledge base and differentially expressed 
genes (figure legend) – genes more highly expressed in native chondrocytes are shown in graduate red, those down-regulated in 
monolayer culture are shown in graduated green.  Genes are grouped into general functional groups including extra-cellular matrix.  
Genes in the mechanistic network are annotated with function and disease terms: ‘differentiation of  chondrocytes’ (13 genes, 
p=1.5e-17); ‘development of  connective tissue cells’ (19 genes, p=2.13e-21); ‘arthritis’ (32 genes, p=5.7e-22). Smad7, Tgf-β1 -inhibitor, is 
highlighted to demonstrate a predicted mechanism for effects on Col2a1 expression.  Chondrogenesis regulator Sox9 is predicted as 
activated in the network. Protein nomenclature used consistent with IPA output.    
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Figure 2.9: Ingenuity mechanistic network formed from Illumina data for native tendon to monolayer transition. Highest scoring up-stream master 
regulator predicted was Kras with downstream targets predicted from Ingenuity knowledge base and differentially expressed genes (figure legend). Genes in 
the mechanistic network are annotated with function and disease terms: ‘differentiation of  connective tissue’ (29 genes, p=6.4e-25); ‘epithelial-mesenchyme 
transition’ (14 genes, p=2.03e-16); ‘fibrosis’ (27 genes, p=6.33e-26); ‘development of  cardiovascular tissue’ (20 genes, 6.6e-17).  Additional annotations given 
for tendon differentiation marker, tenomodulin (Tnmd) to highlight the lack of  tendon-specific annotations.  Key elements in the network include Cnn2/
connective tissue growth factor, gremlin 1 (Grem1), and inhibitor of  DNA binding 1 (Id1, a bHLH transcription factor).  Tendon morphogenesis factors 
scleraxis (Scx) and mohawk (Mkx) were added to the network provide tendon context.  Scx is predicted to be inhibited in the native tendon context (the 
converse predicted for Mkx). Protein nomenclature used consistent with IPA output.      
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2.3.7: Differential expression validation: qPCR 
Genes found to be differentially expressed in microarray analysis, or genes with 
known roles in cartilage and tendon morphogenesis were selected for qPCR 
validation.   
Seven genes were selected for cartilage and chondrocyte gene expression 
validation by qPCR.  These included: cartilage differentiation marker Col2a1, 
higher expression in native cartilage, hindlimb-patterning homeobox Pitx1, found 
to be more highly expressed in monolayer chondrocytes, and two homeobox 
genes found to be more highly expressed in native cartilage and tendon than 
monolayer, Satb2 and Hopx.  The chondrocyte development associated gene Sox9, 
predicted to be activated in cartilage by IPA, was selected, Figure 2.8.   Two 
genes with mesenchyme-associated expression, found to be more highly expressed 
in monolayer, Prnp and Thy1, were also assessed.   
For tenocytes and tendon the differentiation marker Tnmd was chosen for 
validation (more highly expressed in tendon than monolayer).  Tendon-associated 
genes Mkx (differentiation) and Scx and Mustn1 (development) were not 
differentially expressed, but were predicted by IPA to be activate and inhibited, 
respectively, in native tissue, Figure 2.9.  The Drosophila tendon development-
associated gene homolog Slit3, shown to be higher in monolayer tenocytes, was 
also selected.  
 There was general concordance in the direction and magnitude of expression 
changes between the three conditions for cartilage and tendon, although not all 
comparisons were found to be statistically significant.  In summary, the hindlimb 
development homeobox gene Pitx1 was significantly higher (p<0.01) in alginate 
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beads than either native or monolayer chondrocytes, Figure 2.10A.  The cartilage 
development-associated homeobox gene Satb2 was significantly more highly 
expressed in native cartilage than in either of the culture conditions (p<0.05).  The 
corollary was true for Prnp, which was more highly expressed in culture conditions 
than in native cartilage (p<0.05), Figure 2.10B.  Tenogenesis-associated Mustn1 
trended toward higher expression in native tendon than in monolayer cells 
(p=0.057), but the only significantly different was for tenomodulin (Tnmd) for 
native tendon compared to fibrin constructs (p<0.05), Figure 2.11.  Significant 
differences in expression were not shown for Slit3, Sox9 or Thy-1 in tendon, 
monolayer or fibrin culture samples (not shown).   
In summary, these findings suggest that two homeobox genes, Pitx1 and Satb2, 
may represent useful differentiation markers in chondrocytes.  Dedifferentiation 
was confirmed by the reduction in Col2a1 and Tnmd expression in monolayer 
chondrocytes and tenocytes respectively, although this was only significant for the 
latter.  Expression of developmental markers (Scx, Sox9) was equivocal in culture 
systems using qPCR. 
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Figure 2.10A: Validation of  expression changes in chondrocytes in three conditions 
(x-axis):  2D – monolayer culture at passage 5; 3D – alginate beads; Native – whole 
cartilage tissue.  Boxplots present the distribution of  the linear transformed Ct data 
(2^-dCt, y-axis). Sox9, a key regulator of  chondrogenesis, was considered. Sox9 
expression is reduced in monolayer culture, but expression is higher in alginate 
cultures than in monolayer, but not significantly so.  Significance code: * - p<0.05; ** 
- p<0.01; *** - p<0.001 
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2.10B: Validation of  expression changes in chondrocytes in three conditions 
(x-axis):  2D – monolayer culture at passage 5; 3D – alginate beads; Native – 
whole cartilage tissue.  Boxplots present the distribution of  the linear 
transformed Ct data (2^-dCt, y-axis). Significance code: * - p<0.05; ** - 
p<0.01; *** - p<0.001.  Mesenchymal stem cell markers Prnp, prion, and Thy-1 
show higher expression in monolayer cultures; this is significant for Prnp.  
This analysis is performed using cartilage, monolayer chondrocytes and 
alginate beads.   
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Figure 2.11: Validation of  expression changes in tenoocytes in three 
conditions (x-axis):  2D – monolayer culture at passage 5; 3D – fibrin cultures; 
Native – whole tendon tissue.  Boxplots present the distribution of  the linear 
transformed Ct data (2^-dCt, y-axis).  Tenomodulin (Tnmd) expression was 
significantly lower in fibrin than in native tendon.  Although not represented in 
the differential expression analysis scleraxis, Scx, a key regulator of  tenogenesis, 
was also considered.  Scleraxis, and Mohawk (Mkx) expression was not 
significantly different across conditions, however, expression was low in fibrin 
cultures.   
Significance code: * - p<0.05; ** - p<0.01; *** - p<0.001.  
"
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2.3.8: Cell viability in alginate bead cultures 
A trypan-blue exclusion assay was used to define dead chondrocytes or tenocytes 
in alginate beads over a period of fourteen days, Figure 2.12, SD2.27.  There was 
a statistically significant increase in the number of chondrocytes showing positive 
staining at all time points relative to the zero time point (p<0.01).  There was no 
significant difference between chondrocyte and tenocyte values at any time point.  
Although the same trend for reduced viability with time was evident for tenocytes 
in alginate beads there was no significant reduction relative to the zero time point.   
2.3.9: Profiling of homeobox genes in adult cartilage and tendon 
shows evidence of preserved anatomical topographical expression 
The finding of differential expression of homeobox genes, including the hind-limb 
development associated Pitx1, prompted an investigation into the expression of 
homeobox genes associated with topographical anatomy in adult cartilage and 
tendon.  The expression profiles of nineteen homeodomain genes, at four 
anatomical locations, were determined for cartilage and tendon. For the majority 
of genes a significant difference in gene expression between the four tissue sources 
could not be demonstrated, however statistically significant different expression 
was found for Pitx1, Tbx4, Tbx5, Lmx1b, Tbx15, Hoxa13 and Prrx2, as presented 
in Figure 2.13-2.15.  
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Figure 2.12: Viability assay for cells in alginate beads over a period of  14 days (x-axis) using a trypan-
blue exclusion test.  Data points show mean (n=4, technical triplicates) and standard error for 
percentage of  positive/dead cells (y-axis) for chondrocytes (solid) and tenoytes (dash). Significance 
code – as before.  A significant reduction in cell viability for chondrocytes in alginate beads was found 
between day 0 and all other time-points. Significance code: * - p<0.05; ** - p<0.01; *** - p<0.001; nsd 
– no significant difference.   
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Figure 2.13: Z-scores are derived from the studentised, log2 transformed dCt values, higher z-scores are 
associated with higher expression.  Hip and shoulder cartilage, along with forelimb (FL) and hindlimb 
(HL) deep flexor tendon (DDFT) are surveyed for differential expression of  homeobox genes.  Each 
biological replicate is represented in data points.  Significance code: ‘*’ – p<0.05; “**’ – p<0.01; ‘***” – 
p<0.001. There was evidence of  a significant difference in Pitx1 expression between the fore- and hind-
limb tendons.  Hind-limb tendon demonstrated significantly higher expression of  Tbx4 relative to hip 
cartilage.  Relative to hip cartilage Tbx5 was more highly expressed in all other samples.   
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Figure 2.14: Z-scores are derived from the studentised, log2 transformed dCt values.  Hip and shoulder cartilage, 
along with forelimb (FL) and hindlimb (HL) deep flexor tendon (DDFT) are surveyed for differential 
expression of  homeobox genes.  Significance code: ‘*’ – p<0.05; “**’ – p<0.01.  Significant differences are found 
between hip cartilage expression of  Hoxa13 and tendon expression.  Shoulder cartilage exhibits higher 
expression of  Lmx1b than hip, but lower expression of  Prrx2 relative to the fore limb DDFT.    
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Figure 2.15: Z-scores are derived from the studentised, log2 transformed dCt values.  Hip and shoulder cartilage, 
along with forelimb (FL) and hindlimb (HL) deep flexor tendon (DDFT) are surveyed for differential 
expression of  homeobox genes.  Significance code: ‘*’ – p<0.05; “**’ – p<0.01.  Significant differences are found 
between hip cartilage and tendon for Mustn1 and Mkx expression – both are more highly expressed in tendon.  
Tbx15 is shown to be more highly expressed in fore limb DDFT than either cartilage source.   
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2.3.10: Histology and Immunohistochemistry 
In order to validate findings from differential expression analysis in native tissue 
two target proteins were chosen.  For tendon the fast skeletal muscle-associated 
troponin I, type 2 (encoded by Tnni2) was selected to define the presence of 
skeletal muscle-associated transcript expression in tendon. For cartilage the 
cathelicidin-associated anti-microbial peptide, Cramp/Camp, was considered as this 
represented a gene more commonly associated with polymorphonuclear cell 
expression and so would investigate the presence of innate immune responses in 
cartilage tissue or contamination from structures deep to the hyaline cartilage.    
TENDON 
It was not possible, using the described antibody and methodology, to 
categorically demonstrate specificity of staining for troponin I, fast skeletal muscle 
in tendon tissue, Figures 2.16 to 2.18.  Strong, non-specific staining of the IgG 
isotype control (Figure 2.17) precluded further interpretation of low-level positive 
staining that was demonstrable in the myotendinous region of test studies (Figure 
2.18).  Furthermore, inconsistency of positive staining with tissue controls 
(associated skeletal muscle) did not allow for unambiguous interpretation of these 
results.  With these sections, however, the deep invaginations of skeletal muscle 
into the Achilles tendon at the myotendinous junction were noted (Figure 2.16).    
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Figure 2.16: H&E: Proximal Achilles tendon and gastrocnemius muscle. 
A:x4; B:x10; C:x40. Regions of  interest are highlighted with dashed boxes.  
Scale provided in lower right corner.  Figure legend: SM: skeletal muscle; 
AT: Achilles tendon; MTJ: myotendinous junction. Boxes and associated 
upper-case letters indicate region-of-interest magnified in subsequent image.    
 
Skeletal muscle shows deep penetration of  fibres into the Achilles tendon 
and close apposition between tendon and muscle fibres.  
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Figure 2.17: Isotype control: Proximal Achilles tendon and gastrocnemius 
muscle.  Sheep IgG isotype control (40ug/mL). A:x4; B:x10; C:x40.  Counter 
stained with Delafield’s hemeatoxylin.  Anti-sheep secondary antibody and 
enhancer applied as described by the manufacturer.  DAB exposure: 3mins. 
Boxes and associated upper-case letters indicate region-of-interest magnified in 
subsequent image.  Scale provided in lower right corner.  
 
Figure legend: SM: skeletal muscle; AT: Achilles tendon; MTJ: myotendinous 
junction.  
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Figure 2.18:  TNNI2 test: Proximal Achilles tendon and gastrocnemius 
muscle.  TNNI2 (40ug/mL). A:x4; B:x10; C:x40.  Counter stained with 
Delafield’s hemeatoxylin.  Anti-sheep secondary antibody and enhancer 
applied as described by the manufacturer.  DAB exposure: 3mins. Boxes and 
associated upper-case letters indicate region-of-interest magnified in 
subsequent image. Scale provided in lower right corner. No primary and DAB-
only (no H2O2) controls did not show staining. In comparison to IgG isotope 
control the degree of  positive staining is considerably less robust. The 
specificity of  staining is not consistent within the skeletal muscle; incursion of  
low grade staining at the myotendinous junction is evident (*).    
 
 
Figure legend: SM: skeletal muscle; AT: Achilles tendon; MT: myotendinous 
junction.   
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CARTILAGE  
Longitudinal sections of the rat femoro-tibial joint demonstrated the close association 
of sub-chondral blood vessels and the articular cartilage in the rat, Figures 2.19-2.20.  
In the proximal tibia there was evidence for the breaching of the osteochondral junction 
by blood vessels, which may infiltrate the calcified cartilage layer.    As with the tendon 
samples high background staining with the isotype control (Figure 2.21) made 
interpretation of low-grade staining of the superficial layer chondrocytes with the 
CRAMP antibody difficult, Figures 2.22.  
 134 
 
C 
B 
A 
*
A 
C 
B 
Figure 2.19: Longitudinal section through rat femoro-tibial joint. 
Haematoxylin and eosin.  A:x4; B:x10; C:x40. Scale provided in lower 
right corner. Figure legends: j: joint space f: femur; t: tibia. Boxes and 
associated upper-case letters indicate region-of-interest magnified in 
subsequent image.  
 
Samples show the typical hierarchical histology of  articular hyaline 
cartilage with columns of  polyhedral chondrocytes becoming flattened 
towards the articular surface (*).  
 
Extracellular matrix of  hyaline cartilage stains pale pink.  Artefactual 
spaces around chondrocytes are evident (•).  Bone marrow caverns are 
evident within the endochondral region as are blood-filled canals 
(arrows).  The classical ‘tidemark’ defining the separation between the 
calcified cartilage and the subchondral bone is not clear in the rat.      
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Figure 2.20: Longitudinal section through rat femoro-tibial joint. Masson’s 
trichrome.  A:x4; B:x10; C:x40. Scale provided in lower right corner. Figure 
legends: j: joint space f: femur; t: tibia.  Collagen and bone stain green/blue; 
cytoplasm has a basophilic colouring. Boxes and associated upper-case letters 
indicate region-of-interest magnified in subsequent image.  
 
Bone marrow caverns are evident within the endochondral region as are blood 
filled canals (arrows). There is evidence of  blood vessels encroaching and 
possibly penetrating the calcified portion of  the articular cartilage (*).  
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Figure 2.21: IgG isotype control: Longitudinal section through rat femoro-
tibial joint. Haematoxylin and eosin.  A:x4; B:x10; C:x40. Scale provided in 
lower right corner. Rabbit IgG control (10ug/mL). Secondary antibody anti-
rabbit HRP polymer. Boxes and associated upper-case letters indicate region-
of-interest magnified in subsequent image. Figure legends: j: joint space f: 
femur; t: tibia; m: meniscus.   
 
Strong staining is evident within chondrocytes of  superficial layer of  the 
articular cartilage (arrow).  Some staining is also evident within the meniscus 
and the bone marrow chambers (*).   
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Figure 2.22: CRAMP antibody test: Longitudinal section through rat 
femoro-tibial joint. Haematoxylin and eosin.  A:x4; B:x10; C:x40. Scale 
provided in lower right corner of  each image. Rabbit anti-CRAMP (10ug/
mL).  Secondary antibody anti-rabbit HRP polymer. No primary and DAB-
only (no H2O2) controls did not show staining. Boxes and associated upper-
case letters indicate region-of-interest magnified in subsequent image. Figure 
legends: j: joint space; t: tibia; m: meniscus.  
 
Some staining is evident within chondrocytes of  superficial layer of  the 
articular cartilage (arrow).  
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2.4: Discussion 
 
This study explored the phenotypic plasticity of chondrocytes and tenocytes, 
through induction of dedifferentiation in monolayer and subsequent 
redifferentiation in standard three-dimensional cultures, by global gene expression 
analysis.  By defining a reference data set of prioritized genes, implicated signalling 
pathways and infered upstream regulators across three conditions a clearer 
understanding of the mechanisms governing dedifferentiation was sought. These 
objectives contributed to the wider goal of exploration of mechanisms that may 
contribute to degenerative phenotypes in cartilage and tendon and could inform 
the rational development of organotypic culture systems in tissue engineering.   
The gene expression profiles of native, monolayer and standard three-dimensional 
culture systems provided the first comparative data set of its kind. Novel results 
demonstrated an inadequate restitution of native tissue expression profiles by 
commonly used three-dimensional culture models and offered an alternative 
description. In addition, convergence of gene expression profiles in monolayer 
culture, and the expression of development-associated genes in these cells, 
suggested dedifferentiation could represent a permissive phenotype worthy of 
further investigation for re-generation of musculoskeletal tissues.  In particular, the 
expression of a hind-limb development-associated homeobox gene, Pitx1, in 
monolayer chondrocytes was validated indicating that further investigation of 
homeobox genes in dedifferentiation is warranted. 
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2.4.1: Monolayer cell culture gene expression profiles converge  
Dedifferentiation of chondrocytes and tenocytes in monolayer was defined by the 
lower expression of Col2a1 and Tnmd respectively, the latter confirmed by qPCR.   
A striking finding of this study was the convergence of the gene expression 
profiles for chondrocytes, tenocytes and dermal fibroblasts at passage five.  Fewer 
than three-hundred genes with a statistically significant differential expression 
were found between chondrocytes and tenocytes, and of the most highly 
differentially expressed only twenty-five had a log2 fold-change greater than two.     
Given that monolayer culture is a fundamental research tool there is little scrutiny 
or comparison of gene expression profiles across cell types. By comparing 
tenocytes and chondrocytes in parallel it was possible to demonstrate this 
convergence.  It is important to note that although chondrocytes and tenocytes 
were often harvested from the same animal, and from an isogenic line, pairing of 
tissue samples for microarray was not a feature of the initial experimental plan and 
convergence based upon replicate origin is unlikely.    
Tissues are complex as they comprise three-dimensional hierarchical structure 
often with heterogenous cell populations, a vascular and neural supply, with 
caveats related to cartilage and tendon structure.  Given the reduction in the 
complexity of the monolayer environment this finding is perhaps not surprising – 
once a proliferative phenotype is induced, genes concerned with DNA replication 
and metabolism predominate. Although this phenomenon has not been described 
before for cartilage and tendon cells others have reported comparable expression 
profile convergence (Sandberg and Ernberg 2005, Zaitseva, Vollenhoven et al. 
2006, Halfon, Abramov et al. 2011).  In a meta-analysis of human, mouse and rat 
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transcriptome profiles Prasad, et al (2013) demonstrated that, regardless of the 
tissue origin, cells in culture were convergent in their expression profiles and 
divergent from their tissues of origin in an order of magnitude comparable to the 
difference between tissue types (Prasad, Kumar et al. 2013).    
If phenotypic drift and convergence of gene expression profiles in monolayer 
culture is a consistent feature of proliferation of chondrocytes and tenocytes then 
concerns regarding the validity and veracity of findings from monolayer studies 
should be considered. Furthermore, given that periods of expansion in monolayer 
cell culture are a pre-requisite for autologous cell therapeutic interventions 
(Brittberg, Lindahl et al. 1994) in musculoskeletal disease the nature of the cells re-
implanted may be, crucially, functionally divergent from those initially harvested.   
There are few studies that explore the global gene expression profiles of 
chondrocytes or tenocytes in monolayer.  Ma, et al (2013) reported 93 genes that 
were consistently expressed at lower levels in passage 2 and passage 8 cultured 
chondrocytes compared to passage 0 (Ma, Leijten et al. 2013).  There was broad 
overlap with the findings presented here for native chondrocytes with Chi3l2, 
Col2a1, Frzb, Sox9 and Mmp3 showing reduced expression in monolayer; fewer 
were more highly expressed in monolayer and these included Twist1, Gpnmb, 
Smad3, Pparγ, and Tagln.  Long-term culture (up to three weeks) of tenocytes in 
monolayer was found to result in a significant reduction in Tnmd expression across 
all time points, but variable expression of Scx (Güngörmüş and Kolankaya 2012), 
consistent with the qPCR findings presented in this study.   
Failure to define statistically significant differences in gene expression in all gene 
chosen for qPCR validation may have arisen from only using three biological 
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replicates per gene, use of ill-defined and heterogenous cell populations, primers 
of variable efficiency, or there indeed being no difference in expression.  
Clarification with larger, independent samples from enriched sub-populations may 
be required.     
2.4.2:  Establishing a qualitative definition for dedifferentiated cells 
Given that chondroyctes and tenocytes in monolayer culture exhibit gene 
expression convergence some attempt must be made to define what this 
phenotype is; to concur with the definition of dedifferentiation as a regenerative 
mechanism this phenotype should be pre-differentiated and lineage-associated, i.e. 
represent a primitive musculoskeletal cell.    
Comparisons with mesenchymal stem/stromal cells (MSC) was not a feature of 
this study, however the increased expression of a number genes associated with 
mesenchymal condensation and MSC identification indicated that the reduction in 
the expression of markers of differentiated status was not just a consequence of 
the reduction in the complexity of the samples, rather there was a global 
divergence from the native chondrocyte/tenocyte phenotype towards a 
homogenous, dedifferentiated phenotype.   
The expression of the MSC cell-surface marker Thy-1/CD90 (Dominici, Le Blanc 
et al. 2006, Maleki, Ghanbarvand et al. 2014) and Prnp/prion gene expression, 
generally associated with embryonic stem cell differentiation studies (Lee and 
Baskakov 2010, Miranda, Pericuesta et al. 2011), in chondrocytes prompted 
consideration of dedifferentiation in monolayer as representing a proliferative ‘pre-
differentiated’ state in the chondrocyte.  For this to be the case it may be expected 
that overlap between developmental musculoskeletal gene expression profiles and 
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monolayer expanded chondrocytes and tenocytes might occur.  Although a crude 
approach, the differential expression list for cartilage versus monolayer 
chondrocytes presented in this study shared 159 genes with the study by 
(Cameron, Belluoccio et al. 2009) considering the transcriptomic profile of in vivo 
murine chondrogenesis between E11.5 and 13.5.  These genes included: Pitx1, 
Thy1, Wisp1, Six1, Scrg1, S100a, Myh10, Il16, Frzb and Ctgf, which have been 
presented in this study.   
Applying this ‘paint-by-numbers’ approach to results from the first published 
global gene expression study of tendon development by Havis, et al (2014) reveals 
a number of genes differentially expressed between E11.5 and 14.5 familiar to the 
differential analysis for tendon versus monolayer tenocytes (Havis, Bonnin et al. 
2014).  A full gene list was not available, however, Tnmd, Dpt, Clu, Mfap5, Thy1, 
and Bgn, which were associated with higher expression at E14.5, were also 
differentially expressed in this study.   Notably Scx was not a differentially 
expressed gene in the Havis study, but differential expression of cartilage-
associated Ibsp, Ogn and Postn in tendon development was found.   
These are general observations and do not attempt to equate monolayer 
chondrocytes with developing chondrocytes, or tenocytes, per se, rather suggest it 
may indicate a common gene regulatory network that facilitates a proliferative and 
permissive phenotype with potential for regenerative interventions.   
Given the relevance of the development paradigm to musculoskeletal disease and 
regeneration (Tchetina 2011, Connizzo, Yannascoli et al. 2013) further 
consideration should be given to the regulatory networks that govern them.  
Clearly, to develop this would require comparisons between culture systems, 
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mesenchymal stem cells, and developing and healing tissues at the transcriptomic 
and proteomic level.    
2.4.3 Gene expression characteristics of standard 3D cultures  
Two forms of three-dimensional culture systems, alginate beads (De Ceuninck, 
Lesur et al. 2004) for chondrocytes, and fibrin cultures (Kapacee, Richardson et al. 
2008) for tenocytes, fail to restitute an organo-typic profile in dedifferentiated cells 
from monolayer cultures.  As these cultures do not show parity with cartilage and 
tendon it is critical that their characteristics are defined to facilitate refinement in 
tissue engineering.    
Alginate bead cultures: chondrogenic and inflammatory profiles   
The iterative analysis of gene network perturbations is critical to the development 
of rationally devised organo-typic models for in vitro use (Birgersdotter, Sandberg 
et al. 2005) and for the modelling of gene regulatory networks.  To this end a 
global gene expression analysis of chondrocytes in three-dimensional alginate 
cultures was performed as an environmental perturbation. Gene expression 
profiles of passaged chondrocytes suspended in alginate beads under normoxic 
conditions reflected both chondrogenic and inflammatory profiles.  As alginate 
cultures are extensively dealt with elsewhere in this thesis they are not the focus of 
this discussion.     
Alginate expression profiles are suggestive of pro-inflammatory conditions with 
the expression of Cox2, Cxcl1, Il-6 and the alarmin family of osteoarthritis-
associated genes (S100b) all evident.  Chitinase 3-like protein 1 gene (Chi3l1) was 
the most highly expressed gene in alginate beads when compared to monolayer 
and it is a potential biomarker for osteoarthritis (Huang and Wu 2009).  Recently, 
 
144 
CXCL1 has been defined as a target of the SOX9-mediated transcription factor 
AP-2ε (Wenke, Niebler et al. 2011), which is known to have a role in late-stage 
chondrocyte differentiation.  Elsewhere, the expression of chemokines and their 
receptors has been demonstrated to be involved in the chondrogenic induction of 
MSCs (Cristino, Piacentini et al. 2008).   
The S100-family of small-molecular weight calcium binding proteins are strongly 
represented in alginate cultures (S100a1, S100a4, S100a16, S100a11, S100b), 
several of which are identified in normal articular cartilage, but also up-regulated 
and associated with osteoarthritis (Yammani 2012).  S100b and S100a4, for 
example, both are considered to have catabolic effects on matrix through the 
increased production of MMP13.   The extracellular functions of the S100 
proteins are mediated through their interaction with RAGE (receptor for 
advanced glycation end products), or Toll-like receptors, activation of which can 
influence a number of signalling cascades including, MAP kinases (p38, ERK1/2), 
PI-3K and NF-κB. In contrast to the work of Diaz-Romero, et al (2014) (Diaz-
Romero, Quintin et al. 2014), this analysis found that there was an increase in 
expression of S100 genes in monolayer and alginate cultures, except for S100a8, 
which was more highly expressed in native cartilage.  No S100 genes were 
differentially expressed in a pairwise comparison of monolayer and alginate 
cultures.  In an elegant study comparing the effects of gain- or loss-of-function 
using combinations of S100a1 and S100b, Saito, et al (2007) demonstrated that 
over-expression inhibited chondrogenic differentiation; in contrast loss-of-
function, by siRNA transfection, enhanced terminal differentiation (Saito, Ikeda et 
al. 2007).  The S100 proteins are implicated in cartilage homeostasis, associated 
with disease phenotypes, and conflicting reports exist as to the expression status 
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of these genes in chondrocytes in various culture conditions.  In isolation gene 
expression profiles alone do not appear to be sufficiently consistent to warrant 
their labelling as differentiation markers.     
Expression of Bhlhb2/Dec-1 (Shen et al., 2002), Gdf15/Mic-1 (Iliopoulos, Malizos, 
Oikonomou, & Tsezou, 2008), Srcg1 (Ochi, Derfoul et al. 2006) and Id1 (Asp, 
Thornemo, Inerot, & Lindahl, 1998) in alginate-encapsulated chondrocytes are 
also of interest as these all have implicated roles in cartilage development and/or 
disease.  Along with the implicated signalling pathways there are aspects of both 
development- and disease-associated profiles present in the expression profile of 
chondrocytes in alginate beads.  A number of homeobox genes, with 
chondrogenic associations (Prrx1, Prrx2, Pitx1 and Six1), were more highly 
expressed in alginate bead cultures suggestive of a chondrogenic phenotype.    
Global gene expression studies of alginate bead cultures have not been 
undertaken.  These indicate a profile that is both pro-chondrogenic and pro-
inflammatory and consists of known osteoarthritis-associated genes.  Further work 
is required to elucidate the mechanism underlying this phenotype.   
Fibrin cultures are associated with micro-fibril and tendon developmental gene 
expression markers  
Previously fibrin constructs have been shown to demonstrate the presence of 
embryonic fibripositor structures (Kapacee, Yeung et al. 2010).  Whilst this type of 
construct does not recapitulate the complexity of tendon it may serve as a valuable 
model of tendon development. Gene expression findings supporting this 
statement are explored below.     
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From the outset it was stipulated that dedifferentiation required evidence of a loss 
of terminal markers of differentiation; the significant reduction in the expression 
of Tnmd supports this statement.   
Tnmd is considered a late marker of tendon cell differentiation (Liu, Zhu et al. 
2014) and, as such, may explain the lack of expression in fibrin constructs.  Instead 
more subtle markers of tenogenic induction should be considered and comparison 
to chondrocytes in alginate culture aids this investigation. Relative to alginate 
cultures cells in fibrin constructs expressed higher levels of Slit3, Thbs4, 
Mfap5/Magp2, Meox2 and Tnn, which may represent tenogenesis markers for 
further validation.  Three of these novel findings in fibrin cultures are discussed 
further.     
Microfibril-associated gene expression is higher in fibrin cultures 
Microfibril-associated glycoprotein 2 (Magp2) is part of the fibrillin-based 
microfibril complexes, which have key roles in tissue integrity and elastic structure 
(Gibson, Finnis et al. 1998).  In this study higher expression of Magp2/Mfap5 is 
shown in fibrin constructs and native tendon relative to monolayer tenocytes and 
alginate cultures, but not relative to each other.  Expression is present in a number 
of tissues, but high levels of mRNA have been noted in the foetal bovine Achilles 
tendon (Gibson, Finnis et al. 1998).  Originally shown to be co-expressed in the 
foetal nuchal ligament, Magp2 and Magp1 are associated with fibrillin-containing 
microfibrils in the ECM of a number of tissues, which are variably associated with 
elastin fibres.  Ritty, et al (2002) considered the distribution of Magp2 in the deep 
flexor tendon and found that both microfibril-associated glycoproteins were 
distributed throughout the tendon, particularly at the insertional zones (Ritty, 
Ditsios et al. 2002).  Roles for Magp2 are less well described than Magp1.  The 
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availability and activity of some growth factors (TGF-β, BMP, Notch family 
members) are regulated by microfibril assemblies, which provide a specific context 
for TGF-β and BMP signaling (Ramirez and Rifkin 2009).  Fibrillins, mutations of 
which result in Marfan syndrome, have a role in the sequestration of growth 
factors in large latent complexes within the ECM.  Magp1 has been shown to have 
an inhibitory effect on the binding of latent TGF-β-binding protein 1 to fibrillin-1 
in a study of the incorporation of latent TGF-β into the large latent complex in 
the ECM (Massam-Wu, Chiu et al. 2010).  Whether MAGP2, which is 
evolutionarily related, but diverges structurally, has comparable functions is not 
well described. A recent loss-of-function study has shown that MAGP2 has wide-
ranging effects not in keeping with the effects of MAGP1 or fibrillin-1 deficiency 
(Combs, Knutsen et al. 2013).  Biochemical evidence suggests that MAGP2 
protein binds to TGF-β1, TGF-β2 and BMP2.  Unlike MAGP1 knock-out (k-o) 
mice, MAGP2 are not osteopenic, however double k-o mice do show enlarged 
aortic diameter suggesting that some combinatorial effect is in play to maintain the 
integrity of large, elastic blood vessels.  With the recent finding of increasing levels 
of Mfap5/Magp2 in E14.5 developing tendon (Havis, Bonnin et al. 2014) the 
higher expression in fibrin culture here may indicate a tenogenic profile.   
Fibrin constructs show higher expression of tendon development-associated 
tenascin 
Consistently in pairwise comparisons Tnn, encoding the tenascin-W isoform, was 
more highly expressed in fibrin constructs relative to native tendon, monolayer or 
alginate cultures.  Tenascins are high molecular weight glycoproteins within the 
ECM, comprising of variable repeats of identical subunits (Halper and Kjaer 2014) 
with roles in cell motility, proliferation and differentiation.  Their tissue 
distribution is variable but tenascin-C and –W show expression in a number of 
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developing structures and neoplastic stromal tissue (Tucker and Chiquet-
Ehrismann 2009). Expression of tenascin-C in tendon blastema is well-described 
(Schweitzer, Chyung et al. 2001), but tenascin-W less so.  In an avian study of the 
distribution of tenascin-W in development the predominant expression was 
localized in bone and perisoteum, but was also transiently expressed in smooth 
muscle, tendon and ligament, often overlapping with tenascin-C expression 
(Meloty-Kapella, Degen et al. 2006).  The adhesion modulating properties of 
tenascin-W and lack of a connective tissue phenotype for the tenascin-C knock-
out suggests that there may be some functional overlap.  Tenascins are known to 
have adhesion-modulating properties (Chiquet-Ehrismann and Tucker 2011) and 
recently this has been confirmed for tenascin-W (Brellier, Martina et al. 2012).  In 
this study, using a mouse C2C12 myoblast cell line with osteoblast differentiation 
potential, it was shown that cells cultured in the presence of tenascin-W 
maintained a stellate phenotype with pseudopodia, unlike the spreading and stress-
fibres that formed when cultured on fibronectin alone.  
Slit3, with a role in axonal guidance, shows higher expression in monolayer and 
fibrin cultures  
In monolayer cultures a higher expression of Slit3 is found relative to native 
tendon and in fibrin cultures relative to alginate beads.  By qPCR a trend towards 
higher expression in fibrin constructs was presented. The SLIT protein family 
ligands, and their receptors, ROBO proteins, are required for normal axon 
guidance during development in vertebrates (Hinck 2004) and, additionally, 
myogenesis and myotendinous junction formation in Drosophila (Kramer, Kidd et 
al. 2001, Gilsohn and Volk 2010, Krämer, Green et al. 2014).  Slit3 deficiency in 
mice has been demonstrated to result in congenital diaphragmatic hernia as a 
result of failure of the central tendon, which helps suspend the diaphragm from 
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the body wall (Liu, Zhang et al. 2003).  The pattern of Slit expression in the 
developing avian and murine limb would indicate that SLIT:ROBO have 
additional actions.  In the developing chick Slit3 was demonstrated to be strongly 
expressed in the dorsal and ventral central mesenchyme and prospective inter-
digital regions (Holmes and Niswander 2001); later this expression developed 
along the nascent digit borders (Vargesson, Luria et al. 2001).  Whilst Slit1 and 
Slit2 co-localised with the myoblast marker Pax7 the subectodermal Slit3 domains 
did not.  Attempts to co-label tenascin-positive cells, to define developing tendon 
populations, could not localise a particular Slit population.   
The relevance of vertebrate SLIT proteins to tendon development are derived 
from the role of the single gene ortholog, slit, in Drosophila, which is secreted by 
tendon progenitors to influence myotube migration through the ROBO receptor 
(Volk 1999, Gilsohn and Volk 2010, Schweitzer, Zelzer et al. 2010) under the 
influence of the EGR-like transcription factor homolog, Stripe (Volohonsky, 
Edenfeld et al. 2007).  Although early-growth response proteins have been shown 
to be associated with tendon development (Lejard, Blais et al. 2011) in this data set 
higher expression of Egr1 was found in alginate beads relative fibrin cultures.    
Whether the signaling mediators of axonal guidance and neuronal path-finding 
have a role in mammalian neo-tendon formation has yet to be elucidated, but 
there is a rational scope for further work in this area.  
With respect to the developmental associations of the selected genes in the 
literature there is a rationale to explore further the validity of fibrin constructs as a 
tendon development model.  As with alginate cultures, side-by-side gene 
expression studies with embryonic tendon and MSCs would provide valuable 
information on de- and re-differentiation mechanisms in tenocytes.      
 
150 
2.4.4: Pathway topology related to fibrin cultures 
Predicted signalling pathways have not been described for tendon fibrin 
constructs.  In this section one of the identified signalling pathways is discussed 
further with respect to its role in tendon physiology.     
HIF1 signalling  
Pathway topology predicts the activation of the HIF1-signalling pathway in the 
transition from monolayer to fibrin cultures, and in the theoretical comparison of 
fibrin cultures to native tendon.  Expression of the Hif-1α gene, encoding the 
alpha subunit of HIF1, is more highly expressed in fibrin constructs, cultured in 
normoxic conditions, relative to either monolayer or native tendon.  The response 
to changes in oxygen-tension during development and disease process is, partly, 
regulated by the DNA-binding HIF transcription factors.  The transcriptional 
activation of multiple genes is mediated by the binding of HIF heterodimers, of 
which the alpha-subunit is the oxygen-labile component (Brocato, Chervona et al. 
2014).  The role of HIF-1α in human shoulder tendinopathy has been reported by 
several groups (Benson, McDonnell et al. 2010, Lakemeier, Reichelt et al. 2010), 
but studies are not always well controlled and immunohistochemistry findings 
were equivocal. Recently, Miller, et al (2012) presented higher mRNA and protein 
expression of HIF-1α in early subscapularis tendinopathy and passaged tenocytes 
cultured in hypoxic conditions (Millar, Reilly et al. 2012).  The authors proposed 
that hypoxic cell injury was a critical element in the pathophysiology of 
tendinopathy.  Higher expression of clusterin was also demonstrated.   
Gene expression profiling of fibrin cultures demonstrates the higher expression of 
a number of pro-inflammatory cytokines (Ptgs2/Cox2, angiogenic factors (Vegf-B, 
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Angptl4, Angptl2), HIF-repressors (Cited2) and pro-apoptosis genes (Bnip3) some 
with known tendon pathology associations.    
As such, it is proposed that rather than representing an organotypic in vitro model 
of healthy tendon structure the fibrin construct does not adequately recapitulated 
the native tendon expression profile; in contrast, it represents either a 
regenerative/healing, developmental or degenerate phenotype.  This is consistent 
with the conclusions reached for the alginate bead model.  Neither culture system 
appears fit for purpose with respect to native tissue, however, they may still be 
useful as either models of disease or development.  
2.4.5: Histology and Immunohistochemistry 
As a result of the presence of high levels of haemoglobin transcripts and various 
transcripts for genes more commonly associated with white blood cell function 
further consideration of the histological structure of the rat knee was warranted.  
The presence of high levels of Hba and Hbb are not uncommon in cartilage 
studies, although little is made of the presence in gene expression profiles.   
Concerns relating to the infiltration of blood vessels into the articular cartilage are 
verified by Mapp, et al (2008) (Mapp, Avery et al. 2008) where breaching of the 
osteochondral junction by vascular channels in the tibial plateau is found to be a 
normal feature of the rat knee.  Further, they found that the degree of vascularity 
in the tibial plateau decreased with age.  Incursion of blood vessels into the non-
calcified deep zone of articular cartilage appears to be a rare event in normal 
cartilage, however, perforation of the calcified cartilage does occur.  Clark (1990) 
described the trajectory of sub-chondral vascular channels in rabbit, canine and 
human cartilage scanning electron microscopy (SEM) study (Clark 1990).  These 
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SEM studies demonstrated that vascular channels, vertical extensions of 10-30 µm 
canals within the bone plate, variably penetrated the sub-chondral bone layer.  
These vascular channels either contained single capillaries with an open leading 
edge facing the calcified cartilage, or were, instead, covered by a cap of lamellar 
bone.  Vascular channels coming into contact with the non-calcified articular 
cartilage was rare event.  Contamination of native cartilage samples with blood 
cannot be excluded given the potential for encroachment of capillaries into the 
calcified cartilage in the rat.       
Defensins and alarmins in normal cartilage 
Key in this discussion is separating what is contamination of cartilage samples with 
blood and what is part of the normal physiological expression profile of whole 
cartilage.  To this end the expression of defensins, antimicrobial peptides of the 
innate immune system, in whole cartilage must be considered. In this study the 
expression of the cathelicidin-related antimicrobial peptide (CRAMP/CAMP) was 
investigated by immunohistochemistry.  Expression of this protein in normal 
chondrocytes and synoviocytes was reported by Hoffmann, et al (2013) and shown 
to be increased following pristane-induced arthritis in rats (Hoffmann, Bruns et al. 
2013).  In this study the same antibody was used, however, it was not possible to 
confirm the specific staining presented by Hoffmann, et al (2013).  This study did 
not present control images, include isotype controls, nor define in the methods the 
antibody concentrations used.  The high expression levels of alarmins, discussed 
above, and the expression of defensin genes requires further investigation in 
normal cartilage.   
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2.4.6: Evidence of topographical preservation of Hox gene expression 
indicates the heterogeneity of cartilage and tendon sources 
Homeobox genes encode a coordinate system for limb patterning in development 
(Zakany and Duboule 2007).   In a preliminary study, the first of its kind, the 
preservation of site-specific expression of a panel of homeobox genes was 
considered in cartilage and tendon.  Aspects of the study design limited 
interpretation of the data including the confounding association between tissue 
and location - tendon (distal limb) and cartilage (proximal limb).  The variable 
tissue harvest and RNA recovery and technical factors (multiple plates, temporal 
variation in data gathering, technical expertise) may also limit reproducibility.  
Despite these limitations a number of notable findings were evident, for example, 
the significantly higher expression of the hind limb-associated Pitx1 (Marcil, 
Dumontier et al. 2003) gene in hindlimb tendon relative to the forelimb 
equivalent, or the higher expression of the forelimb associated Tbx5 (Takeuchi, 
Koshiba-Takeuchi et al. 1999, Agarwal, Wylie et al. 2003) in shoulder cartilage 
relative to hip.  Whilst these findings are encouraging further investigation would 
benefit from more targeted gene expression profiling of a variety of tissue sites 
(tail tendon, patellar tendon, axial cartilage) in a standardised manner. 
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Appendix 1 
 
R Codes for Illumina microarray analysis 
 
Pre-processing, normalisation and differential expression analysis  
 
 
#series of 40 microarrays are read individually.  Files contain 
raw Bead Level Data (BLData).   
setwd() 
library(beadarray) 
library(illuminaRatv1.db) #correct annotation package 
 
 
BLData.arrayName=readIllumina( 
useImages=FALSE,illuminaAnnotation="Ratv1") #change name 
for each file  
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 #save all loaded raw data text files  
 #check what has been read 
slotNames(BLData. BLData.arrayName) 
#first ten rows of data from all columns  
 BLData.arrayName [[1]][1:10,] 
 #boxplot data 
 boxplot(BLData.arrayName,las=2,outline=FALSE,ylim=c(4,12))  
#apply BASH algorithm – this takes a while for each array! 
BLData.arrayName.bsh 
=BASH(BLData.arrayName,array=1,useLocs=FALSE) 
 
#save a separate file of only .bsh files so that these may 
be accessed.  Remove all raw files prior to saving .bsh 
files 
rm(BLData.arrayName,…) 
#set weights derived from BASH assessment of beads.  This 
needs to be done for each array individually  
 BLData.arrayName=setWeights( 
 BLData.arrayName,wts=BLData.arrayName.bsh$wts,array=1, 
 combine=FALSE,wtName='wts') 
#add quality information from BASH to bead level data for 
each array individually 
BLData.arrayName=insertSectionData(BLData.arrayName,what="B
ASHQC",data=BLData.arrayName.bsh$QC)  
#check that extended score etc have been added 
BLData.arrayName@sectionData  
#plots positive control for housekeeping or biotin 
poscontPlot(BLData.arrayName)  
png('controlplots.png')  
#a general control plot for all data 
combinedControlPlot(BLData.arrayName)  
dev.off() 
#combine all arrays in a single expression set – this has 
to be done one-by-one in beadarray 
BLData=combine(BLData.arrayName1,BLData.arrayName2) 
BLData=combine(BLData,BLData.arrayName3) 
#continue for the other arrays adding to BLData 
#Summarise probe data  
 myMean=function(x)mean(x,na.rm=TRUE) 
mySd=function(x)sd(x,na.rm=TRUE) 
greenChannel=new("illuminaChannel",greenChannelTransform,il
luminaOutlierMethod,myMedian,myMad,"Grn") 
 BSData=summarize(BLData,list(greenChannel), 
 useSampleFac=TRUE,sampleFac=rep(1:36,each=1), 
 weightNames="wts",removeUnMappedProbes=TRUE); 
 det=calculateDetection(BSData,status=fData(BSData)$Status, 
 negativeLabel="negative") 
 Detection(BSData)=det 
#Transform and normalise across arrays.  Both quantile and 
loess strategies are shown 
#QUANTILE 
BSData.q=normaliseIllumina(BSData,method="quantile",transfo
rm="log2") 
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#LOESS 
 
library(limma) 
 
BSData=normaliseIllumina( 
BSData,method="none",transform="log2") 
 BSData.loess<-normalizeCyclicLoess(exprs(BSData),  
weights = NULL, span=0.7, iterations = 3, method = "affy") 
##no longer an eSet, just a normalised matrix 
write.csv(BSData.loess,file=”BSData_loess.csv”) 
 
 
 #filter probes  
 BSData.genes=BSData.q[ 
 which(fData(BSData)$Status=="regular"), ] 
 expressed=apply(Detection(BSData.genes)<0.05,1,any) 
 BSData.filt=BSData.genes[expressed,] 
 ###export BSData.filt to WGCNA and GOstats 
 ############filter 
 ID=as.character(featureNames(BSData.q))   
 #addFeatureData 
 qual=unlist(mget( 
 ID,illuminaRatv1PROBEQUALITY,ifnotfound=NA)) 
 table(qual) 
 rem<- qual == "No match" | qual == "Bad" | is.na(qual) 
#vector of probes to be removed  
 BSData.filt=BSData.q[!rem, ] 
 dim(BSData.filt) 
 
#Matrix design for differential expression analysis for 36 
arrays.  Assign abbreviated names to each array based on 
sample group and replicate 
design<model.matrix(~0+factor( 
c(1,1,1,1,2,2,3,3,3,3,3,3,3,3,4,4,4,5,5,6,6,6,6,6,6,6,6,7,7
,7,7,8,8,8,8,8))) 
colnames(design)<-
c("dC_ALG","dC_FIB","dC","dF","dT_FIB","dT","nC","nT") 
rownames(design)<c("dC_ALG3","dC_ALG4","dC_ALG1","dC_ALG2",
"dC_FIB1","dC_FIB2","dC1","dC2","dC3","dC4","dC5","dC6","dC
7","dC8","dF1","dF2","dF3","dT_FIB1","dT_FIB2","dT1","dT2",
"dT3","dT4","dT5","dT6","dT7","dT8","nC2","nC3","nC4","nC5"
,"nT1","nT2","nT3","nT4","nT5") 
 
###Differential expression and feature data for loess 
normalised matrix 
 ID<-rownames(BSData.loess) 
 symbol=mget(ID,illuminaRatv1SYMBOL,ifnotfound=NA) 
 genename=mget(ID,illuminaRatv1GENENAME,ifnotfound=NA) 
 entrezID=mget(ID,illuminaRatv1ENTREZID,ifnotfound=NA) 
anno=data.frame(Illumina_ID=ID,Symbol=as.character(symbol),
EntrezID=as.numeric(entrezID), 
GeneName=as.character(genename)) 
 fit<-lmFit(ajm.loess,design) 
 contrast.matrix<-makeContrasts(dC-dT,levels=design)  
#set up the matrix and then you can include or exclude the 
samples that you want  
 fit2<-contrasts.fit(fit,contrast.matrix) 
 fit2<-eBayes(fit2) 
 fit2$gene=anno 
 rankCresults=topTable( 
 fit2,coef=1,number=1500,lfc=1.4,adjust.method="fdr", 
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 sort.by="logFC",genelist=fit2$gene) 
#export results to working directory in ranked format  
 write.table(rankCresults,file="rankCresults.txt",sep="\t") 
 
 ########### 
 aw=arrayWeights(exprs(BSData.filt),design) 
#Differential expression analysis for quantile normalised 
data  
 fit<-lmFit(exprs(BSData.filt),design, weights=aw) 
 ID=featureNames(BSData.filt) 
 chr=mget(ID,illuminaRatv1CHR,ifnotfound=NA) 
 refseq=mget(ID,illuminaRatv1REFSEQ,ifnotfound=NA) 
 entrezID=mget(ID,illuminaRatv1ENTREZID,ifnotfound=NA) 
 symbol=mget(ID,illuminaRatv1SYMBOL,ifnotfound=NA) 
 genename=mget(ID,illuminaRatv1GENENAME,ifnotfound=NA) 
 probequality=mget(ID,illuminaRatv1PROBEQUALITY, 
 ifnotfound=NA) 
 GO=mget(ID,illuminaRatv1GO,ifnotfound=NA) 
 
 anno=data.frame( 
 Illumina_ID=ID,Chr=as.character(chr), 
 RefSeq=as.character(refseq), 
 EntrezID=as.numeric(entrezID), 
 Symbol=as.character(symbol), 
 GeneName=as.character(genename), 
 ProbeQuality=as.character(probequality), 
 GOterm=as.character(GO)) 
#linear model fit and contrast matrix 
 fit<-lmFit(exprs(BSData.filt),design)  
 contrast.matrix<-makeContrasts(dC_ALG-dC,levels=design)  
#set up the matrix and then you can include or exclude the 
samples that you want  
 fit2<-contrasts.fit(fit,contrast.matrix) 
 fit2<-eBayes(fit2) 
 fit2$gene=anno 
 rankCresults=topTable( 
 fit2,coef=1,number=1500,lfc=1.4,adjust.method="fdr", 
 sort.by="logFC",genelist=fit2$gene) 
 write.table(rankCresults,file="rankCresults.txt",sep="\t") 
 
 #Hierarchical clustering of quantile normalised data  
 d=dist(t(exprs(BSData.q))) 
 plot(hclust(d)) 
 
Hierarchical clustering and heatmap 
 
  setwd("/Users/XXX") 
  data<-read.csv("BSData_loess.csv",header=TRUE) 
  colnames(data)[1]<-'IlluminaID' 
 
  ArrayName=names(data.frame(data[,-1])) 
  GeneName=data$EntrezID 
  exprs=data.frame(t(data[,-1])) 
  names(exprs)=data[,1] 
  dimnames(exprs)[[1]]=names(data.frame(data[,-1])) 
  exprs.v=as.vector(apply(as.matrix(exprs),2,var,na.rm=T)) 
  keep=exprs.v>0.8 
 
library(WGCNA) 
 
  filt=exprs[,keep]   
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  GeneName=GeneName[keep] 
  ADJ1=abs(cor(filt,use="p"))^9 #create adjacency matrix  
  k=as.vector(apply(ADJ1,2,sum, na.rm=T)) 
 datExpr=filt[, rank(-k,ties.method="first" )<=500] 
  rename<-t(datExpr) 
colnames(rename)<-
c(rep("3D",6),rep("2D",11),rep("3D",2),rep("2D",8), 
 rep("Cartilage",4),rep("Tendon",5)) 
  map<-as.matrix(rename) 
 
  #Define and export the heatmap groups 
 
library(gplots) 
library(RColorBrewer) 
 
  hm <- heatmap.2(map) 
  hc <- as.hclust(hm$rowDendrogram) 
 #define the height at which the dendrogram is cut 
 groups<-cutree(hc, h=25) [hc$order] 
  names<-names(groups) 
  groups1<-unname(groups) 
  groups2<-data.frame("Symbol"=names,"Groups"=groups1) 
  write.csv(groups2,file="heatmapGroups.csv",row.names=FALSE) 
 
  ##Create heatmap with the row groups and columns colour-coded 
  groups<-cutree(hc,h=25) 
  cols <- brewer.pal(max(groups), "Set3") 
  setwd(“”) 
  pdf(file = "Illumina_heatmap2.pdf", width= 8,  
  height = 8,useDingbats=F)  
  par(oma=c(2,2,2,2)) 
 
  heatmap.2(map,scale="row",col=greenred(100), 
  colsep=c(4,9,17),sepcolor="white",sepwidth=c(0.1,0.1), 
  trace="none",density.info="none",RowSideColors=cols[groups], 
  ColSideColors=c(rep("firebrick1",6),rep("midnightblue",11), 
  rep("firebrick1",2),rep("midnightblue",8), 
  rep("lightsteelblue3",4),rep("goldenrod2",5)), 
  cexRow=0.07,cexCol=1) 
 
  dev.off()  
  ##retain ‘map’, a matrix of gene expression values, for PCA 
 
Principal Component Analysis 
 
  #PCA for 36 arrays filtered on covariance 
 
library(FactoMineR) 
library(RColorBrewer) 
 
 #re-order columns from heatmap matrix so that they lie: 2D, 
#3D, native 
 map2<-
map[,c(7,8,9,10,11,12,13,14,15,16,17,20,21,22,23,24,25,26,27,
1,2,3,4,5,6,18,19,28,29,30,31,32,33,34,35,36)]; 
 res.pca<-PCA(t(map2),graph=FALSE,axes=c(1,2)) 
 
  PC1 <- res.pca$ind$coord[,1] 
  PC2 <- res.pca$ind$coord[,2] 
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 #define factors 
  cell.type<-c("chondrocytes", "chondrocytes", "chondrocytes",
 "chondrocytes", "chondrocytes", "chondrocytes",
 "chondrocytes", "chondrocytes", "fibroblasts" ,"fibroblasts",
 "fibroblasts" ,"tenocytes", "tenocytes", "tenocytes",
 "tenocytes", "tenocytes", "tenocytes","tenocytes",
 "tenocytes","chondrocytes", "chondrocytes", "chondrocytes",
 "chondrocytes","chondrocytes","chondrocytes", "tenocytes",
 "tenocytes","chondrocytes", "chondrocytes", "chondrocytes",
 "chondrocytes", "tenocytes", "tenocytes", "tenocytes",
 "tenocytes", "tenocytes") 
  cell.type<-as.data.frame(cell.type) 
 condition<-
c(rep("monolayer",19),rep("model.3D",8),rep("cartilage",4),re
p("tendon",5)) 
  condition<-as.data.frame(condition) 
 
 
  PCs <- data.frame(cbind(PC1,PC2,cell.type,condition)) 
 PCA.comp1<-res.pca$eig[1,2] 
  PCA.comp2<-res.pca$eig[2,2] 
 
 #Colours for plot 
  mypalette<-c("gray0","gray88","gray64","gray40") 
  #Prepare and export PCA plot 
 
library(ggplot2) 
 
 setwd("/Users/XXX") 
 pdf(file = "Illumina_PCA_Figure.pdf", width=8, 
height=8,useDingbats=F) 
  par(mar=c(1,1,1,1)) 
  p<-ggplot(PCs) 
  p<-p+geom_point(aes(PC1,PC2,color=condition,shape=cell.type), 
  size=6,alpha=0.6)+ 
  scale_colour_manual(values=mypalette)+ 
  labs(list(x=sprintf("PC1(%.1f%%)",PCA.comp1), 
  y=sprintf("PC2(%.1f%%)",PCA.comp2)))+ 
  theme_minimal(base_size=10,base_family="Helvetica")+ 
 theme(legend.position = c(.85,.7),text = 
element_text(size=12),plot.title=element_text( 
 lineheight=.8,face="bold"))+ 
  ggtitle("Principal Component Analysis")+ 
  scale_shape_discrete(solid=T) 
  p 
 
  dev.off() 
 
 
Hypergeometric testing of gene ontology analysis  
 
#####Define the universe – all the genes on the Illumina 
microarray.  Remove duplicate entries from Entrez annotations 
##Whole chip  
setwd("/Users/… ") 
universe<-
read.csv("RatRefv1.csv",header=TRUE,sep=",",as.is=TRUE) 
rem.dups<-universe[!duplicated(universe$Entrez_Gene_ID),] 
universe.entrez<-as.vector(rem.dups$Entrez_Gene_ID) 
length(universe.entrez) 
table(is.na(universe.entrez)) 
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rem.universe<-universe.entrez=="NA"|is.na(universe.entrez) 
filt<-universe.entrez[!rem.universe] 
UNIVERSE<-as.numeric(filt) 
 
#setwd("/Users/……. ") 
#read in differential expression lists of genes by Entrez ID 
to functionally annotate  
nt.up<-read.csv("working.csv",header=TRUE) 
nt.entrez<-nt.up$Entrez 
rem.NA<-nt.entrez=="NA"|is.na(nt.entrez) 
table(rem.NA) 
#filt<-nt.entrez[!rem.NA] 
dups<-duplicated(nt.entrez) 
table(dups) 
 
no.dups=nt.entrez[!dups] 
nt.final<-as.numeric(no.dups) 
 
library(illuminaRatv1.db) 
library(GOstats) 
 
hgCutoff <- 0.001  #statistical cut-off 
 
#Perform each in turn for biological process, cellular 
compartment and metabolic function.  Change name of output 
file on each occasion.   
params <- 
new("GOHyperGParams",geneIds=nt.final,universeGeneIds=UNIVERS
E,annotation="illuminaRatv1.db",ontology="BP",pvalueCutoff=hg
Cutoff,conditional=FALSE,testDirection="over") 
 
#params <- 
new("GOHyperGParams",geneIds=nt.final,universeGeneIds=UNIVERS
E,annotation="illuminaRatv1.db",ontology="MF",pvalueCutoff=hg
Cutoff,conditional=FALSE,testDirection="over") 
 
#params <- 
new("GOHyperGParams",geneIds=nt.final,universeGeneIds=UNIVERS
E,annotation="illuminaRatv1.db",ontology="CC",pvalueCutoff=hg
Cutoff,conditional=FALSE,testDirection="over") 
 
hgOver <- hyperGTest(params) 
df=summary(hgOver,htmlLinks=FALSE) #TRUE returns links to 
AmiGO 
hgOver 
 
p.value<-df$Pvalue 
adjusted.p<-p.adjust(p.value,method="fdr") 
df$adj.Pvalue<-adjusted.p 
 
 write.csv(file='GO.csv',df,row.names=FALSE) 
 
 
SPIA pathway topology analysis 
 
 
#Requires XML files to be downloaded from KEGG and stored within 
a named folder within the same directory; 
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library(SPIA) 
 
setwd("/Volumes/XXX/SPIA") 
makeSPIAdata(kgml.path="/Volumes/XXX/kegg",organism="rno",out
.path="/Volumes/XXX/kegg") 
#read in lists of differentially expressed genes as Entrez 
IDs 
top<-read.csv("SPIA.csv",header=TRUE,sep=",") 
setwd("/Users/alanmueller/Desktop/Thesis") 
#create universe based on microarray probes  
universe<-
read.csv("RatRefv1.csv",header=TRUE,sep=",",as.is=TRUE) 
 
#ensure that everything in universe is found in top 
merged<-merge(top,universe,by.x<-
"EntrezID",by.y="Entrez_Gene_ID") 
 
dim(merged) 
#[1] 2007 37 
top<-merged[!duplicated(merged$EntrezID),] 
dim(top) 
#[1] 1842 37 
top<-top[top$adj.P.Val<0.01,] 
dim(top) 
#[1] 1658 37 
 
de<-as.vector(top$log2FC) 
names(de)<-as.vector(top$EntrezID) 
head(de) 
 
dim(universe) 
#[1] 23405 28 
rem.dups<-universe[!duplicated(universe$Entrez_Gene_ID),] 
dim(rem.dups) 
#[1] 21494 28 
 
universe.entrez<-as.vector(rem.dups$Entrez_Gene_ID) 
 
#The SPIA algorithm takes as input the two vectors above and 
produces a table of pathways ranked from the most to the 
least significant. 
res<-spia(de=de, all=universe.entrez, 
organism="rno",data.dir="/Volumes/XXX/kegg/",nB=2000, 
plots=FALSE) 
#show first 15 pathways, omit KEGG links 
res[1:20,-12] 
plotP(res,threshold=0.05) 
 
setwd("/Users/XXX/SPIA_pathways") 
pdf("SPIA_pathways_SPIA.pdf") 
plotP(res,threshold=0.05) 
dev.off() 
results<-res[1:20,] 
write.table(results,file="SPIA_pathways_SPIA.txt") 
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3 :  A pathway topology  approach 
pred ic ts  involvement  of  the  PI-
3K/Akt  s igna l l ing  pathway in  
muscu loske le ta l  ce l l  
d i f ferent ia t ion  
 
Abstract 
The systems biology approach that has been defined in this thesis demands 
iterative perturbation and quantification of network responses to rationally model 
a system.  For comparisons to be relevant inherent differences in matricellular 
components between musculoskeletal tissues require to be resolved if common 
mechanistic processes are to be revealed. Defining consistent alterations in 
common prevailing regulatory mechanisms induced by the transition from in vivo 
to in vitro culture conditions for cartilage and tendon may be obscured by 
differences in sample complexity and composition. To extract evidence-based 
targets for future intervention studies depletion of extra- and peri-cellular matrix 
of cartilage and tendon cells was employed to reduce the complexity of samples 
and act as a system perturbation.   
Matrix-depleted cells exhibited strong clustering by condition rather than cell type 
including co-clustering of native cartilage and tendon cells.  High overlap in 
expression profiles and functional annotations for different cell types in the same 
condition suggested a common regulatory mechanism underlying de- and re-
differentiation for both chondrocytes and tenocytes.  Supporting previous results 
musculoskeletal development-associated genes including Scx (scleraxis), Mkx 
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(mohawk) and Mustn1 (musculoskeletal, embryonic nuclear protein 1) were all 
more highly expressed in monolayer cells from both tissues.  Defining consensus 
genes across microarray data sets isolated tissue-associated genes from those 
arising from other components of heterogenous samples providing putative 
tendon-associated genes including Serpinf1 and Mfap5.   
The PI-3K/Akt signalling pathway is a core signal transduction mechanism with 
multiple integrated roles including cellular differentiation. Results implicate the PI-
3K/Akt signalling pathway as a key regulator of chondrocyte and tenocyte de- and 
re-differentiation using a pathway topology approach.  Expression profiles were 
supportive of active PI-3K signalling in native cells and inhibition in monolayer 
cultures for both cell types indicative of a common regulatory pathway in de- and 
re-differentiation.  
 
3.1: Introduction 
 
3.1.1: Study rationale 
Several concerns relating to the study design presented in Chapter 2 encouraged 
the development of a second transcriptomic survey of chondrocytes and tenocytes 
from different environmental contexts.   
Microarray platform  
The Illumina RatRef-12 v1.0 Gene Expression BeadChip array, unlike, the human 
or mice equivalents from the same manufacturer, had not been re-annotated since 
the first market release; the omission of key musculoskeletal developmental 
regulators from the gene manifest for this platform (Sox9 and Scx) was evident.  
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Furthermore, this platform was discontinued in December 2011 negating the 
possibility of additional samples being surveyed to equalize groups sizes, for 
example for fibrin constructs.  
 Reduction of study and sample complexity     
Concerns arose with regard to the comparison of native cartilage and tendon to 
isolated cells in culture used in Chapter 2 due to the inherent difference in the 
complexity of native tissue relative to monolayer culture and the relevance of 
comparing tissues of distinct composition.  Gene expression profiles from native 
samples were also likely to be confounded by heterogenous cell populations, 
contaminants, and complex matrix components reduced in culture conditions.    
Evidence in Chapter 2 demonstrated that dedifferentiated cells developed a 
convergent gene expression profile when passaged in culture.  There was support 
for the statement that cells in monolayer and in three-dimensional culture systems 
had expression profiles that were more akin to developmental and reparative 
profiles than to their tissues of origin.  However, there was no consistent 
prediction for perturbed signalling pathways limiting rationale identification of the 
prevailing regulatory signalling mechanisms for de- and re-differentiation. This 
either suggested that the mechanisms of de- and re-differentiation were in fact 
different between cartilage and tendon or that the common regulatory 
mechanisms were obfuscated by the inherent differences in the complexity of each 
condition, differences in sample handling, and the presence of heterogenous cell 
populations.    
In proteomic studies reduction of sample complexity, for example by fractionation 
(Cox and Emili 2006) or depletion (Fonslow, Stein et al. 2013), is encouraged. 
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Abundant matrix proteins can swamp mass spectrometry analysis and greatly limit 
the depth, or coverage, of a proteomic survey (Wilson, Whitelock et al. 2009).  As 
part of a parallel proteomics study, presented in Chapter 6, a strategy to reduce 
sample complexity was devised.  To ensure comparability between studies this 
strategy was extended to samples for transcriptomic survey.  Globin (Mastrokolias, 
den Dunnen et al. 2012) and ribosomal (Sims, Sudbery et al. 2014) transcript 
depletion are shown to increase sensitivity of next-generation sequencing 
expression profiling.  It is not evident whether depletion of abundant matrix 
transcripts would have a comparable effect for microarray-based profiling.  
Furthermore, by ensuring that a small, enriched cell population was obtained 
lower RNA concentrations could be used as the reduced heterogeneity in the 
sample may also reduce the signal-to-noise ratio (Nygaard and Hovig 2008).  A 
critical limitation to use of rat native tendon and fibrin constructs was the number 
of cells harvested, therefore, matrix depletion could have additional benefit for 
samples with low cellularity.    
3.1.2: Study hypothesis 
It was hypothesized that this approach to reduction of sample complexity, by 
matrix depletion, across all conditions would standardize sample handling with 
isolated, matrix-depleted cells the resultant input for transcriptomic and proteomic 
survey.  A study consisting of parallel gene and protein surveys would facilitate 
analysis of prevailing regulatory mechanisms at two levels within the biological 
hierarchy.  A contemporary and well-annotated platform was considered to 
provide a more robust survey of the transcriptome.  By surveying only isolated 
cells from all conditions it was hypothesised that consistent network perturbations 
would emerge using pathway topology approaches.       
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3.1.3: Review: the phosphoinositide-3 kinase (PI-3K)/Akt pathway 
The PI-3K pathway is a core signal transduction mechanism for a plethora of 
physiological cellular mechanisms including differentiation, survival, apoptosis, 
metabolism and protein synthesis (Cantley 2002).  When mutated regulators 
permit unrestricted activation the PI-3K pathway is responsible for a number of 
cancers and is also implicated in inflammatory and autoimmune conditions, for 
example rheumatoid arthritis and systemic lupus erythematosus (SLE) (Foster, 
Blunt et al. 2012).  
PI-3 kinases are a conserved family of lipid kinases; they may be divided into four 
sub-families, or classes (I-IV), on the basis of their substrate specificity, primary 
structures, regulation and content of their domains.  Class I PI-3 kinases are the 
best described and consist of four isoforms, α-δ, and are receptor regulated.   
The PI-3 kinases may be activated by a number of ligands, including IGF-1, 
through various receptor tyrosine kinases. Phosphorylation of hydroxyl groups on 
membrane-bound inositol phospholipids, by PI-3 kinases, allows these to act as 
secondary messengers.  Considering only the receptor-regulated Class I PI-3 
kinases these are phosphatidylinositol-4,5,-bisphosphonate (PtdIns(4,5)P2)/PIP2 
kinases that generate PtdIns(3,4,5)P3/PIP3 following phosphorylation of the 3-
OH moiety on inositol membrane lipids.  The conversion of PIP2 to PIP3 is a key 
step in the initiation of the signalling cascade (Cantley 2002).  The broad range of 
ligands, secondary messengers, downstream targets and feedback loops makes the 
PI-3K pathway complex (Vanhaesebroeck, Stephens et al. 2012).  A cursory 
overview of the receptor-regulated Class I PI-3 kinase signal transduction pathway 
is provided in Figure 3.1.  Ligand binding to receptor tyrosine kinases results in 
the auto-phosphorylation of tyrosine residues. PI-3 kinases are recruited to the 
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membrane.  The catalytic p110 subunit is constitutively bound to the p85 
regulatory subunit; the latter has an SH2 domain allowing interaction with 
phosphorylated Tyr (pTyr) and adaptor molecules.    This brings the Class I PI-3 
kinases in contact with their lipid substrates.  Activation by the appropriate 
tyrosine kinase receptors, for example IGFR1, stimulates the rapid 
phosphorylation of PIP2 to PIP3.  These lipid secondary messengers recruit a 
number of signalling proteins with the pleckstrin-homology (PH) domain to 
facilitate their activation.  Proteins with these domains include the 
serine/threonine kinase Akt, below.  The binding of PIP2 to PIP3 drives the 
translocation of Akt to the plasma membrane where it is phosphorylated at the 
Thr308 and Ser473 residues by phosphoinositide-dependent kinase (PDK1) and 
mammalian target of rapamycin complex 2 (MTORC2) respectively.   
The best-described effector of PI-3K signalling is the serine/threonine kinase AK, 
also known as protein kinase B – more commonly this signaling pathway is written 
as the PI-3K/Akt signalling pathway.  As with all effectors of Class I PI-3 kinases 
Akt has a pleckstrin homology (PH) domain, which binds directly to 
phosphorylated inositol lipids, facilitating the Thr308 phosphorylation of Akt by the 
phosphatidylinositide-dependent kinase, Pdk1. More than 100 Akt substrates have 
been identified, these include: p21, p27, BCL2, FoxOs and GSK-3 (Foster, Blunt 
et al. 2012).  Signalling is inhibited by the action of the phosphatase and tensin 
homolog (PTEN) by inducing the dephosphorylation of PIP3 back to PIP2.  The 
dysregulation of PTEN is a significant contributor to tumourigenesis.  Numerous 
small molecule inhibitors of the PI-3K signalling pathway are described, including 
non-specific, reversible inhibition by LY294002 (McNamara and Degterev 2011).  
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Akt is only one example of a number of PI-3K effectors, which, when activated, 
result in a phosphorylation cascade.  Downstream targets regulate a diverse range 
of physiological functions including: proliferation, cell growth, metabolism, 
protein synthesis, differentiation and apoptosis.   
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Figure 3.1: Schematic diagram to represent the PI-3K/Akt signaling pathway for class I 
PI-3 kinases.  Full description of  the pathway is made in the main text 
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3.2: Methods 
 
3.2.1: Samples 
12 week-old, male, Lewis (n = 12, isogenic, Charles River) rats were obtained (as 
per Chapter 2), Figure 3.2.  For each biological replicate cartilage was obtained 
from the coxo-femoral and femoro-tibial joints and pooled (0.63 g ± 0.23, mean 
and s.d., wet weight); tendon was obtained from the Achilles tendon of the 
gastrocnemius muscle and the deep digital flexor tendon (0.59 g ± 0.28), these 
were also pooled.  Reagent sources are as described in Chapter 2 unless otherwise 
stated.   
Biological replicates were divided into three groups (n = 4 in each): Group I - 
primary tissue-derived cells; Group II - cells that underwent dedifferentiation in 
two-dimensional culture by serial passage on three occasions; Group III - cells that 
underwent dedifferentiation in two-dimensional culture then, at the end of the 
second passage, were transferred to three-dimensional culture systems appropriate 
for chondrocytes or tenocytes as previously described.  The extra- and peri-cellular 
matrix was depleted in all samples as described below.    
Group I: Cells derived from native tissue 
Samples were dissected and minced on sterilised, glass petri dishes.  Samples were 
washed twice in DMEM, free of phenol-red and serum, containing only antibiotic 
and anti-fungal agents.  Samples were placed in 50 mL Falcon tubes containing a 
total volume of 10 mL of 0.4 % collagenase type II prepared with complete media 
(CM1) and incubated for > 20 hours.  Following this, samples were centrifuged: 
samples from cartilage at 500 x g for 8 minutes; samples from tendon at 1000 x g 
to ensure that partially digested fascicular material, containing linear cell arrays in 
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peri-cellular matrix, would pellet (Ritty, Roth et al. 2003).  The supernatant was 
removed and replaced with 10 mL of 0.25 % trypsin from bovine pancreas (Sigma, 
#T1426) resuspended in serum-free DMEM.  Samples were incubated at 37 °C 
for four hours.  After this period samples were centrifuged as before, washed with 
complete media, re-suspended in 10 mL and passed through a 70 µm sterile cell 
strainer to produce a single-cell suspension.  A 10 µL sample was obtained and 
cells counted and evaluated for viability using the trypan-blue exclusion test. Cells 
for native cells analysis were pelleted and stored in 1 mL of TriReagent® at -80 °C.   
Group II: Cells expanded in monolayer culture  
Chondrocytes and tenocytes were expanded to passage three.  Primary cultures for 
both tissues started with 2.5x105 cells seeded at 104 /cm2. At confluence cells were 
split and seeded as for primary culture.  Cells in two- and three-dimensional 
culture were both grown in complete media as described before, but with DMEM 
with the absence of the phenol-red indicator and with the addition of 200 mM L-
glutamine (Gibco, Invitrogen).  At passage three cells were dissociated from 
monolayer, centrifuged and re-suspended in 10 mL 0.4 % (w/v) collagenase type 
II and incubated at 37 °C for one hour.  Cells were washed in PBS twice, counted 
and live/dead stained.  
Group III: Cells retained in three-dimensional cultures 
Following monolayer expansion chondrocytes were suspended in alginate 
following polymerisation in calcium chloride at 4x106 cells mL-1 of sterile-filtered 
alginate.  Cells were maintained in 25 mL of complete media 3 (CM3) as described 
previously with media changed every other day. Cells were released from alginate 
on day 7.  Cell pellets were digested in 0.4 % collagenase as above.  Monolayer 
expanded tenocytes were used to prepare constructs using fibrin gels and cultured 
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until linear tendon-like constructs were formed. Six technical replicates for each 
biological replicate (n = 4) were pooled and then digested directly in 0.4 % 
collagenase type II for 60 minutes. After this period the suspension of cells and 
fibrillar material was passed through a 70 µm cell strainer.  Cell pellets were treated 
as for Group II monolayer.   
RNA preparation and integrity 
RNA was extracted and prepared as described in Chapter 2.  Samples were 
standardised to a concentration of 20 ng/µL (total volume 25 µL) and all samples 
had a 260/280 ratio of > 1.8.  Samples were stored in Lo-Bind Eppendorf tubes, 
as before, at -80 °C. Samples were submitted to Molecular Genetic Services, 
Hologic, Manchester, for microarray analysis.  Bioanalyzer analysis provided RIN 
scores of > 8 for all samples with the majority of samples scoring a maximum of 
10 indicating minimal RNA degradation.   
3.2.2: Microarray analysis and bioinformatics 
Whole transcriptome profiling of 24 samples was undertaken using the 
GeneChip® Rat Gene 2.0 ST Arrays (Affymetrix, Inc., Santa Clara, USA) with six 
arrays per chip and all samples prepared in parallel and scanned on the same day.  
The microarrays interrogated expression of 28,407 RefSeq transcripts. Total RNA 
was amplified using the Affymetrix GeneChip® WT PLUS Reagent Kit according 
to manufacturer’s instructions. The resulting cDNA was quantified using optical 
density (NanoDrop, Thermo Scientific). The cDNA was normalised and 
hybridised onto Affymetrix Mouse Gene ST 2.0 microarrays for 16 hours at 45 °C.  
Microarrays were washed and stained using the Affymetrix GeneChip® 
Hybridization, wash, and stain kit were used according to manufacturer’s 
instructions using the Affymetrix GeneChip® Fluidics Station 450. Microarrays 
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were scanned using an Affymetrix GeneChip® 7G microarray scanner. Data 
quality control was analysed using Affymetrix® Expression Console™ Software. 
Raw .CEL files were imported into R (as before) and pre-processed, annotated 
and statistically assessed as described in the supplied code, Appendix 3.  
Specifically the oligo package (Carvalho and Irizarry 2010) was used for pre-
processing of .CEL files and the limma package for differential expression 
analysis, as before.  All arrays passed quality control thresholds and were retained 
for further analysis.  Filtering, statistical thresholds for inclusion in bioinformatic 
analysis and methodology (including pathway topology and Ingenuity Pathway 
Analysis) are consistent with methods presented in Chapter 2. Normalised 
expression data was also used an input to analysis in Chapters 4 and 7.   
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Native cartilage 
N=4 
Native tendon 
n=5 
Monolayer, passage 2 tenocytes|
chondrocytes|fibroblasts, n=16 
3D cultures, fibrin or 
alginate cultures, n=8 
Isolated cells Whole tissue 
3.2.1: Sample Collection 
Lewis male rats 
12 weeks old, n=24 
Monolayer, passage 3 tenocytes|
chondrocytes|fibroblasts, n=8 
n=12, proteomics Chapter 6 
n=12, microarrays 
Chapter 3 
Transcriptomic survey of  cartilage and tendon implicates PI-3K signalling in dedifferentiation mechanism 
3.2.2: Microarray analysis 
Affymetrix GeneChip 2.0 ST  
n= 24 
2.2.2: RNA extraction 
From single cell suspensions 
Data analysis pipeline,  
Figure 2.1b  
3.22: Bioinformatic analysis 
Figure 3.2: Overview of  experimental design for results presented in Chapter 3.  Source of  samples for 
microarray data is indicated (n  = 12). Two tissues, cartilage and tendon, were harvested.  For each condition 
(native, monolayer or 3D cultures) there were four biological replicates.  Extra- and peri-cellular matrix was 
depleted by enzymatic digestion as described.  Gene expression profile was surveyed using the Affymetrix 
GeneChip Rat 2.0 ST array, 24 arrays performed in parallel.  Data analysis pipeline follows that described in 
Figure 2.1b with microarray platform appropriate R packages as described in 3.2.2.  Expression data also 
used in subsequent analysis in Chapters 4 and 7.       
Matrix depletion 
0.4 % collagenase type II >20 hours + 
0.25 % trypsin for 4 hours 
Matrix depletion 
0.4 % collagenase type II for 1 hour 
 189 
3.3: Results 
 
3.3.1: Quality Control  
 
Quality controls of microarrays 
Probe-level intensity data was used to produce pseudo-images of the arrays to 
determine the presence of any systematic or random spatial artifacts across the 
array, Figure 3.3. Fitting of a probe-level model to normalised data did not 
demonstrate any arrays that significantly departed from expected standards in 
NUSE and RLE plots, Figure 3.4.  High correlation was also evident between 
replicates within a condition, Figure 3.5.  There was no evidence from quality 
control analysis that any of the arrays should be removed.   
Comparing normalisation techniques 
To define whether the cyclic LOESS normalisation strategy, described in Chapter 
2, was applicable to this dataset it was compared to the standard RMA algorithm 
(Irizarry, Hobbs et al. 2003), which employs a quantile normalisation method. 
Background correction methods were identical for both strategies.  There was no 
appreciable difference between the methodologies (slight improvement in the 
distribution of the densities, Figure 3.6, in using a quantile normalisation versus 
LOESS), however, the latter was retained for continuity of analysis between 
datasets.  An uncertainty propagating method, puma (Pearson, Liu et al. 2009), 
was also explored using R, but could not be integrated with downstream analysis 
in subsequent chapters.    
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Figure 3.3: Pseudo-coloured 
images of  24 Affymetrix arrays to 
visualise spatial artifacts (A).  The 
residual images are coloured so 
that large positive residuals are red, 
large negative residuals are blue 
and small residuals are white. 
Examples of  poor quality arrays 
below (B).  There do not appear to 
be systematic technical errors 
associated with array preparation.     
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Figure 3.4: The RLE (Relative Log 
Expression) and NUSE (Normalized 
Unscaled Standard Error) plots are 
used assess array quality. Both are 
derived from a probe-level model 
(PLM) that computes an expression 
measure using M-estimator robust 
regression.  NUSE plot (top) – 
shows the normalised standard error 
(SE) estimates from the PLM such 
that the median SE=1.  Arrays with 
lower quality are centred higher and 
have a wider spread.  No arrays are 
centred above 1.1, the threshold for 
discarding arrays. The RLE plot 
(bottom) uses log-scale estimates for 
probe expression on each array.  For 
each probe set and array ratios are 
calculated between a probe set and 
the median expression value across 
the same probe set across all other 
arrays.  Relative expression values are 
presented.  Boxes are centered 
around 0 and have similar range.  
This is expected given that few genes 
are differentially expressed across 
arrays.     
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A 
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Figure 3.5: Array-array intensity correlations (correlation coefficient) for n=24 
Affymetrix arrays profiling chondrocyte and tenocyte expression across different 
conditions (Group legend).   
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Figure 3.6:  Density (y-axis) distribution of  normalised, log2-transformed, intensity 
data (x-axis) using the RMA (A) or LOESS (B) methods across 24 arrays. There is 
moderate improvement in the reproducibility of  the sample distribution of  the 
intensities using the LOESS technique for normalisation.  Given that this was used 
for the Illumina data it was elected to continue using this technique for Affymetrix 
microarray normalisation  
A. B. 
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3.3.2: Reduction of dimensionality 
 
Principal component analysis 
Unsupervised principal component analysis presented four distinct groups defined 
by experimental condition, Figure 3.7.  The first two principal components 
accounted for over 90 % of the variation using expression data from the 500 most 
co-variant genes (SD3.1). Concurring with findings in Chapter 2 chondrocytes 
and tenocytes in monolayer culture had convergent gene expression profiles at 
passage three. Cells derived from whole cartilage and tendon tissue, when matrix-
depleted, clustered more closely with each other, whilst cells in either alginate or 
fibrin cultures were the most divergent and did not cluster together as previously 
shown.  Of the 500 most covariant genes only 31 matched across both Affymetrix 
and Illumina data sets including, clusterin (Clu), transgelin (Tagln), Tgfβ3, paired-
related homeobox 2 (Prrx2), integrin α11 (Itga11) and glypican 4 (Gpc4).       
Hierarchical clustering 
Unsupervised, hierarchical clustering demonstrated two principal clades consisting 
of samples from monolayer cultures and fibrin cultures containing tenocytes, and a 
second consisting of cells isolated from native tissue and chondrocytes in alginate 
beads, Figure 3.8. 
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Figure 3.7: Principal Component Analysis. Top 500 most co-variant genes from normalised and filtered expression data from 24 samples (data 
points indicate individual arrays with sample type defined by the figure key). Chondrocytes and tenocytes isolated from native tissue and digested 
free of  extra-cellular matrix cluster more closely with each other than with monolayer or three-dimensional cultures.  Chondrocytes derived from 
alginate cultures cluster remote from both monolayer and fibrin constructs, but also from native chondrocytes.  Gene ontology analysis using a 
hypergeometric distribution with Entrez annotated probes from Affymetrix Gene ST 2.0 used as background.  Redundant terms filtered out 
using SimRel (ReviGO). Biological Process (BP) ontology annotations are based upon genes more highly expressed in each specific condition 
relative to the native tissue.  Gene ontology analysis was undertaken on all genes passing differential expression thresholds and not restricted to 
the 500 most covariant genes.   
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Figure 3.8: Heatmap and hierarchical clustering 
Data derived from the 500 most co-variant genes (rows) across 24 samples (columns).  
Using unsupervised clustering the data clusters into two main clades, the first defined 
by monolayer culture and fibrin constructs, the second by isolated native cells and 
alginate cultures.  Expression levels are normalised and scaled by row with red 
indicating high expression and green indicating low expression as defined by the key.  
The row groups legend indicates the group associations defined by the dashed line 
bisecting row clades.  Functional annotation, using DAVID, is not significant for some 
groups.  Row annotations and groups in SD3.1.          
C: Intracellular part | Nitrogen compound metabolic process  
| Transition metal ion binding     
B: No significant functional annotation 
A:  Endoplasmic reticulum | cytoplasm    
D: No significant functional annotation 
Functional Annotation per group (p<0.05) 
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3.3.3: Differential gene expression analysis 
Differential expression analysis of arrays reflected those findings from the Illumina 
dataset, Chapter 2.  The greatest number of differentially expressed genes was 
found between cells isolated from native tissue when compared to passage three 
dedifferentiated chondrocytes or tenocytes – 3863 genes were differentially 
expressed between native chondrocytes and dedifferentiated chondrocytes.  The 
fewest differentially expressed genes were found between passage three 
chondrocytes and tenocytes.  Notably, the comparison of native chondrocytes to 
tenocytes presented fewer differentially expressed genes (n=1771) than the 
comparison between fibrin constructs and alginate beads (n=2251). Full pairwise 
comparison lists are found in supplementary data SD3.2-3.10.    
Chondrocytes: Dedifferentiation transition 
A summary of the most differentially expressed genes is provided in Figure 3.9.  
At passage three, chondrocytes in monolayer were characterized by the high 
expression of the actin-binding protein transgelin, Tagln, an inhibitor of receptor 
tyrosine kinase signaling, Grb14, and galectin, a beta-galactosidase binding lectin 
(Lgals1).  Genes associated with oxidative phosphorylation (ATPase synthase 
subunits, NADH dehydrogenase complexes) were all more highly expressed in 
monolayer cells.  Additionally, as expected, many genes were associated with cell 
cycle and microtubule processes.  Relative to native chondrocytes, collagen I, III, 
V, VIII and XVIII alpha subunits were all more highly expressed in monolayer.   
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|Highest-expression  
Hba1, Chad, Clec3A, Ccl3, Nos2, F13a1, Mmp8, 
Lyz2 
 
|Lowest-expression  
Tagln, Grb14, LgalS1, ArsI, Wisp2, Vgll3, Clec11a, 
Ncam1, Ccdc80 
Native chondrocytes 
Monolayer chondrocytes 
3D culture chondrocytes 
Legend 
Pairwise comparison  
|Highest-expression  
Pi15, Mme, Cxcl13, Flrt2, Ccl20, Postn, Igf1, 
Orm1, Gpmb, Itgb8 
 
|Lowest-expression  
Hba1, Ccl3, Chad, LOC363060, LOC287167, 
F13a1, Mmp8, Lyz2, Serpinb1a, Hbb-b1 
*"
|Highest-expression  
Tagln, Tnfrs11b, Thy1, Cdkn3, Arsi, 
Ccdc80, Fads2, Vgll3, Eno3, Col1a1 
 
|Lowest-expression  
Pi15, Orm1, C3, Cxcl13, Lcn2, Igf1, 
Egln3, Cp, Chi3l, Mmp13 
Figure 3.9: Schematic diagram: Genes showing the most extreme differential expression in pairwise comparisons between different environmental conditions 
for chondrocytes.  In each case extra- and peri-cellular matrix has been depleted.   The direction of  the arrow indicates the direction of  the pairwise 
comparison, e.g. in * genes are expressed more highly in native chondrocytes relative to the monolayer environment. Full differential expression lists, 
including full gene annotations, are found in Supplementary Data 3.2-3.4.  Elements of  schematic are defined in figure legend. Genes are not italicised for 
this figure.    
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‘System development’ annotated genes including receptor-Smad Smad3, and 
inhibitor-Smads Smad6 and Smad7, SoxC group genes Sox12 and Sox4, and Bmp3 
(osteogenin) and Bmp4 were all also more highly expressed in monolayer 
chondrocytes.   Genes with musculoskeletal system development associations 
Mustang/Mustn1, scleraxis/Scx and mohawk/Mkx, investigated in the qPCR 
analysis in Chapter 2, were more highly expressed in monolayer chondrocytes.  
The hindlimb specific homeobox gene, Pitx1, and Pitx2 were also up-regulated in 
this comparison.  Members of the transforming growth factor superfamily Tgfβ1-3 
were all represented in this analysis. The presence of non-muscle myosins and 
tenascin was also confirmed in this study, in addition to the high expression of 
chemokines and their receptors in cells derived from native cartilage.  The CCN 
family was represented by the higher expression of Wisp1 and Wisp2; 
mesenchyme-associated Thy-1 and Snai1, presented in Chapter 2, were also more 
highly expressed in monolayer.   
In native chondrocytes there was higher expression of type II collagen alpha-1 
subunit (Col2a1), decorin (Dcn), aggrecan (Acan), lubricin (Prg4), chitinase 3-like 1 
(Chi3l1), and the matrix metalloproteinases Mmp3 and Mmp13.  The bone 
morphogenetic proteins Bmp6 and Bmp2, interleukin 1-beta (Il-1b), and 
chemokines Cxcl2 and Cxcl16 were also more highly expressed in native 
chondrocytes relative to monolayer.   
Chondrocytes: Re-differentiation transition 
In alginate beads chondrocytes were characterized by the expression of genes 
associated with the regulation of chondrogenesis including Sox4 and SoxD group 
genes Sox6 and Sox5, differentiation factors Egr1 and Egr2, and Bmpr1a and 
Bmpr1b.  Numerous chemokines, some implicated in cartilage pathology, were also 
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more highly expressed in alginate beads relative to monolayer, including: Pi15, 
Cxcl2, Cxcl12, Ccl20, and interleukins Il-6 and Il-7.  The Col2a1 expression 
regulators Sp1 and Sp3 transcription factors were up-regulated in alginate. 
Aggrecanases Adamts5 and Adamts1 were also more highly expressed. 
Chondrogenesis and matrix regulators such as Grem1, Frzb, and Dkk were more 
highly expressed in alginate beads than monolayer or native chondrocytes. 
Alginate cultures in this study were characterized by the increased expression of 
Mmp13, Hif1a, the PI-3K inhibitor Pten, and lower expression of Runx2 relative to 
monolayer, native cartilage and fibrin cultures.    
Monolayer tenocytes 
A summary of the most differentially expressed genes in tenocytes is provided in 
Figure 3.10.  In addition to Tagln, monolayer tenocytes at passage three had 
higher expression of integrin alpha-11 (Itga11), sushi-repeats containing protein 
Srpx, and coiled-coil domain containing protein Ccdc80.  As shown for monolayer 
chondrocytes CCN-family members Wisp1 and Wisp2 and tendon development-
associated genes, Scx, Mkx and Mustn1 were all more highly expressed in 
monolayer tenocytes.  Genes associated with SLIT-ROBO neuronal guidance and 
tendon development in Drosophila, Slit3 and Robo2, were both highly expressed in 
monolayer tenocytes. Concurring with monolayer chondrocyte expression profiles 
inhibitor Smads, Smad6 and Smad7, were more highly expressed in monolayer 
tenocytes than tenocytes from native tendon.    
Native tenocytes   
In comparison to monolayer tenocytes there was higher expression of 
tenomodulin (Tnmd), clusterin (Clu), chondroadherin (Chad), lubricin, and 
chemokines Cxcl2 and Cxcl13 in native tenocytes. The expression of superoxide 
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dismutase (Sod2), frizzled B (Frzb), SRY (sex determining region Y)-box 5 (Sox5), 
angiopoietin-like 4 (Angptl4), was higher in native tenocytes relative to monolayer 
concurring with the equivalent comparison in native chondrocytes.  
Fibrin constructs 
Chemokines, including, Cxcl13, Cxcl5 and Cxcl1 and the interleukins Il-6, Il-1a, Il-
11 and Il-33 were all more highly expressed in tenocytes in fibrin constructs.  
Modulators of the Wnt-signalling cascade, secreted frizzled related proteins Sfrp1, 
2 and 4, and the BMP antagonist gremlin 1, Grem1, were all more highly expressed 
in fibrin constructs.  Dedifferentiated tenocytes had significantly higher expression 
of transcripts to Bmp1, 3, 4, and 6; in contrast higher expression of Bmp2 was 
evident in fibrin constructs.  Relative to native tenocytes expression of tenascin 
N/W, Tnn, and the matricellular integrin ligand periostin, Postn, were significantly 
higher in fibrin constructs.  Tendon development-associated scleraxis (Scx) was 
also more highly expressed.  
Relative to alginate cultures the higher expression of microfibril-associated genes 
Mfap4 and Mfap5, Tnn, Thbs4, Fbln2, and development regulators Mustn1 and 
Meox2 was demonstrated – these have been presented and discussed in Chapter 2.  
Runx2 was more highly expressed in fibrin and monolayer cultures relative to 
native tendon and alginate cultures.    
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Native tenocytes 
Monolayer tenocytes 
3D culture tenocytes 
Legend 
Pairwise comparison  
*"
Figure 3.10: Schematic diagram: Genes showing the most extreme differential expression in pairwise comparisons between different environmental 
conditions for tenocytes.  In each case extra- and peri-cellular matrix has been depleted.   The direction of  the arrow indicates the direction of  the 
pairwise comparison, e.g. in * genes are expressed more highly in native tenoocytes relative to the monolayer environment. Full differential expression 
lists, including full gene annotations, are found in Supplementary Data 3.5-3.7.  Elements of  schematic are defined in figure legend. Genes are not 
italicised for this figure.    
|Highest-expression  
Tnn, Postn, Ccbe1, Mme, Itga11, Rrm2, 
Col8a1, Lum, Lgals, Mki67 
 
|Lowest-expression  
Chad, Ccl3, Clec3A, Htra4, Emcn, Cdh5, 
Mmp12, Eltd1, Cd34, Gpr116 
|Highest-expression  
Chad, Clec3A, Pla2g2a, Ccl3, Htra4, Emnc, 
Mmp12, Cdh5, Mmp3 
 
|Lowest-expression 
Itga11, Tagln, Srpx, Ncam1, Ccdc80, Sgcg, 
Wisp1, Tgfb3, Wisp2 
|Highest-expression  
Pln, Olr1, Tnfsf18, Actg2, Casq2, 
Slco2a1, Trib3, Cryab, Cmklr1 
 
|Lowest-expression  
Cxcl13, Lcn2, Tnn, Slpi, Angptl4, Cxcl5, 
Lum, C1s, Egln3, Cxcl1 
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3.3.4 Functional annotations 
For gene ontology analysis complete, filtered, differential expression lists were 
used.  A summary of significant terms is presented in Figure 3.7. 
Chondrocytes 
Cells isolated from cartilage were annotated with biological process functions: 
‘immune system process’, ‘developmental process’, ‘cellular component 
organisation’, ‘response to stress’ and ‘negative regulation of biological process’.   
In comparison, chondrocytes from monolayer expression profiles were described 
by biological process terms including: ‘cytoskeletal organisation’, ‘biological 
adhesion’, ‘developmental process’, and ‘ossification’.  Notably terms such as 
‘regulation of ossification’, ‘fibril organisation’, ‘skeletal system development’ and 
‘tendon development’ were all gene ontology terms significantly enriched in this 
expression profile.  Notably, the latter term was only found in monolayer 
chondrocyte expression data.     
Functional annotation of gene transcripts found to be more highly expressed in 
chondrocytes within alginate beads, relative to their native counterparts, was 
significantly enriched with terms relating to: ‘metabolic process’, ‘skeletal system 
development’, ‘anatomical structure morphogenesis’, ‘embryonic limb 
morphogenesis’ and ‘regulation of cell differentiation’.   
Full gene ontology lists are found in SD3.15.  Using Ingenuity Pathway Analysis 
general disease, metabolic and physiological functional annotations for 
chondrocytes are provided in Table 3.1.  
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Comparison  IPA descriptors  
Native cartilage to monolayer  DD: Cancer| Cardiovascular disease| Gastrointestinal disease; 
MCF: Cell growth and proliferation | Cell movement | Cell death and survival  
PS: Cardiovascular system development and function | Organismal development | 
Immune cell trafficking | Tissue development  
Monolayer to alginate  DD: Cancer | Organismal injuries and Abnormalities |Reproductive system disease  
MCF: Cell growth and proliferation | Cell death and survival | Cellular movement  
PS: Cardiovascular system development and function | Organismal development | 
Tissue development | Skeletal and muscular system development and function  
Alginate to native cartilage DD:  Inflammatory response | Cardiovascular disease | Connective tissue disease | 
Skeletal and muscular disorders 
MCF:  Cellular movement | Cellular growth and proliferation | Cell death and 
survival 
PS:  Immune cell trafficking |  Hematological system development and function | 
Cardiovascular system development and function | Organismal development  
Table 3.1: Functional descriptors of  differentially expressed gene lists derived using Ingenuity Pathway Analysis.  Legend: DD – 
Diseases and Disorders; MCF: Molecular and Cellular Function; PS: Physiological System Development and Function. Within each 
parent summary term lie numerous ‘child’ terms carrying their own p-values and activation z-scores. In the comparison ‘alginate to native 
cartilage’ the term ‘Skeletal and muscular disorders’ defines ‘Rheumatic Disease’ as the top child term (p=4.31e-24) with a predicted 
decreased activation (z=-2.99).    
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Comparison  IPA descriptors  
Native tendon to monolayer  DD:  Cancer | Cardiovascular disease | Inflammatory response 
MCF: Cell growth and proliferation | Cell death and survival | Cellular 
movement 
PS: Cardiovascular system development and function | Tissue 
morphology | 
Monolayer to fibrin  DD: Inflammatory response | Cancer | Organismal injury and 
abnormalities | Cardiovascular disease  
MCF: Cellular movement | Cellular growth and proliferation | Cellular 
development  
PS: Cardiovascular system development and function | Organismal 
development | Embryonic development | Immune cell trafficking 
Fibrin to Native tendon DD:  Cancer| Cardiovascular disease | Organismal injury and 
abnormalities  
MCF:  Cellular movement | Cellular growth and proliferation | Cell 
death and survival  
PS:  Cardiovascular system development and function | Organismal 
development | Organismal survival | Tissue development  
Table 3.2: Functional descriptors of  differentially expressed gene lists derived using Ingenuity Pathway Analysis.  Legend: DD – Diseases and 
Disorders; MCF: Molecular and Cellular Function; PS: Physiological System Development and Function. Terms for tenocyte comparisons show 
consensus with the same comparisons between chondrocyte conditions.    
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Tenocytes  
In tenocytes isolated from native tissue gene ontology biological process 
annotations included: ‘immune system process’, ‘regulation of metabolic process’, 
‘muscle cell proliferation, ‘vasculature development’, and ‘macromolecule 
catabolism’, SD3.16.   
In comparison, monolayer tenocytes at passage three were annotated with 
biological process terms including: ‘developmental process’, ‘muscle structure 
development’, ‘ossification’, ‘extracellular matrix organisation’, ‘skeletal system 
development’ and ‘Wnt-receptor signaling pathway’.   
Those isolated from fibrin constructs were represented by gene ontology terms 
including: ‘carbohydrate metabolic process’, ‘cell cycle’, ‘developmental process’, 
‘regulation of ossification’, ‘tissue morphogenesis’, ‘regulation of cell 
differentiation’ and ‘tube development’.   
IPA descriptors for tenocytes are presented in Table 3.2.  Functional terms 
associated with cardiovascular disease and cardiovascular system development and 
function were common to both chondrocyte and tenocyte analyses.    
In comparisons of three-dimensional culture systems alginate beads were 
significantly enriched for general terms associated with, ‘metabolic process’, 
‘organic substance metabolic process’ and ‘nitrogen compound metabolic process’, 
but additionally with more specific terms, including – ‘stem cell differentiation’ 
and ‘anatomical structure formation involved in morphogenesis’.  In contrast, cells 
isolated from fibrin cultures had a gene expression profile that was reflected in the 
terms: ‘cytoskeletal organisation’, ‘cardiovascular system development’, ‘cell 
adhesion’, ‘regulation of anatomical structure morphogenesis’, SD3.17.  
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3.3.5: Consensus of differentially expressed genes across cell types 
As shown in Figure 3.3 the depletion of peri-cellular matrix resulted in a co-
clustering of native tenocytes and chondrocytes relative to other conditions. A 
pairwise comparison between native tenocytes and chondrocytes and monolayer 
equivalents was prepared with the intention of defining a consensus gene 
expression profile for dedifferentiation, SD3.11. There were 2538 genes that were 
common to the dedifferentiation transition for chondrocytes and tenocytes.  In 
Figure 3.11 an overview of consensus gene expression and tissue-specific findings 
are presented.   
Functional annotation of native to monolayer dedifferentiation genes 
Gene ontology biological process functional annotations (DAVID) were used to 
present consensus genes in a functional context; the number of genes and false 
discovery rate (FDR) for each term are provided.  Genes listed were contained 
within each gene ontology term and were common to both chondrocytes and 
tenocytes.    
Native chondrocytes and tenocytes shared genes with functional annotations 
relating to ‘regulation of cellular process’ (FDR=1.6e-26; 444 genes; Sp1, Sp3, Sp4, 
Timp3, Atf3, Igf2), ‘regulation of gene expression’ (FDR=3.6e-13, 197 genes; Klf4, 
Klf6 and Klf9, Pou2f1, ApoE, Foxo1, Foxo3), ‘response to oxygen levels’ 
(FDR=8.7e-4; 30 genes; Hif1a, Tlr2, Tgfb1, Angptl4), ‘immune response’ 
(FDR=5.7e-5; 53 genes; Ccl3, Il-1a, Il-1b), ‘regulation of cell differentiation’ 
(FDR=2.3e-4; 59 genes; Sox5, Klf4, Bmp2, Clu, Fgf9, Tgif1, Jun).      
Dedifferentiated chondrocytes and tenocytes in monolayer shared functional 
annotations related to: ‘cell cycle’ (FDR=2.1e-6; 68 genes; Ilk, Ccnb2, Aurkb); 
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‘cytoskeleton organisation’ (FDR=3.2e-6; 52 genes; Dbn1, Eln, Itgb1, Myh10, Thy-
1); ‘extracellular matrix organisation’ (FDR=1.3e-3; 20 genes; Adamts2, Ccdc80, 
Col1a1, Col3a1, Tgfb2) and ‘developmental process’ (FDR=3.4e-5; 237 genes; 
Meis1, Smad3, Smad6, Smad7, Fgf10, Fzd1, Fzd2, Meox2, Mkx, Pitx1, Snai1).   
Genes unique to a tissue comparison were extracted from the expression profiles 
and are available in SD3.12-3.13. 
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Figure 3.11: Euler diagram: Overlap between differentially expressed gene lists was evident in Affymetrix data in the native cell to monolayer 
transition.  There were 2538 genes that were differentially expressed in common.  Genes that were unique to a tissue-specific comparison were 
considered in terms of  their log2-fold change and annotated with gene ontology terms. Selected genes are provided based upon the fold-change 
and relevance in the literature.  Gene ontology terms were all significant at p<0.05 after Benjamini-Hochberg (FDR) correction.   
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3.3.6: Comparison of independent data sets identifies tissue-associated 
genes targets for expression validation 
In order to explore gene expression profiles that may be unique to native cartilage 
or native tendon, and so isolate tissue-associated gene profiles within 
heterogenous samples, differentially expressed genes were considered from both 
Illumina and Affymetrix data sets.  Only those genes differentially expressed in 
both studies were considered.  Across the two datasets there were 311 genes 
common to both differential expression lists, of which 71 did not match in the 
direction of the fold-change, Figure 3.12, SD3.14.  There was a moderately high 
correlation between the fold changes of these common genes (non-matches 
included), cor = 0.66, p < 2.2e-16).  
For tendon-derived cells several genes were identified which showed higher 
expression relative to cartilage, with log2 fold change > 1.5 in both data sets, 
including: Tnmd, Serpinf1, Igfbp6, Cxcl13, Cpxm2, Mfap5, and Aspn. Within the gene 
lists Meox2, Mustn1, Thbs4 and Thbs2, and Prrx1 were also represented, but had 
more divergent fold changes between data sets.  When these ‘tendon-associated’ 
genes were functionally annotated using gene ontology terms the following 
biological process and cellular compartment terms were significant (p<0.05): 
‘blood vessel development’, ‘developmental process’, ‘extracellular matrix’.  
Tendon or muscle-associated gene ontology terms were not present.     
For cartilage-derived cells considered relative to tendon high consensus expression 
was noted for Col2a1, Mmp8, Serpinb1a, Sell and Ibsp.  Cartilage-associated genes 
were annotated with the following functional terms: ‘defense response’, 
‘extracellular region’, ‘bio-mineral formation’. 
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Figure 3.12: Correlation scatterplot:  
Genes found to be differentially expressed between native cartilage (top right 
quadrant) and tendon (bottom left quadrant) in both Illumina (x-axis) and Affymetrix 
(y-axis) dat sets plotted by log2 fold change.  For clarity only some data points are 
annotated.  Full lists are available in SD3.14.  Data points are defined in figure legend.  
Where genes have the same directional change the data point is defined as a dark dot, 
whereas genes with conflicting (anti-correlated) expression changes are defined as grey 
points (see relationship legend).  For tendon Tnmd, Igfbp6, Serpinf1, Mfap5 and Ecm1 
are all highly expressed in two independent datasets.  For cartilage Col2a1, Serpinb1a, 
Mmp8, Defa5 and Ibsp are confirmed to be highly expressed.   
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3.3.7: Pathway topology analysis defines PI-3K signalling as 
differentially activated between monolayer and three-dimensional 
cultures 
The activity status of canonical KEGG pathways was inferred by SPIA using all 
filtered genes within a pairwise comparison and their log2 fold change as the effect 
size.  Pathways significant after FDR adjustment are presented. The conditions are 
represented in Figures 3.13-3.14.   
Chondrocytes   
The transition from native chondrocytes (baseline condition) to the 
dedifferentiated state was defined by activation of the canonical KEGG pathways: 
‘osteoclast differentiation’, ‘chemokine signalling pathway’ and ‘PI-3K/Akt 
pathway’.  With monolayer chondrocytes as the baseline the re-differentiation 
transition was defined by activated pathways: ‘focal adhesion’, ‘cell cycle’ and 
‘extra-cellular matrix-receptor interaction’; the ‘PI-3K/Akt pathway’ was predicted 
as inhibited, along with the associated ‘HIF-signalling’ and ‘FOXO-signalling’ 
pathways.  Comparing alginate beads to native chondrocytes the most significant, 
activated pathways were: ‘PI-3K/Akt pathway’, ‘cytokine-cytokine receptor 
interaction’ and ‘Ras signalling pathway’.  Full lists are available in SD3.18. 
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|KEGG   
+ Osteoclast differentiation    
+ Chemokine signalling pathway   
+ PI3K-AKT signalling   
 
- Focal adhesion 
- Cell cycle 
- FoxO signalling pathway 
|KEGG  
+ PI3K-AKT signalling 
+ Cytokine-cytokine receptor interaction 
+ Ras-signalling 
 
- ECM-receptor interaction 
- Focal adhesion  
- Osteoclast differentiation 
|IPA  
•  Hepatic stellate cell activation; 
•  Atherosclerosis  signaling  
•  Aryl hydrocarbon receptor signalling;  
•  p53 signalling; 
•  Integrin signalling.   
|IPA 
•  Granulocyte adhesion & diapedesis; 
•  Atherosclerosis signaling 
•  LXR/RXR activation; 
•  Hepatic stellate cell activation. 
|KEGG   
+ Focal adhesion;  
+ Cell Cycle; 
+ ECM-receptor interaction.  
 
- HIF-1 signalling pathway; 
- FoxO signalling pathway; 
- PI3K-AKT signalling pathway. 
|IPA 
•  Hepatic stellate cell activation; 
•  Acute phase response signalling 
•  Axonal guidance signalling. 
•  Role of  osteoblasts, osteoclasts and  
chondrocytes in rheumatoid 
arthritis 
TP53, TGFβ1, HRAS, HGF, 
PDGF BB, TNF, IL6, IL1B 
Native chondrocytes 
Monolayer chondrocytes 
3D culture chondrocytes 
Legend 
Pairwise comparison  
Common upstream regulators  
Canonical signalling pathways inferred 
using SPIA Pathway Topology and 
Ingenuity Pathway Analysis 
Figure 3.13: Schematic diagram.  Differentially 
expressed genes from chondrocyte comparisons used for 
pathway topology analysis and pathway prediction.  
Pathways are predicted as activated (+) or inhibited (-).  
Arrows indicated the direction of  the comparison.  Most 
significantly perturbed KEGG pathways are shown; 
Ingenuity (IPA) canonical pathways enriched with the 
same data sets are shown.  Common upstream regulators 
are predicted by IPA (box).   
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Native tenocytes 
Monolayer tenocytes 
3D culture tenocytes 
Legend 
Pairwise comparison  
Common upstream regulators  
Canonical signalling pathways inferred 
using SPIA Pathway Topology and 
Ingenuity Pathway Analysis 
Figure 3.14: Schematic diagram.  Differentially 
expressed genes from tenocyte comparisons used for 
pathway topology analysis and pathway prediction.  
Pathways are predicted as activated (+) or inhibited (-).  
Arrows indicated the direction of  the comparison.  Most 
significantly perturbed KEGG pathways are shown; 
Ingenuity (IPA) canonical pathways enriched with the 
same data sets are shown.  Common upstream regulators 
are predicted by IPA (box).   
|KEGG   
+ PI3K-AKT signalling; 
+ Chemokine signalling pathway; 
+ Cytokine-cytokine receptor interaction. 
 
- Cell cycle; 
- Transcriptional mis-regulation in cancer; 
- Focal adhesion. 
|KEGG   
+ Cell cycle; 
+ p53 signalling pathway; 
+ Focal adhesion. 
 
- Transcriptional mis-regulation in cancer; 
- PI3K-Akt signalling pathway; 
- Axon guidance/ 
|KEGG   
+ MAPK signalling pathway  
+ Transcriptional mis-regulation in cancer 
+ ECM-receptor interaction 
 
- Cytokine-cytokine receptor interaction 
- HIF-1 signalling pathway 
- PI3K-Akt signalling pathway |IPA 
•  Hepatic stellate cell activation; 
•  NRF2-mediated oxidative stress response; 
•  Role of  macrophages, fibroblasts and 
endothelial cells in rheumatoid arthritis. 
|IPA 
•  Role of  osteoblasts, osteoclasts, and  
chondrocytes in rheumatoid arthritis, 
•  Hepatic stellate cell activation, 
•  Granulocyte adhesion and diapedesis 
•  Role of  macrophages, fibroblasts and 
endothelial cells in rheumatoid arthritis 
|IPA  
•  Granulocyte adhesion & diapedesis, 
•  NRF-2 mediated oxidative stress response; 
•  Hepatic stellate cell activation 
•  Inhibition of  matrix metalloproteinases; 
TP53, TGFβ1, PDGF BB, 
TNF, IL1B, LPS, ERBB2 
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Tenocytes 
In tenocytes derived from native tendon tissue there was remarkable overlap with 
chondrocytes in the predicted activated canonical pathways, Figure 3.14.  The ‘PI-
3K/Akt pathway’ was predicted as activated in the dedifferentiation transition, 
plus ‘cytokine-cytokine receptor interaction’.  For the re-differentiation transition 
there was predicted activation of: ‘MAPK signalling pathway’, ‘transcriptional mis-
regulation in cancer’, ‘ECM receptor signalling pathway’, but inhibition of the ‘PI-
3K/Akt pathway’.   In fibrin cultures the expression profile relative to native tissue 
predicted activation of the canonical pathways ‘cell cycle’, ‘p53 signalling pathway’, 
‘focal adhesion’ and ‘FOXO signalling pathway’.  In contrast to the same 
comparison in chondrocytes there was predicted inhibition of the ‘PI-3K/Akt 
pathway’.  Full lists in SD3.19.      
3.3.8: Ingenuity® Pathway Analysis confirms PI-3K activation in 
mechanistic networks  
As previously described, Ingenuity® Pathway Analysis (IPA) was used to further 
infer key regulators and mechanistic networks for the Affymetrix dataset. 
Ingenuity® analysis defined several master regulators, the activation status of which 
was consistent with the differential expression analysis provided from different 
pairwise comparisons, Figure 3.15-3.16.  To explore the PI-3K signalling pathway 
predictions made using pathway topology in 3.3.7 two highly significant upstream 
regulators were chosen from IPA analysis, the PI-3K activator PDGF BB and the 
small-molecule inhibitor of PI-3K signalling, LY294002. The PI-3K signalling 
pathway was predicted to be active in the native to monolayer comparison, whilst 
inhibited in the monolayer to three-dimensional culture comparison for both 
chondrocytes and tenocytes.   
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For the dedifferentiation transition, Figure 3.15, the differential gene expression 
profiles were consistent with PEDF BB activation in chondrocytes (z-score = 3.64, 
p = 2.4e-22) and tenocytes (z-score = 3.86, p = 4.7e-39).  The expression profiles 
of chondrocytes (z-score = -1.68, p = 1.8e-18) and tenocytes (z-score = -3.14, p = 
1.7e-23) from native to monolayer were inconsistent with the suppression of the 
PI-3K pathway by inhibitor LY294002, i.e. consistent with PI-3K pathway 
activation in native cells.  The activation of the PI-3K pathway in native 
chondrocytes and tenocytes concur with the findings from pathway topology 
analysis.    
In the re-differentiation transition, Figure 3.16, monolayer to three-dimensional 
cultures, for both cell types, pathway inhibition by LY294002 was predicted, 
indicated by positive z-scores:  chondrocytes (z-score = 3.5, p = 6.8e-17), 
tenocytes (z-score = 5.19, p = 5.98e-26).  The converse was true for PEDF BB 
with inhibition predicted in chondrocytes (z-score = -4.78, p = 4.56e-30) and 
tenocytes (z-score = -6.85, p = 1.04e-48).  These findings supported PI-3K 
pathway inhibition in monolayer cells and the converse in cells in three-
dimensional cultures.   
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Figure 3.15: IPA Mechanistic Network: 
Using the PI-3K small molecule inhibitor LY294002 (see 
Figure 3.1) as the core upstream regulator the mechanistic 
network presented is coded with differential expression 
values for the dedifferentiation transition from native 
chondrocytes to monolayer chondrocytes.  Here up-
regulated genes (red) represent higher expression in native 
chondrocytes.  The figure legend describes the predicted 
activation status for other genes in the network.  Ingenuity 
Pathway Analysis predicts that the gene expression profile 
is consistent with PI-3K signalling activation, i.e. LY294002 
not applied. The PI-3K activator PDGF BB is predicted to 
be active.  In this mechanistic network native chondrocytes 
have higher expression of  IL-1B, JUN, ATF3, and NFkB.  
Components of  the PI-3K complex show lower express 
and the PI-3K inhibitor PTEN is predicted to be inhibited. 
The most significant functional annotation ‘differentiation 
of  connective tissue cells’ (p=2.4e-26, 24 genes) shows 
‘activation’ where genes native chondrocytes are more 
highly expressed consistent with the differentiated state.   
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Figure 3.16: IPA Mechanistic Network: 
Using the PI-3K small molecule inhibitor LY294002 as the 
core upstream regulator the mechanistic network presented 
is coded with differential expression values for the re-
differentiation transition from monolayer chondrocytes to 
alginate beads.  Here up-regulated genes (red) represent 
higher expression in monolayer chondrocytes.  The figure 
legend describes the predicted activation status for other 
genes in the network.  Ingenuity Pathway Analysis predicts 
that the gene expression profile is consistent with PI-3K 
signalling inhibition through the application of  LY294002.  
The PI-3K activator PDGF BB is predicted to be inactive.  
In this mechanistic network chondrocytes in alginate beads 
have higher expression of  IL-6, JUN, ATF3, components 
of  the PI-3K complex and the PI-3K inhibitor PTEN.  
The functional annotation ‘differentiation of  connective 
tissue cells’ (p=2.4e-26, 24 genes) shows ‘inhibition’ where 
genes in monolayer are more highly expressed.   
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3.4: Discussion  
 
3.4.1: Study design and rationale  
The experimental design in Chapter 2 compared three three cellular environments 
– native tissue, passage five monolayer and three-dimensional culture systems – 
for chondrocytes and tenocytes.  Useful comparisons that would elucidate core 
regulatory pathways in de- and re-differentiation were confounded by the 
complexity of tissue-specific matricellular components and heterogenous cell 
populations, e.g. blood cells.  To resolve this complexity extra- and peri-cellular 
matrix was depleted by enzymatic digestion in all conditions.  This intervention 
also acted as a relevant system perturbation as loss of matrix components is 
common to degenerative disease in cartilage and tendon.  Furthermore, 
underpowered group sizes for some conditions in Chapter 2 (fibrin cultures, n=2) 
could not be resolved as production of the Illumina microarray platform ceased.  
Consequently a novel microarray platform was employed. 
Key findings 
Gene expression analysis demonstrated considerable overlap in differentially 
expressed genes between chondrocytes and tenocytes during de- and re-
differentiation transitions suggesting a common regulatory pathway could be 
present.  The well-annotated Affymetrix array defined extensive development-
associated gene expression in monolayer and three-dimensional cultures for 
chondrocytes and tenocytes.  There were fewer differentially expressed genes 
found between native cells than between three-dimensional culture-derived cells.  
By comparing differentially expressed genes common to cartilage or tendon in 
both Affymetrix and Illumina data sets it was possible to refine a list of tissue-
associated genes beyond those found in the published literature.  Pathway 
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topology analysis of matrix-depleted chondrocytes and tenocytes from three 
conditions defined PI-3K/Akt signalling as the common regulatory pathway, 
active in native cells and three-dimensional cultures, and inhibited in monolayer 
culture.    
3.4.2: Development-associated genes show higher expression in 
monolayer 
Evidence was presented in Chapter 2 indicating a trend toward the higher 
expression of musculoskeletal development-associated genes during 
dedifferentiation, but this was not consistent and several key genes were not found 
in the microarray gene lists.  In this independent dataset there is further support 
for the statement that dedifferentiated cells shows a gene expression profile 
associated with musculoskeletal developmental stages.      
At passage three differential expression analysis demonstrated higher expression 
of scleraxis (Scx), Mustang (Mustn1) and mohawk (Mkx) gene transcripts in both 
chondrocytes and tenocytes.  The author alludes to the common origin of limb 
tendon and cartilage progenitor cells presented in the Chapter 1 and the relevance 
of scleraxis and mohawk to tenogenesis.  The role of Mustang is now well-
described in chondrogenesis (Lombardo, Komatsu et al. 2004, Gersch and 
Hadjiargyrou 2009) and has recently been demonstrated to have a role in the 
regulation of differentiation of myoblasts (Liu, Gersch et al. 2010, Krause, Moradi 
et al. 2013) likely to be under AP-1 (Fos-Jun dimer) transcriptional activation (Liu 
and Hadjiargyrou 2006).  Given the co-expression of Mustang in areas of 
chondro- and myo-genesis the expression profile should be further investigated in 
tendon.  In Chapter 2 significantly higher expression of Mustn1 was shown in 
fore- and hind-limb tendons relative to hip cartilage from adult rats.  In this 
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Affymetrix dataset higher expression is also noted in native tendon relative to 
native cartilage.  This is consistent with previously published findings of high 
expression of Mustang in adult skeletal muscle and tendon (Lombardo, Komatsu 
et al. 2004).  Whilst further studies have begun to elucidate the relevance of 
Mustang to cartilage and muscle differentiation further work, including confirming 
marker status in adult tissue, is required for tendon.   
3.4.3: Identification of genes expression profiles unique to native 
tenocytes and chondrocytes 
Other than markers of tendon progenitors such as scleraxis, or mature tendon, 
tenomodulin (Tnmd), few tissue-specific markers exist for tendon.  Using a 
consensus differential expression list from the Illumina and Affymetrix data genes 
with comparable fold changes were considered.  Using this approach it was 
possible to begin to deconstruct the expression profiles defined in Chapter 2, 
which were confounded by heterogenous cell populations.  Of the most 
consistently highly expressed genes, Tnmd, Igfbp6, Prrx1, Ker, and Aspn, many have 
been described elsewhere as being strongly representative of tendon relative to 
other tissues (Jelinsky, Archambault et al. 2010).  This analysis contributes several 
novel candidates for tissue-associated genes, exhibiting consistently higher 
expression in tendon, for further validation including Serpinf1/Pedf, Cxcl13, Ecm1 
and Cpxm2.  
Mutations in Serpinf1, which encodes pigment epithelium-derived factor (PEDF), 
are responsible for the phenotype of osteogenesis imperfect (OI) type VI (Homan, 
Rauch et al. 2011).  The spectrum of genetic disorders resulting in the phenotype 
of bone fragility in OI is derived from mutations affecting the structure and/or 
synthesis of Type I pro-collagen. However, OI type VI arises from defects in 
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normal bone mineralization and a recent study suggested that type I collagen 
formation is normal in these patients. PEDF is collagen binding and has 
interactions with multiple extracellular matrix components including heparin 
sulphate proteoglycans (HSPG) and hyaluron.  The PEDF-binding motif in the 
collagen triple helix is overlapping with that of heparin/HSPG and is competed by 
it; these motifs also localize to the covalent cross-linking sites between the 
collagen molecules (Sekiya, Okano-Kosugi et al. 2011). It is likely that these genes 
have key physiological actions in these cells and may not represent tissue-specific 
markers, e.g. Serpinf1 shows higher expression in cultured chondrocytes that in 
native chondrocytes.  This study supports the higher expression of Serpinf1 in 
isolated native tenocytes (Affymetrix) and whole tendon (Illumina), however, the 
physiological role of PEDF in mature tendon has yet to be elucidated.   
For cartilage, given the greater availability of data defining novel, or candidate, 
tissue markers is less likely, however, adding to the reference of healthy cartilage 
expression profiles is relevant.  For example, the high expression of Mmp8 
(neutrophil collagenase) is found; together with Mmp13, Mmp8 forms the 
collagenase superfamily.  Mmp13 is well described as a mediator of cartilage 
degradation, however, Mmp8 is expressed in chondrocyte development and in 
mature articular cartilage (Sasano, Zhu et al. 2002), and may have a protective role 
in arthritis (García, Forteza et al. 2010). 
3.4.4: The PI-3 kinase/Akt pathway in de- and re-differentiation is a 
common to chondrocytes and tenocytes 
In Chapter 2 there was no clear prevailing signaling pathway defined for de- and 
re-differentiation transitions using a pathway topology approach.  This may have 
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arisen due to the inherent matricellular differences and complexity of the samples 
from native tissue.   
As described in Chapter 1 common approaches to defining the signalling 
pathways resulting in a particular phenotype have relied on two standard statistical 
techniques, over-representation analysis and functional class scoring.  Both of 
these techniques are limited by the fact that they fail to account for dependencies 
and interactions at a systems level; by considering each element of a pathway 
independently these techniques do not provide a unified understanding of the 
system (Khatri, Draghici et al. 2007).  For both the Illumina and Affymetrix data 
sets an impact analysis method was employed to determine the most perturbed 
signalling pathways in a given context.  This methodology combines the 
magnitude of gene expression changes, statistical analysis of a set of pathway genes 
and incorporates knowledge of the pathway topology, signalling interactions and 
position of differentially expressed genes within a pathway.  Against traditional 
techniques impact factor analysis has been shown to be more sensitive and specific 
(Tarca, Draghici et al. 2009).      
In this study the PI-3K/Akt signalling pathway was shown to be active in native 
cells and inhibited in monolayer cultures. The activation status was conflicted 
when alginate or fibrin cultures were compared to their respective native cells 
using SPIA.  However, the pathway was considered to be active in both three-
dimensional cultures when a restricted expression profile was analysed using 
Ingenuity® Pathway Analysis.  It is possible that within three-dimensional cultures 
a re-activation of PI-3K signaling may occur, associated with a redifferentiation 
phenotype, that may result in conflicted categorical predictions of pathway status 
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when expression profiles are compared to native cells where the pathway is also 
active.     
The PI-3K/Akt signalling pathway has been implicated in a range of physiological 
activities including dedifferentiation, proliferation, matrix synthesis and cell 
survival (Beier and Loeser 2010). Cellular effects are regulated through a broad 
range of downstream targets including mTOR, NF-κB, GSK-3B and p53 (Chen, 
Crawford et al. 2013).  
The promotion of matrix synthesis and survival by PI-3K signalling in 
chondrocytes has been demonstrated in a number of studies. Enhanced 
proteoglycan synthesis by IGF1-mediated stimulation of chondrocytes, either in 
monolayer or alginate beads, is PI-3K/Akt/mTOR-mediated, possibly by 
promotion of translational activity (Starkman, Cravero et al. 2005). Constitutive 
expression of Akt in human articular chondrocytes resulted in the significant 
increase of proteoglycan synthesis and elevated Sox9 and Col2a1 expression (Yin, 
Park et al. 2009); in contrast, oxidative stress is shown to inhibit these IGF1-
induced effects (Oh and Chun 2003, Yin, Park et al. 2009). Recently, the negative 
regulator of PI-3K signaling Pten, when down-regulated by siRNA, was shown to 
result in an increase in the expression of hallmarks of differentiated cartilage and 
promoted proteoglycan synthesis under oxidative stress conditions (Iwasa, 
Hayashi et al. 2014), thereby confirming the pro-matrix effects of PI-3K signalling.   
Much of our understanding of PI-3K effects on chondrocyte differentiation arises 
from the study of endochondral ossification. PI-3K signalling is critical for long 
bone formation, as demonstrated by Akt knockout mice (Ulici, Hoenselaar et al. 
2009) and in the terminal differentiation of chondrocytes in the growth plate 
 223 
(Ulici, Hoenselaar et al. 2008).  A number of studies implicate the wider PI-3K 
pathway as being of relevance in the differentiation status of chondrocytes or 
MSCs (Chen, Crawford et al. 2013).  
The manner by which PI-3K signalling is involved in the balance of chondrocyte 
survival and terminal differentiation is not clear.  Kita, et al (2008), reported that 
conditional Akt activation in organ cultures suppressed the expression of markers 
of chondrocyte hypertrophy whilst increasing proliferation. Furthermore, 
inhibition of PI-3K signalling increased chondrocyte terminal differentiation and 
resulted in reduced bone length in a an embryonic fore-limb culture (Kita, Kimura 
et al. 2008).  Reduced bone length, proliferative and hypertrophic growth plate 
zones were also reported by Ulici, et al (2008) in response to pharmacological 
inhibition of PI-3K by LY294002 (Ulici, Hoenselaar et al. 2008); this study 
reported that PI-3K inhibition suppressed early and late markers of chondrocyte 
differentiation, rather than enhancing hypertrophic differentiation.  
Phosphorylated Akt was found, however, throughout the late proliferative and 
early hypertrophic chondrocytes in the growth plate.    Ikegami, et al (2011) found 
that constitutive expression of Sox9 in the developing mouse growth plate was 
essential for chondrocyte survival and subsequent hypertrophy by promotion of 
Akt phosphorylation (Ikegami, Akiyama et al. 2011) supporting a pro-hypertrophy 
role for PI-3K signalling.  This study also stated that PI-3K/Akt signalling 
retarded the transition to hypertrophic differentiation from the proliferative state 
during endochondral ossification; temporal expression of Runx2 would, however, 
drive terminal differentiation in concert with PI-3K signalling.    
Comparison of in silico predictions in this study with previous in vitro work is 
problematic.  The studies above consider the findings of their investigations in 
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isolated terms and so also the status of the pathway under investigation is defined 
by binary expression of individual elements.  Pathway topology techniques define, 
on the basis of global perturbations, the activation status across multiple pathways.    
Novel findings in this study, employing pathway topology analysis using canonical 
KEGG pathways and inference of upstream regulators by Ingenuity® Pathway 
Analysis, supported activation of PI-3K signalling in native chondrocytes and 
tenocytes.  This is consistent with a pro-differentiation, pro-matrix role for PI-3K 
signalling.  In contrast, monolayer culture was associated with a predicted 
inhibition of PI-3K activity.  In both native chondrocytes and tenocytes this 
analysis shows the increased expression of PI-3K inhibitor Pten phosphatase 
relative to monolayer culture, but also higher expression of Pten in monolayer 
chondrocytes relative to alginate cultures.  If the activation status of the PI-3K 
pathway were considered prima facie this would imply that the pathway was 
inhibited in both transitions by Pten expression.  However, because of the 
inclusion thresholds set by IPA the expression levels of Pten in native 
chondrocytes and tenocytes were considered too low and this exclusion may 
influence the activation status predicted.  Clearly validation of the mRNA and 
protein levels of PI-3K pathway components is required.       
The interplay between PI-3K and other pathways requires further discussion.  In 
the mechanistic networks generated by IPA the top upstream regulators were 
TGF-β, IL-6 and IL-1β.  It is possible to rationalize these predicted regulators 
with known PI-3K signalling interactions. 
In human articular chondrocytes phosphorylation of Akt has been found 
following exposure to IL-6 (plus soluble IL-6R) or oncostatin M (OSM) 
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(Litherland, Dixon et al. 2008).  In contrast IL-1 exposure alone did not result in 
Akt activation.  The PI-3K inhibitor LY294002 inhibited cartilage degradation in 
the presence of IL-1+OSM with a concentration dependent reduction in the 
induction of MMP1 and MMP13.  Given the strong evidence for the role of 
mediators such as IL-6 and OSM in cartilage ECM degradation the role of PI-
3K/Akt in cartilage destruction is relevant.  Shakibaei, et al (2007) presented 
evidence to support inhibition of phosphorylation of Akt by curcumin as a 
mechanism to suppress Il-1β -mediated up-regulation of COX2 and MMP9 
(Shakibaei, John et al. 2007).    
The balance of anabolic or catabolic processes in cartilage in response to PI-3K 
signaling may be ligand specific (Beier and Loeser 2010). TGF-β, by binding to cell 
surface receptor serine/threonine kinases, initiates signal transduction via SMAD 
and non-SMAD signaling pathways; transduction through the PI-3K/Akt/mTOR 
pathway has been described for chondrocytes. Qureshi, et al (2007) found that 
TGF-β stimulation of human chondrocytes activated Akt in a delayed manner; this 
induction was suppressed by PI-3K and Akt inhibitors (Qureshi, Ahmad et al. 
2007).  Rapamycin, an inhibitor of mTOR, suppressed transcription of the tissue 
inhibitor of metalloproteinases-3, TIMP3, in response to TGF-β stimulation.  This 
suggested that, in part, TGF-β signaling occurred through pro-matrix PI-
3K/Akt/mTOR signalling. Recently signaling through Akt/mTOR, following 
TGF-β activation, was required for the expression of chondrogenesis-associated 
genes in mouse pre-cartilaginous stem cells (Li, Wang et al. 2014). 
Whilst it must be recognised that the prevailing signals resulting in these gene 
expression profiles arise from the interplay and convergence of multiple signalling 
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pathways the dominance of PI-3K/Akt signalling in this study provides a strong 
rational for further investigation.  
In conclusion, the PI-3K/Akt signaling pathway has established effects on the 
differentiation, matrix synthesis, survival, and homeostasis of chondrocytes; 
additionally key roles in the regulation of inflammatory mediators and downstream 
effector pathways, such as NF-κB, implicates PI-3K/Akt signaling further in 
chondrocyte dysregulation. Some intervention studies have suggested modulation 
of this pathway as a mechanism for the treatment of osteoarthritis (Chen, 
Crawford et al. 2013).  In a study of tendon-derived stem cells PI-3K signaling was 
associated with a promotion of osteogenic differentiation implicating this signaling 
cascade in tendon calcification (Liu, Chen et al. 2013). In this chapter evidence 
suggests involvement of PI-3K/Akt signalling in the mediation of de- and re-
differentiation for both chondrocytes and tenocytes.  Clearly the complexity of the 
pathway is lost in categorical descriptions of pathway activation – the ratio of PI-
3K isoforms, the Akt subunit targeted, the downstream effector signaling cascade, 
and activation state/phosphorylation, cannot be interpreted from this data.  
Further work with immunoblotting, qPCR, small-molecule inhibition and further 
genome-wide transcriptome analysis would be required to validate these findings. 
3.4.4: Data and study limitations 
In line with the majority of microarray studies investigations the study presented 
here is likely to be underpowered, with four biological replicates in each group.  
The use of isogenic rats and paired tissue samples should mitigate this to some 
extent by reducing the signal-to-noise ratio.  Although considerable overlap is 
demonstrated in differential gene expression between the Illumina and Affymetrix 
studies the greatest correlation is evident only for highly differentially expressed 
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genes.  That comparable expression profiles are evident across two microarray 
platforms increases the confidence of these findings.  This comparability also goes 
some way to explain that the close association in expression profiles between 
matrix-depleted native chondrocytes and tenocytes in this study is not a response 
to extended enzymatic digestion protocols alone.  
It is not unexpected that a strong comparison in pathway prediction between the 
Illumina and Affymetrix datasets is not found.  In the former monolayer cells were 
considered at passage five, the latter at passage three.  Chondrocytes in alginate 
beads were only retained in situ for seven days to match the total culture period for 
fibrin constructs; in the Illumina study alginate beads spent two weeks in culture.  
Furthermore, by depleting the matrix in this study the sample complexity was 
reduced relative to the Illumina study.     
Methodological and conceptual evolution of systems biology is still required. 
Issues associated with pathway analysis include the lack of consistent appraisal, no 
consensus on the representation of pathways in knowledge-bases, varied 
definitions of a pathway, failure to reproduce pathway analysis results, and the lack 
of integration with biochemical models, lack of condition or tissue-specificity, or 
inclusion of time-dependent models, for example, developmental stages (Mitrea, 
Taghavi et al. 2013, Conesa and Mortazavi 2014). Most functional annotation 
databases are not dynamic, rather they are biased by the weight of publications 
toward high impact research topics such as cancer and neurodegenerative disease.  
The boundaries of pathway definitions and gene annotations are often arbitrary, 
incomplete, and the functional assignment of genes is often redundant or 
nebulous.  However, methodology presented here goes some way to 
deconstructing the gene expression profile associated with in vivo complexity and 
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isolating the regulatory pathways involved in chondrocyte and tenocyte responses 
to changes in the three-dimensional environment.   
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Appendix 3 
 
R Codes  
 
Processing and analysis of raw Affymetrix microarray data  
setwd("/Users/XXX") 
 
library(oligo) 
library(pd.ragene.2.0.st) 
library(ragene20sttranscriptcluster.db)  
#library(ragene20stprobeset.db) 
 
 cels<-list.celfiles(full.names=TRUE) 
 affymetrix.data<-read.celfiles(cels) 
 
affy.corrected<-
rma(affymetrix.data,normalize=FALSE,target="core") 
  
######################################################## 
####NON-SPECIFIC FILTERING############################## 
######################################################## 
  
library(genefilter) 
  
filter<-
nsFilter(affy.corrected,require.entrez=FALSE,var.func=IQR,v
ar.cutoff=0.5,var.filter=TRUE,filterByQuantile=TRUE, 
feature.exclude="^AFFX",remove.dupEntrez=FALSE) 
  
 affy.filtered<-filter$eset  
 dim(exprs(affy.filtered)) 
 
######################################################## 
####LOESS NORMALISATION################################# 
######################################################## 
##tidy-up and release memory 
#rm(cels, affy.corrected,affymetrix.data,filter,affy.filtered) 
library(WGCNA) 
collectGarbage() 
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detach("package:WGCNA") 
 
 
 
library(limma) 
affy.loess<-normalizeCyclicLoess(exprs(affy.filtered), 
weights = NULL, span=0.7, iterations = 3, method = "affy") 
  
 save(affy.loess,file="AFFY2014_loess_filtered.RData") 
######################################################## 
####CONTRAST MATRIX FOR MODEL########################### 
######################################################## 
 design<-model.matrix(~0+factor( 
 c(1,1,1,1,2,2,2,2,3,3,3,3,4,4,4,4,5,5,5,5,6,6,6,6))) 
 colnames(design)<-c("ALG","dC","dT","FIB","nC","nT") 
 rownames(design)<-c("ALG_1.CEL", "ALG_2.CEL", "ALG_3.CEL" , 
 "ALG_4.CEL" ,"dC_1.CEL" , "dC_2.CEL"  ,"dC_3.CEL", 
 "dC_4.CEL" , "dT_1.CEL" , "dT_2.CEL" , "dT_3.CEL",  
 "dT_4.CEL" , "FIB_1.CEL" ,"FIB_2.CEL" ,"FIB_3.CEL", 
"FIB_4.CEL", "nC_1.CEL" , "nC_2.CEL"  ,"nC_3.CEL",  
"nC_4.CEL" , "nT_1.CEL" , "nT_2.CEL" , 
 "nT_3.CEL" , "nT_4.CEL") 
 
######################################################## 
####ANNOTATION FILE##################################### 
######################################################## 
 ID<-rownames(affy.loess) 
symbol<-
mget(ID,ragene20sttranscriptclusterSYMBOL,ifnotfound=NA) 
 genename=mget(ID,ragene20sttranscriptclusterGENENAME, 
 ifnotfound=NA) 
 entrezID=mget(ID,ragene20sttranscriptclusterENTREZID, 
 ifnotfound=NA) 
 
anno=data.frame(Illumina_ID=ID, 
Symbol=as.character(symbol), 
EntrezID=as.numeric(entrezID), 
GeneName=as.character(genename)) 
 
######################################################## 
####DIFFERENTIAL EXPRESSION############################# 
######################################################## 
library(limma) 
 
 fit<-lmFit(affy.loess,design) 
 contrast.matrix<-makeContrasts(nC-dC,levels=design)  
#set up the matrix and then you can include or exclude the 
samples that you want  
 fit2<-contrasts.fit(fit,contrast.matrix) 
 fit2<-eBayes(fit2) 
 fit2$gene=anno 
 
 DEgenes=topTable(fit2,coef=1,number=5000,lfc=0.5, 
 adjust.method="fdr",sort.by="logFC",genelist=fit2$gene) 
 
 DEgenes$Probe.ID<-rownames(DEgenes) 
 
 write.csv(DEgenes, 
 file="Differential_expression_Affy_June2014.csv") 
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######################################################## 
####COEXPRESSION AND PLOTS############################## 
######################################################## 
 data<-affy.loess 
 write.csv(data,file="data.csv") 
 data<-read.csv(file="data.csv",sep=",",header=TRUE) 
 colnames(data)[1] <- c("ProbeID") 
 
 ArrayName=names(data.frame(data[,-1])) 
GeneName=data$EntrezID 
 exprs=data.frame(t(data[,-1])) 
 names(exprs)=data[,1] 
 dimnames(exprs)[[1]]=names(data.frame(data[,-1])) 
 exprs.v=as.vector(apply(as.matrix(exprs),2,var,na.rm=T)) 
#calculate variance across the expression data - default Chapter 
2 is v>0.2 
 
 present=as.vector(apply(!is.na(as.matrix(exprs)),2,sum)) 
 keep=exprs.v>0.3 & present>=4 
 table(keep) 
 
filt=exprs[,keep]  
 
library(WGCNA) 
 
 powers = c(c(1:10), seq(from = 12, to=20, by=2)) 
 # Call the network topology analysis function 
 sft = pickSoftThreshold(filt,  
 powerVector = powers, verbose = 5) 
# Plot the results: 
#setwd("/Users/alanmueller/Desktop/Thesis/Chapter_2/Chapter2_ima
ges") 
#pdf("Soft_Threshold_Choice.pdf",height=8,width=12) 
#sizeGrWindow(9, 5) 
#par(mfrow = c(1,2)) 
cex1 = 0.9 
 
 
#Scale-free topology fit index as a function of the soft-
thresholding power 
plot(sft$fitIndices[,1], -
sign(sft$fitIndices[,3])*sft$fitIndices[,2],xlab="Soft 
Threshold (power)",ylab="Scale Free Topology Model 
Fit,signed R^2",type="n",main = paste("Scale 
independence")) 
text(sft$fitIndices[,1], -
sign(sft$fitIndices[,3])*sft$fitIndices[,2],labels=powers,c
ex=cex1,col="steelblue2") 
# this line corresponds to using an Rˆ2 cut-off of h 
 abline(h=0.90,col="grey66") 
 
 
#####create adjacency matrix  
 ADJ1=abs(cor(filt,use="p"))^4 
 k=as.vector(apply(ADJ1,2,sum, na.rm=T))  
##define connectivities  
sizeGrWindow(10,5)  
par(mfrow=c(1,2))  
hist(k)  
scaleFreePlot(k, main="Check scale free topology\n") 
datExpr=filt[, rank(-k,ties.method="first" )<=500] 
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setwd("/Users/XXX") 
save(datExpr,file="matrix_for_affy2014_PCA_heatmap.RData") 
 
######################################################## 
####PCA PLOT############################################ 
######################################################## 
library(FactoMineR) 
library(RColorBrewer) 
 
scaled<-scale(t(datExpr)) 
colnames(scaled) 
 
res.pca<-PCA(t(scaled),graph=FALSE,axes=c(1,2))##or 'map'  
 
PC1 <- res.pca$ind$coord[,1] 
PC2 <- res.pca$ind$coord[,2] 
 
 
condition<-
c(rep("3D.Model",4),rep("Monolayer",8),rep("3D.Model",4),re
p("Native",8)) 
condition<-as.data.frame(condition) 
cell.type<-
c(rep("chondrocyte",8),rep("tenocyte",8),rep("chondrocyte",
4),rep("tenocyte",4)) 
cell.type<-as.data.frame(cell.type) 
 
PCs <- data.frame(cbind(PC1,PC2,cell.type,condition)) 
 
PCA.comp1<-res.pca$eig[1,2] 
PCA.comp2<-res.pca$eig[2,2] 
 
#mypalette<-brewer.pal(3,"Greys") 
#or 
mypalette<-c("gray0","gray88","gray64") 
 
library(ggplot2) 
 
setwd("/Users/XXX") 
pdf(file = "Affymetrix_PCA.pdf", width= 8,  
height = 8,useDingbats=F) 
par(mar=c(1,1,1,1)) 
p<-ggplot(PCs) 
p<-
p+geom_point(aes(PC1,PC2,color=condition,shape=cell.type), 
size=6,alpha=0.6)+ 
scale_colour_manual(values=mypalette)+ 
labs(list(x=sprintf("PC1(%.1f%%)",PCA.comp1), 
y=sprintf("PC2(%.1f%%)",PCA.comp2)))+ 
theme_minimal(base_size=10,base_family="Helvetica")+ 
theme(legend.position = "bottom",text = 
element_text(size=12), 
plot.title=element_text(lineheight=.8,face="bold"))+ 
ggtitle("Principal Component Analysis\nn=24 Affymetrix Rat 
Gene ST 2.0")+ 
scale_shape_discrete(solid=T) 
p 
dev.off() 
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######################################################## 
####HEATMAP PLOT######################################## 
######################################################## 
library(gplots) 
 
matrix<-as.matrix(t(datExpr))ß 
h<-heatmap.2(matrix) 
labels(h$rowDendrogram[[1]]) 
labels(h$rowDendrogram[[2]][[2]]) 
 
##Prepare row groupings 
setwd("/Users/XXX") 
load(file="matrix_for_affy2014_PCA_heatmap.RData") 
 
hc.rows<- hclust(dist(matrix)) 
plot(hc.rows) 
ct<-cutree(hc.rows,h=15) 
plot(hc.rows) 
rect.hclust(hc.rows,h=15) 
##have prepared as four groups - this looks the most 
sensible split 
##number of genes in each group 
table(ct) 
 
hm <- heatmap.2(matrix) 
hc <- as.hclust(hm$rowDendrogram ) 
groups<-cutree(hc, h=25.5) [hc$order] 
names<-names(groups) 
groups1<-unname(groups) 
groups2<-data.frame("Symbol"=names,"Groups"=groups1) 
 
##load annotation of the top 500 genes 
data<-
read.csv(file="500_covariant_genes_PCA_heatmap.csv",header=
TRUE) 
merged<-merge(data,groups2,by.x="Probe_ID",by.y="Symbol") 
write.csv(merged,file="heatmapGroups_sept2014.csv",row.name
s=FALSE) 
 
library(gplots) 
 
matrix<-as.matrix(t(datExpr)) 
 
colnames(matrix)<-
c("ALGINATE.1","ALGINATE.2","ALGINATE.3","ALGINATE.4","MONO
LAYER_C.1","MONOLAYER_C.2","MONOLAYER_C.3","MONOLAYER_C.4",
"MONOLAYER_T.1","MONOLAYER_T.2","MONOLAYER_T.3","MONOLAYER_
T.4","FIBRIN.1","FIBRIN.2","FIBRIN.3","FIBRIN.4","NATIVE_C.
1","NATIVE_C.2","NATIVE_C.3","NATIVE_C.4","NATIVE_T.1","NAT
IVE_T.2","NATIVE_T.3","NATIVE_T.4") 
 
##Create heatmap with the row groups coloured too 
library(RColorBrewer) 
groups<-cutree(hc,h=25.5) 
cols <- brewer.pal(max(groups), "Set3") 
#pdf(file = "Affymetrix_PCA.pdf", width= 8, height = 
8,useDingbats=F) 
#library(WGCNA) 
pdf("affy2014_heatmap_Sept.pdf",height=12,width=12) 
#sizeGrWindow(9,9) 
#par(mar=c(10,2,10,2)) 
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heatmap.2(matrix,col=greenred(100),symkey=TRUE,trace='none'
,density.info='none',RowSideColors=cols[groups],ColSideColo
rs=c(rep("lightsteelblue1",4),rep("goldenrod3",8),rep("ligh
tsteelblue3",4),rep("midnightblue",4),rep("firebrick1",4)) 
,cexRow=0.09,cexCol=0.8,scale='row',mar=c(4,4),dendrogram='
both',colsep=c(4,8,12,16,20),sepcolor="white",sepwidth=c(0.
05,0.05)) 
dev.off() 
 
 
################################################################
##Finding overlaps between DE genes in Illumina and Affymetrix## 
################################################################
##Need lists of Entrez IDs from each data set 
setwd("/Users/XXX") 
illumina<-read.csv(file="illumina.csv",header=TRUE,sep=",") 
affymetrix<-
read.csv(file="affymetrix.csv",header=TRUE,sep=",") 
 
consensus<-merge( 
affymetrix,illumina,by.x="EntrezID",by.y="EntrezID",all.x=T
RUE)  
 
##ensure those unique to affymetrix data are clear 
setwd("/Users/XXX")  
write.csv(consensus,file="Illumina_Affymetrix_consensus.csv
") 
 
 
####Plot common log fold changes and correlations 
setwd("/Users/XXX") 
cor<-read.csv(file="test_data.csv",header=TRUE) 
x<-cor$logFC.Affy 
y<-cor$log2FC.Illumina 
cor.test(x,y,method="pearson") 
 
library(ggplots2) 
 
#mypalette<- see above 
condition<-
c(rep("Upregulated",168),rep("Downregulated",226)) 
setwd("/Users/XXX") 
pdf("nT_dT_Illumina_Affy_correlation.pdf",height=8,width=8) 
g<-ggplot(cor, aes(x=logFC.Affy, y=log2FC.Illumina, 
color=condition, shape=condition),alpha=0.5,size=10) + 
geom_point()+geom_smooth(method=lm,se=FALSE) 
g<-
g+scale_color_manual(values=mypalette)+scale_shape_discrete
(solid=T) 
g<-
g+theme_minimal(base_size=10,base_family="Helvetica")+theme
(plot.title=element_text(lineheight=.9,face="bold")) 
g<-g+ggtitle("Differentially Expressed Genes Common to 
Illumina and Affymetrix Studies\n Native Chondrocytes vs. 
Dedifferentiated Chondrocytes") 
g<-g+labs(list(x=sprintf("log2 fold change 
Affymetrix"),y=sprintf("log2 fold change Illumina"))) 
g<-g+annotate("text",label="r=0.81, p<2.2e-16",x=3,y=-
2.5,size=4,colour="black") 
g 
dev.off() 
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################################################################
######Venn Euler Diagrams####################################### 
################################################################ 
library(venneuler) 
 
v<-venneuler(c(A=3863,B=2709,"A&B"=782)) 
 
##covert the colours to R readable colour-strings 
col.fn <- function(col, alpha=0.3) { 
    col<- hcl(col * 360, 130, 60) 
    col <- col2rgb(col)/255 
    col <- rgb(col[1, ], col[2, ], col[3, ], alpha) 
    col 
} 
COL <- col.fn(v$colors) 
LABS <- v$labels 
id <- match(names(v$colors), LABS) 
 
leg.txt<-c("Affymetrix","Illumina") 
 
par(font.main=1,font.lab=1,family="Helvetica",mai=c(1,1,1,1
),col.main="Gray66") 
 plot(v) 
#legend(.05, .9, legend = LABS[id], fill = COL[id], 
x="topleft",bty="n",) 
legend(.9, .9, legend = leg.txt, fill = 
COL[id],x="topleft",bty="n",text.col="Gray66",horiz=FALSE,b
order=COL[id],cex=0.85) 
title(main="Native chondrocytes to monolayer chondrocytes") 
 
 
########################################## 
###Prioritised gene lists################# 
########################################## 
 
library(RobustRankAggreg) 
 
illumina_rank<-
as.list(read.csv("illumina.csv",sep=",",header=TRUE)) 
affymetrix_rank<-
as.list(read.csv("affymetrix.csv",sep=",",header=TRUE)) 
 
ill<-as.list(illumina_rank$Symbol.x) 
affy<-as.list(affymetrix_rank$Symbol.x) 
 
ill<-unlist(ill) 
affy<-unlist(affy) 
ill_rank<-as.character(ill) 
affy_rank<-as.character(affy) 
 
glist<-list(ill_rank,affy_rank) 
r = rankMatrix(glist) 
AGGREGATE<-aggregateRanks(glist,full=TRUE) 
head(AGGREGATE) 
write.csv(AGGREGATE,file="ranked_illumina_affymetrix.csv") 
 
################################################################ 
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4 :  Weighted gene  co-express ion 
network ana lys i s  of  car t i l age  and 
tendon gene  express ion data  
 
Abstract 
The construction, and comparison, of gene-gene co-expression networks is a 
fundamental tool in systems biology and has the potential to extract biologically 
relevant gene regulatory sub-networks (modules) with strong phenotypic 
associations.  Application of this methodology can facilitate the rational 
identification of central regulators, ‘hubs’, against which gain- or loss- of function 
studies can be designed.    
This study outlines and applies a conceptual and methodological framework, 
weighted gene network co-expression analysis (WGCNA), to elucidate the 
regulatory sub-networks and hub genes that control differentiation status in 
chondrocytes and tenocytes in three-dimensional cultures.  This approach was 
applied to two independent gene expression data sets from different microarray 
platforms and the global transcriptome network structures were compared.  
Defining modules with a strong phenotypic association with three-dimensional 
cultures may describe emergent behavior of organotypic systems with view to 
improving in vitro biomimetic cultures.      
Consensus network analysis defined a preserved module of genes containing 
chondrocyte-associated genes Pi15, Gpnmb and Serpina3n identified as potential 
regulators of the alginate bead culture phenotype.  The leucine zipper tumour 
suppressor (Lstz2) was identified as a potential modulator of dedifferentiation in a 
 
242 
monolayer-associated gene module.  A siRNA study considering the effects of 
Lzts2 knock-down on the expression of markers of differentiated status in 
chondrocytes produced equivocal results.   
Additionally, this study demonstrated that small gene expression studies failed to 
robustly meet the criteria of scale-free topology required for this methodology, 
however, it represented a useful methodology for dealing with expression data 
from diverse sources and defined candidate regulators of the alginate bead culture 
phenotype.        
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4.1: Introduction  
 
4.1.1: Dimensionality in gene expression data 
A problem inherent to many microarray-based studies is the generation of highly 
dimensional data arising from tens of thousands of genes and relatively few 
biological samples (Wang, Miller et al. 2008).  In the main the objective of these 
studies is to identify differentially expressed genes, which requires arbitrary 
thresholds to be set, often with the purpose of classifying groups. This ‘hard-
thresholding’ results in prioritized gene lists representing the most extreme 
responses between two systems with no reference to the relationship between the 
genes (Conesa and Mortazavi 2014, Gaiteri, Ding et al. 2014). The dimensionality 
of these expression profiles may be reduced through the use of principal 
component analysis, supervised and unsupervised clustering techniques (Slonim 
2002), as employed in the initial analysis of chondrocyte and tenocytes described 
in Chapters 2 and 3.   
These methods, however, do not systematically study the interconnectivity of the 
individual genes identified, consequently they ignore the cumulative behavior of 
the regulatory pathways that contribute to perturb the gene expression patterns 
observed in differential gene expression analysis (Zhao, Langfelder et al. 2010). 
Methods that attempt to infer gene regulatory networks include Bayesian 
techniques and weighted gene co-expression network analysis (WGCNA) 
(Langfelder and Horvath 2008).  These methods seek to describe the functions of 
the system rather than deconstructing and itemizing the component parts.   
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4.1.2: Conceptual understanding of gene co-expression networks and 
WGCNA methodology 
Weighted gene co-expression network analysis (WGCNA) is a systems biology 
methodology that facilitates investigation of the global network properties of a 
transcriptome and provides functional insights into the organization of the 
network.  The practical output of this type of analysis is the elucidation of higher-
order relationships between groups of highly co-expressed genes (modules) and 
their associations with phenotypic traits.  These modules represent the core units 
of the transcriptome network.  It is possible, therefore, to also compare these 
functional units and the global network structure between gene expression studies 
or even across species (Miller, Horvath et al. 2010).  Identification of the 
preservation of highly connected hubs within functional units across conditions 
can direct researchers to regulatory elements with potential phenotype-modulating 
properties.  
Conceptually a co-expression network is relatively straightforward, although 
mathematically complex.  Useful analogies are often made to social networks, 
which follow comparable network structures. Nodes, some connection point, 
represent genes that are expressed in a sample. Edges, or vertices, connect nodes 
based upon their co-expression across samples.  WGCNA assumes that all nodes 
are connected and the connectivity has different strengths.  The strength of the 
connections between nodes, in this case, indicates the importance of the genes in 
the networks and the measures are derived from the correlation of gene 
expression (Zhao, Langfelder et al. 2010).   
These gene co-expression networks allow the exploration of the system level 
features and functionality of genes.  As the co-expression of genes encodes the 
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downstream protein interactions the study of transcriptional co-expression 
patterns can reveal emergent properties of a cellular system.  This application is a 
valid systems biology approach (Conesa and Mortazavi 2014) using comparisons 
of global transcriptomic network changes to define changes in the system.  
Network-associated methods are not limited to gene co-expression, but are widely 
applicable to biological networks (protein-protein interactions), as well as 
technological (e.g. world-wide web) and social interaction networks (Barabási and 
Oltvai 2004, Zhang and Horvath 2005).   Global co-expression networks arise 
from a multitude of regulatory systems and information from every gene profiled 
may be used.   
The network topology, the spatial relationships of the genes within the network, 
may have functional relevance.  Networks may be reduced and binned into 
modules of highly correlated gene sets, which have been demonstrated to have 
functional commonality; these modules are not isolated and autonomous, but 
highly interconnected (Gaiteri, Ding et al. 2014).   
The goals and philosophies of systems biology are well-placed to inform tissue 
engineering and regenerative medicine through the modeling of cell signalling and 
behavioural phenotypes (Cosgrove, Griffith et al. 2008) especially as regenerative 
strategies often aim to recapitulate dynamic processes, e.g. tissue morphogenesis.  
It is proposed that systems biology approaches (including co-expression network 
analysis) using multi-level data sources can facilitate the development of predictive 
models for bioengineered tissues to inform and refine these systems (Rajagopalan, 
Kasif et al. 2013).  Systems biology tools are applied in this thesis to explore novel 
approaches to inform the future development of organotypic cultures.   
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Scale-free networks 
Most biological networks are ‘scale-free’ (Barabási and Oltvai 2004, Albert 2005, 
Zhu, Gerstein et al. 2007), as opposed to random or hierarchical networks.  
Characteristically these scale-free networks follow a ‘power-law’ distribution, see 
below for clarification.  In a scale-free network the probability that a node is 
connected to another node is statistically higher than in a random network; the 
properties of a scale free network are often defined by a small number of nodes 
that are highly connected  - these may be referred to as ‘hubs’.   
Weighted gene co-expression network analysis (WGCNA) is based on the concept 
of ‘scale-free topology’ (Zhao, Langfelder et al. 2010), an overview of the 
methodology is presented in Figure 4.1.  In a network that is considered to be 
‘scale-free’ the connectivity, or degree, (k) of its components (nodes) follows a 
power-law distribution, such that: 
! ! ~!!!   Equation 1. 
, where γ is the degree exponent.  In other terms, the frequency distribution of 
degree, p(k), is the probability of a node having k links to other nodes of a 
network decays as a power-law (Barabási and Oltvai 2004).  This confers a number 
of properties to scale-free networks: 
i) The degree distribution decays as a function of the scaling parameter, the 
degree exponent, γ (above), such that the frequency distribution of node 
connectivity has a heavy tail; 
ii) Scale-free networks are not homogenous with the network topology being 
defined by a few nodes of high degree or connectivity, which are linked to 
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most other nodes in the network; by analogy, the Google search page or an 
international airport; 
iii) There is considerable redundancy in a scale-free network and, therefore, a high 
tolerance of errors.  The potential to communicate is not diminished by high 
failure rates;     
iv) Scale-free networks are vulnerable to targeted attacks, i.e. the selection and 
removal of a hub node could negate communication throughout a system; 
v) Growth and preferential attachment occur to already highly connected nodes, 
i.e. ‘the rich get richer’.   
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An n × n similarity matrix (b), 
S=[sij], describes the pairwise co-
expression relationships between 
the genes i and j, such that:  
sij = |cor(i,j)|.    
 
Using an adjacency function the 
similarity matrix is converted to a 
symmetrical adjacency matrix (c), 
A=[a i j ] wh ich encodes the 
connection strength between pairs 
of  nodes, such that  aij  [0,1]. 
Diagonal elements of  A are 1, i.e 
aii.  This matrix is used to define 
node connectivity.   
Input is gene expression data.  Nodes, balls (a), represent genes.  
The edges connecting them are associated with the absolute 
Pearson correlation coefficients as a measure of  co-expression.   
a.   
b.   
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In order to construct a co-expression network complete gene expression data 
from microarray analysis is the input and the co-expression measure between 
genes is often defined by the absolute Pearson correlation coefficient, Figure 4.1a 
and b.  Critically, to define that a connection, or co-expression edge, exists 
between two genes the Pearson correlation coefficient has to have a threshold; a 
‘hard’ threshold would represent an absolute value of statistical significance 
(analogous to the arbitrary definitions of differential gene expression), however, 
defining connectivity in a dichomtomised manner (1, connected; 0, unconnected), 
is unlikely to be biologically relevant and would result in a considerable loss of 
information.  In the general framework for the methodology ‘soft’-thresholding is 
used to ‘weight’ each pairwise gene connection (Zhang and Horvath 2005) thereby 
encoding the relative importance of each gene.  
An adjacency function is used to convert the matrix of co-expression similarity, 
the level of concordance in expression profiles across samples, into an adjacency 
matrix, which defines the connection ‘strength’ between each node/gene pair, i 
and j (Horvath 2011), Figure 4.1c.  In other terms, an adjacency function allows 
the conversion of the original network into an alternative form. This adjacency 
matrix may be weighted through the application of a ‘power adjacency function’, 
β, (Equation 2) (Zhang and Horvath 2005).   
!!"! !"# !!,!! !  Equation 2 
The application of the power adjacency function changes the topological 
properties of a weighted network (Horvath 2011). A primary objective of co-
expression network analysis is the detection of aggregates of nodes, termed 
‘modules’, that are highly connected to each other.  Methodologies used to define 
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these modules differ between techniques so only the approach used in this study is 
described.    
Topological overlap and dissimilarity  
A topological overlap matrix (TOM) is a similarity measure of relative connectivity 
formed from the adjacency matrix; 1-TOM defines the dissimilarity measure, 
which is the fundamental input to the clustering methods used to detect modules.  
An adjacency matrix represents each pair of genes aij in isolation, whilst a 
topological overlap matrix considers each pair of genes relative to all other genes 
within the network.  Sets of genes have high topological overlap if they connect to 
approximately the same groups, or neighbourhood, of genes in the network, 
Figure 4.1d.  Topological overlap is calculated on the comparative connectivity of 
a pair of genes to all other genes in a network (Yip and Horvath 2007).  Two 
elements that have high topological overlap are more likely to have the same 
functionality than elements with lower topological overlap.  Extended to genes it 
can be intimated that genes with high topological overlap are likely to be 
functionally comparable.  In summary, this measure not only considers the 
expression correlation between two genes, but also, using a social networking 
analogy, how many ‘friends’ they share.    
Identification of gene modules 
Cell biology is inherently modular (Hartwell, Hopfield et al. 1999).  Reductionist 
approaches attempted to reduce the understanding of biological phenomena to 
linear relationships.  The ability, however, to apply discrete biological functions to 
individual molecules is rare; biological functions arise from molecular interactions 
organized into functional modules.  Supervised and unsupervised clustering 
methods are widely used in genomic studies (e.g. hierarchical and k-means 
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clustering), each with their own limitations.   The methodology applied here uses a 
dynamic hybrid approach where, first, hierarchical clustering is used to define a 
cluster dendrogram/tree, Figure 4.1e and 4.1f, with clusters defined as ‘branches’, 
then secondly uses a PAM-like (partition-around medioids) algorithm to define the 
clusters (Horvath 2011).  Here, modules (used in place of the term ‘clusters’) are 
defined as genes that are highly connected to one another, and specifically within 
this methodology, genes with high topological overlap.  These modules represent 
the fundamental functional unit of the transcriptional network (Miller, Horvath et 
al. 2010).  As clustering techniques are non-robust (dendrograms can appear very 
differently depending on the form of hierarchical clustering used) the 
reproducibility of clusters/modules must be validated against other data sets.  In 
this chapter modules defined in two independent data sets are used and validation 
techniques applied to assess their reproducibility.  This approach is extended in 
Chapter 5 to a meta-analysis across species.   
Consensus networks and differential eigengene network analysis 
In the context of systems biology functional modules span the knowledge gap 
between individual genes and the global properties emerging from the system 
(Zhao, Langfelder et al. 2010).  As described above these co-expression modules 
represent the basic components of the system.  When considered together co-
expression modules may form a meta-network from which higher order 
organization of the transcriptome may be apparent.  Module representatives, 
eigengenes, can be used to describe these meta-networks and are called eiegengene 
networks, Figure 4.1k and 4.1l.  Single eigengene network analysis may be used to 
describe the module relationships in a single data set, or differential eigengene 
network analysis, when used to compare the network relationships between data 
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sets.  To achieve the latter WGCNA employs methods to define consensus 
modules from consensus dissimilarity measures derived from comparisons of the 
topological overlap matrices from the different data sets, Figure 4.1j.  Whole 
network preservation between a reference and test data set may then be assessed 
using permutation tests.  This study utilizes these methods to define co-expression 
modules conserved across two gene expression data sets profiling chondrocyte 
and tenocyte transcriptomes in different environmental conditions.      
4.1.3: WGCNA:  Recent applications 
Weighted gene co-expression network analysis is now a well-established 
methodology that has been applied to diverse contexts.  Recent work has 
demonstrated genes are highly connected in modules conserved across different 
types of cancer revealing robust prognostic signatures (Yang, Han et al. 2014). 
Horvath’s group, in a seminal paper, demonstrated divergent co-expression 
modules in human and mouse brain transcriptomes with application to a better 
understanding of the relevance of murine models of human brain disorders 
(Miller, Horvath et al. 2010).  Later work, contributing to an atlas of the brain 
transcriptome, showed that the topographical anatomy of the brain was reflected 
in the molecular topography (Hawrylycz, Lein et al. 2012).  To date the author is 
only aware of two studies that apply this methodology to musculoskeletal tissues.  
In a study of chondrocyte differentiation Suwanwela and colleagues (2011) 
integrated co-expression network analysis of gene expression data from 27 mouse 
strains with quantitative data on bone geometry and bone mineral density 
(Suwanwela, Farber et al. 2011).  In another study associating mouse gene 
expression data with bone mineral density Calabrese, et al (2012) identified a 
module with strong osteoblast-association; siRNA knock-down of an intra-
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modular hub supported a role in osteoblasts proliferation and differentiation 
(Calabrese, Bennett et al. 2012).  There are no publications considering cartilage 
and tendon gene expression responses to culture systems.   
The rationale for the use of this type of technique is that it should permit the 
discovery of biologically interesting modules of genes with shared functionality in 
a phenotype-specific manner.  Module preservation can be studied across different 
data sets to identify how conserved modules and their hubs are; it is suggested that 
this type of methodology may be more useful and robust than traditional meta-
analysis techniques (Langfelder, Mischel et al. 2013). 
Study hypothesis 
It was hypothesized that emergent properties of three-dimensional culture systems 
would become apparent through the integration of co-expression network data 
from two gene expression data sets.  By associating intra-modular hubs with cell-
specific culture phenotypes gene targets may be identified that could inform 
improvements in organo-typic systems.  It is proposed that the knock-down of 
gene transcripts for hubs with strong phenotypic associations for dedifferentiation 
could result in improved expression of markers of differentiated status.  More 
broadly, the comparison of whole tissue and matrix-depleted chondrocyte and 
tenocyte transcriptome networks could define regulatory sub-networks relevant to 
the understanding of musculoskeletal degenerative disease.      
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4.2: Methods  
 
4.2.1: Weighted Gene Co-expression Network Analysis 
 
Data pre-processing, network construction and module detection 
All analysis was undertaken in R using a comprehensive suite of functions 
implemented in the WGCNA (v1.41.1) package (Langfelder and Horvath 2008, 
Langfelder and Horvath 2012), Figure 4.2a.  Equivalent codes for this 
methodology are provided in Appendix 5.  The complete normalised expression 
data sets from Illumina (Chapter 2, n=36) and Affymetrix (Chapter 3, n=24) 
were filtered initially on variance and invariant genes were removed.  In the 
preliminary analysis each data set was studied autonomously, Figure 4.2b.  The 
expression preservation, the Pearson correlation of the ranked average gene 
expression, was calculated across these two data sets to assess the comparability of 
analysis across platforms.   
The general co-expression network analysis methodology described by Zhang and 
Horvath (2005) (Zhang and Horvath 2005) was applied to these data sets. The soft 
threshold value, β, was chosen such that the lowest power that maintained an 
approximate scale-free topology was used.  
The filtered genes were ranked on their connectivity and the top 3600 genes from 
each data set were retained for further analysis. A measure of node similarity, 
topological overlap, was calculated (Ravasz, Somera et al. 2002, Zhang and 
Horvath 2005).  The dissimilarity measure, 1-TOM, was used as the input for 
average linkage hierarchical clustering to define gene modules.  Modules were 
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merged at a dendrogram cut-height of 0.2 using a dynamic tree-cutting algorithm 
(Langfelder, Zhang et al. 2008), corresponding to a correlation of 1-0.2 = 0.80.  All 
genes associated with a module were used as an input for gene ontology functional 
annotation using the R package GOstats, as before, and ensuring that the 
background for hypergeometric testing was restricted to the appropriate data 
source; ontology terms were statistically significant after FDR adjustments at 
p<0.001.     
Module eigengenes were calculate to provide single representative expression 
pattern for a module (Langfelder and Horvath 2007).  Correlations of eigengenes 
were used to form networks; these were plotted and manually assessed for 
correlation and the dendrogram cut height amended where necessary to merge 
highly correlated modules.  The minimum entry to a module was retained at 
default settings to allow greater flexibility in later filtering for module hubs.  
Consensus network and module preservation across data sets 
To determine whether the set of modules identified in one data set were present in 
another a standard marginal model analysis was undertaken.  A consensus network 
was derived from the Illumina and Affymetrix data sets and is defined as a single 
network created from the weighted average of correlation matrices from the 
separate data sets (Langfelder and Horvath 2007, Miller, Horvath et al. 2010).  The 
consensus network was based upon the intersection of common Entrez identifiers 
across the two data sets after filtering of invariant data; this left 2795 genes, 
Figure 4.2c.   
Module overlap, the number of genes common to two separate modules was used 
to defined how well modules identified in autonomous data set analysis were 
 
257 
conserved in consensus modules.  This was further characterised by calculating the 
module preservation summary z-score from a series of permutation tests 
(Langfelder and Horvath 2007, Langfelder and Horvath 2008).  Differential 
analysis of the eigengene networks were undertaken to define preservation of the 
network structures across data sets.   
Consensus hub genes  
Module Membership (kME) is the Pearson correlation between the expression 
level of each gene in a dataset and each module eigengene in a network.  It 
quantifies the ‘belonging’ of a gene to a module.  To define consensus module hub 
genes kME was calculated for all genes with module assignments and values 
ranked for each module; the genes with the highest kME in both networks were 
defined as consensus hubs.   
Correlating modules to cellular conditions/traits  
To determine whether modules were associated with the sample phenotypes the 
module eigengenes were correlated with a binary matrix defining phenotypic 
group membership.  These phenotype, or trait, groups were inclusive of all 
samples with a common origin or condition, for example, “cartilage”, “tendon”, or 
“native”.  
Glossary  
The unique terminology used within the WGCNA methodology is defined for 
reference, with respect to (Miller, Horvath et al. 2010).  Terms associated with 
module analysis: a) Module eigengene – the first principal component of a module 
(Figure 4.1g); this represents a summary of the expression pattern characteristics 
of a module; b) module overlap – the number of common genes between two 
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modules arising from different data sets; c) module preservation – a collection of 
statistical tests that quantify how well module characteristics in one network are 
replicated in a second network.   
Terms associated with correlation analysis are defined here: a) Gene Significance 
(GS), the absolute correlation between a module eigengene and a trait; b) the 
connections of a node within a module is the ‘intramodular connectivity’ defined 
as the summed connections of a node with all other nodes within a module; c) a 
global module eigengene-based connectivity measure, Module Membership 
(kME), defined above.  
4.2.2: Data visualization and network representation  
Modules were represented graphically using Cytoscape (v3.1.1, October 2014), 
(Cline, Smoot et al. 2007, Killcoyne, Carter et al. 2009). The network structure, 
consisting of nodes (genes filtered for high module membership) and edges 
(weighted intra-modular connections based upon the topological overlap matrix) 
were exported to Cytoscape. The web-application STRING, version 9.1 
(Franceschini, Szklarczyk et al. 2013), (http://string-db.org) was used to define 
protein-protein interactions between genes identified to be consensus hub genes.   
Circos plots were rendered using the Circos web application (http://circos.ca) 
(Krzywinski, Schein et al. 2009) to summarise module overlaps between data sets.     
4.2.3: Silencing of Lzts2 expression using siRNA 
Chondrocytes were obtained from 12-week old male Wistar rats (n=3, Chapter 2 
stock), Figure 4.2a. Passage three chondrocytes cells were plated in 24-well 
culture plates at a density of 2.5 x104 cells/well and allowed to adhere overnight 
(~12 h) in complete media, free of phenol red. For each biological replicate 
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siRNA experiments were performed in triplicate and these were pooled prior to 
RNA extraction.  
Prior to transfection all instrumentation, Eppendorfs, micro-pipettes and reagent 
containers were treated with RNAzap® (Ambion, Life Technologies) according to 
the manufacturers instructions. Optimal concentrations of siRNA and 
Lipofectamine® 2000 were derived from comparisons of maximal transfection 
efficiency based upon varying concentration of siRNA (15 or 30 ρmols), 
Lipofectamine® 2000 (0.5-4 mL), and cell number (2.5 x104 – x104) per well in a 
preliminary study.   
Small interfering RNAs (siRNAs) directed against the leucine zipper, putative 
tumour suppressor 2, Lzts2, transcripts (Rat Silencer Select siRNA (s1722155, 
#4390771) (Ambion, Life Technologies)) were used at 30 ρmols per well.  
Equimolar concentrations of negative control (Silencer Select Negative Control 
No. 1 siRNA (AM4611).  Transfection efficiency was assessed using a Cy3-labeled 
control (Silencer Cy3-Labelled Negative Control siRNA).  Cells were transfected 
with siRNA incubated with 2.5 µl Lipofectamine® 2000 Transfection Reagent 
(Ambion, as before) according to the manufacturer’s guidelines in a final volume 
of 0.5 mL of CM1, as before.  Adherent cells were washed with warmed PBS twice 
to remove media and FBS.  To each well 100 µl of the siRNA/lipofectamine 
solution was added; additionally 400 µl of Optim-MEM (with 3 % FBS, no 
antibiotics/anti-fungal) was added. Cells were incubated at 37 °C for 6 hours; after 
this time media was removed, cells washed with PBS and 500 µl of complete 
media added. Cells were left overnight (>12 hrs).  Cells transfected with Cy3-
labelled negative control siRNA were inspected under green fluorescent light (547-
563 nm) for evidence of transfection. Cultures were harvested and stored in Trizol 
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at -80 °C for RNA extraction as previously described. Following RNA quality 
control RNA some samples were re-precipitated and further concentration steps 
performed.  Briefly, sterile filtered 5M ammonium acetate (Ambion, Applied 
Biosystems) was added to the RNA suspension to bring the final concentration of 
ammonium acetate to 2.5M; 2 µl of glycogen/20 µl RNA solution was 
subsequently added.  To this 2.5 volumes of 100 % molecular grade ethanol 
(EtOH) (Sigma-Aldrich) was added and the solution was frozen at -80 °C 
overnight.  Following this samples were allowed to defrost on ice, were 
centrifuged at 20,000 * g for 15 minutes at 4 °C.  The supernatant was discarded 
and the RNA pellet washed with 1 mL glacial 75 % EtOH to remove residual salt.  
RNA pellets were centrifuged as before, supernatant discarded once more and the 
residual EtOH allowed to evaporate.  Pellets were re-suspended with 10 µl of 
RNAse-free water.        
4.2.4: Quantitative PCR    
The design and validation of primer pairs targeting Lzts2 was undertaken as 
described in Chapter 2.  The primer pairs were designed to target exon two of the 
Lzts2 transcript as this was the siRNA target: 5’-GATCCCCGAGAACATCAGGC 
(60.25 °C, forward), and 5’-TCTCCATATTCTTCTCCAGCCTTC (59.65 °C, reverse), 
producing a 94 base product.  Previously described qPCR protocols were applied 
to this study.  In a serial ten-fold dilution study the primer pair had a 90 % 
amplification efficiency.  Expression analysis was undertaken using the ΔCt 
method, as before.  Statistical analysis was undertaken on the 2^-ΔCt values by 
ANOVA (Tukey post-hoc analysis) after a Shapiro-Wilks test to assess deviations 
from a Gaussian distribution. 
  
 
261 
Re-annotation 
Rat Entrez gene identifiers 
Normalised matrix of  gene expression values Chapter 5 
Chapter 4 
Application of  weighted gene co-expression network analysis to two cartilage and tendon data sets 
siRNA knockdown 
Lzts2 in monolayer chondrocytes 
Hub gene selection 
From modules with high phenotype association 
qPCR knockdown validation and assessment of  
differentiation markers 
Figure 4.2a: Overview of  experimental design for results presented in Chapter 4.  Input data is derived from 
Chapters 2 and 3 using Illumina and Affymetrix microarray gene expression data respectively.  Each data set 
follows, i) a round of  independent network generation and module detection and, ii) consensus network 
generation and comparative module analysis.  Only hub gene detected in Illumina data is used for siRNA study.  
Specific data analysis pipeline follows that described in Figure 4.2b (single data set) and c (comparative 
analysis).  Expression data also used in subsequent analysis in Chapter 5.  Statistical analysis of  qPCR data was 
undertaken in R.         
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Figure 4.2b: Data analysis pipeline within R using a suite of  functions within the WGCNA package.  Pipeline 
represents the individual analysis undertaken for each data set.  Specific functions are defined in Appendix 4 R 
codes.  Third-party web applications are indicated.     
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e.g. conditions, species.  Preserved (consensus) and unique modules were defined and annotated.   Specific 
functions are defined in Appendix 4 R codes.  Third-party web applications are indicated.     
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4.3: Results 
 
4.3.1: Data preparation, module formation and functional annotation  
 
Network topology and module detection  
Initially the data was considered against the general scale-free topology criterion to 
define the adjacency function parameters.  The soft-thresholding powers which 
resulted in an approximate scale-free topology for both Illumina (β = 9) and 
Affymetrix (β = 12) data was determined.  The datasets differed in their network 
topology with the Affymetrix data only having approximate scale-free topology at 
higher soft-threshold values (R^2 < 0.72 at β = 12), Figure 4.2 and 4.3. This would 
normally not satisfy the scale-free topology criterion (R^2 > 0.8), however, in a 
plot of the regression line between log10(p(k)) and log10(p(k)) the slope was -1.13, 
comparable to that of the Illumina data, which did meet scale-free topology 
criterion. 
Module detection using hierarchical clustering of the dissimilarity matrix defined 
seven module eigengenes for the Illumina data (Figure 4.5) and six for the 
Affymetrix (Figure 4.6) dataset. Genes included within a module were 
functionally annotated using gene ontology terms (p<0.001), Tables 4.1 and 4.2.   
Modules were allocated arbitrary colours for each dataset - these are not 
comparable between data sets.  For clarity an alphanumeric code is employed as 
defined in the previous tables.  Broadly, there were modules that shared functional 
annotations across data sets, in particular those relating to metabolic and cell cycle 
processes, but also immune and defense response annotations and anatomical 
structure development. 
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Figure 4.3:  Upper panel - Assessment of  Illumina data for weighted gene co-expression 
network analysis.  i) Scale-free topology index (y-axis) as a function of  the soft-thresholding 
power, β  (x-axis), left panel.  Intersection line at R^2=0.9.  Right Panel ii) shows the mean 
connectivity, or degree, (y-axis) as a function of  the soft-thresholding power (x-axis).  Degree 
decreases with increasing soft-threshold value.  Lower panel – (iii) histogram of  connectivity 
values (k), (iv) log-log plot of  the connectivities fitted to a linear model. The R^2 value, the 
square of  the correlation between log10(p(k)) and log10(k), can be read as an index of  the  
scale-freedom of  the network topology.  The Illumina data is shown to have approximate scale-
free topology.  Beta, β=8 is chosen as it is an effective trade-off  between maximising scale-free 
topology and retaining a high mean number of  connections.   
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Figure 4.4:  Upper panel - Assessment of  Affymetrix data for weighted gene co-
expression network analysis.  i) Scale-free topology index (y-axis) as a function of  the soft-
thresholding power, β  (x-axis), left panel.  Intersection line at R^2=0.8.  Right panel ii) 
shows the mean connectivity, or degree, (y-axis) as a function of  the soft-thresholding 
power (x-axis). Lower panel – (iii) histogram of  connectivity values (k), (iv) log-log plot of  
the connectivities fitted to a linear model. The Affymetrix data is shown to have only 
moderate scale-free topology.  Beta, β=12 is chosen as it is an effective trade-off  between 
maximising scale-free topology and retaining a high mean number of  connections.  
Although R^2=0.8 is the recommended threshold value for approximate scale-free 
topology the slope of  the linear regression between log10(p(k)) and log10(k) is <-1 and 
comparable to the Illumina data.  On this basis the data was retained for further analysis.   
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Figure 4.6: Gene co-expression dendrogram (top) and modules with phenotypic trait 
correlations (below) for Affymetrix data (n=24).  Six modules were defined for the Affymetrix 
data on the top 3600 most connected genes.  In contrast to the Illumina data modules are not 
as defined and module eigengenes more strongly correlated to each other as demonstrated by 
the height legend (y-axis).  This dendrogram is based on a dissimilarity adjacency matrix and so 
the longer the branch the more dissimilar it is to other modules.  This is also reflected in the 
gene significance distribution for different traits (linear heatmaps).  Although some clear 
associations are present, e.g. native chondrocytes with the brown module, association is much 
more variable across phenotypes 
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Biological Process Metabolic Function  Cell Compartment  
Response to organo-nitrogen compound (3.1e-9) 
Inflammatory response (1.3e-07) 
Response to cytokine stimulus (2.5e-5) 
NIK/NF-kappaB cascade (2.2e-4) 
Methyl indole-3-acetate esterase activity (1.1e-5) 
Protein binding (2.1e-4) 
MRF binding (2.6e-4) 
Protein heterodimerisation activity (4.1e-4) 
Extracellular space (1.6e-5) 
 
Cellular protein metabolic process (2.4e-11) 
Gene expression (2.4e-6) 
Cellular response to stress (3.8e-5) 
Apoptotic signalling pathway (4.9e-4) 
Protein binding (5.1e-15) 
RNA binding (2.9e-5) 
Peptidase activator activity (3.03e-4) 
Intracellular part (4.9e-30) 
Ribonucleoprotein complex  
(6.02e-9) 
 
Translation (5.3e-14) 
Metabolic process (7.7e-11) 
Organic substance metabolic process (4.6e-8) 
Nitrogen compound metabolic process (5.5e-4) 
Structural constituent of  ribosome (1.6e-15) 
RNA binding (3.2e-8) 
Translation factor activity, nucleic acid binding (3.2e-4) 
Intracellular part (1.4e-35) 
Mitochondrion (6.8e-15) 
Muscle system process (2.9e-14) 
Skeletal muscle tissue development (1.6e-6) 
Actin filmament-based process (1.02e-5) 
Tissue regeneration (4.8e-5) 
Structural constituent of  muscle (9.1e-12) 
Cytoskeletal protein binding (9.8e-11) 
Actin binding (3.2e-7) 
Myofibril (1.03e-27) 
Actin cytoskeleton (5.9e-11) 
Cytoskeleton (6.3e-6) 
Response to external stimulus (2.7e-4) 
Bone mineralisation (6.8e-4) 
Response to stress (6.8e-4) 
Biomineral tissue development (8.2e-4) 
Proton-transporting ATPase activity (3.1e-4) Cytoplasm (4.7e-6) 
Mitochondrion (5.9-6) 
Extracellular matrix (7.8e-4) 
Cell cycle (1.7e-10) 
Immune system process (6.3e-10) 
Response to biotic stimulus (6.5e-9) 
Co-factor biosynthetic process (5.7e-6) 
Binding (1.9e-16) 
Catalytic activity (1.2e-11) 
Oxidoreductase activity (5.3e-5) 
Intracellular part (3.2e-21) 
Nucleus (2.8e-13) 
Cytoplasm (4.8e-11) 
Cellular response to organic substance (8.7e-5) 
Cell adhesion (8.7e-5) 
Response to cytokine stimulus (8.8e-5)  
Anatomical structure development (1.7e-4) 
Oligosaccharyl transferase activity (8.2e-4) Cytoplasmic part (2.2e-12) 
Intracellular (9.5e-9) 
Lysosome (5.5e-8) 
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(1e-04)
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-0.69
(4e-06)
0.91
(2e-14)
-0.24
(0.2)
-0.15
(0.4)
-0.38
(0.02)
-0.71
(1e-06)
-0.59
(2e-04)
-0.99
(9e-28)
0.62
(5e-05)
0.17
(0.3)
0.15
(0.4)
0.28
(0.1)
-0.045
(0.8)
-0.019
(0.9)
-0.048
(0.8)
-0.56
(4e-04)
0.97
(2e-21)
-0.078
(0.7)
0.72
(7e-07)
0.026
(0.9)
0.23
(0.2)
0.2
(0.2)
-0.83
(3e-10)
0.49
(0.002)
0.37
(0.03)
0.79
(1e-08)
-0.35
(0.04)
-0.32
(0.06)
-0.51
(0.002)
-0.35
(0.03)
0.62
(6e-05)
0.43
(0.009)
0.95
(2e-19)
-0.063
(0.7)
0.99
(2e-29)
0.74
(2e-07)
-0.46
(0.005)
-0.12
(0.5)
-0.11
(0.5)
-0.22
(0.2)
0.99
(6e-30)
-0.056
(0.7)
0.67
(7e-06)
-0.41
(0.01)
-0.16
(0.4)
-0.098
(0.6)
-0.21
(0.2)
Table 4.1: Gene ontology annotation for modules defined from Illumina data set.  Each module has an arbitrary colour allocated, which is 
comparable only between other modules from the same data set. Gene ontology terms for biological process, metabolic function and cell 
compartment are significant at p<0.001 after hypergeometric testing and FDR adjustment of  p-values; values are shown in parentheses. Universe 
for hypergeometric testing was genes from the Illumina RatRefv1 microarray with valid Entrez gene identifiers.  Duplicates were removed.  Terms 
provided are representative, but not exhaustive. Alphanumeric codes are used to unambiguously define modules between analysis and are used in 
the text.   
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Biological Process Metabolic Function  Cell Compartment  
Cellular macromolecule metabolic process (4.9e-20) 
Gene expression (2.2e-18) 
Biosynthetic process (2.4e-15) 
Binding (2.6e-22) 
Organic cyclic compound binding (2.7e-15) 
DNA binding (3.1e-9) 
Intracellular part (6.9e-41) 
Organelle (2.5e-30) 
Nucleus (3.9e-27) 
Immune system process (3.5e-13) 
Response to stress (6.7e-11) 
Cell activation (2e-8) 
Protein binding (2.2e-10) 
PI3-kinase regulator activity (6.8e-4) 
Chemokine receptor binding (6.8e-4) 
Cytoplasm (9.02e-9) 
Actin filament (8.9e-5) 
Intracellular (7.3e-4) 
Blood vessel morphogenesis (1.2e-7) 
Cardiovascular system development (2.8e-6) 
Anatomical structure formation involved in 
morphogenesis (1.1e-5) 
Cyclase activity (5.5e-4) 
Guanylate cyclase activity (6.1e-4) 
Ion binding (8.5e-4) 
Plasma membrane (1.2e-4) 
Cell periphery (1.4e-4) 
Membrane (1.7e-4) 
Mitotic cell cycle (2.2e-12) 
Developmental process (9.7e-9) 
Anatomical structure development (2.02e-7) 
Protein binding (1.2e-17) 
Cytoskeletal protein binding (1.01e-11) 
ECM structural constituent (4.7e-5) 
Cytoskeleton (1.5e-10) 
Extracellular matrix (4.6e-10) 
Stress fibre (5.8e-7) 
Response to external stimulus (2.9e-4) 
Regulation of  signalling (2.9e-4) 
Negative regulation of  MAPK cascade (6.9e-4) 
Receptor binding (2.3e-4) Extracellular region part (2.3e-4) 
Anatomical structure morphogenesis (5.5e-7) 
Developmental process (3.2e-6) 
Tissue morphogenesis (4.2e-5) 
Carbohydrate binding (3.1e-4) 
Coreceptor activity (8.7e-4) 
Receptor tyrosine kinase binding (8.7e-4) 
Membrane raft (5.3e-4) 
Plasma membrane part (6.7e-4) 
Vesicle (7.8e-4) 
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0.56
(0.005)
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(5e-09)
0.48
(0.02)
-0.064
(0.8)
0.33
(0.1)
0.8
(3e-06)
0.41
(0.05)
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(3e-13)
-0.56
(0.005)
-0.19
(0.4)
-0.32
(0.1)
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(0.05)
0.11
(0.6)
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0.84
(3e-07)
-0.38
(0.06)
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-0.26
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-0.19
(0.4)
-0.32
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(0.05)
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0.92
(2e-10)
0.17
(0.4)
0.86
(5e-08)
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(0.01)
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(0.002)
-0.87
(4e-08)
0.065
(0.8)
0.68
(3e-04)
0.34
(0.1)
0.8
(3e-06)
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Table 4.2: Gene ontology annotation for modules defined from Affymetrix data set. Each module has an arbitrary colour allocated, which 
is comparable only between other modules from the same data set. Gene ontology terms for biological process, metabolic function and cell 
compartment are significant at p<0.001 after hypergeometric testing and FDR adjustment of  p-values; values are shown in parentheses. 
Universe for hypergeometric testing was genes from the Affymetrix Gene ST 2.0 microarray with valid Entrez gene identifiers.  Duplicates 
were removed. Alphanumeric codes are used to unambiguously define modules between analysis and are used in the text.   
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Relating modules to phenotypic traits  
In order to evaluate whether any of the data set-specific modules had associations 
with the sample phenotypes a binary matrix was prepared to define membership 
of a phenotype, e.g. alginate cultures.  These phenotypes, or traits, were correlated 
with the module eigengenes for each network. Illumina gene expression data 
showed divergent module eigengenes for cartilage and tendon, Figure 4.7.  In line 
with the findings in Chapter 3 co-expression module AFF2 for Affymetrix data 
was more highly correlated with both native matrix-depleted chondrocytes and 
tenocytes than either group alone, suggesting a closer phenotype, Figure 4.8.  
Alginate cultures in both datasets were found to have strong module eigengene 
associations (ILL1 and AFF5), but associations were equivocal for fibrin cultures 
alone.  
Relating the module-trait associations back to the biological process functional 
annotations (Table 4.1 and 4.2) confirmed the annotations associated with the 
differential expression analysis in Chapter 2 and 3.  For example, the alginate trait 
was association with the Illumina ILL1-module eigengene (cor = 0.97, p = 2e-21) 
and the terms ‘inflammatory response’ and ‘response to cytokine stimulus’, Figure 
4.7. In the matrix-depleted chondrocytes from alginate beads in the Affymetrix 
data these samples were associated with the AFF5 module, Figure 4.8, (cor = 
0.92, p = 2e-10) and the terms ‘response to external stimulus’ and ‘negative 
regulation of MAPK cascade’.   
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Figure 4.7:  Associations between Illumina module eigengenes (rows) and 
sample traits (columns). Within each cell is the corresponding correlation 
(coded by colour – heatmap) and p-value (parenthesis). Samples may be 
members of  more than one trait, for example, ‘Native’ comprises both cartilage 
and tendon samples, whilst ‘Models’ are an aggregation of  both alginate and 
fibrin culture samples.  Strong associations are found between the ILL6 and 
ILL4 modules with the native cartilage and tendon samples respectively.  
Monolayer (ILL2 module eigengene) and alginate (ILL1 module eigengene) 
traits also show strong associations.  Weaker associations are found for the 
ILL5 and ILL3 module eigengenes and various traits.   
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Figure 4.8:  Associations between Affymetrix module eigengenes (rows) and 
sample traits (columns) as described above. Here matrix depleted cells were the 
input, native chondrocytes and tenocytes are cells isolated directly from tissue; 
monolayer is passage three.  Strong associations are found between native 
samples and the AFF2 and AFF3 modules, whilst three-dimensional culture 
systems are more highly associated with the AFF5 and AFF6 modules.  The 
monolayer trait appears associated with the AFF4 module, but this is not a 
strong statistical association.       
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4.3.2: Gene significance and module membership 
 
In order to identify genes that are central elements to functional modules, i.e. 
module hubs, and also strongly associated with a phenotypic trait, three 
quantitative measures were calculated – Gene Significance (GS), intramodular 
connectivity, and Module Membership (kME). Gene significance for every gene 
against each module is shown in Figures 4.5 and 4.6. As Module Membership is 
the more practical value for network comparisons this was used over intramodular 
connectivity, however, there was high correlation between the two values (data not 
shown).   
For the Illumina data there was evidence to support the statement that genes with 
strong trait association were also the most highly connected within a module and 
had high Module Membership (correlation > 0.9), Figure 4.9.  The cartilage- and 
tendon-associated modules (ILL6 and ILL4) had high correlation between GS and 
kME (cartilage - 0.99, p<1e-200; tendon – 0.98, p<1e-200).  This would indicate 
that genes that are highly associated with these phenotypes are also likely to be 
highly connected genes in these modules and could be considered hub elements.  
In contrast the ILL3 module, which had moderate association with three-
dimensional culture models, demonstrated poor correlation between GS and kME 
(cor = 0.34) indicating that the assumption that high trait association was related 
to high gene connectivity did not hold true in this module.   In comparison, for 
the Affymetrix data similar confidence could not be extended to native cells, 
monolayer and alginate culture models and their associated modules, with 
correlations below 0.9 evident. Divergent relationships were evident for the 
combined native cell phenotype; this was consistent with two cell populations 
contributing to this analysis, Figure 4.10.                            
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Figure 4.9: Scatterplots – the Gene 
Significance (y-axis) for a trait (the 
absolute correlation between the module 
eigengene and the trait) vs. Module 
Membership (kME), the correlation 
between the module eigengene and the 
whole gene expression profile (x-axis).  
 
Plots for all traits versus all modules was 
undertaken, but only the most significant 
are shown here.  Plots with strong 
positive correlation indicate that genes 
that are highly associated with a trait are 
also the central elements within a module, 
the definition of  a module hub.  These 
genes are represented in the top right 
corner of  each plot.  This relationship is 
true for modules ILL1, ILL4 and ILL6, 
however, for low correlations (ILL5) hub 
genes cannot be confidently identified.    
ILL6 | Cartilage ILL4 | Tendon 
ILL2 | Monolayer ILL1 | Alginate 
ILL5 | Models 
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4.3.3: Defining putative module hubs 
  
For modules with high trait significance, and for which there was a strong 
association between Gene Significance and Module Membership (kME), the 
predicted hubs were chosen as the top twenty genes with a kME >0.9, consistent 
with standard methodology.  Gene ontology annotation was performed on the top 
50 genes where kME >0.9 and GS >0.5.  Results for both network analysis are 
shown in Table 4.3 and 4.4. 
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Figure 4.10: Scatterplot of  Gene Significance (GS) (y-axis) versus Module 
Membership (kME) (x-axis) relating to Affymetrix data.  Associated modules and 
phenotypic traits are provided.  Moderate correlations between GS for a trait and kME 
were only found for the A: ‘native’ cell phenotype (matrix-depleted cells isolated from 
cartilage and tendon ); B: monolayer cultures, and alginate beads (not shown).  
Although the AFF2 module eigengene had a high correlation with the matrix-depleted 
phenotype from native cells (cor = 0.96) the relationship between GS and kME was 
only highly correlated at high values of  GS and kME with divergent relationships 
evident with genes that had lower associations with the phenotypic trait indicative of  
the presence of  two phenotypes.  The monolayer associated module demonstrated 
poor associations between GS and kME indicating that hub genes for this module 
could not be confidently identified.   
A. B. 
AFF2 | Native AFF4| Monolayer 
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Native chondrocyte-associated modules 
The ILL6 module (1007 genes) had the highest association with the trait ‘cartilage’.  
The genes with the highest kME for ‘cartilage’ included the cathepsins Ctse and 
Ctsg, and genes identified as highly expressed in both cartilage datasets, Sell 
(selectin L) and Dmp1 (dentin matrix acidic phosphoprotein 1). In the Affymetrix 
data set the module associated with native cells, AFF2 (948 genes), was 
represented by Srgn (serglycin) and Vamp1 (vesicle-associated membrane protein 
1).  In both accounts the biological process annotation ‘response to stress’ was 
significantly enriched.  
Native tenocyte-associated modules 
The modules with the strongest associations for native tenocytes, ILL4 and AFF3, 
demonstrated divergence in their hubs and annotation.  ILL4 was found to 
contain troponins Tnnt3 and Tnni1, Kera (keratocan) and Gap43 (growth associated 
protein 43) as the most highly connected.  The AFF3 module was represented by 
Angpt2 (angiopoetin 2), Robo4 (roundabout homolog 4), and the EMILIN-family 
member Mmrn2 (multimerin 2).  The module hubs differed in their annotations 
with the Illumina data defined by muscle contraction and muscle tissue 
development, whereas the Affymetrix module was described by blood vessel 
development and cardiovascular system development.  
Monolayer-associated modules   
Sample origins for monolayer differed in passage number with passage 5 for 
Illumina data and passage 3 for Affymetrix.  The Illumina monolayer-associated 
module ILL2 had as hubs the beta-catanin inhibitor Lzts2, and regulators of 
growth plate differentiation Igfr1 and Sirt6.  The AFF4 module was found to 
contain Fzd2 and Bmp1 as central regulators.  The Affymetrix module was 
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annotated with the terms ‘regulation of cell-substrate adhesion’ and ‘extra-cellular 
matrix organisation’, whilst the Illumina module was described by ‘polysaccharide 
catabolic process’.   
Alginate-associated modules 
The Illumina alginate-associated module ILL1 contained the serine peptidase 
inhibitors Serpina1 and Serpina3n, peptidase inhibitor Pi15 and the transcription 
factor Atf3.   The inhibitor of nuclear factor kappa-B kinase Ikbke was a hub in 
both the ILL1 and AFF5 alginate culture-associated modules.  Additionally the 
AFF5 module contained Ier2 (immediate early response 2) and Sfrp2 (secreted 
frizzled-related protein 2). The ILL1 module was described by the term 
‘inflammatory response’, whilst AFF5 was significantly enriched for the term 
‘positive regulation of cell differentiation’.   
In summary, there was evidence for common functional annotations between 
modules from the two data sets using standalone analysis of these expression 
profiles, however, the qualitative preservation of hub gene candidates across 
phenotypic traits was equivocal nor consistently meet assumptions for confidently 
calling hub genes in some conditions.     
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Phenotypic 
Trait 
Module 
association   
[cor, p-value] 
Gene significance vs. 
Module Membership 
[cor, p-value] 
Top 20 kME – Hub genes 
Biological Process (Top 50) 
annotation (adj.p-value) 
Cartilage ILL6/Turquoise 
[0.99,  p=6e-30] 
0.99, p<1e-200 Prg2, Nkg7, Add2, Napsa, Ppbp, Dnase1l3, Ctse, 
Plac8, Cfp, Fcnb, Loc24906, Ptprcap, Ifitm6, Ctsg, 
Camp, Sell, Retnlg, Ngp, Dmp1, Ms4a2 
Immune system process (1.08e-7) 
Response to stress (1.3e-4) 
Tendon ILL4/Green 
[0.99,  p=2e-29] 
0.98, p<1e-200 Mb, Cox8b, Dhrs7c, Tnnt3, Myl1, Ryr1, Ckm, Myoz1, 
Tmod4, Itih3, Kera, Ccdc3, Art3, Tnni2, Rbfox1, 
Gap43, Eno3, Pgam2, Lyve1, Myoc 
Muscle contraction (2.4e-16) 
Muscle tissue development (6.9e-6) 
Monolayer ILL2/Blue 
[0.91,  p=2e-14] 
0.83, p<1e-200 Scamp4, Srsf9, Apba3, Mrrf, Wsb2, RGD1559909, 
Dolk, Pcgf3, Leprel2, Prelid1, Igf1r, Ipo4, Lzts2, 
Clip2, Pygb, Prmt2, Slc30a5, Tm2d2, Sirt6, Eef1g 
Polysaccharide catabolic process 
(9.6e-4) 
Alginate ILL1/Black 
[0.97,  p=2e-21] 
0.9, p=1.4e-30 Ptgds, Serpina1, Abcc9, Cesl1, Atf3, Gem, Ces1c, 
Gpr88, Pcsk1, Serpina3n, Ikbke, Map3k8, Rilp, 
Adipoq, Sectm1b, Maob, Ces1d, Akr1cl, Ppp1r1b, 
Pi15 
Response to organonitrogen 
compound (3.6e-7) 
Inflammatory response (1.1e-4) 
Models ILL5/Red [0.95, 
p=2e-19] 
0.88, p=1.1e-50 Armcx3, Ak3, Sat2, Eci2, P2rx4, Maoa, Pgrmc1, 
Commd10, Atp11a, LOC290595, Acsl4, Plin2, Psma1, 
Errfi1, Dnajc14, Sod2, Ctsd, Rbbp7, Tomm20, Mcfd2 
Protein targeting to mitochondria 
(2.2e-4) 
Oxygen homeostasis (2.2e-4) 
Table 4.3: Summary table highlights the phenotypic trait association with modules from Illumina data.  Correlation of  gene significance and 
module membership indicate confidence in modular hubs associated with traits.  The top 20 genes with highest module membership (kME>.9) as 
shown; the biological process annotation for these genes is also provided where significant annotations are present (GS>.5). The combined 
phenotype of  ‘Models’ (both alginate and fibrin cultures) had a more robust association than fibrin alone and is presented.  The gene Lzts2 is 
highlighted as a monolayer hub – this is investigated further in 4.3.7.   
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Phenotypic 
Trait 
Module 
association   
[cor, p-value] 
Gene significance vs. 
Module Membership Top 20 kME – Hub genes 
Biological Process (Top 50) 
annotation (adj.p-value) 
Native 
chondrocytes 
AFF2/Brown  
[0.8, p=3e-6] 
0.99, p<1e-200 Dnajb1, Mir29b2, F13a1, Hsph1, Pdk4, Pf4 ,Arid1b, 
Hsp90ab1, Isg20, Clec4d, Vamp1, Srgn, LOC363060, 
Fcer1g, Depdc7, Tcp11, Igsf6, Hspbap1, Cd53, Uspl1 
Chaperone mediated protein folding 
(8.2e-6) 
Response to stress (8.7e-4) 
Native 
tenocytes 
AFF3/Green 
[0.95, p=3e-12] 
0.59, p=9.1e-20 Gpr116, Cd93, Cdh5, Emcn, Tie1, Cd34, Myct1, 
Podxl, Eltd1, Prex2, Mfng, Angpt2, Npr1, Kit, Gpr4, 
Prkch, Tek, Robo4, Mmrn2, Plxnd1 
Blood vessel development (4.6e-8) 
Cardiovascular system development 
(1.6e-6) 
Native cells AFF2/Brown 
[0.96, p=3e-13] 
0.82, p<1e-200 Hubs based on module membership as per native 
chondrocytes above – gene significance value is higher 
for each gene for ‘native’ phenotype 
NA 
Monolayer AFF4/Blue 
[0.69, p=2e-4] 
0.5, p=8.4e-63 Loxl1, Adamtsl4, Flnc, Scrn1, Col8a1, Fzd2, Large, 
Lgals1, St5, Nkain1, Nuak1, Pcolce, Fam198b, St3gal2, 
Lhfp, Bmp1, Nxn, Ebpl, Ccbe1, Fbn1 
Regulation of  cell-substrate adhesion 
(8.4e-5) 
Extracellular matrix organisation (3.6e-4) 
Alginate AFF5/Red 
[0.92, p=2e-10] 
0.42, p=3.6e-6 Ptprz1, Atp11a, Robo1, Etv1, Sfrp2, Tmem200a, 
Cyp7b1, RGD1310819, Nceh1, Ikbke, Itgb8, 
Fam168a, Tnfsf15, Acvr1b, Entpd4, Ptn, Ier2, 
Ppargc1a, Acadsb, Plekha5 
JAK-STAT cascade involved in growth 
hormone signaling (6.1e-4) 
Positive regulation of  cell differentiation 
(8.4e-4) 
Model AFF6/Yellow  
[0.8, p=3e-6] 
0.3, p=1.8e-5 Galnt2, Junb, Efna4, Traf3ip2, Prickle2, Nudt4, Bst1, 
Naprt1, Lrp6, Pecr, Gnb5, Flrt2, P2rx4, Gpr153, 
Zmynd8, Shc1, Stxbp4, RGD1309534, Slc41a2, Sox4 
Neurogenesis (8.7e-4) 
Cellular response to insulin stimulus 
(8.7e-4) 
Table 4.4: Summary table highlights the phenotypic trait association with modules for Affymetrix data.  Correlation of  gene significance and 
module membership indicate confidence in modular hubs associated with traits.  The top 20 genes with highest module membership (>0.9) are 
shown; genes are ordered (L-R) from highest module membership.  The biological process annotation for these genes is also provided where 
significant annotations are present and are based on the top 50 genes. The relationship between the trait ‘Model’ and the yellow module was greater 
than that with ‘Fibrin’ and so the former is presented.   
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4.3.4:  Consensus network generation for 3D culture systems 
It is not possible to directly compare the networks features derived from 
individual data analysis, other that by functional annotation of the modules, as 
described above.  In order to define the emergent properties in the three-
dimensional culture systems it was necessary to undertake a differential eigengene 
network analysis to determine, and quantify, whether a set of modules found in 
one network was preserved in another.  By pursuing this method a comprehensive 
analysis of network structures across two data sets would allow conserved and 
divergent functional modules to be defined to reveal biologically relevant pathway 
dependencies for a phenotype.    
Expression data and eigengene network structure 
To establish if the Illumina and Affymetrix studies were comparable the average 
expression rank for each gene in a data set was calculated and correlated between 
the two studies. The high expression correlation (cor = 0.7, p < 1e-200), Figure 
4.11, suggested that the gene expression profile was significantly preserved 
between data sets.  For module identification genes common to both data sets, 
after non-specific filtering, were identified (n=2795) and only these were used in 
further analysis. Soft-thresholding powers were tested across both data sets and β 
= 7 was chosen.  
Consensus modules are identified from both data sets 
Consensus modules are modules that are common to two gene co-expression 
networks and may represent biological mechanisms that are shared between the 
two data sources.  Comparing the relationships between the consensus eigengene 
networks can reveal important differences between the systems.  A consensus 
network was established by hierarchical clustering of a consensus dissimilarity 
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matrix.  The consensus network analysis defined 15 modules, including one 
module (‘grey’ for unassigned genes). Additionally, new data set-specific single 
networks were prepared that were derived only from the 2795 common genes 
used for consensus network analysis, Figures 4.12 and 4.13 (upper panels).  As 
such, module identifiers used in sections 4.3.1-4.3.2 are not applicable to this 
section.      
Module overlap with consensus modules is variable between data sets 
Revised Illlumina and Affymetrix module eigengenes (derived from 2795 common 
genes) were considered against the 15 consensus modules to assess the gene 
overlap, i.e. whether genes comprising modules in the individual network analyses 
were wholly replicated in the consensus network.  In general, there was overlap 
between module eigengenes from the individual networks and the consensus 
network, however, these overlaps were often not associated with a single 
consensus module eigengene, Figures 4.12 and 4.13 (lower panels) and Table 4.5. 
Module overlaps are summarized in Figure 4.14.   
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Figure 4.11:  Upper panel -  
scatterplot of  mean ranked 
expression values for every gene 
common to both Illumina (x-axis) 
and Affymetrix (y-axis) data sets 
(n=2975).  
  
Lower panel: Soft-thresholding 
powers (x-axis) are plotted against 
scale-free topology criterion or 
connectivity values for either 
Illumina or Affymetrix data (boxed 
legends), y-axis.   
 
Using the reduced gene numbers 
the scale-free topology issues 
arising in the earlier Affymetrix 
analysis are still evident.  A power 
of  beta=7 was chosen based upon 
the reduction in connectivity 
associated with increasing power 
in the Illumina data.   
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Figure 4.12: Upper panel - Clustering dendrogram for Illumina data using genes 
common to both data sets (top) with associated modules.  General network structure 
is approximately comparable to that of  the larger gene set. Nine modules were 
identified using the smaller data set (ILL8-ILL16) including the grey module, which 
contains unassigned genes. 2795 genes with deepSplit=1, beta=7, cut-height=0.2.   
ILL8 
Figure 4.12: Lower panel - Gene overlaps between the revised Illumina modules 
(rows) and those defined by the consensus network for Illumina and Affymetrix 
(columns).  Broadly, all Illumina network modules have representation in the 
consensus network, however, this may be over several consensus modules.  Coloured 
cells define the number of  genes from the consensus module that are overlapping 
with the Illumina-specific modules (linear heatmap).   The number of  genes in each 
module are indicated beside the colour blocks allocated to each module.     
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Figure 4.13: Upper panel - Clustering dendrogram for Affymetrix data using genes 
common to both data sets (top) with associated modules.  General network structure 
is approximately comparable to that of  the larger gene set. Eleven modules were 
identified (AFF7-AFF17) using the smaller data set. 2795 genes with deepSplit=1, 
beta=7, cut-height=0.2.   
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Figure 4.13: Lower panel - Gene overlaps between the revised Affymetrix modules 
(rows) and those defined by the consensus network for Illumina and Affymetrix 
(columns).  Broadly, all Affymetrix network modules (AFF7-17) have representation 
in the consensus network, however, this may be over several consensus modules.  
Coloured cells define the number of  genes from the consensus module that are 
overlapping with the Affymetrix-specific modules (linear heatmap).   The number of  
genes in each module are indicated beside the colour blocks allocated to each module.     
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 NA 
 
286 
 
Figure 4.14: Circos plot to present Affymetrix (‘AFF’ prefix) and Illumina (‘ILL’ prefix) module 
overlaps with consensus modules (C prefix).  Figure derived from tabular data where rows 
(Affymetrix or Illumina modules) and columns (consensus modules) are represented by coloured 
segments (inner circle) the size of  which defines the total number of  genes that overlap with the 
Affymetrix and Illumina modules.  Ribbons connect rows and columns and are coloured by 
consensus module to show the overlap with each Affymetrix or Illumina module.  The outer two 
rings define the relative contribution of  each cell in a table to the row and column totals (stacked bar 
plots).  The figure summarises the  tabular data shown in Figures 4.12, 4.13  and Table 4.5.  N.B. 
The colours rendered have no association with the assigned module colours.  The consensus modules 
with the highest trait associations for native and monolayer chondrocytes and alginate cultures are 
defined. The most highly preserved Illumina module in Table 4.7 was ILL9, which together with 
AFF7, contribute the greatest number of  overlapping genes with the C8, monolayer-associated, 
module.   
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Consensus Module 
(size) 
Illumina Modules 
(overlap/illumina 
module size) 
Affymetrix Modules 
(overlap/affymetrix module 
size) 
C1: Tan (103) ILL8/Red           (25/179) AFF13/Red (48/116) 
C2: Cyan (66) ILL11/Turquoise (58/832) AFF7/Blue (40/369) 
C3: Pink (158) Turquoise (129/832) AFF10/Yellow (120/178) 
C4: Red (184) Turquoise (149/832) AFF16/Turquoise (156/1505) 
C5: Salmon  (82) Turquoise   (46/832) Turquoise (43/1505) 
C6: Purple  (127) ILL9/Blue           (49/536) AFF14/Purple (22/43) 
C7: Turquoise  (360) Blue           (185/536) Turquoise (290/1505) 
C8: Yellow  (304) Blue           (154/536) Blue (103/369) 
C9: Blue (358) ILL14/Brown   (89/391) AFF8/Brown (152/201) 
C10: Black (160) Brown (109/391) Turquoise (112/1505) 
C11: Magenta (142) ILL12/Yellow (123/291) Turquoise (100/1505) 
C12: Greenyellow (104) Yellow (41/291) Turquoise (61/1505) 
C13: Brown (305) Turquoise (261/8320 Turquoise (261/1505) 
C14:  Green (286) ILL15/Green (149/283) Turquoise (103/369) 
Table 4.5: Module overlap – A summary of  the 
module overlap between Illumina or Affymetrix single 
network modules and the consensus modules.  
Consensus modules (C) are grouped into the meta-
modules defined in Figure 4.15, with the exclusion of  
C13 and C14.  For consensus modules the total number 
of  genes in given in parentheses.  For Illumina and 
Affymetrix modules the number of  overlapping genes 
with consensus modules, relative to the total number of  
genes in the module, is provided in parentheses.  
 
Only the greatest module overlaps are shown, complete 
overlap values are found in Figures 4.12 and 4.13.  For 
data set-specific modules the reader is reminded that 
the allocation of  colours to modules is arbitrary and so, 
for example, the ‘brown’ Illumina module is not 
necessarily equivalent to the ‘brown’ Affymetrix 
module.   
 
Module equivalence is defined by the consensus module 
overlaps and statistical definitions in Table 4.7.  To aid 
discussion alternative alphanumeric names are given to 
the consensus modules (C1…Cn).   
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4.3.5: Differential eigengene network analysis and meta-modules  
The analysis proceeded by summarizing consensus modules for each data set by 
the first principal component, the module eigengene.  As eigenegenes from 
different modules show correlations eigengene networks can be defined.  This may 
show whether the identified consensus modules that are highly related in one data 
set (Illumina) are also highly related in another data set (Affymetrix).  
An eigengene network was constructed for each data set such that highly 
correlated eigengenes for different modules were grouped together, Figure 4.15:i-
ii.  For each module eigenegene the scaled connectivity (degree) was defined as the 
mean connection strength with other eigengenes (Figure 4.15:iv). The average 
scaled connectivity across the whole eigengene network was defined as the density, 
D.  If most eigengenes within a network have high, positive correlations with each 
other the value of D approaches 1, i.e. the eigengene network relationships are 
highly comparable between the data sets.    
Between the eigengene networks of consensus modules for Illumina and 
Affymetrix data sets there was moderate preservation as defined by the density 
value, D= 0.68. The relationship of each individual eigengene with all others in the 
network was variable, reflected by the differences in individual module scaled 
connectivity values in the preservation network (Figure 14.5:iv.).  The C9 (blue) 
module eigengene was found to have the highest scaled connectivity in the 
preservation network.   
As eigengenes form networks analogous to the earlier analysis modules comprised 
of eigengenes, ‘meta-modules’ can be identified, Figure 14.5: iii and vi, which 
show high, positive correlations with each other.  Meta-modules can demonstrate 
 
289 
higher order relationships in the gene co-expression organization that are not 
evident in standard module detection.  In the Illumina data the module eigengene 
network was clustered in four meta-modules: meta-module C1:C4 - tan, cyan, pink 
and red; C5:C8 - purple, salmon, turquoise and yellow; C9:C10 - black and blue; 
and C11:C12 - greenyellow and magenta.  Whilst there was some evidence of the 
conservation of meta-modules in the Affymetrix data, especially C1:C4 and C5:C8, 
preservation values were often poor. The meta-modules were functionally 
annotated and are summarized in Table 4.6.       
Module preservation analysis  
Module overlap, and the definition of module equivalence between data sets, was 
not clear. To define the preservation of Illumina modules (considered the 
reference data set) in Affymetrix modules (test data set) statistically a permutation 
test was employed.  Module preservation was generally low, however, the ILL9, 
ILL15, ILL13 and ILL10 Illumina modules were the most significantly preserved 
in the Affymetrix network, Table 4.7.   
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Figure 4.15: Differential eigengene analysis in Illumina and Affymetrix data sets -  i, ii. - 
dendrograms of  consensus module eigengenes for Illumina and Affymetrix networks; iii. - 
heatmap of  eigengene adjacencies for the consensus eigengene network relative to the Illumina 
data. Four meta-modules are evident in i. and iii.  Rows and columns relate to one consensus 
eigengene (labelled by the consensus module colours) – positive correlation/high adjacency is 
shown by red intensity; blue represents negative correlation as defined by the vertical colour 
bar; vi. – represents the equivalent plot for the Affymetrix data; v. – histogram of  the 
preservation values for each consensus eigengene (bar colour) – height (y-axis) represents the 
eigengene preservation measure.  D, density, represents the overall eigenegene network 
preservation; v. – heatmap of  preservation network adjacencies with figure structure as per iii.  
Generally, the consensus module eigenegene network preservation is moderate between the 
data sets with limited replication of  meta-modules in Affymetrix data.     
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Consensus  
Meta-module 
Phenotypic 
Trait Biological Process 
Metabolic 
Function 
Cellular  
Compartment KEGG pathway 
C1-C4 
Tan 
Cyan 
Red 
Pink 
 
Native cells Transmembrane receptor protein 
serine/threonine kinase signaling 
pathway (1.9e-3) 
Anatomical structure formation 
involved in morphogenesis (2.4e-4) 
Developmental process (1.8e-6) 
Extracellular matrix organisation 
(9.8e-3) 
Actin binding (4.8e-3) Extracellular matrix (1.9e-3) 
Vesicle (4.9e-3) 
TGF-beta signalling 
pathway (9.8e-3) 
C5-C8 
Purple 
Salmon 
Turquoise 
Yellow 
Monolayer Response to stress (1.6e-8) 
Defense response (6.7e-5) 
Biological adhesion (1.8e-3) 
Response to organic substance 
(1.6e-4) 
Catalytic activity (1.7e-9) 
Oxidoreductase activity 
(1.9e-5) 
 
 
Cytoplasm (4.9e-4) 
Extracellular region (1.3e-2) 
NA 
C9-C10 
Black 
Blue 
Model cultures Developmental process (2.5e-7) 
Cell differentiation (6.1e-5) 
Response to stress (1.9e-8) 
Response to inorganic substance 
(3.2e-7) 
Catalytic activity (5e-6)  
 
 
 
Extracellular region part 
(4.3e-12)  
Extracellular matrix (8e-6) 
Lytic vacuole (3.9e-3) 
 
 
Lysosome (3.9e-2) 
C11-C12  
Magenta 
Greenyellow 
No consensus 
association 
Cholesterol biosynthetic process 
(1.1e-3) 
Cellular process (1.9e-3) 
Ion binding (4.1e-3) 
Insulin-like growth factor 
binding (2.1e-2) 
Cytoplasm (4e-13) 
Proteinaceous extracellular 
matrix (5.2e-3) 
Steroid biosynthesis 
(4.5e-2) 
C13:  
Brown 
No consensus 
association 
Cell cycle phase (8.9e-10) 
Microtubule-based process (2.6e-5) 
Microtubule motor 
activity (ns) 
Intracellular organelle part 
(3.1e-12) 
DNA replication 
(4.7e-9) 
C14:  
Green 
No consensus 
association 
Cellular metabolic process (2e-3) 
Response to organic substance 
(1.4e-2) 
NA Cytoplasm (2.4e-12) 
Mitochondrion (9.8e-5) 
NA 
Table 4.6: Consensus modules are gathered into meta-modules (Figure 4.15) and the overall trait association is presented.  Using all the genes 
within the meta-modules the gene ontology analysis is shown for biological process, metabolic function and cellular compartment using DAVID 
with a general Rattus norvegicus background.  Modules below the black line show no consensus associations with phenotypic traits. 
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Illumina 
Module 
Module 
size 
Z-score,  
Preservation 
summary 
Log10 p-value,  
Bonferoni 
ILL9/blue 400 13.29 -42.81 
ILL15/green 283 7.51 -16.22 
IL13/pink 111 7.24 -17.02 
ILL10/black 155 5.17 -6.66 
ILL11/turquoise 400 4.73 -5.94 
ILL8/red 179 4.51 -6.89 
ILL14/brown 391 4.49 -6.09 
gold 100 2.82 -2.71 
ILL12/yellow 291 -0.39 0 
grey 17 -0.85 0 
Table 4.7: Module preservation  - To quantify how well the modules in the 
Illumina (reference) network were preserved in the Affymetrix (test) network a 
permutation test was employed.  The maximum module size used for calculations 
was 400 genes; modules larger than this consisted of  random samples of  genes 
within the specified module.   
 
In general terms, the higher the Z-score summary preservation value the more 
preserved the module is between data sets.  Values 5>Z<10 represent moderate 
preservation, whilst Z>10 indicates high preservation.  Uncharacterised genes are 
within the ‘grey’ module, whilst the ‘gold’ module is generated as part of  the test 
and contains randomly assigned genes from any module; ‘grey’ and ‘gold’ 
modules should score consistently lower than preserved modules. The ILL9 
module (Figure 4.12) shows the strongest preservation   
Phenotypic 
Trait 
Module 
association   
[cor, p-value] 
kME correlations Top 20 kME 
Monolayer ILL9/blue  
[0.88,  p=1e-12] 
0.59,  p=1.4e-51 Rgd1566262, Prelid1, Chpf, Lmf2, Wsb2, 
Lass5, Geft, Itga11, Gpc4, Ccs, Pofut2, 
Pygb, Mrpl55, Lman1, C1qtnf5, Stub1, 
Rab30, Ipo4, Rgd1559909, Smyd2, Tagln 
Alginate ILL13/pink 
[0.97, p=3e-22] 
0.64,  p=4e-14 Gpnmb, Cp, Orm1, Sectm1b, Chi3l1, 
Obfc2a, Serpina3n, Crispld2, Enpp2, 
Atf3, Map3k8, Zfp347, Coro6, Pi15, Btg2, 
Cd302, Maoa, C3, Phlda1, Cfh 
Table 4.8: Top consensus hubs based on high 
kME values across networks – only the ILL9 and 
ILL13 modules shared significant kME 
preservation (Figure 4.17) with the Affymetrix 
network.  These modules were associated with 
the ‘monolayer’ and ‘alginate’ traits for Illumina 
modules.  For monolayer the consensus hubs 
included glypican 4 and integrin alpha 11; for 
alginate peptidase inhibitors Serpina3n and Pi15, 
and glycoprotein Gpnmb were called as consensus 
hubs.     
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Figure 4.16:  Summary relationship between the consensus module eigengenes (rows) and 
common conditional traits (columns) for Illumina and Affymetrix data sets. Within each 
matrix cell the correlations between the the corresponding module eigengene and the trait is 
reported.  The p-values are provided in parentheses below.  The cell colour represents the 
correlation value (red - positive, blue - negative) and is coded in the vertical colour bar on the 
right of  the figure.  Some traits combine terms, for example, ‘Native’ contains both native 
chondrocyte and tenocyte data, whilst ‘Model cultures’ contains both alginate and fibrin 
samples.  Missing (NA) cells indicate that correlations in the module-trait pairs in the Illumina 
and Affymetrix data sets had opposite signs and no summary relationship can be defined.  
Native chondrocytes were generally associated with modules in the pink|red|cyan meta-
module with the pink module showing the greatest association with the trait.  Strong 
consensus relationships were not found for tenocytes, but their inclusion in the ‘Native’ 
phenotype improved association with the tan and cyan modules.  The ‘monolayer’ trait was 
associated with the purple|salmon|turquoise|yellow meta-module with the yellow module 
having the strongest association with this trait.  There was no strong association with any 
module for the trait ‘fibrin’, but when aggregated with the alginate samples the trait ‘model 
cultures’ was strongly associated with the blue consensus module eigengene.      
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Sample traits 
C1 
C2 
C3 
C4 
C5 
C6 
C7 
C8 
C9 
C10 
C11 
C12 
C13 
C14 
NA 
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Functional annotation of meta-modules and assigning consensus hub genes 
Considering the module-trait associations with the functional annotations of the 
meta-modules validated the annotations found in the two data sets.  Monolayer, 
for example, was associated with the C5:C8 meta-module and the functional terms 
‘developmental process’ and ‘anatomical structure formation involved in 
morphogenesis’; model cultures, alginate and fibrin, were defined by the C9 and 
C10 meta-module and the terms ‘developmental process’ and ‘cell differentiation’.  
These functional annotations have been consistent in the analysis across both the 
Illumina and Affymetrix data sets.   
To determine common hub genes across studies, which may act as central 
regulators, Module Memberships were calculated for all genes using the module 
eigengenes for the Illumina data. The Module Membership value, kME, is useful 
in comparing networks as it is a global measure of the correlation between every 
gene and each module eigengene.  This allows genes not initially found to be 
assigned to a module to be considered as central regulators between networks.  In 
essence this method superimposes the modular structure (colour assignments) of 
one network onto another.  
Module Membership values for every gene in the Illumina data set were 
considered against the equivalent gene kME in the Affymetrix data.  Only the 
Illumina ILL13/pink (0.64, p = 4e-14) and Illumina ILL9/blue (0.59, p = 1.4e-51) 
modules demonstrated high correlation between the kME values indicated 
preserved module connectivity, Figure 4.17.    On this basis only these two 
modules will be considered further.   
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Figure 4.17: Scatterplots of  kME Illumina (x-axis) against kME Affymetrix (y-axis).  
Using only in-module genes is a visual way of  assessing hub gene conservation: if  
these genes show between-set correlation, then the genes in the upper right of  the 
plot are likely to be common hub genes between data sets. Hub genes are genes that 
show significant correlation with module eigengenes and high within-module 
connectivity.  Module membership values (kME) were calculated for all genes in both 
data sets using the Illumina module classifiers as the reference network.  Only 
conserved hubs should have high kME value correlations when the test network 
(Affymetrix) is compared to the reference.  Only the Illumina ILL13 (pink) and ILL9 
(blue) modules (highlighted with grey boxes) were found to have this association.  In 
other terms, confidence in calling consensus hub genes could only be extended to 
genes from these two modules.  
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To define which genes were hubs in both datasets gene lists were ranked on their 
module membership and the top twenty selected, Table 4.8.  The common 
central regulators found with the ILL13 alginate-associated module, included Atf3, 
the peptidase inhibitor Pi15, chitinase Chi3l1 and the regulator of osteoblast-
osteoclast differentiation and function osteoactivin/Gpnmb and the serine protease 
inhibitor Serpina3n. The ILL9 module, monolayer-associated, contained the 
common hubs Itgna11 (integrin α11), Gpc4 (glypican 4) and Tagln (transgelin).   
To qualify these findings for alginate cultures the modular network for 
ILL13/pink was visualized using Cytoscape with either the Illumina or Affymetrix 
gene expression data from Chapter 2 and 3.  The topological overlap matrix of 
either data set was used as the basis for the network and the gene members of the 
ILL13 module were the nodes around which the network was built.  In Figure 
4.18 the consensus network hubs that show the strongest intramodular 
connectivity are Pi15 and Serpina3n; few of these consensus hubs show evidence of 
protein-protein interactions, Figure 4.19. In Figure 4.20 the topological overlap 
of the Affymetrix data on the ILL13 module also placed Serpina3n, Pi15, along 
with Chi3l1, as modular hubs, which were more highly expressed in alginate 
cultures relative to either monolayer or native chondrocytes.   
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Figure legend (4.18) 
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Node 
Edge 
Degree 
Figure 4.18 Graphical representation of  topological overlap of  the Illumina 
ILL13/pink module.  Nodes represent genes within the module and Chapter 2 log2 
fold-changes for the native cartilage to alginate differential expression analysis are 
overlain such that genes more highly expressed in cartilage are red (figure legend).  
Genes identified as consensus hub genes are highlighted by a yellow corona.  From 
the Illumina data the topological overlap would indicate that of  the consensus hubs 
PI15 and Serpina3n have the highest intramodular connectivity  The network 
structure may be compared against the putative hub genes defined in the single 
network analysis for Illumina data in Table 4.3.   
Figure 4.19: Output from STRING to show the protein-protein 
interaction (PPI) evidence view for the top 20 consensus hub genes 
identified as having strong association with chondrocytes in alginate 
beads.  Using this database there is no evidence for PPI between 
Serpin3an, Pi15 and Gpnmb.   
Activation 
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Catalysis 
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Reaction 
Expression 
Figure legend (4.19) 
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Figure 4.20:  
Graphical representation of  
topological overlap of  nodes 
arising from Affymetrix data.  
Nodes, representing genes, are 
those within the Illumina ILL9/
pink module with strong 
association with alginate-encased 
chondrocytes.   
 
Node size varies with degree, or 
total connectivity; edges are 
defined by weight of  interaction 
( c o l o u r ,  t h i c k n e s s a n d 
transparency) figure legend.  
W h i t e  n o d e s  a r e  n o t 
differential ly expressed in 
supplied data.    Some network 
elements have been cropped to 
focus on highly connected 
nodes. 
Weight 
Figure legend 
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4.3.7: Lzts2 silencing does not influence chondrocyte differentiation 
status  
In the independent analysis of the Illumina data the leuzine-zipper, putative 
tumour suppressor 2, Lzts2, was identified as a potential hub or central regulator 
within a module showing strong correlation with the monolayer trait for 
chondrocytes and tenocytes.  Expression was found to be lower in both 
monolayer chondrocytes (log2 fold change = -1.56; false discovery rate = 1.14e-08, 
log odds ratio = 12.01) and in tenocytes at passage five (log2 fold change = -0.86, 
false discovery rate = 1.4e-4, log odds ratio = 2.9) relative to native tissue 
(Chapter 2).  To determine whether Lzts2 was a central regulator in the 
dedifferentiation of chondrocytes a siRNA approach was employed to silence 
Lzts2 expression and evaluate the impact on differentiation markers by qPCR.  
Based upon differential expression analysis Col2a1 and Acan were selected as 
markers of differentiated status; genes more highly expressed in dedifferentiation 
Pitx1 and Thy1, and the chondrogenesis regulator Sox9, were also considered.     
Robust reduction (~77% knockdown) of expression of Lzts2 was consistently 
shown in chondrocytes at passage three, Figure 4.21.  Trending differences in 
expression between Lzts2 siRNA treated and negative control samples, for 
aggrecan (Acan), were confounded, however, by higher expression of target genes 
in some samples only treated with the transfection agent, Lipofectamine 2000.  
Two independent studies could not demonstrate clear evidence of an impact of 
Lzts2 knock-down on marker of chondrocyte differentiated status (data not 
shown).   
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Figure 4.21 – Plots of  quantitative 
PCR data (2^-dCt, y-axis) for three 
treatment conditions (x-axis) for 
passage 2 chondrocytes – i) treated 
with Lzts2 siRNA, ii) treated with 
negative control siRNA, iii) treated 
with comparable volume of  
Lipofectamine 2000. Significance 
code: (*) – p<0.05; (**) – p<0.01  
 
Expression of  the leucine zipper 
Lzts2 was significantly reduced in 
cultures following application of  
siRNA targeted to this transcript 
(p<0.01).  
There was also a significant 
difference in expression between 
the negative control siRNA-
treated chondrocytes and the 
lipofectamine controls for Thy1.  
 
D i f f e r e n t i a t i o n (Co l 2 a1 ) ,          
dedifferentiation (Pitx1, Thy1) 
and development markers (Sox9) 
were not significantly different 
between groups.   Differential 
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significance (p=0.051).  All 
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Rps20.   
Col2a1 
Lzts2 
Sox9 
Agcn 
Pitx1 
Thy1/CD90 
 
302 
4.4: Discussion 
Weighted gene co-expression network analysis (WGCNA) is a systems biology 
methodology that facilitates investigation of the global network properties of a 
transcriptome and provides functional insights into the organization of the 
network.  The practical output of this type of analysis is the elucidation of higher-
order relationships between groups of highly co-expressed genes (modules) and 
their associations with phenotypic traits.  Comparative analysis of network 
structures allows the definition of conserved and divergent functional modules 
between data sets providing a global network perspective of changes in the system 
under investigation.   
Differential expression analysis in Chapters 2 and 3 focused on the selection of 
individual genes as candidates for modulation of differentiation status in 
chondrocytes and tenocytes.  The gene expression profiles defined in these earlier 
studies arose from the collective responses of multiple regulatory networks and 
this information is lost in single gene analysis (Zhao, Langfelder et al. 2010).  In 
order to determine regulatory units that may modulate differentiation status in 
chondrocytes and tenocytes the WGCNA approach was employed to consider the 
connectivity of all genes analysed and derive co-expression networks that describe 
the strength of relationships between genes and their topological overlap with 
other genes in the network.   
As outlined in Chapter 3 the transition to an alternative microarray platform 
negates the direct comparisons between the gene expression profiles derived from 
Affymetrix and Illumina studies.  Comparison of the global network properties 
using WGCNA overcomes this limitation and can facilitate the definition of 
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regulatory sub-networks driving phenotypic changes that was not otherwise 
possible using data arising from two different platforms.  The hurdle of integrating 
gene expression profiles across platforms is explored further in Chapter 5.   
4.4.1 Application of methodology 
The practicalities of this type of methodology should be considered and whether it 
readily improves interpretation of gene expression data beyond what is possible by 
standard differential gene expression analysis alone.   
To identify consistent and unambiguous behavior of putative hub genes is likely to 
be difficult.  Langfelder, et al (2013) stated that in the majority of cases global hub 
genes are not important and the focus should be on trait-associated intra-modular 
(sub-network) hubs, those highly interconnected within a functional gene 
aggregate (module).  Furthermore, gene selection strategies based on networks are 
not necessarily any more reproducible in terms of their trait associations that 
standard approaches such as differential gene expression when it comes to 
validation (Langfelder, Mischel et al. 2013).  The question arises as to whether 
candidates selected from hub gene lists any more likely to be predictive biomarkers 
than those derived from standard differential expression or meta-analysis 
techniques.  In a recent example Yang, et al (2014) found cancer genes with 
prognostic potential lay within modules, i.e., they were not global hubs (Yang, Han 
et al. 2014).   
Co-expression analysis may be influenced by a number of extraneous systematic 
differences between data sets that may result in the discovery of erroneous 
correlations (Gaiteri, Ding et al. 2014).  Therefore, feting intra-modular hubs from 
single data sets analysis may be dangerous.  The definitive performance criterion 
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would be the evidence of preservation of trait associations and hub genes from 
modules in independent datasets.  Langfelder, et al (2013), as before, showed that 
use of putative biomarkers derived from marginal meta-analysis often outperforms 
selection of intra-modular hub genes in prediction testing; however, in noisy, 
heterogenous data with weak signals, but strong module membership preservation 
(as is the case in the data sets presented here) the inverse is true.  In practical 
terms, the wider significance of predicted regulatory hubs in isolated data sets still 
requires substantial validation, as discussed further below.   
4.4.2: Genes identified as hubs in single network analysis are not 
reproduced in consensus network analysis 
As part of the WGCNA analysis global gene expression profiles from two data 
sets were initially analysed independently.  Hub genes in single data sets were 
selected on the basis of high module membership (kME), which was strongly 
related to intra-modular connectivity.  The decision to investigate the relevance of 
one hub gene (Lzts2) over others was defined by the findings in the literature, 
discussed below, and financial restrictions on investigating each identified hub.     
Hub genes from single network analysis were not reproducible in the consensus 
analysis, i.e. trait-associated modules did not show overlap in the predicted hubs 
across Affymetrix and Illumina studies.  Common hubs with high kME were 
identified between the two networks as part of the consensus network analysis, 
but the veracity of these findings is questionable given the poor preservation of 
module eigengenes across the two networks.   
It is not clear why the network structures, and therefore also the hubs, were so 
poorly preserved across the data sets. There were multiple modules associated 
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with each trait, which can complicate the selection of hubs.  Further to this, robust 
definition of intra-modular hubs is critically related to their identification across 
very different datasets and, as such, the definition of module membership is only 
relevant and successful where the module is actually present across data sets 
(Gaiteri, Ding et al. 2014) and a reproducible relationship exists with a trait.  
Although there was high correlation of mean rank expression across these two 
datasets the fact that they arose from different platforms and differing 
experimental designs may have had a critical bearing on the ability to find 
consensus modules related to the various phenotypes.  On this basis, it is not 
possible to confidently state that the hubs identified using this methodology on 
these data sets has identified more reproducible markers of de- and re-
differentiation than those already highlighted in the standard differential analysis in 
Chapter 2 and 3 without further validation.   
Beyond the hub: are module hubs relevant? 
There are multiple approaches to defining co-expression networks, functional 
modules and selecting hub genes.  There appears to be no systematic analysis of 
these techniques, or indeed of publications that have used them, to determine how 
robust they are across datasets.  In many cases, and this cannot be considered an 
exception, the complexity of the approaches relegates each technique to a ‘black-
box’  - the emergent hubs may have little relevance beyond the context of the 
study. Whether similar hubs are found across divergent studies would be of 
interest. 
Co-expression links between two or more genes are made without reference to the 
molecular mechanisms through which the mRNA (or protein) came to be 
expressed.  As such, this approach, together with the clustering of functional 
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modules, can overcome limitations of knowledge.  The biological relevance of 
these functional modules and hub genes cannot be surmised on the basis of 
associations with phenotypic traits and without credence to the molecular 
mechanisms that drove them.  Co-expression links may arise from any source, 
from unresolved batch-effects to mRNA degradation patterns, and all sources of 
correlation are indistinguishable (Gaiteri, Ding et al. 2014).  In the Illumina data 
set spurious module:trait associations may arise from the use of divergent tissue 
types (cartilage and tendon), or from batch-effects. 
4.4.3: Consensus hubs associated with alginate culture systems 
In spite of the caveats outlined above the most significant findings from 
consensus network analysis should be considered.  This study was concerned with 
determining central regulators of the gene expression profiles found with three-
dimensional cultures.  No significant associations were found for tenocytes in 
fibrin cultures alone.  For alginate cultures a consensus module was identified 
across the two data sets, which a) had a strong association with the alginate culture 
phenotype, and b) defined Pi15, Chi3l, Serpina3n and Gpnmb as potential core 
regulators.  Of these Pi15 and Gpnmb were both found to be more highly 
expressed in alginate cultures in both data sets by differential expression analysis.  
This does not preclude, however, involvement of the remaining. Notably, the 
model culture associated meta-module had a strong functional annotation relating 
to cell differentiation and development.    It would be expected that genes with 
high intra-modular connectivity also have strong evidence of protein-protein 
interactions, however from STRING analysis there is little support for this 
statement for these limited data sets.  It is, however, worth considering the 
relevance of these genes to cartilage function and differentiation.   
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Osteoactivin/transmembrane glycoprotein NMB in the protein encoded by Gpnmb 
and, as the name intimates, it has well-established relevance to osteoblast and 
osteoclast differentiation as shown by the work of Abdelmagid and colleagues 
(Selim, Abdelmagid et al. 2003, Abdelmagid, Barbe et al. 2008, Belcher, Rico et al. 
2010) with evidence that this is BMP2 mediated (Abdelmagid, Barbe et al. 2007).  
It may be in secreted or transmembrane form (Abdelmagid, Barbe et al. 2008).  
Mutations in Gpnmb result in a loss of trabecular mass, reduced osteoid and 
mineralized regions and increased number of osteoblasts; there was enhanced 
levels of TGF-β receptors and phosphorylation of Smad-2/3 in mice with a 
Gpnmb loss-of-function mutation indicating a role for TGF-β signaling associated 
with osteoactivin (Abdelmagid, Belcher et al. 2014).  Temporal localization of 
mRNA and protein expression in fracture repair coincided with chondrogenesis; 
staining was found in hypertrophic chondrocytes in the epiphyseal growth plates 
in normal bone, but also was increased in the fracture-healing callus (Abdelmagid, 
Barbe et al. 2010).  In work by Karlsson, et al (2010) Gpnmb was found to be more 
highly expressed in OA-derived cartilage (approximately 9-fold change) than in 
cartilage from normal donors (Karlsson, Dehne et al. 2010).  In micromass 
cultures derived from murine limb buds (E11.5) James, et al (2005) found higher 
expression of Gpnmb with Affymetrix microarrays between day 3 and day 15 of 
culture (James, Thomas et al. 2005).   There is clear evidence to support a role for 
Gpnmb in the differentiation of cartilage and bone cells; whether it is a core 
regulator of chondrogenesis has not demonstrated and requires further validation 
of expression in alginate bead cultures.   
Both Pi15 and Serpina3 code peptidase inhibitors and have been found to be 
differentially expressed in differentiating chondrocytes and diseased cartilage. 
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Serine peptidase inhibitor (Clade, A, member 3)/alpha-1-antichymotrypsin is 
encoded by Serpina3; the rat homolog is Serpina3n.  Expression of Serpina3 in 
differentiating MSCs and dedifferentiating chondrocytes has been documented 
(Boeuf, Steck et al. 2008). Peptidase inhibitor 15, Pi15, a trypsin inhibitor, was 
shown to be markedly suppressed in Grade I (Pritzker)-damaged cartilage in an 
monoiodoacetate-induced arthritis model, in addition to Serpina3 (Nam, Perera et 
al. 2011).  
These genes seem, ostensibly, rational targets for further investigation given their 
associations with cartilage phenotypes.  Further investigation of the impact of 
gain- and loss- of function of these genes and their protein products on 
differentiation markers is warranted.  
4.4.5: Data and study limitations 
One of the key advantages of using the WGCNA approach over Bayesian network 
modeling of gene expression networks is that the latter requires very large sample 
sizes that are usually not available for microarray studies (Zhao, Langfelder et al. 
2010).  In this study it is apparent that even moderately sized microarray studies, 
such as the Affymetrix study (n=24), may not adequately meet the scale-free 
topology criterion required for this methodology.  This is borne out in the 
indistinct gene cluster dendrogram for this dataset and the failure to adequately 
meet the approximate scale-free criterion.  The Illumina data set (n=36), however, 
does approximate scale-free topology and had much more distinct module 
definitions. 
In a study of murine chondrocyte differentiation Suwanwela, et al (2011) applied 
the WGCNA methodology to gene expression data from 27 microarrays, each 
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arising from the rib cartilage of a different recombinant inbred strain of mouse 
(Suwanwela, Farber et al. 2011).  This study defined 14 modules, however, evident 
in the cluster dendrogram was the high similarity between all modules, modules 
were unusually small and comparable gene ontology annotations were evident 
between the modules.  Quantitative findings associated with bone growth were 
correlated to module eigengenes, comparable to this study, and had significant 
associations at p<0.05.  In the results presented in this analysis multiple narrowly 
significant associations are found between traits and modules, however, there is 
often poor correlation between the gene significance for a trait and module 
membership, which undermines any definition of a hub gene.  It could be 
suggested that a higher level of significance is required in these studies than that 
often used as a standard threshold of significance.  In this analysis for example, 
module-trait correlations less than 0.9 were considered to be tenuous associations.            
The analysis presents strong associations between phenotypes and module 
eigengenes, however, the definition of these modules is derived from the co-
expression of genes from disparate data sources.  In the Illumina data set native 
cartilage and tendon are very distinct phenotypes and the strong association of 
module eigengenes with these phenotypes is not unexpected.  It is probable, 
therefore, that the identification of modular hub genes arise uniquely within this 
dataset.  For example, the identification of robust cartilage-associated genes as 
hubs for the ‘cartilage’ trait is not serendipitous, but likely to arise from the 
analysis of a small, divergent sample group.  Furthermore, it only reinforces our 
differential expression analysis and fails to describe any emergent properties of the 
system.  Consequently, results of hub gene analysis in single data sets are included 
here to demonstrate the outcomes and limitations of the methodology in small 
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data sets, rather than as an assertion that these genes are elusive core regulators.  
Those genes identified as core regulators of chondrocytes in alginate beads are 
relevant to chondrocyte differentiation status, but Gpnmb, for example, is highly 
expressed in both datasets and so may result in spurious correlations.     
The co-expression analysis used here circumvents many of the issues associated 
with cross-platform microarray meta-analysis (see Chapter 5) by comparing 
network structures rather than absolute gene expression changes.  The average 
rank gene expression was highly correlated between the data sets, which suggested 
that these sources were sufficiently comparable.      
Whilst the benefits of comprehensively and inclusively defining the modular 
organization of a biological system are clear it is evident from this analysis that 
caution in extrapolating results from co-expression network analysis should be 
taken.  The fallacy of correlation and causation can be readily exploited in under-
powered studies with discrete phenotypes and as such findings would need to be 
challenged in a wider data context and mechanistic processes explored further.  
4.4.5: Leucine zipper Lzts2 silencing does not influence markers of 
chondrocyte differentiation in monolayer culture 
As defined in Chapter 1 the systems biology philosophy expects cyclical data 
gathering and analysis in response to targeted perturbations of the system under 
investigation.  In exploration of the Illumina data using weighted gene network co-
expression analysis the leucine zipper, putative tumour suppressor 2, Lzts2, was 
defined as a member of a module with strong association with the gene expression 
profiles in monolayer culture.  Furthermore, it had high module membership and 
intra-modular connectivity.  This would suggest that it had potential to be a central 
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regulator of this functional module.  Higher expression of Lzts2 in monolayer 
culture in both tenocytes and chondrocytes advocated further investigation.   
Expression of Lzts2 inhibits the nuclear translocation of beta-catenin (Thyssen, Li 
et al. 2006); in turn the transactivation of Lzts2 is mediated by NF-κB activity.  
Reduction in the expression of Lzts2 by RNA interference has been shown to 
promote the nuclear translocation of beta-catenin and NF-κB activity in adipose-
derived human MSCs (Hyun Hwa, Hye Joon et al. 2008).  These findings 
supported the complex interactions between Wnt- and NF-κB signaling.  Both 
NF-κB and Wnt-signalling (through GSK3) are downstream effectors of the PI-
3K/Akt-signalling cascade; GSK3, which phosphorylates β-catanin and targets it 
for degradation, has been shown to interact with Lzts2 (Pilot-Storck, Chopin et al. 
2010). Therefore, perturbation of a cross-pathway regulator, such as Lzts2, was 
considered to be a rational target.     
Critical roles for Wnt-/beta-catenin signalling in chondrocyte development and 
differentiation is well recognised.  Constitutive knock-out of beta-catenin is lethal 
to embryos at E7.5 prior to the formation of skeletal units (Haegel, Larue et al. 
1995); enhanced chondrogenesis is observed in the conditional deletion of beta-
catenin in mesenchymal condensations (Day, Guo et al. 2005, Hill, Später et al. 
2005) and the inverse is true where beta-catenin fails to be degraded by GSK3 
(Ryu, Kim et al. 2002); whilst delayed maturation is evident in growth-plate 
chondrocytes in a COL2A1-ICAT model that functionally inhibits beta-catenin 
(Chen, Zhu et al. 2008).  Consequently, the implicated role of beta-catenin in the 
development of osteoarthritis is through the promotion of terminal differentiation 
in articular hyaline cartilage (Zhu, Tang et al. 2009, Wu, Zhu et al. 2010).   
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In a quantitative PCR study there was no evidence to support an effect of Lzts2 
inhibition on markers of differentiation status in dedifferentiated chondrocytes.  
Reasons for this may be technical or relate to redundancy within the system, i.e. 
knock-down does not sufficiently disturb the functional network.  The genes that 
were defined as markers of differentiated, or de-differentiated status, may be only 
weakly discriminatory outside the context of the Illumina study in which they were 
defined.  
Although the efficiency of transfection was high (>80%) the percentage 
knockdown was only 77% with a single siRNA to Lzts2.  Additionally, in response 
to apparently cytotoxic effects on chondrocytes from extended incubation with 
the transfection reagent an exposure period of 6 hours was used.  Although this in 
line with evidence from the manufacturer, this study could have benefitted from 
more robust inhibition, either through the use of two siRNA or a longer exposure 
period.   
Finally, although isogenic tissue sources were used three biological replicates, and 
pooled technical replicates, are likely to be insufficient to resolve subtle changes in 
gene expression related to differentiation status.  Primer efficiency was also 
variable, Lzts2 was 90%, which could be considered poor for these profiling 
studies.  Analysis using PCR arrays to a battery of differentiation and signalling 
pathway markers may reduce technical errors.   
4.4.6: Closing statements 
This study implemented WGCNA, a systems biology approach to objectively 
assess global transcriptome network properties between data sets arising from two 
different microarray platforms.  This methodology supported findings from earlier 
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analysis by defining genes within modules that were strongly expressed in 
chondrocytes in alginate cultures and identified Gpnmb and Pi15 as consensus 
network hubs.  Knockdown of a NF-κB and Wnt-signalling cross-pathway 
regulator, Lzts2, failed to have an impact on the expression levels of markers of 
differentiation or dedifferentiation.  The expression profiles arose from small data 
sets and related to highly divergent phenotypes and as such spurious correlations 
in the data may arise with no wider biological significance to functional modules 
and hub gene identification.  In order to make more general statements about 
discrete chondrocyte and tenocyte responses to different conditions would require 
larger data sets or microarray meta-analysis and further validation of expression 
profiles of candidate hubs.    
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5 :  In tegra t ion of  Car t i l age  and 
Tendon Microarray  Express ion 
Prof i l es  Revea l s  Cross-spec ies  
Preservat ion of  Gene Modules   
 
“A big computer, a complex algorithm and a long time does not equal science.” 
Robert Gentleman 
 
Abstract 
Integration and comparison of gene expression profiles across multiple studies 
and microarray platforms is fraught with difficulties, which can limit the biological 
relevance of findings.  Microarray studies are often underpowered and in 
musculoskeletal biology limited biological replicates arising from rare samples 
compound this problem.  The integration of data from multiple small studies can 
improve the statistical power of an analysis.  The use of rodent in vivo models of 
musculoskeletal disease, or as part of in vitro studies, is frequent, however, the 
translational relevance to complex and diverse human disease is not always clear.  
Furthermore, three-dimensional culture systems are used to mimic spatial 
conditions for chondrocytes and tenocytes, but these methods have not been 
systematically considered relative to normal or diseased tissue.    
The relative merits of data-merging approaches, including cross-platform 
normalisation, and sequence- and target-matching of oligo probes across 
platforms, were investigated to integrate expression data into single species-
specific meta-matrices.    
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This study presents the first cross-species systematic integration of cartilage and 
tendon gene expression data utilising a data-merging approach in the rat and 
human.  A global transcriptomic network comparison approach was employed 
applying gene co-expression analysis, WGCNA, to define functional modules 
associated with disease and three-dimensional culture phenotypes.  By comparing 
the networks structures across species the suitability of rodent models to inform 
human disease is considered.   
An IL-6 containing module was found to be significantly associated with a 
perturbed chondrocyte phenotype and, more specifically, with alginate bead 
cultures.  From this module thirteen, mostly pro-inflammatory, genes were found, 
by a nearest shrunken centroids approach, to adequately discriminate between 
three-dimensional culture systems and all other samples.  This was consistent 
across rat and human studies and when compared to an independent data set   
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5.1: Introduction  
 
Increasingly gene expression profiling data is submitted to public-access 
repositories, including Gene Expression Omnibus (Barrett, Troup et al. 2011) and 
ArrayExpress (Rustici, Kolesnikov et al. 2013), and is available for re-use by 
researchers in large-scale integrative analyses.  Relative to other areas of research 
there are few transcriptomic profiles of normal musculoskeletal tissues available in 
these repositories; the small number of biological replicates in each experiment 
can represent an important bottleneck in the exploration of biological problems.  
To improve the statistical power and return more reliable conclusions from 
transcriptome profiling some form of integrative analysis is required to increase 
the number of samples (Taminau, Lazar et al. 2014).  
5.1.1: Systematic analysis of microarrays 
The terminology associated with the re-use of gene expression data is inconsistent 
and requires some explanation.  Commonly the term ‘meta-analysis’ has referred 
to the systematic and standardised study of a focused issue in research literature. 
In the main a meta-analysis considers a particular intervention, usually medical, 
across all the published literature allowing both quantitative and qualitative 
assessment of the relative strength of each of the individual studies (Russo 2007).  
Combining the marginal findings in small, underpowered studies may facilitate the 
detection of statistically significant responses to an intervention; equally, a meta-
analysis may repudiate weak findings in individual studies.  
Integral to the development of a meta-analysis, as described by Russo (2007) are 
the inclusion of: i) an explicit study question; ii) an exhaustive literature search; iii) 
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defined criteria for inclusion of a study, or data abstraction, which may include 
sourcing raw data, quality scoring studies and the presentation of excluded data; iv) 
and the description of statistical tests, in particular, tests for sample homogeneity, 
and the use of fixed or random effects models (Russo 2007).   
Recently, the term ‘meta-analysis’ has been applied to any systematic study of 
multiple smaller studies including genome-wide association studies (GWAS) 
(Evangelou and Ioannidis 2013) and the analysis of microarray data sets (Rudy and 
Valafar 2011). The availability of microarray data from public-access repositories 
has encouraged researchers to integrate multiple microarray studies, although these 
investigations may lack the stringency with which clinical meta-analysis have been 
performed.  An explicit study question may not be apparent at the data collection 
stage, for example GWAS meta-analysis considers the presence of any genetic risk 
loci for a population.  The general structure of phenotype specification, data 
collection, data inclusion/exclusion, and reduction of data heterogeneity still 
apply, however, to these other forms of meta-analyses.  
Whilst some have used ‘meta-analysis’ for any large-scale analysis of microarray 
expression data in this study the term will be restricted to discussions relating to 
the integration at the interpretive level, and ‘data-merging’ to describe the 
agglomeration of raw expression data from multiple data sets, consistent other 
investigators (Sarmah and Samarasinghe 2010, Taminau, Lazar et al. 2014).  These 
definitions are explored further below.     
Motivations for microarray data integration 
There are several principal drivers for the integration of microarray expression 
data.  Integration, a) increases sample sizes, thereby improving statistical power; b) 
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facilitates a broader understanding of a biological problem, c) compensates for 
data errors and missing data in individual studies, d) provides more accurate and 
consistent data mining, e) explores the variance and noise in the data, and f) can 
define biological markers and prognostic signatures not evident in small analyses 
(Sarmah and Samarasinghe 2010).  Furthermore, consistent with the tenets of 
reduction, refinement and replacement, in silico analysis allows the re-use of 
existing data to derive novel results and inform future experimental design.     
Issues of statistical power, for example, often arise in microarray studies as too few 
biological replicates are used, these are often not independent samples (i.e. 
biological replicates are re-used within a study), and they measure the expression 
levels of large number of genes simultaneously (Ramasamy, Mondry et al. 2008). 
Through gathering data from multiple sources there is potential to discover of 
emergent properties of the data, explores new biological insights and improve the 
statistical power of gene expression analysis (Taminau, Meganck et al. 2012).  
Approaches to expression data integration 
There is no definitive methodology for tackling microarray data integration with 
studies employing a number of strategies.  Data is rarely considered at the probe-
level, with strategies considering higher order analysis, for example, published 
differentially expressed gene lists, combining p-values, combining ranks or effect 
sizes (Tseng, Ghosh et al. 2012). An essential step in approaching an over-arching 
analysis of microarray data is to ensure that there is a consistent and standardized 
data handling.  This can mean the application of the same pre-processing and 
normalization techniques, incorporating an adjustment for batch effects and 
platform, and maximising consensus gene identifiers across platforms (Taminau, 
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Meganck et al. 2012).  Whilst all this is done the true biological variance that exists 
in the individual datasets has to be retained.   
Rung and Brazma (2012) present sage advice on the pitfalls of tackling such 
microarray meta-analysis, in particular that ‘summary level meta-analysis is often a 
better option’ (Rung and Brazma 2012).  Whether the analysis is based upon the 
summary results from individual experiments or based upon the merging of raw 
data is a choice made based upon what will be most informative to the researcher.  
The intended question may be unavoidably and strongly biased by the differences 
that are found in diverse experimental conditions.  
These methods usually lead to four main types of microarray meta-analysis, as 
described by Tseng, et al (2012): i) differential gene expression; ii) pathway analysis; 
iii) co-expression analysis; iv) prediction analysis.  Each resolves the data in a 
different way and produces results with varied potential of generalization or 
clinical utility.  The integration and meta-analysis of microarray studies by gene co-
expression network analysis has facilitated and yielded outputs that provide a 
functional appreciation of the tissues under investigation (Miller, Horvath et al. 
2010, Hawrylycz, Lein et al. 2012).  Methods already explored in Chapter 4 are re-
visited in this study to facilitate integration of multiple gene expression studies.   
In essence the re-use of expression data is a form of integrative analysis that may 
involve either, a) integration at the interpretive level, or b) integration at the level 
of expression values (Sarmah and Samarasinghe 2010).  
Integration at the interpretative level – ‘meta-analysis’ 
The approach, which may be termed ‘meta-analysis’, requires the comprehensive 
and consistent re-analysis of each data set followed by the combination of 
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summary statistics (P-values, ranks) at an interpretative level.  Consistency and 
comparability in the raw data collection technique, whether that is patient-level 
data, microarray expression studies or RNA-sequencing data, is critical.  In the 
case of microarrays, where the raw data arises from different technology platforms 
and platform generations, neither consistency nor comparability can be assumed 
and, as such, these types of studies are more correctly termed ‘cross-platform’ 
studies (Rudy and Valafar 2011).   
Data-merging – integration at the level of expression values 
Microarray data-merging utilises raw expression data from multiple sources then 
transforms and normalises the data to make it numerically comparable.  Many of 
the key issues relating to meta-analysis of microarrays are applicable to data-
merging (Sarmah and Samarasinghe 2010, Taminau, Lazar et al. 2014).  The output 
is a new, larger data set upon which further analysis is performed, for example, 
evaluation of prognostic gene signatures indicating suitability of therapeutic 
interventions (Xu, Tan et al. 2008).  Data handling approaches are defined further 
below.  Which approach is more consistent in terms of defining prognostic 
markers or differentially expressed genes is not clear in the literature, however, 
recent investigation suggests that significantly more differentially expressed genes 
may be found through a data-merging approach (Taminau, Lazar et al. 2014).   
Obstacles to integration of expression studies  
Whilst the motivation to integrate gene expression data is attractive a number of 
data-handling challenges retard easy implementation. Direct combination of gene 
expression studies is not possible without further normalisation, neither are 
independent studies from different microarray platforms directly comparable.  
Furthermore, in terms of experimental design, integration needs to be biologically 
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meaningful, rather than exhaustive harvesting and collation of incompatible 
samples (Sarmah and Samarasinghe 2010).    
Concerns with regard to microarray data integration have been evident for over a 
decade and despite the implementation of minimal expected standards (MIAME) 
(Brazma, Hingamp et al. 2001, Moreau, Aerts et al. 2003) for microarray data 
deposited in public databases one study found little over a third of data submitted 
met the format required and quality standards (Larsson and Sandberg 2006).  The 
absence of raw data (permitting future re-annotation and application of novel 
computational methods) and low quality noisy data, were highlighted as particular 
hurdles to integration.   
Microarray data integration is obstructed by relevant studies having been 
undertaken on microarray platforms from numerous vendors, some of which may 
be archaic and poorly annotated.  In addition to the biological variation inherent in 
each study sample microarray platforms each have unique chemistries, 
hybridization protocols, probe identifiers and probe lengths.  Furthermore, the 
well-described issues associated with systematic bias, relating to ‘batch effects’ 
associated with temporal and technical variations (Leek, Scharpf et al. 2010, Chen, 
Grennan et al. 2011), are unlikely to be considered in a microarray meta-analysis or 
cross-platform data-merging as information relating to the time and location of 
microarray processing are often not available.  Noise is an inescapable problem in 
any microarray study, but this is propagated further with the addition of data from 
diversified sources (Sarmah and Samarasinghe 2010).   
Ramasamy, et al (2008) provided a practical framework by which to tackle 
microarray meta-analysis with the greatest emphasis being on the data collection 
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and curation methods (Ramasamy, Mondry et al. 2008). In choosing which data to 
work with feature-level/probe-level data was recommended, thereby allowing the 
researcher flexibility in which pre-processing and normalisation techniques were 
employed, and ensuring that the same method was used across all studies.   
Dealing with obstacles to data-merging 
 
Probe-matching  
Two microarrays from two platforms can, in reality, never be fundamentally 
comparable.  Platforms differ not only in their chemistries but also their probe 
designs and lengths.  The design of the probes reflects a trade-off between 
sensitivity and specificity, the probe sequences defining the hybridization 
characteristics of the probes; as two platforms may not share probe sequences the 
data cannot be directly comparable (Rudy and Valafar 2011).  Direct probe-level 
data integration would only be possible between datasets using the same or 
technically similar platforms, e.g. platform generations from the same 
manufacturer (Tseng, Ghosh et al. 2012); there is evidence that sequence matching 
of oligonucleotide probes across platforms would improve the reproducibility and 
concordance of a cross-platform analysis (Mecham, Klus et al. 2004, Carter, 
Eklund et al. 2005, Kuo, Liu et al. 2006, Ramasamy, Mondry et al. 2008, Allen, 
Wang et al. 2012).  However, two of the studies above considered only 
comparisons between two platforms at a time (Allen (2012), Carter (2006)), 
whereas Kuo, et al (2006) considered ten platforms.  The latter presented good 
correlation of expression measurements for exon-matched probes even where the 
probe sequences did not overlap, however, they could only find four genes for 
which probes from all ten platforms mapped to the same exon.   
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Normalisation strategies 
Integration across microarray data sets often requires recursive data normalisation, 
for example, between samples in a data set and then across data sets; this can 
occur at the expense of the true biological variation in the data resulting in an 
‘over-smoothing’ making any analysis largely redundant or introduces spurious 
correlations (Sîrbu, Ruskin et al. 2010).  Subsequently correlations between 
interacting genes may be lost making the use of inferential algorithms downstream 
problematic; alternatively, as discussed in the previous chapter, such interventions 
may introduce spurious correlations between the data sets (Gaiteri, Ding et al. 
2014).  The complexity of rescaling approaches to gene expression data varies 
from z-score standardization (Cheadle, Cho-Chung et al. 2003a) to Bayesian batch-
correction methods (Johnson, Li et al. 2007).     
Sîrbu, et al (2010) collected arrays from three different platforms and, following 
three types of preprocessing on the raw data, performed cross-platform 
normalisation undertaken by i) z-score standardization (scaling such that 
expression values lay in [0,1], ii) a Bayesian approach to batch-effect removal 
(ComBat), and iii) an iterative k-means clustering technique (XPN).  In this study 
it was found that for normalisation of time-series data for quantitative model 
inference a combination of loess normalisation during pre-processing and 
subsequent use of the XPN algorithm resulted in acceptably low variation.   
Rudy and Valafar (2011) also found the XPN algorithm generated the highest 
inter-platform concordance, but only when treatment groups were of equal size 
(Rudy and Valafar 2011).  In analysis of four methods for cross-platform 
normalisation they found that the DWD (Distance Weighted Discrimination) 
algorithm (Benito, Parker et al. 2004) was more robust to these inequalities.  From 
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these observations there is clearly discordance between the capabilities of 
normalisation algorithms, their complexity, and the practicalities of sourcing 
groups of equal size, on the same platform, or establishing comparable co-variants 
and samples derived from the same experimental methodology.  
5.1.2: Meta-analysis of cartilage and tendon pathologies   
As highlighted in Chapter 2, the scope of gene expression studies of cartilage and 
tendon have been limited with little evaluation of the baseline expression profiles 
of the constituent cells nor further evaluation of their expression profiles in 
perturbed environments.  Consequently there is, to the author’s knowledge, no 
systematic integration of microarray data sets interrogating cartilage or tendon 
gene expression. Furthermore, there is no coherent or comprehensive 
understanding of the chondrocyte or tenocyte response profiles to perturbations 
on a global transcriptomic scale.     
Of the meta-analyses that have been performed for cartilage and tendon 
pathologies the majority are clinical, intervention-based, investigations.  Of the 
others genome-wide association studies (GWAS) of arthritic and rheumatic 
conditions are most prevalent.  Microarray meta-analysis of osteoarthritis and 
rheumatoid arthritis invariably study either synovial tissue or use grossly normal 
and abnormal articular cartilage samples from the same patient.  Given the 
numerous hurdles described it is not unexpected that systematic analysis of gene 
expression profiles is not common.  For tendinopathies the lack of systematic 
analyses is more acute – in this review there were no non-clinical publications 
exploring gene expression of tenocytes across publications.   
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A number of GWAS studies have implicated various genetic risk loci in the 
development of osteoarthritis, including GDF5 and SMAD3 (Valdes, Spector et al. 
2010, Reynard and Loughlin 2013), or found conflicting associations with other 
candidates, such as IL-6 (Valdes, Arden et al. 2010, Cai, Sun et al. 2014).  
However, a recent meta-analysis of GWAS studies, considering 199 candidate 
genes, found that SNPs associated with only two genes (COL11A1 and VEGF) 
had a statistical association with the development of osteoarthritis (Rodriguez-
Fontenla, Calaza et al. 2014). 
Animal models of musculoskeletal disease 
For animals models to inform human musculoskeletal disease those proxies must 
be appropriate and relevant, the former referring to the comparability of a disease 
process in the model to that in the human, the latter considering the relevance of a 
complex whole animal model where simpler experimental set-ups would suffice 
(Pritzker 1994).  This is problematic in the study of musculoskeletal disease where 
small studies, diverse models, and animal differing strains have been used for gene 
expression profiling.  Interrogation of expression profiling studies is required to 
define whether regulatory mechanisms are present or absent in models of 
osteoarthritis relative to the complex and diverse human disease (Goldring 2012).   
5.1.3: Summary and study rationale 
This study is driven by three main concerns arising from the literature.  First, there 
is no evidence of a systematic analysis of global transcriptomic networks having 
been undertaken to explore common regulatory mechanisms between rodent and 
human musculoskeletal disease or to validate these models.  Second, in-vivo culture 
models have not been defined relative to diseased tissue, the assumption being 
made that their gene expression profiles are sufficiently comparable to normal 
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samples.  Third, by reviewing the available studies gaps in community knowledge 
may be highlighted; this may facilitate development of future targeted research 
projects.  It is prescient, therefore, that these concerns are challenged.  
This study utilizes a data-merging approach to integrate comprehensive expression 
data from multiple small cartilage and tendon transcriptome profiling studies from 
the rat and human.  A global transcriptome network comparison approach, 
WGCNA, is applied to define functional modules associated with disease and 
three-dimensional culture phenotypes.  By comparing the networks structures 
across species the suitability of rodent models for informing human disease is 
considered.   
To accommodate diverse data sources from relatively few studies a number of 
data integration methods are explored.  An IL-6 containing module is found to be 
significantly associated with a perturbed chondrocyte phenotype and, more 
specifically, with alginate bead cultures.  From this module thirteen, mostly pro-
inflammatory, genes were found, by a nearest shrunken centroids approach, to 
adequately discriminate between three-dimensional culture systems and all other 
samples.  This was consistent across rat and human studies and when compared to 
an independent data set.   
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5.2: Methods 
 
5.2.1: Identification of datasets and inclusion criteria 
Curated, open-access microarray repositories ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/) (Rustici, Kolesnikov et al. 2013) and Gene 
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) (Barrett, Troup et al. 
2011) were trawled for data sets profiling tissues of musculoskeletal origin derived 
from Rattus norvegicus, namely: ‘cartilage’, ‘tendon’, and ‘ligament’, Figure 5.1a.  
Additionally, disease-orientated searches of data were undertaken using the terms: 
‘osteoarthritis’, ‘rheumatoid arthritis’, ‘tendinopathy’, and ‘tendinitis’.  Further to 
this data sets were collected if they contained musculoskeletal developmental 
stages or directed differentiation studies, e.g. mesenchymal stem cells.  All 
recorded studies available prior to June 2014 were considered. A literature search 
of PubMed (http://www.ncbi.nlm.nih.gov) was undertaken using the 
aforementioned terms to collect studies where expression data was not publically 
available and corresponding authors were contacted.  All collected data sets were 
tested against the inclusion criteria described in Table 5.1.  The signalment of the 
animal specimens (age, sex, breed) was recorded, but this did not influence 
inclusion of data in the study.    
5.2.2 Data preparation  
The microarray pre-processing and merging pipeline is provided in Figure 5.1b.  
Briefly, raw data was imported into R and arrays were visually assessed for 
systematic technical issues and underwent the same quality control appraisal as 
applied to microarray data in Chapter 2 and 3.  Expression data was background 
corrected using the RMA algorithm (Irizarry, Hobbs et al. 2003) and a cyclic loess 
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normalisation method applied across each study data set, as described before.  
Probe sets were re-annotated with the appropriate Entrez gene identifier.  
Expression data for each gene was aggregated and collapsed into a single gene 
measurement consisting of the maximum mean expression value using the 
‘collapseRows’ function in the WGCNA package (Miller, Cai et al. 2011).  The 
output of this workflow was a normalised matrix of expression values consisting 
of one summarized gene per row.  Each platform expression matrix had a 
differing number of genes at this stage.  Data sets were intersected by Entrez gene 
identifiers for cross-study normalisation such that all studies contained the same 
gene identifiers.   The matrix of aggregated data sets was termed a ‘meta-matrix’.  
The final rat meta-matrix contained 170 microarray samples and profiled 11,152 
genes derived from four Affymetrix platforms and was the input for weighted 
gene co-expression network analysis.          
Inclusion criteria Exclusion Criteria 
Raw, probe-level data files were available 
and studies achieved >3 of  the 
requirements of  the MIAME conditions.  
Some level of  pre-processing had been 
undertaken, e.g. quantile normalisation.    
Data sets were derived exclusively from 
Rattus norvegicus 
Individual arrays within a dataset failed 
to meet quality control thresholds 
Probe annotation files were available Platforms with small transcript coverage, 
e.g. Affymetrix Rat U34A array 
Datasets could be manipulated using the 
R programming platform  
Data sets were re-used across multiple 
studies  
Study design and sample phenotypes and 
descriptors were available.   
Single biological replicate used over 
multiple arrays in a study.   
Studies investigated cartilage, tendon or 
ligament in their native state or their 
cellular components in vitro.   
Studies with fewer than three arrays in a 
study group.   
Table 5.1: Definition of  inclusion and exclusion criteria for microarray meta-analysis.    
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Data collection 
Public gene expression 
data repositories 
Literature Search  
Inclusion criteria  
Quality control and pre-
processing 
In silico analysis 
Probe matching 
Data-merging 
methodology 
 studies 
Data normalisation 
strategies 
WGCNA 
Class prediction 
Independent data test 
Chapter 2 (Illumina data) 
Chapter 3 (Affymetrix data) 
Author contacted 
R 
Excluded  
data 
Prognostic signature 
Expression data 
merging 
Figure 5.1a: Overview of  experimental workflow for results presented in Chapter 5.  Input data is derived 
from Chapters 2 and 3, public repositories and personal requests.  Inclusion and exclusion criteria are defined 
in Table 5.1.  Parallel studies informing and refining data analysis pipelines are defined in Figure 5.1b – d and 
WGCNA pipeline in Figure 4.2c.   
Figure 5.1b 
Figure 5.1c 
Figure 4.2c 
Figure 5.1d 
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Study sample descriptors 
Array annotation files  
Comparison to 
published 
study 
RLE and 
NUSE plots 
Principal 
Component 
Analysis  
Hierarchical 
clustering  
A: Microarray pre-
processing 
RMA background 
correction 
Cyclic loess  
normalisation 
Universal Entrez annotation of  probe identifiers 
Aggregation of  expression data –  
collapse rows into single gene maximum mean measurement 
B: Study level  
Quality Control 
Affymetrix Rat 
Genome 230 2.0 
Genes, n=13,915 
Affymetrix Rat 
GeneST 1.0 
Genes, n=15,798 
Affymetrix Rat 
GeneST 1.1 
Genes, n=15,798 
Affymetrix Rat 
GeneST 2.0 
Genes, n=18,686 
Intersect all data sets on common Entrez gene identifiers, n=11152 genes 
     Z-score normalisation applied across all 170 studies 
C: Re-annotation and 
aggregation 
Oligo 
WGCNA 
Limma 
inSilicoMerging 
D: Data 
merging and 
normalisation 
Single meta-matrix:  
Rows/Genes = 11152,  
Samples/Columns = 170 
Meta-level quality control:  
PCA; reference to original study 
results 
Figure 5.1b: Data merging pipeline for rat studies profiling chondrocyte and tenocyte transcriptomes from four 
Affymetrix microarray platforms.  All analysis was undertaken in the R environment with critical work packages 
indicated, e.g. limma.  All study data sets underwent separate analysis through tasks A to D before final merging 
and global normalisation.  This process was repeated for human microarray data sets (n = 166).     
Task summary 
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Cross-platform data-merging methodology studies 
Illumina 
RatRefv1 
Affymetrix Rat 
GeneST 1.0 
 
Affymetrix Rat 
Genome 230 2.0 
Agilent 4x44K 
Real data 
Toy data madsim 
Seed data madsim 
Oligo, beadarray 
Distance 
Weighted 
Discrimination 
XPN 
None 
BMC 
Z-score 
normalisation/ 
Genenorm 
inSilicoMerging 
Probe sequence- and target-matching across platforms 
Platform annotation packages and vendor probe manifest files 
Probe 
sequences and 
descriptors 
Re-annotation 
of  probes 
bioMart 
 
Ensembl Entrez 
Gene  
Symbol 
Chromosome 
number Strand 
Probe sequences binned by 
chromosome 1-20 + X 
Sequences 
as .fasta 
Sequences aligned to rat 
genome by chromosome 
Bowtie (QuasR) 
Alignments 
as .bam 
Quantify probe overlaps with 
Agilent 60-mer oligos 
GenomicRanges 
Probe overlaps 
‘within’ 
Probe overlaps 
‘any’ 
Plot histograms of  overlap 
frequency by chromosome 
Sequence 
Principal 
component 
analysis 
Correlation 
density plots 
B: Apply different  
cross-platform  
normalisation strategies 
A: Collect real data sets and create ‘toy’ expression data 
C: Assess 
effect of  
normalisation 
strategy on 
sample 
groupings 
Validate overlaps by plotting 
on ideogram Gviz 
R 
R 
Figure 5.1c: Data manipulation and analysis pipelines for cross-platform normalisation (upper panel) and  probe 
sequence- and target-matching across platforms (lower panel).  Outcomes of  studies informed Figure 5.1b.  
Critical work-packages within the R environment are provided, e.g. Gviz.   
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WGCNA 
pipeline 
Figure 4.2c  
Module 2 
Module 1 Module 3 
Module 4 
Modules preserved across species  
Select phenotype-associated module 
+
Feature selection: consensus module genes with highest kME. 
Rat meta-matrix,  
n=170 
Human meta-matrix,  
n=166 
Split into Test and Training groups 
Apply nearest-shrunken centroids approach to  
Training set using genes selected in WGCNA 
2x2 confusion marrix: assess 
misclassification error rates 
Define threshold, Delta, by ten-fold cross-validation 
Extract smallest cohort of  genes with the  
smallest error rate for prediction  
Define sample groups 
TEST TEST 
Gene cohort or ‘signature’ for phenotype 
TRAINING  
pamr 
10% of  samples 10% of  samples 
Rat signature 
Human signature Rat signature 
Human signature 
Misclassification error 
PCA 
Receiver-Operator Curve 
Misclassification error 
PCA 
Receiver-Operator Curve  
WGCNA 
R 
X10 interations 
Illumina data 
Chapter 2 
Test against 
independent 
data 
Figure 5.1d: Data manipulation and analysis pipelines for class-prediction using pamr.  Genes were filtered for 
‘feature-selection’ by restricting available genes to those found within a highly phenotype-associated consensus 
module in WGCNA.  This was common to both human and rat analysis.  Gene signatures identified for each 
species were used to classify test data from the same species and vice versa.  Misclassification error rates and areas 
under receiver-operator curves defined the predictive success of  each signature.  Illumina expression data 
(Chapter 2) was used as an independent data data set against which to assess the rat signature.    
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5.2.3: Analysis of cross-platform normalisation techniques 
Rat expression data was derived from four platforms from three manufacturers: 
Affymetrix Rat Genome 230 2.0, Illumina RatRef.v1, Affymetrix Gene ST 1.0, and 
Agilent 4x44k.  In order to explore the impact of cross-platform normalisation 
strategies on data a series of test datasets were prepared, Figure 5.1c upper 
panel: i) simulated or ‘toy’ data set was prepared consisting of a set of four 
randomly generated arrays using the madsim R package (Dembélé 2013); ii) ‘Seed’ 
data sets were simulated arrays prepared as for (i), but used real data sets as the 
kernel around which the distribution of expression values was built.  Both ‘case’ 
and ‘control’ data sets were produced; iii) real data sets from public repositories 
were chosen to represent each of the four platforms collected in this study.  As 
many real data sets are underpowered and have few biological replicates three case 
and three controls were taken from each platform. Data sets used: Illumina 
(Chapter 2); Affymetrix 1.0 (Nam, Perera et al. 2011); Affymetrix 230 (Appleton, 
Pitelka et al. 2007); Agilent 44k (Zhang, Fang et al. 2012).   
Several normalisation strategies available within the inSilicoMerging R 
package (Taminau, Meganck et al. 2012) were applied to all data sets: ‘DWD’ 
(Benito, Parker et al. 2004), ‘XPN’ (Shabalin, Tjelmeland et al. 2008), ‘BMC’ (Sims, 
Smethurst et al. 2008), ‘Genenorm’ (z-score normalisation (Cheadle, Cho-Chung 
et al. 2003a, Cheadle, Vawter et al. 2003b)) or ‘NONE’ (merging with no 
normalisation). Empirical-Bayes batch-correction method, ‘COMBAT’ (Johnson, 
Li et al. 2007), was not used as this method assumes covariates to be consistent 
across samples.  Data for simulated and real data analysis were pre-processed and 
normalised in the same manner.  
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Single manufacturer data sets 
The use of data sets arising from one platform provider only, Affymetrix, was 
considered.  These are the most numerous for rat studies in the public repositories 
and all use 25-mer oligo ‘probe-sets’. Three Affymetrix platform generations were 
represented in the cartilage and tendon data collected: Genome 230 2.0, 
GeneST1.0 and GeneST2.0.  Data was pre-processed as described previously.  
One data set for each platform was considered initially (n=37). 
5.2.4:  Sequence- and target-matching of probes from three platforms 
In order to maximize the number of available cartilage and tendon studies the 
most commonly used rat microarray platforms were assessed for probe sequence- 
and target-matching: i) Illumina RatRef.v1 BeadChip; ii) Affymetrix GeneST 1.0; 
iii) Affymetrix 230 Expression Array; iii) Agilent 4x44K version G4131F, Figure 
5.1c lower panel. Unique probe and probe-set identifiers and their associated 
sequences were collected from Bioconductor annotation packages or from 
manifest files from the manufacturer or GEO.   
Probes were re-annotated using functions within the biomaRt package, an 
interface with the Biomart database (www.biomart.org), implemented in R 
(Durinck, Moreau et al. 2005, Durinck, Spellman et al. 2009, Kasprzyk 2011). 
Probes were annotated with Ensembl and Entrez identifiers, common gene 
symbols, chromosome number and location (band/strand) for orientation 
purposes.  Annotated probe sequence files were binned by chromosome number, 
to create 20 somatic chromosome and one X chromosome file for each platform. 
Per chromosome files were converted to .fasta format.   
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Probe sequences from each platform were treated as analogous to short-reads 
from RNASeq data and aligned to each chromosome of the rat genome (Ensembl 
Rat genome assembly, 'Rnor_5.0', release 75, March 2012) (Consortium 2004) 
using a short-read, un-spliced alignment algorithm ‘Bowtie’ (Langmead, Trapnell 
et al. 2009) as implemented in the Quasr R package  (Lerch, et al 2012).  General 
methodology was adapted from Kim, et al (2011) (Kim, Patel et al. 2011).  The 
unmasked genomic DNA sequences from Ensembl were used, where interspersed 
repeats and low complexity regions are retained, as this improved probe hits.   
Aligned reads, .bam files, were handled using the GenomicRanges package 
(Lawrence, Huber et al. 2013) and visualised using the Gviz package (Hahn, et al, 
2014).  Probe overlaps were defined as probes sequences from Affymetrix (25-
mer) or Illumina (50-mer) that were: a) contained entirely within or, b) had any 
sequence overlap with Agilent (60-mer) probes.  Probes were only used if the same 
gene was mapped uniquely for each platform.  
5.2.5: Human Affymetrix data set collection 
The collection of Affymetrix microarray expression datasets profiling human 
cartilage and tendon samples followed the same protocol as outline above (5.2.1-
5.2.2).  The datasets retained for cross-species analysis are presented in Appendix 
Table SD5.2.  Following pre-processing, re-annotation and cross-platform 
normalisation a human meta-set of 166 samples and 12,215 genes was prepared.  
Samples were obtained from the following platforms: Affymetrix Human Genome 
U133 Plus 2.0, U133A, Gene 1.0 ST and Gene 1.1 ST.  A non-musculoskeletal 
tissue meta-matrix was also prepared from human liver microarray studies 
performed on the Affymetrix Human Genome U133 Plus 2 platform (n=150) 
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from 5 studies, Appendix Table SD5.3, profiling 19,851 transcripts.  Samples 
were handled as described above.           
5.2.6: Network comparisons of Affymetrix microarrays across species 
through the application of weighted gene co-expression network 
analysis (WGCNA) 
Using a weighted gene co-expression network analysis it is possible to collate 
multiple data-sets into a single correlation matrix to define consensus network 
structures and modules which are strongly conserved or divergent across 
conditions, or species, and functionally annotate these modules. The protocol 
employed follows those defined in Chapter 4.  The reader is referred to Figure 
4.2c for a schematic overview of the methodology.    
To establish universal gene identifiers and facilitate comparison across species rat 
gene identifiers were re-annotated with human Ensembl gene orthologs; the 
human meta-matrix was also re-annotated with Ensembl identifiers – only a single 
probe set per gene was permitted.  After re-annotation this left rat and human 
meta-matrices of 10,221 and 11,904 genes respectively. Only identifiers that were 
common to both meta-matrices were retained and genes with a global variance less 
than 0.4 were removed to reduce noise and computational demands.  This left 
5278 genes for co-expression analysis. The general approach employed to develop 
cross-species co-expression modules is described by Miller, et al (2010) (Miller, 
Horvath et al. 2010).  Consensus network and module generation was performed 
in WGCNA with the following changes to the default settings for consensus network 
generation: β=7, deepSplit=1, cutHeight =0.25 and a minimum module size of 30 
genes. All other settings were left at default.  
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Sub-setting data sets to challenge network structures 
To assess whether network structures would be robust to changes in data set each 
species meta-matrix was split into two groups consisting of a randomly selected 
sub-set of samples.  For each group the average expression rank for each gene in 
the network was calculated.  Within each species these ranks were correlated 
between the two random groups; ten iterations of random sample selection were 
performed.  This was performed both using the 5,278 genes prepared for co-
expression analysis.  Two of the randomized sub-sets for each species were then 
used as inputs for full co-expression analysis to assess how robust the analysis was 
to sub-setting and changes in the input data sets.  
Correlation of phenotypic traits to module eigengenes 
Defining the relationship between phenotypic traits from the constituent samples 
within the individual data sets was undertaken as described in Chapter 4, 4.2.1.  
Binary classification tables were prepared for either the rat or human datasets as 
before.  For the human data multi-dimensional scaling plots were prepared to 
define groups that were then used as phenotypic classifiers.  For consensus 
module-trait relationships the lowest absolute value was defined as the correlation 
for a consensus module-trait pair if the two correlations had the same sign.   
5.2.7: Class prediction analysis  
Class prediction for culture subsets within the meta-sets was performed using the 
pamr package implemented in R and as described by Tibshirani, et al (2002), 
(Tibshirani, Hastie et al. 2002), Figure 5.1d. Briefly, this method employs a 
‘nearest shrunken centroids’ approach to determine cohorts of genes that best 
characterise the defined classes.  Modules defined by co-expression network 
analysis were used to filter the features (genes) for selection.  Expression data 
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from rat or human were split into a randomized test group (10% of all samples for 
a meta-set) and a training set; the latter was used to develop the minimal gene 
signature.  The gene signature for each species was cross-validated by testing 
against both species test groups.  Principal component analysis was used to 
present separation of samples using the minimal gene signature.      
All graphics, network visualization, functional annotation tools, and 
methodologies are consistent with previous descriptions.    
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5.3: Results 
 
5.3.1: Cross-platform normalisation techniques 
Multiple cross-platform normalisation strategies are available within R packages.  
To explore the impact on diverse samples alternative cross-platform normalisation 
strategies were applied to simulated data (not shown), ‘seed’ data (derived from 
real expression profiles) or real data to provide an objective analysis.  Data sets 
derived from ‘seed’ expression values from the real data sets presented similar 
findings using either DWD or XPN normalisation methods with global increases 
in the average Pearson correlation between all samples and platforms, Figure 5.2.   
For real data sets BMC and Genenorm (z-score normalisation) presented with 
identical distributions where the majority of correlations between samples were 
centered on zero, i.e. not correlated.  In contrast, the DWD method again 
produced a high correlation, >0.98, across all samples and platforms, but with 
Affymetrix Genome 230 and GeneST 1.0 arrays showing the greatest overlap of 
correlation distributions, Figure 5.3. Using the real data sets (n = 12) it was not 
possible to apply the XPN method.  Principal component analysis of real data, 
Figure 5.4, found that BMC and DWD methods resulted in a strong clustering of 
two platforms, Affymetrix 230 and Agilent, regardless of whether the samples 
were considered ‘case’ or ‘control’.  This was not replicated for z-score normalised 
data where ‘case’ and ‘control’ samples were still separated between Affymetrix 
and Agilent platforms.    
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Figure 5.2 – Correlation density plots:  Five cross-platform normalisation strategies 
were considered using artificial data sets created using real data-sets as a ‘seed’ around 
which the distribution of  expression values was created.  Normalisation algorithms of  
differing complexity were used: BMC; DWD; Genenorm; None; or XPN.  Data from 
four platforms were considered, representative of  those available in public 
repositories – see figure legend (platform).   Normalisation algorithms such as XPN 
and DWD have assumptions that the data to be normalised arises from the same 
sample type, but analysis undertaken on different platforms.  As such, these 
algorithms result in global correlations of  >0.8 across samples known to come from 
different conditions. Genenorm and BMC use a standardisation method where the 
expression data is ‘studentised’, i.e. mean=0, SD+/- 1.   
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Figure 5.3 – Correlation density plots:  Four cross-platform normalisation strategies 
were considered using real data sets creating consisting of  three case and three 
control studies.  Normalisation algorithms of  differing complexity were used: BMC; 
DWD; Genenorm; None.  Data from four platforms were considered, representative 
of  those available in public repositories – see figure legend (platform).    
 
Application of  the DWD algorithm to all platforms resulted in high cross-platform 
correlations, >0.98, with the two Affymetrix platforms (230 and GeneST) showing 
the highest correlation.  Applying no normalisation technique resulted in variable 
correlations including some very high correlations approaching cor=1.    
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Figure 5.4 – Principal Component Analysis – Data arising from real microarray expression data sets 
derived from cartilage samples applied across four platforms.  Four cross-platform normalisation 
techniques were considered as per Figure 5.3.  PCA explained the greatest variance in the first two 
components for BMC and DWD strategies. These methods strongly clustered data from Affymetrix 
Genome 230 and Agilent 4x44k arrays, including both real case and control data.  Genenorm 
normalised data clustered in the same manner as for BMC and DWD, but with a smaller total PCA 
percentage, but retained less stringent clustering of  the case and control arrays across the two arrays.  
Combining the expression data without applying a cross-platform normalisation strategy resulted in 
strong clustering of  arrays by platform only.     
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Affymetrix cross-platform normalisation  
To investigate whether cross-platform normalisation was required between 
platform generations from a single manufacturer the steps outlined above were 
applied to three generations of Affymetrix platform: a) GeneChip Rat 1.0 ST; b) 
GeneChip Rat 2.0 ST; c) Rat Genome 230 2.0 arrays. As before, BMC and 
Genenorm resulted in a similar distribution of correlation values across the 
expression data; DWD resulted in a global cross-platform increase in correlation, 
Figure 5.5.  Notably, not employing a cross-platform normalisation technique for 
Affymetrix platforms resulted in a higher cross-platform correlation than 
compared to the previous multi-platform analysis.   
By principal component analysis DWD and BMC normalisation clustered all 
samples from the Affymetrix 230 and Affymetrix ST 1.0 arrays, Figure 5.6.  This 
was considered over-smoothing of the data and resulted in groups that were not 
biologically plausible with respect to the sample descriptors from the original 
studies.  Z-score normalisation resulted in less-stringent clustering of the replicates 
and, although less of the data variation was described by the first two components, 
this was considered to be more biological plausible clustering of samples, Figure 
5.7.   
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Figure 5.5 – Correlation Density Plots– Application of  normalisation strategies presented in 
Figure 5.3 to arrays derived only from Affymetrix platforms – a) GeneChip Rat 1.0 ST; b) 
GeneChip Rat 2.0 ST; c) Rat Genome 230 2.0 arrays – see figure legend (platform).  In general the 
findings were comparable with findings across multiple platforms.  DWD resulted in high inter-array 
correlations.  No normalisation resulted in moderate to high correlations between platforms, but 
these values were more widely distributed.  BMC and Genenorm strategies resulted in distributions 
comparable with previous findings.   
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Figure 5.6 – Principal Component Analysis  - as demonstrated in Figure 5.3 the DWD and BMC 
strategies resulted in strong clustering of  all data from Affymetrix 1.0 ST and Genome 230.  In 
contrast, data derived from Chapter 3 Affymetrix 2.0 ST arrays were divergent from this central 
cluster.  No normalisation strategy resulted in clustering by Affymetrix platform generation.  
Genenorm normlisation resulted in a broadly similar distribution of  samples, but more relaxed 
clustering was evident with separation of  case and control samples – see figure legend (groups, 
condition).   
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Figure 5.7: Annotated principal 
component analysis plot –  
 
Genenorm normalised data from 
Affymetrix microarrays (Figure 
5.6) annotated for sample origin – 
figure legend (groups, condition). 
   
 
U n l i k e  D W D a n d  B M C 
normalisation strategies Genenorm 
normalisation resulted in separation 
of  samples in a biologically relevant 
manner, i.e. consistent with sample 
descriptors from the source data 
sets.   
   
Perturbed chondrocytes, either 
from inflammatory or in vitro 
conditions, clustered separate from 
sham inter vent ions, control 
cartilage and matrix-depleted native 
chondrocytes.     
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5.3.2 Sequence- and target-matching of probes across platforms 
curtails numbers of available probes for data integration 
Given the dearth of publically available expression profiles for cartilage and 
tendon including data from multiple platforms would be useful.  To investigate 
whether sequence- and target-matching probes from different platform 
manufacturers would be a valid methodology for improving reproducibility of the 
analysis oligo probe sequences from two Affymetrix arrays (1.0 GeneST and 
Genome 230), one Illumina, and one Agilent platform were aligned to the Rattus 
norvegicus genome and probes were considered sequence- and target-matched 
across platforms if the shorter probes from the Affymetrix (25-mer) or Illumina 
(50-mer) platforms could be unambiguously matched within the larger Agilent 
probes (60-mer) uniquely aligned to the genome.  The number of sequence 
matches, or ‘hits’, within Agilent probes was highest across all chromosomes with 
the shorter 25-mer Genome 230 probes.  Comparatively, GeneST 1.0 probes, of 
the same length, had few hits within Agilent probes in most chromosomes; in 
some cases there were no hits in a chromosome, Figure 5.8  
Given this very stringent definition of sequence matching severely limited the 
number of matching probes a more relaxed definition was considered, which 
allowed any overlap with an Agilent probe to be considered a hit.  Generally, the 
number of matched probes increased considerably for Affymetrix 230 and 
Illumina probes, but had little impact on the GeneST 1.0 probes, Figure 5.9. 
Multiple Affymetrix probes (probe-sets) are annotated to the same gene; mapped 
hits for all probes were re-annotated to define uniquely represented genes that 
were matched across all platforms.  Given the poor number of hits for the 
GeneST 1.0 array the consensus genes for only Affymetrix 230, Illumina and 
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Agilent were considered with duplicates removed.  After annotating with Entrez 
gene identifiers the number of unique identifiers across platforms was associated 
with 620 (Agilent), 615 (Illumina) and 616 (Affymetrix 230) unique genes matched.   
Sequence matching of probes across three platforms resulted in considerable loss 
of gene expression profiling capability; given that just over six-hundred probes 
could be uniquely identified as confidently hybridizing to the same region of a 
transcript this methodology was considered as an unacceptable way of tackling a 
cross-platform meta-analysis using multiple platforms.   
The simplest normalisation strategy, z-score normlisation, did not over-smooth 
the data, resulted in clustering that was less stringent and described less of the 
variability in the data, but was more relevant to the biological understanding of the 
samples. Consequently, data merging was undertaken entirely with microarrays 
developed by Affymetrix using 25-mer oligo probes.  
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Figure 5.8 – Histogram of  probes hits within Agilent probes per chromosome -  Affymetrix platforms use 
25-mer oligo probes, but have multiple probes for each gene or exon depending on the platform.  There is a 
notable difference between the number of  Affymetrix 230 probes that lie within a 60-mer Aglient probe (and 
so verified as sequence-matched) and the Affymetrix GeneST 1.0 array where, in some chromosomes, there are 
no probes that lie within an Agilent probe.  Illumina arrays, like Agilent, have only one probe per gene and are 
50-mer oligos – few of  these probes lie completely within an Agilent probe on the same chromosome.  The 
number of  overlapping probes do not necessarily following the approximate size of  each chromosome (inset).     
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Figure 5.9 – Histogram of  probes overlapping Agilent probes per chromosome – relaxing the qualification for sequence 
matching to include ANY overlap between Agilent probes and those from other platforms increased the number of  probe hits 
(y-axis) across sequences chromosomes (x-axis).  It was still the case in some chromosomes that there was no overlap called 
between Agilent probes and Affymetrix Gene ST 1.0 arrays
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5.3.3: Analysis of co-expression networks across rat and human data 
identifies cross-species preservation of functional gene modules 
 
Constructing networks for rat and human meta-sets 
To develop an insight into musculoskeletal disorders co-expression networks were 
developed to survey the general responses of chondrocytes and tenocytes to 
system perturbations.  After filtering by defined inclusion qualifiers the analysis 
included 336 microarray samples consisting of cartilage and tendon studies from 
166 human and 170 rat investigations. A single gene expression meta-matrix was 
prepared for rat or human data. Each meta-matrix was assessed to determine 
whether it met an approximately scale-free topology, Figure 5.10.  Strong scale-
free topology was evident.  Initially species-specific single networks were prepared 
and, using the topological overlap measurement described in Chapter 4, 
hierarchical clustering was used to group genes with high co-expression 
relationships into modules.  After conversion of rat gene identifiers to converted 
to human orthologs, intersection of common genes and non-specific filtering to 
facilitate computational analysis a set of 5278 genes common to both species 
meta-matrices remained for co-expression analysis. All further analysis uses this 
gene set.  
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Figure 5.10:  Visual assessment of  scale free topology after non-specific 
filtering  for rat (A) and human (B)– Histograms: Frequency (y-axis) of  
gene connectivities (x-axis).  The majority of  genes have few connections;  
Log-log plot of  the connectivity values shown in the associated histogram 
with fitted linear model.  The R^2 value is considered an index of  the 
scale-free network topology.  For the rat (7616 genes) and human (7759 
genes) meta-sets there was good evidence of  scale-free network topology.   
A. 
B. 
Rat data 
Human data 
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5.3.4 Assessment of general network properties  
 
Networks and module definitions are robust to the choice of data-set 
As the constituent data sets for each species meta-matrix came from disparate 
sources it was necessary to demonstrate that networks would be robust to changes 
in the data sets. The single species meta-matrices were randomly split to contain 
half the number of total samples (rat, 85; human, 83) and were processed using the 
same protocol as described previously.  Ten iterations of random data sets were 
prepared and analysed.     
Correlation of the mean expression rank between random data sets in the rat were, 
in 9/10 iterations, positively correlated (range: R=0.04 - 0.36; p=1.3e-05 to 2.6e-
191) and for all iterations using human data (range: R=0.1 – 0.43; p=3.7e-02 to 1e-
200).  In the majority of random permutations of the gene expression data in 
either rat meta-matrix the data was internally comparable with reference to 
published guidelines for WGCNA.     
Gene expression rank was also correlated between species.  Correlation was 
positive for rat versus human expression data (R=0.13, p=2.5e-21), but negative 
for the human cartilage/tendon meta-matrix versus the human liver meta-matrix 
(R= -0.091, p=3.5e-11) indicating cartilage/tendon meta-matrices across species 
were more comparable than between tissues within the same species.  
Two random data-set pairs from each species were chosen, consensus networks 
prepared on these sub-sets and module preservation considered.  Module 
eigengene differential analysis, module functional annotation and consensus hub 
gene definitions were consistent with the findings defined in the succeeding 
sections (data not shown).  
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These findings demonstrate that within each species meta-matrix there was no 
significant data bias; networks derived from randomized sub-sets of the meta-
matrices resulted in highly comparable module structures and definitions, 
functional annotation and hub gene prediction.  It was concluded that the findings 
did not arise as a function of the meta-matrix construction alone.   
Functional annotation of rat network modules 
The rat network consisted of eleven modules, and one additional module 
containing unassigned genes (grey).  These modules are described in terms of their 
functional annotation in Table 5.2.  Module colours are not interchangeable 
between rat and human. In general terms these functional annotations were very 
similar to those previously identified for cartilage and tendon samples, Chapter 4. 
Human modules share rat functional annotation 
Network generation for the human meta-matrix defined six distinct modules, plus 
one module containing unassigned genes. Functional annotation of modules, 
Table 5.3, demonstrated significant enrichment for terms also found in rat 
modules.  For example, the H3 module was described by terms relating to: 
‘immune system process’ and ‘defense response’.  The H2 module was described 
by terms relating to ‘muscle process’, ‘skeletal muscle contraction’ – terms 
previously highly correlated with native tendon. The H5 module was strongly 
associated with terms relating to ‘cytokine activity’ and ‘chemokine signalling’ 
pathways.  
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Biological Process Metabolic Function  Cell Compartment  KEGG Pathway 
Cell cycle  
(8.2e-44) 
DNA binding  
(3.4e-6) 
Nuclear part  
(1.3e-34) 
DNA replication  
(8.4e-27) 
Anatomical structure 
development (1.0e-6) 
Actin binding  
(1.7e-5) 
Extracellular matrix  
(5.7e-9) 
NA 
Cellular protein 
metabolic process (ns)  
Transferase activity, glycosyl 
groups (2.0e-3) 
Endoplasmic reticulum  
(9.7e-9) 
NA 
Ossification  
(ns) 
Growth factor activity  
(ns) 
Organelle  
(ns) 
Hedgehog signaling pathway (7.2e-3) 
Heme biosynthetic 
process  
(1.3e-2) 
Lyase activity  
(ns) 
Cortical cytoskeleton  
(ns) 
Porphyrin and chlorophyll metabolism 
(6.7e-3) 
Response to external 
stimulus (7.2e-17) 
Cytokine activity  
(2.9e-11) 
Extracellular space  
(5.8e-16) 
Cytokine-cytokine receptor interaction 
(1.2e-9) 
Immune response  
(1.8e-9) 
Peptidase activity (ns) TAP complex  
(4.1e-3) 
Toll-like receptor signalling pathway (ns) 
Immune system process  
(3.3e-23) 
Molecular transducer activity 
(5.4e-6) 
Plasma membrane  
(1.2e-16) 
Lysosome (4.9e-3) 
Signal transduction 
(3.7e-9) 
Molecular transducer activity 
(4.7e-8) 
Plasma membrane  
(3.9e-5) 
Cytokine-cytokine receptor interaction 
(3.1e-2) 
Generation of  
precursor metabolites 
and energy (2.5e-51) 
NADH dehydrogenase 
activity (1.1e-16) 
Mitochondrial part  
(5.6e-54) 
Parkinson’s Disease (2.4e-24) 
Skeletal system 
development (5.4e-7) 
Extracellular matrix 
structural component 
(3.3e-3) 
Extracellular region part  
(5.9e-8) 
NA 
 
Table 5.2: Rat meta-matrix specific modules.  Genes assigned to modules in Figure 5.13 were assessed for functional annotations 
using an over-representation analysis in DAVID.  Terms that are not significant are indicated (ns) and are provided for completeness.  
The most significant term (Bonferroni-corrected) for each of  the GO families is provided alongside over-represented KEGG 
pathways.  NA – not available 
R1 
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R3 
R4 
R5 
R6 
R7 
R8 
R9 
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R11 
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Biological Process Metabolic Function  
Cell 
Compartment  
KEGG Pathway 
Cell cycle (4.6e-48) 
DNA binding  
(2.3e-3) 
Nuclear part  
(1.5e-28) 
DNA replication  
(1.5e-22) 
Muscle contraction  
(2.0e-23) 
Cytoskeletal protein 
binding (5.9e-5) 
Actin cytoskeleton   
(8.6e-10) 
Insulin signaling pathway  
(4e-2) 
Immune system process (4.7e-19) 
Molecular transducer 
activity (4.4e-4) 
Lysosome  
(1.9e-6) 
Antigen processing and 
presentation (2.7e-2) 
Blood vessel development (1e-9) 
Calcium ion binding  
(ns) 
Plasma membrane  
(8.4e-8) 
Notch signaling pathway  
(ns) 
Response to external stimulus (6.6e-12) 
Cytokine activity 
(7.3e-12) 
Extracellular space  
(5.1e-8) 
Cytokine-cytokine receptor 
interaction (7.3e-12) 
Interphase of  mitotic cell cycle (ns) 
Oxidoreductase 
activity  
(ns) 
Cell fraction  
(ns)  
Cell Cycle  
(ns) 
Table 5.3: Gene ontology descriptors of  the human meta-set modules defined in Figure 5.14.  For each of  the eigengene 
modules for the human cartilage and tendon meta-set the most significant biological process, metabolic function and 
cellular compartment gene ontology annotations are provided.  The Bonferroni-corrected p-value is provided in 
parentheses; ns indicates p > 0.05 and annotations are provided for completeness.  The ‘red’ module is the only human set-
specific module, but shows no enrichment for gene ontology terms.     
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Generating consensus networks between rat and human meta-sets  
In order to consider the preservation of network structure across species, beyond 
functional annotation, a consensus network was prepared.  Across a range of soft-
threshold values β=7 was considered suitable for both data set, Figure 5.11.  Five 
consensus modules were defined, Figure 5.12.   
Significant module overlap exists between rat and human network modules 
The modules defined in single networks for the rat (Figure 5.13) and human 
(Figure 5.14) meta-matrices were assessed for overlap with the new consensus 
network modules.  In general, modules from each species-specific network had a 
corresponding module in the consensus network and had significant enrichment 
for genes found in those modules using a permutation test to define a module 
preservation summary z-score, Table 5.4.  In Figure 5.15 the relative overlap 
between species-specific modules and consensus modules is summarized.   
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Figure 5.12 (lower panel): Hierarchical clustering gene dendrogram and consensus module 
definition: Rat and human meta-set analysis.  Five consensus modules were defined, genes in 
each module are assigned the same colour (colour band below dendrogram).  Grey areas 
represent unassigned genes.    
Figure 5.11 (upper panel): Determination of  soft-thresholding powers for rat and human 
meta-sets– Plots show the summary network indices (y-axes) as a function of  the soft-
thresholding power (x-axis) for 5278 common genes.  An approximate scale-free topology is 
reached at beta=7 for both sets (A).  This was also chosen as it was the lowest power that still 
approximated the criterion for scale-free topology without losing the summary connectivity 
(B-D), which declines rapidly with increasing soft-thresholding power.   
A. B. 
C. D. 
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Figure 5.13:  Rat meta-set modules (top) show multiple module eigengenes in the 
network.  Relative to the rat–human consensus network several modules are not 
represented within the consensus network (below). Alternative alphanumeric annotations 
for rat and consensus modules are shown and these are used in the text.  The total size of  
each module is indicated beside each module code.  Degree of  overlap between modules is 
represented in the graduated colour bar   
Rat network modules 
Consensus network modules 
R1: 331 
R2: 320 
R3: 172 
R2: 173 4:  
R5:   70 
R6: 240 
R7:   44 
R8: 285 
R9:   70 
R10: 268 
R11:   68 
R12: 3237 
C1: 106 C2: 200 C3: 46 C4: 101  C5: 33 C6: 4792 
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Figure 5.14: a) Human gene dendrogram and module definitions -  b) Overlap of  
human module eigengenes with those identified in the consensus network – all 
modules from the human set-specific modules (rows) have an assigned module within 
the consensus network (columns), except the red module. Degree of  overlap between 
modules is represented in the graduated colour bar.   
C1: 106 C2  200 C3: 46 C4: 101  C5: 33 C6: 4792 
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H2: 140 
H3: 306 
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H6:    80  
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Human 
Module 
Rat  
Module 
Consensus 
Module 
Module Preservation Z-score  
(genes in rat modules,  
Bonferroni log10 p-value) 
Consensus Gene Ontology  
BP | MF | CC | KEGG pathway  
(Bonferroni p-value <0.05) 
Yellow (H2) Yellow  
(R10) 
Blue 
(C1) 
29.6 (268, -271.2) Muscle contraction | cytoskeletal protein binding | contractile fibre 
part | cardiac muscle contraction  
Blue  
(H1) 
Turquoise 
(R1) 
Turquoise 
(C2) 
36.7 (331, -422.9) Cell cycle | chromosome | DNA binding | DNA replication  
Green  
(H5) 
Green  
(R6) 
Yellow 
 (C3) 
15.5 (240, -52.8) Response to wounding | cytokine activity | extracellular space 
| NOD-like receptor signaling pathway  
Turquoise 
(H3) 
Brown  
(R8) 
Brown  
(C4) 
24.1 (285,  -163.9) Immune system process | molecular transducer activity | plasma 
membrane | antigen presentation and processing 
Brown (H4) Magenta 
(R9) 
Green  
(C5) 
13.4 (70, -54.6) Signal transduction | plasma membrane | signal transduction activity 
| neuroactive ligand-receptor interaction  
- Green-
yellow 
(R7) 
- 14.1 (44, -64.4) Immune response | Peptidase activity ns | TLR complex |Toll-like 
receptor signalling pathway ns 
- Black 
(R3) 
-  10.8 (172, -25.7) Anatomical structure development | Actin binding | Extracellular 
matrix | NA 
- Purple 
(R11) 
- 7.32 (68, -13.4) Skeletal system development |Extracellular matrix structural 
component  | Extracellular region part | NA 
- Red 
(R4) 
- 5.44 (173, -9.7) Ossificationns | Growth factor activityns| Organellens | Hedgehog 
signaling pathway  
Red 
(H6) 
- - - Interphase of  mitotic cell cyclens | oxidoreductase activity ns    | Cell 
fractionns | Cell Cyclens 
Table 5.4: Module preservation table – Using the defined module overlaps in Figure 5.13 and 5.14 the table indicates the module equivalents 
for both rat and human modules and the consensus modules.  The module preservation score is based upon the rat module eigengenes.  Where 
a module is species-specific this is indicated by the absence of  an equivalent in the other module columns.  The consensus gene ontology is 
provided to demonstrate the module equivalence across meta-sets.  Where an annotation is not significant this is indicated (ns), otherwise 
annotations indicate the most significant terms for the consensus module genes.   
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Figure 5.15: Circos plot to present rat (‘R’ prefix) and human (‘H’ prefix) module overlaps with 
consensus modules (‘C’ prefix). Figure derived from tabular data where rows (rat or human 
modules) and columns (consensus modules) are represented by coloured segments (inner circle) 
the size of  which defines the total number of  genes that overlap with the rat or human modules.  
Ribbons connect rows and columns and are coloured by consensus module to show the overlap 
with each rat or human module.  The outer two rings define the relative contribution of  each cell 
in a table to the row and column totals (stacked bar plots).  The figure summarises the tabular 
data shown in Figures 5.13, 5.14  and Table 5.4.   
The C3 module is the rat (R6, *) and human (H5, •) consensus module (z-score=15.5, log10 p-
value=-52.8) with a strong association with the alginate culture trait (cor=0.44, p=8e-10) and an 
functional annotation relating to cytokine activity.   
*
•
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5.3.5: Differential eigengene network analysis shows greater 
preservation of network structure across species than between rat 
Affymetrix and Illumina data 
Differential eigengene network analysis was used to define the strength of the 
correlation preservation for all eigengene pairs across the two networks, Figure 
5.16.  There was strong evidence for eigengene network preservation across rat 
and human networks (D = 0.9), which was greater than in preliminary analysis 
greater undertaken between the rat Affymetrix and Illumina data sets (4.3.5).     
Two consensus modules (C4 and C5) were highly correlated between the two data 
sources and formed a ‘meta-module’.  Meta-modules can represent biologically 
relevant gene ‘super-sets’.  The meta-module contained 134 genes, which was 
functionally annotated by the terms: ‘immune system process’ (biological process, 
p=2.6e-15), ‘plasma membrane’ (cellular compartment, p=2.3e-13) and ‘signal 
transducer activity’ (metabolic function, p=4.7e-11).   
Species-specific modules were defined by considering the overlap with consensus 
network modules.  Only one module from the human meta-set was not 
represented in the consensus network (H6), but this had no functionally enriched 
annotation, Figure 5.14 and Table 5.4, and demonstrated the most overlap with 
the grey module of unassigned genes.  As such this was not considered to be 
biologically meaningful.    
There were a number of rat meta-matrix specific modules for which there was no 
eigengene representation in the consensus network, Figure 5.13 and Table 5.4. 
As a consensus module can only be created if a module exists in both data sets this 
may represent modules that are specific to the rat meta-matrix rather than species-
specific per se. Figure 5.15 highlights orphan modules.   
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Figure 5.16: Differential eigengene network analysis across rat and human networks 
using Affymetrix array data.  A.-B. Clustering dendrograms of  consensus module 
eigengenes demonstrates the presence of  a meta-module consisting of  the green and 
brown consensus modules (black bar).  C.-F. Heat-map plots of  eigengene 
adjacencies for each of  the eigengene networks (C- Rat; F – Human).  Each of  the 
rows and columns indicate an eigengene labelled by the consensus module colour.  
Red indicates high-adjacency (positive correlation), whilst blue indicates the inverse, as 
depicted by the colour legend.  D. Barplot of  the preservation of  the consensus 
eigengene relationships between the two meta-sets.  Additionally, the overall network 
preservation measure D for this differential analysis is also provided.  E. Adjacency 
heatmaps for the pair-wise preservation networks of  the two meta-sets.  Each 
consensus module is represented by the rows and columns with the level of  red 
saturation indicating adjacency according to the colour legend.   
A 
D
B 
C 
E F 
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5.3.6: Relating phenotypic traits to modules 
The categorical membership of samples to phenotypic traits was assessed for 
correlation with eigengene modules for each species-specific network. In order to 
reduce the number of phenotypic terms, and to explore emerging trends in the 
data, samples descriptors were iteratively merged into larger trait groups consisting 
of broader, more inclusive terms. Binary classification tables were produced to 
categorise the arrays based upon disease status, tissue source, location, or 
experimental condition.   
Rat module-trait relationships 
The strongest module-trait relationship was found for the R4 module, Figure 5.17 
– the combined traits of ‘hypertrophic’ and ‘transitional’ for chondrocytes derived 
from growth-plate studies were positively correlated with this module eigengene 
(cor = 0.71, p = 4e-27), which was enriched for the KEGG canonical ‘Hedgehog-
signalling’ pathway; this module was negatively correlated with the physiological 
trait for ‘epiphyseal’, ‘proliferative’ and ‘resting’ growth plate zones.  The R6 
module eigengene was positively correlated with the term ‘perturbed’, an 
aggregated group consisting of surgical and inflammatory models of osteoarthritis 
in the rat, in addition to three-dimensional culture models (alginate and fibrin) and 
healing ligament samples.  In contrast, the ‘monolayer’ trait was negatively 
correlated with R6 (cor = -0.55, p = 6e-15)  
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Figure 5.17:  Heat-map of  rat module-trait relationships -  Rows represented rat-specific module 
eigengenes, columns are descriptive terms based upon the data sample descriptions.  Samples 
may appear in more than one descriptor.  Cells are coloured on the strength of  the correlation 
between the module and the trait (side bar).  The absolute correlation is provided in the cell with 
the associated p-value in parentheses below.  Strong positive correlations are seen between the R4 
module and chondrocytes in transitional/hypertrophic zones of  growth plates, also between the 
R3 module and cells in monolayer.  Strong negative correlations are seen between the R4 module 
and the remaining growth plates zones, suggesting a biologically relevant difference in the 
expression of  these module genes.  Normal cartilage (‘normal’) is negatively correlated with the 
R3 and R2 modules, found to be associated with monolayer culture.   
R1: 331 
R2: 320 
R3: 172 
R4: 173 
R5:   70 
R6: 240 
R7:   44 
R8: 285 
R9:   70 
R10: 268 
R11:   68 
R12: 3237 
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Human module-trait relationships 
Initially twelve phenotypic categories for the human meta-set samples were chosen 
based upon the declared sample phenotypes in the microarray repositories.  On 
this basis, however, there was no phenotypic trait that demonstrated a strong 
positive association with any of the module eigengenes. To aid definition of 
sample traits in the human data a multi-dimensional scaling plot was used to 
define divergent sample clusters (data not shown).  This allowed samples to be 
grouped for module-trait correlation in a manner that was not intuitive from an 
understanding of the published sample phenotypes alone, for example, by disease 
status.  
The strongest module-trait correlation was seen with the human module H5 and 
‘Group 2’ (cor = 0.57, p = 1e-15), Figure 5.18, which consisted of: foetal cartilage, 
chondrocytes in alginate beads treated with conditioned media from fibroblasts 
from patients with rheumatoid arthritis (RA), whole joint tissue at 17 weeks and 
differentiating mesenchymal stem cells at week 1 and 2.  This module was 
negatively correlated with samples assigned to ‘Group 1’, which consisted of 
chondrocyte condensations, and other alginate cultures treated with 
pharmaceutical small-molecules that inhibit inflammatory process, e.g. 
corticosteroids and non-steroidal drugs.  
Across the two species networks the R6 and H5 modules correlated with 
chondrocytes within inflammatory environments, but also differentiating 
chondrocytes and mesenchymal stem cells and chondrocytes in three-dimensional 
alginate constructs.  When these samples (‘perturbed’ (rat) and ‘Group 2’ (human)) 
were associated with the consensus network C3 module there was also a moderate 
correlation, C3 (cor = 0.44, p=8e-10), Figure 5.19, indicating that the consensus 
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module, representative of the R6 and H5 modules, was also positively correlated 
with an inflammatory or differentiating phenotype in chondrocytes.   
Hub genes are conserved between rat and human module 
As a measure of the validity of defining hub genes from the consensus module for 
each gene associated with the R6 or H5 modules, the Gene Significance (GS) for 
the trait ‘perturbed’ was plotted against intra-modular connectivity.  For both 
species-specific networks there was a moderate, but significant, correlation 
between these two measures, range: cor = 0.36 – 0.38, p=2.2e-05 - 9.4e-09, Figure 
5.20, comparable in both the rat and human data.  Using the Module Membership 
measure kME in the rat was plotted against kME in the human.  This presented 
strong evidence that module-hub genes were conserved in the R6 and H5 
modules, cor = 0.49, p = 6.7e-16, Figure 5.21. 
 376 
   
Module-trait relationships
-1
-0.5
0
0.5
1
GR
OU
P1
GR
OU
P2
Ea
rly
.P
as
sa
ge
La
te
.P
as
sa
ge
GR
OU
P5
GR
OU
P3
GR
OU
P4
Ar
tic
ula
r.C
ar
tila
ge
GP
.ca
rti
lag
e
Le
sio
na
l.T
en
do
n
No
n.
Le
sio
na
l
MEblue
MEyellow
MEbrown
MEturquoise
MEgreen
MEred
MEgrey
0.14
(0.08)
-0.0038
(1)
0.34
(7e-06)
-0.28
(3e-04)
0.13
(0.1)
0.15
(0.05)
-0.044
(0.6)
-0.072
(0.4)
0.035
(0.7)
0.093
(0.2)
-0.09
(0.2)
-0.017
(0.8)
-0.17
(0.03)
-0.0059
(0.9)
0.016
(0.8)
0.37
(1e-06)
-0.16
(0.04)
-0.044
(0.6)
0.0028
(1)
-0.0015
(1)
-0.33
(1e-05)
0.2
(0.01)
-0.029
(0.7)
-0.27
(6e-04)
-0.041
(0.6)
-0.074
(0.3)
0.44
(2e-09)
0.31
(4e-05)
-0.34
(8e-06)
-0.24
(0.002)
0.065
(0.4)
0.13
(0.09)
-0.11
(0.1)
-0.0064
(0.9)
-0.029
(0.7)
-0.04
(0.6)
-0.015
(0.9)
0.16
(0.04)
0.58
(3e-16)
-0.51
(2e-12)
-0.21
(0.007)
0.037
(0.6)
0.07
(0.4)
-0.029
(0.7)
-0.57
(1e-15)
0.57
(1e-15)
-0.018
(0.8)
0.073
(0.4)
-0.16
(0.04)
0.1
(0.2)
-0.073
(0.4)
0.00045
(1)
-0.05
(0.5)
0.051
(0.5)
-0.0079
(0.9)
0.079
(0.3)
-0.091
(0.2)
-0.039
(0.6)
0.00029
(1)
-0.068
(0.4)
-0.28
(3e-04)
0.031
(0.7)
0.2
(0.01)
0.034
(0.7)
-0.12
(0.1)
0.096
(0.2)
0.063
(0.4)
0.053
(0.5)
0.028
(0.7)
-0.016
(0.8)
0.23
(0.003)
0.21
(0.008)
-0.011
(0.9)
-0.12
(0.1)
-0.055
(0.5)
0.13
(0.1)
-0.14
(0.08)
Figure 5.18:  Heat-map of  human module-trait relationships -  Rows represented meta-set 
module eigengenes, columns are descriptive terms based upon the data sample descriptions.  
Samples may appear in more than one descriptor.  Cells are coloured on the strength of  the 
correlation between the module and the trait (linear heatmap).  The absolute correlation is 
provided in the cell with the associated p-value in parentheses below.  
H1: 263 
H2: 140 
H3: 306 
H4: 152 
H5:  118 
H6:    80  
H7: 4219 
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Module--trait relationships in Human
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Figure 5.19: Module:trait associations - Using the consensus eigengene modules the yellow module (C3), rows, was the only 
module that shared a positive correlation with a trait (columns) across the rat and human meta-sets (defined by coloured vertical 
bar).  Use a conservative method to define a union statistic the lowest correlation, where directionality was shared, leaves the C3 
module with a consensus correlation= 0.44 (p=8e-10) for the trait ‘perturbed’.  This trait consisted of  all the samples from the 
human ‘Group 2’ and the rat ‘perturbed’ definitions.   
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Figure 5.20: Gene significance for the consensus trait ‘perturbed’ shows moderate 
correlation with intra-modular connectivity in the rat (A) and human (B).  Although 
the correlation is not strong there results are comparable across the two networks 
indicating that hub genes are also likely to have strong phenotypic associations   
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Figure 5.22: Consensus module hubs for rat and human R6 and H5 modules 
presented with protein-protein interactions using STRING.  The top 20 genes with 
the highest ranking kME were chosen from each of  R6 and H5.  Legend colours 
define protein-protein interactions.    
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Figure 5.21: Only genes with a positive 
association for module membership (kME 
values ) were plotted, per module, for the rat 
(y-axis) and human (x-axis) networks using the 
rat modules as the reference data set.  This 
provided a visual assessment of  hub gene 
conservation.  The rat R6 module kME is 
correlated with the human kME indicating 
that genes with high module membership in 
the rat module are are likely to have high 
module membership in the human module 
(box).   
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5.3.7: Differences in human and rat network modules define 
osteoarthritis-associated module 
There were several rat modules for which there was no equivalent module in the 
consensus network or any evidence of overlap with consensus modules, 
suggesting that these modules were not present in the human network. The R11 
module was defined by the gene ontology terms ‘skeletal system development’ and 
‘extracellular matrix structural component’ and was moderately associated with 
normal cartilage samples, Figure 5.17.  The R11 module had low module 
preservation statistics when compared to the human network, Table 5.4. Using 
genes within the R11 module with a kME >0.6 (46 genes) this module was 
significantly associated with the terms ‘skeletal system development’ (p = 4.4e-6), 
‘extracellular region part’ (p = 3.9e-4) and ‘osteoarthritis’ (p = 9.4e-3) using the 
Genetic Association database annotations in DAVID. A number of genes with 
robust associations with osteoarthritis were present in this module: Col2a1, Frzb, 
Tnfrsf11b, along with key regulators of chondrogenesis and cartilage turnover, 
Wif1, Dlk1 and Scrg1.   The genes with the highest correlation with the skeletal 
development module were: Mfge8, Chst3, Eps8l2, Mif2 and Col9a2.   
5.3.8: Defining conserved hub genes between rat and human modules 
 
H5 and R6 consensus hub genes are key pro-inflammatory mediators  
In order to assess the conservation of modules the gene Module Membership, as 
described previously, was the qualifier of module hubs. Those genes in paired-
modules that had the highest kME represented hubs in both rat and human 
networks.  The top 20 genes for each module, for which there was a consensus 
match, are presented in Table 5.5.  These module hubs had highly significant gene 
ontology annotations given the small input number and also had known protein-
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protein interactions, Figure 5.22. When the network topography of the R6 and 
H5 modules was considered the most highly inter-connected genes differed 
between the two modules, Figure 5.23, which may reflect biologically relevant 
differences between the two data sets.    
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Figure 5.20: Gene significance for the consensus trait ‘perturbed’ shows moderate 
correlation with intra-modular connectivity in the rat (A) and human (B).  Although 
the correlation is not strong there results are comparable across the two meta-sets.     
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Figure 5.22: Consensus module hubs for rat and human R6 and H5 modules 
presented with protein-protein interactions using STRING.  The top 20 genes with 
the highest ranking kME were chosen from each of  R6 and H5.  Legend colours 
define protein-protein interactions.    
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Figure 5.23: 
Cytoscape generated connectivity 
networks for the R6 and H5 
modules using the genes with the 
highest module membership across 
both species.   
Figure Legend 
Intra-modular connectivity (figure 
legend) of  the consensus hub genes 
differs between the rat and human 
networks.  In the rat module  (top) 
the chemokines Ptges and Cxcl5, and 
Upp1 were the most highly connected 
(figure legend, Node degree).  
 
In the human module the network 
topography was such that IL6, IL11, 
and MMP10 were the most highly 
connected.  CCL20 and CXCL1 were 
moderately connected in both 
networks.    
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C12ORF48, ASPM, TTK, CCNB1, KIF2C, 
CDK1, GINS1, CDCA8, KIF11, MCM5, 
MELK, KIF23, SPAG5, AURKB, CCNA2 
Nuclear division | ATP binding | Microtubule 
cytoskeleton | Cell cycle  
Green  
(H5) 
Green  
(R6) 
Yellow 
 (C3) 
NFKBIA, CCL20, IL11, PTGES, TFPI2, 
FOSL1, CXCL1, BIRC3, TNIP1, CXCL6, 
DUSP5 , TLR2 , CXCL3 , ADORA2A, 
TNFRSF1B, NFKB2, IL6, CXCL2, GCH1, IL8 
Defense response | Chemokine activity | Extracellular 
region part | Cytokine-cytokine receptor interaction  
Turquoise 
(H3) 
Brown  
(R8) 
Brown  
(C4) 
GPR116, EMCN, GPR4, TIE1, PLVAP, 
PODXL, CD93, APLNR, MYCT1, RASIP1, 
CALCRL, TRPC6, PDE2A, PRKCH, F11R, 
C1ORF115, MMRN2, MFNG, NPY1R, LPAR6 
Immune system process | Receptor activityns | Integral 
to plasma membrane | Leukocyte transendothelial 
migration  
Brown (H4) Magenta 
(R9) 
Green  
(C5) 
IGSF6, IL10RA, PTPRC, LCP1, NCKAP1L, 
HCK, CD53, TBXAS1, VAV1, LAPTM5, CCR1, 
PLEK, CYBB, ITGB2, CSF1R, ITGAM, 
FCER1G, NCF4, LCP2, HLA-DMB 
Signal transductionns| Receptor activity | Plasma 
membrane | Neuroactive ligand-receptor interaction  
Table 5.5:  Top 20 consensus hubs between human and rat modules – consensus modules are shown for reference, Table 5.4.  Gene ontology 
functional annotations based upon only the top 20 hub genes.  The H5 and R6 modules are both associated with the perturbed chondrocyte 
trait.  Gene ontology annotations: BP – biological process; CC: cellular compartment; MF: metabolic function; KEGG: canonical signalling 
pathway.   
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5.3.9: Hierarchical clustering discriminates samples by consensus hub 
genes 
To explore species-associated similarities in the module hubs the gene expression 
profile of the twenty consensus hub genes defined for the H5 and R6 module 
were considered for all rat and human samples. Samples from human data 
contained within the trait collection ‘Group 2’, in general, demonstrated higher 
expression of the twenty consensus hub genes, Figure 5.24. In particular 
chondrocytes in alginate beads, treated with synovial fibroblast conditioned media 
derived from rheumatoid arthritis patients, were the most extreme.   
Similarly, in the rat, hierarchical clustering defined alginate bead cultures and 
‘perturbed’ sample as showing higher expression of the top twenty consensus hub 
genes, Figure 5.25.  Using unsupervised hierarchical clustering alone it was 
suggestive that this gene profile could discriminate alginate three-dimensional 
cultures and the ‘perturbed’ chondrocyte phenotype from other samples.  
Monolayer samples, in the rat study, had the lowest expression of the consensus 
hubs, whilst native chondrocytes and tenocytes had an expression profile that lay 
between these extremes.  Notably, expression profiles from surgical and 
inflammatory models of osteoarthritis in the rat were not as extreme as those from 
three-dimensional cultures.   
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NFKB2   ##
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CXCL3 
CXCL2 
CCL20  
IL-8 
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FOSL1   
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Figure 5.24: Heatmap – Genes expression values for the top 20 consensus hubs defined for the 
H5 and R6 modules are plotted for all 166 human meta-set samples. The samples defined 
within this group are coded as described in the column legend.  High expression is defined by 
red cells and low expression by green cells.  Rows represent genes (row annotation). Hierarchical 
clustering does not completely discriminate between groups, however, the majority of  Group 2 
samples were defined within clades showing higher expression of  these hub genes.     
Column Legend 
Group 2 
Other samples 
Figure 5.25: Heatmap – Genes expression values for the top 20 consensus hubs defined for the 
H5 and R6 modules are plotted for all 170 rat meta-set samples.  Legends as for Figure 5.24.  
Alginate and fibrin three-dimensional cultures represent the most extreme expression profile in 
the dataset and show the highest expression of  the consensus hub genes.   
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5.3.10: IL-6 containing inflammatory profile is predictive of 
three-dimensional cultures  
A key objective in this analysis was to establish a gene cohort that would 
accurately and consistently predict class membership for three-dimensional culture 
conditions based on a limited gene expression profile.  Feature selection for class 
prediction was based on the C3 module (n = 46 genes) that was shown to have a 
strong association with the gene expression profile of chondrocytes in alginate 
beads.   
Class prediction, by a least-shrunken centroids approach, was considered for 
membership of either model cultures (alginate and fibrin) or any other sample 
(tissue, monolayer).  For rat samples, using a 13 gene signature, low classification 
error rates were achieved using the training data set (0.026 – 0.046 on five 
iterations), Figure 5.26.  The top predictors were Cxcl6, Lif, Ccl20, Il11 and Il6. 
On test data the model gene signature correctly classified all other samples as ‘not 
model’ (posterior probability (PP) = 0.61-0.99), however, for two alginate cultures 
in the test set the posterior probability was less confident (PP=0.42-0.59).   
The same process applied to the human data was able to discriminate alginate bead 
cultures, with or without conditioned media, from other samples (total error rate: 
0.013-0.027 on five iterations), Figure 5.27.  Between 13 and 16 genes achieved 
low error rates, 
 however, 13 genes performed better.  The prediction model differed to the rat 
with TFPI2, IL6 and PTGS2 the best predictors; LIF and NR4A3 were not 
present in the human signature, whereas MMP10 was included.  When considered 
against the network topology, Figure 5.23, the human class predictors were 
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consistent with the most highly connected nodes in the C3 module; this did not 
appear as consistent for the rat data.  On test data the human signature performed 
well with all models correctly identified (PP = 0.56-0.79) and all other samples 
classified as non-model cultures (PP = 0.75-0.99).   
To assess how well each gene signature would perform across species each 
signature was used to define the test data set from the other species. The human 
signature versus the rat test data was poorly predictive with both alginate cultures in 
the test data set misclassified (PP = 0.713).   In contrast, the rat signature versus the 
human test set correctly classified all three alginate samples as model cultures (PP 
= 0.6-0.89). Using the rat gene signature did reduce from 77.3% to 70% the 
proportion of the data variation described in principal component analysis (data 
not shown).   
A fundamental test for any prediction model is how well it deals with unseen data, 
especially where small class sizes can result in all members of class being within 
the training set and so biasing the data. The Illlumina data set (Chapter 2) was not 
used in training and served as an independent data set. Of the thirteen genes 
identified as the rat gene signature interleukin 11 (IL-11) probes could not be 
identified from the Illumina RatRef.v1 probe manifest file or from re-annotation 
of probes by Ensembl (November 2014), therefore, only twelve gene were used to 
discriminate between the Illumina samples. A low classification error rate was 
evident for the binary classification of ‘models’ versus all other sample (0.033), 
indicating that this gene cohort was a sufficient model of three-dimensional 
culture models in two independent data sets, Figure 5.28.   
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B: Plot of  shrunken centroids for each class for genes surviving the 
threshold for at least one class 
A: Plot of  error rate (y-axis) against threshold value, Delta (lower x-
axis).  As the mumber of  remaining genes (upper x-axis) from C3 
module decreases the misclassification error for model cultures is low.  
At Delta=1.796 (vertical line), 13 genes (B), the smallest number of  
errors are made( 4) 
A. 
B. 
Prediction on genes from consensus module C. 
C: 2x2 confusion matrix to define the number of  samples in each class 
that were correctly identified.  No model cultures were misclassified in 
the training set as ‘other’, whilst five samples known not to be model 
cultures were classified as such.  Overall error rate =  0.033 
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(AUC) = 1.   
E: Principal component analysis 
(n=170) rat expression data on 13 
genes from B .  First two 
components explain 73.9% of  the 
variation in the data.   
D. E. 
Figure 5.26: Class prediction for alginate cultures from rat gene expression data 
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Prediction on genes from consensus module C. 
C: 2x2 confusion matrix to define the number of  samples in each class 
that were correctly identified.  Three model cultures were misclassified 
as ‘other’ in the training set, whilst one sample known not to be model 
cultures were classified as such. Overall error rate = 0.027   
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Figure 5.27: Class prediction for alginate cultures from human gene expression data 
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Figure 5.28: Principal component analysis – 
Loess normalised expression data from Illumina 
data (Chapter 2, n=36) comprising twelve genes 
(excluding IL11) from the rat class predictor 
model.  Data points represent individual arrays 
and are coded as per the figure legend.  Although 
alginate and fibrin cultures do not cluster 
together they are distinct from both native and 
monolayer samples on the basis of  expression of  
twelve genes.  Two samples, marked as triangles, 
do not follow this trend completely and 
represent samples from dermal fibroblasts at 
passage five.   
Overall error rate: 0.033 
Prediction on 12 genes from consensus module 
In the majority of  cases three-dimensional model 
cultures are correctly identified using a 12 gene 
signature.   
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5.4.11:  Alginate culture-associated module is not preserved in human 
liver transcriptome network  
 
Rationale   
To challenge the methodology, and condition or cell specificity of module 
definitions a gene expression meta-matrix from human liver microarray studies 
(n=150) was prepared and the co-expression network compared to those of rat 
and human cartilage/tendon data. These microarrays were included in the meta-
matrix without a priori understanding of liver studies. Specifically only data derived 
from the Affymetrix Human Genome U133 Plus 2 array was chosen.  The same 
gene-set applied to the rat and human comparison (n=5278) was used so that the 
modules would be comparable.  Liver data was selected because there was a 
number of large data sets available using a single platform.   
Rat and human IL-6-containing module is poorly preserved in a liver co-
expression network     
A consensus network was prepared from the human cartilage/tendon and liver 
networks, Figure 5.29. High overall preservation of consensus eigengene 
networks (D = 0.93) between human cartilage/tendon and liver networks was 
demonstrable, Figure 5.30.  High preservation of tissue networks within a species 
is not unexpected.  Specifically the eigengene network contained a meta-module, 
an aggregation of highly correlated eigengenes, which was strongly preserved in 
both the cartilage/tendon and liver networks. Considering whether the human 
cartilage/tendon network structure was well described in the consensus network 
the gene overlap in modules was investigated.  Only four genes from the H5 
module were found any consensus module, other than the unassigned module, 
Figure 5.29.   
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A consensus network was produced using the rat cartilage/tendon and human 
liver networks to considered whether the R6 module would also be excluded from 
a consensus network structure with human liver data.  Analysis of the eigengene 
network structure, found the lowest network eigengene preservation, D=0.86, of 
these analyses (data not shown).  Comparing the rat set-specific network structure 
against the consensus network the R5 had 46 genes that overlapped with a 
consensus module, Figure 5.31, i.e the total number of genes in the R5 module. 
Finally, for both the human and rat cartilage/tendon networks a permutation test 
was prepared to quantify how preserved set-specific modules were in the 
consensus network prepared with the human liver data.  In both cases the R6 and 
H5, IL-6-containing modules, were the lowest scoring modules for preservation in 
each consensus network, Figure 5.29 and 5.31.  This is supportive of the earlier 
findings of the specific association of the R6 and H5 modules with a perturbed or 
differentiating chondrocyte phenotype.    
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Figure 5.29:  
Gene dendrogram for human liver 
and cartilage|tendon meta-sets 
with consensus module definition. 
Five modules are defined by the 
consensus network (A).   
 
 
 
 
 
 
 
 
 
The overlap of  genes within 
modules der ived f rom the 
cartilage|tendon meta-set (rows) 
were compared to those from the 
consensus network (columns) (B).  
All human modules overlapped 
with the consensus modules 
except for the human H5 module 
(dashed lines).  Cells contain the 
number of  genes common to both 
modules.  Colour intensity (vertical 
colour chart) represents the 
number of  overlapping genes 
 
      
onse su  n twork odules 
C.  Module preservation table for 
human cartilage|tendon modules 
compared to the consensus 
network module definitions.  The 
human H5 module (green) has a z-
score comparable to that of  the 
‘gold’ module, which consists of  a 
random allocation of  genes.  Z-
scores lower than 5 are unlikely to 
be preserved.   
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Figure 5.30: Differential eigengene network analysis across human liver and 
cartilage/tendon networks using Affymetrix array data.  A.-B. Clustering 
dendrograms of  consensus module eigengenes demonstrates the presence of  
a meta-module consisting of  the green and turquoise consensus modules.  
C.-F. Heat-map plots of  eigengene adjacencies for each of  the eigengene 
networks (C- Liver; F – Human cartilage/tendon).  Meta-module is defined 
by black bar in each plot..  Each of  the rows and columns indicate an 
eigengene labeled by the consensus module colour.  Red indicates high-
adjacency (positive correlation), whilst blue indicates the inverse, as depicted 
by the colour legend.  D. Barplot of  the preservation of  the consensus 
eigengene relationships between the two meta-sets.  Additionally, the overall 
network preservation measure D for this differential analysis is also provided.  
E. Adjacency heatmaps for the pair-wise preservation networks of  the two 
meta-sets.  Each consensus module is represented by the rows and columns 
with the level of  red saturation indicating adjacency according to the colour 
legend.  High preservation is often evident between tissues from the same 
species.   
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Figure 5.31 : Gene dendrogram 
for human liver and rat cartilage|
tendon networks with consensus 
module definition. Five modules 
are defined by the consensus 
network (A).   
 
 
 
 
 
 
 
 
 
The overlap of  genes within 
modules derived from the rat 
cartilage/tendon network (rows) 
were compared to those from the 
consensus network (columns) (B).   
Only four consensus modules 
(plus the unassigned grey module) 
overlapped strongly with those 
modules specified in the rat 
n e t w o r k ( F i g u r e 5 . 1 3 ) . 
Specifically the green, R5, module 
had 46 genes that overlapped with 
the turquoise module. Matrix cells 
contain the number of  genes 
common to both modules.  
Colour intensity (vertical colour 
chart) represents the degree of  
overlap.    
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C: Module preservation table for 
rat cartilage/tendon modules 
compared to the consensus 
network module definitions.  The 
rat R5 module (green) has a z-
score comparable to that of  the 
‘gold’ module, which consists of  a 
random allocation of  genes.  Z-
scores lower than 5 are unlikely to 
be preserved, i.e. the R5 module 
is not preserved in the human 
liver network.     
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5.4: Discussion  
As demonstrated in Chapter 4 weighted co-expression network analysis may be 
used to compare modular units of transcriptome networks to extract highly co-
expressed aggregates of genes that may confer deeper understanding of the 
regulatory mechanisms underlying a particular phenotype.  Global network 
comparisons may be made between conditions, or, as is the case in this study, 
between species.  This approach, where multiple small gene expression data sets 
are merged and compared between species, has been well-described for the mouse 
and human brain transcriptome (Miller, Horvath et al. 2010).     
The remit of this study was to employ this methodology to define divergent and 
conserved gene co-expression modules in rat and human transcriptomic networks 
derived from cartilage or tendon, and their derivative cells.  At the outset the goals 
of this study w 
ere four-fold: i) to integrate microarray gene expression profiles in cartilage and 
tendon and compare this across species; ii) highlight data gaps to facilitate 
development within the musculoskeletal research community for future targeted 
research projects; iii) define in-vitro culture models relative to normal and disease-
associated gene expression profiles; iv) to consider whether rat studies represent 
adequate proxies for complex musculoskeletal disease in the human.   Each point 
shall be addressed in turn in four sections. 
5.4.1 Implementation of data integration methods for gene 
expression profiles 
In trying to compare the results of differential expression analysis in Chapters 2 
and 3 it became evident that placing the findings in a wider context simply by 
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matching genes or functional annotations across publications would not be 
sufficient.  For example, findings of functional annotations associated with muscle 
in tendon expression profiles could not be validated by analysis of published gene 
lists.  Meta-analysis and data integration methods were explored to identify the 
most effective methods to compare gene expression studies and utilize complete 
sample transcriptome profiles.  
Sequence- and target-matching probes across unique platforms 
As described in the introduction, reports in the literature indicate that sequence-
matching of probes from multiple platforms can result in more robust and 
repeatable estimates of gene expression.  The exercise in this study was driven by 
the poor availability of microarray studies profiling cartilage and tendon in public 
repositories both for rat and humans and the desire to maximize the number of 
studies that could be included.  The low number of probes that could be 
confidently sequence-matched and also represented unique targets would have 
prohibited the application of the co-expression network analysis.  Although the 
final analysis was restricted to platforms from the same manufacturer (Affymetrix) 
several platform generations were used in both the rat and human studies.  
Evidence suggests that reproducibility of analysis and improved correlation 
between samples may be achieved through sequence- and/or target-matching of 
probes between Affymetrix generations (Nimgaonkar, Sanoudou et al. 2003, 
Hwang, Kong et al. 2004, Elo, Lahti et al. 2005). It may be recommended that 
sequence- and target-matching of probe-sets across Affymetrix generations is 
undertaken in further rounds of analysis or where data is added.  
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Cross-platform normalisation 
It is clear from this analysis that noise in the individual studies cannot be resolved 
by global normalisation techniques.  Furthermore, addition of data did not 
facilitate the creation of discrete phenotypic groups, rather adding data 
contributed to noise in the analysis effectively ‘filling in’ the expression space.  Of 
the studies included information on temporal batching of expression profiles 
would have facilitated batch-correction of each data set prior to integration; this is 
not currently a requirement of the MIAME recommendations.  The most popular 
cross-platform normalisation strategies require equivalent covariates to be present 
in samples across multiple platforms, consequently, they cannot be relied upon to 
be able to consistently separate data arising from diverse sources or experiemental 
techniques in a biologically relevant way.  Hence, the simplest z-score 
normalisation strategy was applied as it was the least disruptive to the underlying 
biological information.  
Whether z-score normalisation was the most appropriate is worth discussion.  In a 
study normalizing across five Affymetrix platform generations and 6,926 
experiments Autio, et al (2009) reported that their Array Generation based gene 
Centering (ABC) normalisation technique outperformed standardization, equalized 
quantile, and Weibull distribution based methods (Autio, Kilpinen et al. 2009).  
This methodology is not implemented in R and there is little evidence for its 
widespread use elsewhere; furthermore, z-score standardization retained clustering 
of biological replicates, whilst overcoming within-platform clustering.  The 
decision to employ z-score normalisation was supported by data from Andreas, et 
al (2009), from which the human alginate bead data arose, where the distinct 
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separation of samples treated with different pharmaceutical compounds shown in 
the publication was retained (Andreas, Häupl et al. 2009). This implies that simple 
z-score normalisation across Affymetrix generations did not adversely impact the 
data distribution or sample relationships.   
Limitations in available musculoskeletal gene expression profiles governs study 
inclusion criteria 
Data integration, whether using quantitative clinical data or, in this study, 
microarray expression data, is bounded by the availability of good quality data sets.  
The dearth of microarray studies, relative to other tissue sources, for both cartilage 
and tendon is a primary limitation of this study.  Comparable cross-species analysis 
(Miller, Horvath et al. 2010) using the WGCNA methodology used much larger 
datasets (>1000 microarrays from approximately 20 individual studies) with very 
much higher gene expression correlations across the tissue samples.    
As a consequence of this it may be argued that the inclusion criteria of this study 
was too broad, including as it did both cartilage and tendon, monolayer, novel cell 
culture techniques and interventional studies.  Important associations between co-
expression modules and sample phenotypes may have been obscured by the 
diverse conditions and would have benefitted from a more restricted inclusion 
criteria, for example, only whole cartilage.  In response, the results outlined in 
Chapter 2 and 3 highlighted the importance of tissue comparisons in 
musculoskeletal studies especially where the aim of the investigation is the 
derivation of novel tissue biomarkers or an understanding of common regulatory 
mechanisms.  The number of available datasets is critical to the use of methods 
using co-expression data (Ostlund and Sonnhammer 2014).  As demonstrated in 
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Chapter 3 small datasets do not have a stable network structure and so attempts 
were made to meet the recommended numbers for this type of analysis.  
The diversity of studies, use of alternative breeds and genders, lack of tissue 
controls within many studies and the use of multiple microarray platforms make 
data integration especially problematic, if not incomparable.  Strategies were used 
to best deal with these qualitative issues.  By using only raw expression data it was 
possible to apply pre-processing and normalisation strategies consistently and 
universally.  Stringent quality control of each study data set ensured that outlier 
arrays were removed, despite these having been included in the original 
publications.  Using a co-expression analysis method avoided integration of 
differential expression statistics across studies, which are often not reproducible 
(Ostlund and Sonnhammer 2014), by considering only the global network 
structures. 
In summary, the strategies applied here were driven by the data availability and the 
methodology could be refined where more specific data sets become available.  
Despite these limitations a systematic data integration approach was developed 
with results derived from careful quality control of studies and consistent 
manipulation of raw expression data, approaches that should lend credence to the 
results presented.      
5.4.2 Global comparison of the rat and human transcriptome 
networks should inform future musculoskeletal research 
This analysis has highlighted some of the key limitations to developing good 
models for musculoskeletal disorders and obstacles to the extrapolation of results 
from model species to humans.  Firstly, there is a lack of publically available data, 
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especially for tendon from either species.  Secondly, the quality of these data sets 
was often poor, with retention of outlier arrays, small group sizes and re-use of 
single biological replicates across multiple arrays.  Thirdly, when placed in a wider 
context most gene expression profiles for cartilage and tendon clustered together 
indicative of the noisy nature of the data.  For some studies it was not possible to 
replicate the published clustering of experimental groups even where comparable 
bioinformatic techniques were used.  Together these points suggest that concerted 
community efforts are required to standardize approaches to gene expression 
profiling of cartilage and tendon.  Whilst collecting sufficient disparate data sets to 
perform co-expression analysis may be a promiscuous approach this analysis 
represents a first step in developing a systems understanding of cartilage and 
tendon responses to perturbations and is a novel resource for musculoskeletal 
researchers to exploit for future experimental design.   
 
Validity of cross-species comparisons of expression data 
Low, but positive, correlation between the expression profiles of the rat and 
human cartilage and tendon meta-sets was shown, which still permitted 
comparison of these data sets as defined by documentation associated with this 
method. The cross-species expression correlations defined by Miller, et al (Miller, 
Horvath et al. 2010) between mouse and human brain transcriptomes were highly 
positive, however, in that study all data sets were derived from whole tissue 
transcriptome analysis.  In contrast this study datasets were derived from diverse 
sources and multiple Affymetrix platforms.  Confidence in this analysis of these 
data sets is derived from the very high module preservation across the species 
networks and strong consensus eigengene network structure.  
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 Studies considering the comparative structure of the rodent and human 
transcriptomes have found that tissue-specific transcriptome architecture is highly 
conserved across mouse, rat and human with tissue-specific variance accountable 
for the greatest alterations in expression profile, more so than either perturbations 
or disease (Prasad, Kumar et al. 2013).  It would perhaps be expected that the 
expression correlation would have been higher between the two meta-matrices.  
The compound nature of the meta-matrices, containing two tissues, and multiple 
array platforms may have influenced this correlation.  Furthermore, the inclusion 
of heterogenous cell populations from tissue, as compared to the monoculture in 
vitro, can influence the generation of co-expression modules (Gaiteri, Ding et al. 
2014).  Random resampling of these data sets, however, did not greatly alter the 
intra-species expression correlation, nor the network structures, and so the 
consensus network architecture generated is likely to be robust to the inclusion of 
other data sets.  It is critical that these findings are validated against new gene 
expression profiles.    
‘Normal’ cartilage module is not represented in the human network 
Through differential analysis of the network architecture the presence of a rat-
specific module, associated with unperturbed cartilage samples, was found.  Within 
this module a number of genes with strong osteoarthritis associations, and novel 
candidates, were presented.  This module, annotated with terms relating to 
cartilage and skeletal development, was strongly correlated with the normal 
cartilage phenotype in the rat network, specifically with samples derived from 
controls; it was strongly negatively correlated with the ‘perturbed’ phenotype, i.e. 
those from surgical interventions.   Given the role of these genes in cartilage 
health it is not initially intuitive as to why this module is so poorly preserved in the 
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human network.  The rat meta-matrix contains a number of normal cartilage 
control samples and sham interventions that comprise the ‘normal’ phenotype; 
there is no equivalent for this in the human meta-matrix. This highlights the 
dearth of control data available in human studies against which to compare the 
rodent models.    
This module contained genes recently found to be highly differentially expressed 
between paired normal and OA-affected samples (Ramos, den Hollander et al. 
2014) including Frzb, Tnfrsf11b (which encodes the protein osteoprotegerin) and 
Col9a1.  Furthermore, key modulators of cartilage turnover, Wif1 (Witte, Dokas et 
al. 2009, Stock, Böhm et al. 2013) and regulators of differentiation, Dlk1 (Chen, 
Qanie et al. 2011) and Scrg1 (Ochi, Derfoul et al. 2006).  The most highly 
correlated genes were those with relative sparse associations with cartilage – 
Mfge8/lactadherin has previously been shown to be expressed in cartilage 
(Yoshimi, Miyaishi et al. 2005), but only recently reconsidered.  In ColIX-/- 21 days 
post-natal mouse cartilage increased MFGE8 protein expression was 
demonstrated (Brachvogel, Zaucke et al. 2013).  It is not clear from this analysis 
whether these findings are a consequence of a rat-specific functional module or 
reflect bias in the data as a consequence of few normal cartilage samples in the 
human meta-set.   
Relevance of animal models of musculoskeletal disease 
Ultimately it is expected that rodent model studies are translatable and inform 
human disease pathogenesis in some way.  The gene expression studies presented 
in Chapters 2 and 3 may, as with many other rodent model expression studies, 
have restricted translational potential to human musculoskeletal disorders and 
there is little evidence in the literature to suggest that the validity of assumptions 
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have been investigated.  A literature search of rat studies found that these studies 
are difficult to compare in isolation as they are derived from different disease 
models, tissue sources, in vitro interventions, breeds and sexes, and are often 
underpowered.   
In general the transcriptome networks for both species were comparable, however 
a number of rat modules were not present in the human network.  Furthermore, 
the connectivity of genes within a preserved module was not equivalent across the 
species and the components of the alginate bead culture gene signature also 
differed between rat and human networks.   Human gene expression studies of 
whole cartilage or tendon were scant; only three microarray samples in the human 
data set were defined as coming from ostensibly normal cartilage (Minogue, 
Richardson et al. 2010).  There were no normal tendon gene expression profiles 
available in the public repositories.   
Given the dearth of data, and differences in network structure, no assumptions 
can be made about the relevance of rodent gene expression profiles from 
musculoskeletal disease models for informing the complex human condition.   
5.4.3: Conflicting roles of IL-6 
In this study a co-expression module consisting of multiple chemokines was 
demonstrated, most notably represented by members of the IL-6 family of 
chemokines: Il-6, Il-11 and Lif.  A pleiotrophic battery of functions are associated 
with classical and trans-signalling by IL-6 including the transition from innate to 
acquired immunity in inflammation, and roles in regeneration, metabolic control 
and bone metabolism/osteoclast differentiation (Scheller, Chalaris et al. 2011).  
This indicates both physiological and pathological roles for IL-6 signalling.   This 
 404 
is evident in the samples from the rat and human data sets showing the greatest 
correlation with this module.  In the rat, expression profiles arising from 
osteoarthritis models and three-dimensional culture models were associated with 
the same consensus module as human data arising from foetal cartilage, 
differentiating MSCs and alginate cultures.   
There is conflicting evidence for the association between IL-6 and osteoarthritis.  
IL-6 and its receptor are found in the synovial fluid of symptomatic and 
osteoarthritic joints (Doss, Menard et al. 2007, Tsuchida, Beekhuizen et al. 2012), 
yet both anabolic and catabolic effects of Il-6 have been found.  In the work of de 
Hooge, et al (2005) male Il-6 -/- mice developed evidence of osteoarthritis more 
rapidly that age-matched wild-type controls; this was characterized by complete 
cartilage erosion, subchondral bone sclerosis and ossification of the collateral 
ligaments of the femoro-tibial joint (de Hooge, van de Loo et al. 2005).  This 
conflict is further highlighted by evidence both catabolic effects of Il-6, through 
induction of MMP3 and MMP13 production, and anabolic roles through the 
induction of alpha1-anti-trypsin and TIMP1.  Ryu, et al (2011) demonstrated that 
IL-6 was a potent effector of Epas1/HIF2α-induced cartilage destruction (Ryu, 
Yang et al. 2011).  Hypoxia-inducible factor 2-alpha (HIF2α) has been previously 
demonstrated to be a regulator of cartilage catabolism (Yang, Kim et al. 2010); 
inhibition of IL-6 resulted in reduced MMP3 and MMP13 production in response 
to intra-articular HIF2α adenovirus.  Referring to the discussion in Chapter 3, 
Litherland, et al (2008) reported cartilage collagenolysis dependent on PI-
3Ksignalling by the activation of Akt by IL-6 stimulation (Litherland, Dixon et al. 
2008).  These findings are relevant with respect to the evidence presented in this 
thesis of high Il-6, Mmp13 and Hif1α expression in rat chondrocytes in alginate 
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beads (3.3.3) and the associated prediction of active PI-3K signalling by pathway 
topology analysis (3.3.7).   
These findings in rat chondrocytes would suggest a catabolic process in action in 
alginate cultures.  However, in a study comparing IL-6 production by 
chondrocytes from symptomatic cartilage defects, osteoarthritic or normal 
cartilage Tsuchida, et al (2012) found that chondrocytes retained in a regeneration 
culture system of collagen type II-coated filters produced higher levels of IL-6, by 
ELISA, than the synovial fluid from each associated donor category (Tsuchida, 
Beekhuizen et al. 2012).  Levels of IL-6 were highest in chondrocytes from OA 
cartilage.  Although antibody-mediated inhibition of IL-6 in regeneration cultures 
had no effect on cartilage matrix production the addition of recombinant IL-6 and 
IL-6R resulted in significant increases in GAG production in chondrocytes 
derived from healthy donors and reduced production, but not content, of GAGs 
in OA-derived chondrocytes. Other co-culture studies have indicated a negative 
modulation of matrix by IL-6 (Leyh, Seitz et al. 2014a, Leyh, Seitz et al. 2014b).      
Studies are also conflicted with regard to genetic susceptibility associated with IL-6 
polymorphisms. Susceptibility to hip and knee OA associated with IL-6 promoter 
polymorphisms could not be demonstrated (Valdes, Arden et al. 2010), however, a 
more recent study observed a high frequency of IL-6 polymorphisms associated 
with knee and hand OA, but not hip OA (Cai, Sun et al. 2014).   
5.4.4: Alginate culture associated with inflammatory profiles  
This thesis has not sought to develop novel organotypic culture systems rather 
interrogate the gene expression profile of common in vitro models and question the 
rational for their use with the view that this will inform future developments.  The 
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analysis here confirmed the findings of enhanced expression of genes associated 
with inflammatory profiles in these models.  This was preserved in studies using 
human chondrocytes in a comparable three-dimensional culture model.  
Furthermore, when restricted to twenty genes these models had an expression 
profile more extreme than diseased cartilage or tendon in the human study.  To 
interpret these findings alternative solutions should be considered.      
Alginate, or alginic acid, is a seaweed-derived linear polysaccharide consisting of 
alpha-L-guluronic acid (G) and beta-D-mannuronic acid (M). It is considered to 
contain impurities including lipopolysaccharide (LPS, endotoxin). Alginate alone 
has also been shown to induce the production of pro-inflammatory cytokines, 
including IL-6, in macrophages through NF-κB activation (Yang and Jones 2009).  
Basal expression and secretion of IL-6 has been found in OA chondrocytes 
retained in alginate beads, as a function of culture duration, with an increase in 
expression following IL-1β application and variable reductions in expression in 
response to the application of common NSAIDs (Sanchez, Mateus et al. 2002).   
Given the critical role of pro-inflammatory mediators in our understanding of 
cartilage and tendon pathology stringency in cell culture preparation cannot be 
overlooked.  Screening for endogenous endotoxin is not routine outside of GMP 
labs and those familiar with biomaterial research. Also, as the role of IL-6 is 
conflicted this needs to be separated from any inherent pro-inflammatory and 
endotoxin sequestration effects of biomaterials (Breger, Lyle et al. 2009). 
Anecdotal reports of reduced viability of chondrocytes in alginate beads and the 
evidence of this in Chapter 2 indicate another argument for investigating pro-
inflammatory effects more closely (2.3.8).  Further work should include batch-
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testing of alginate for endotoxin prior to use, in addition to a time-course study of 
IL-6 production in both alginate and fibrin three-dimensional culture models.         
The findings from the rat Affymetrix and Illumina class prediction were most 
comparable with a study by Andreas, et al (2009) (Andreas, Häupl et al. 2009).  It 
was found that a subset of samples consisting of chondrocytes suspended in 
alginate beads and exposed to RA serum had a profile very like that of the rat 
alginate culture studies.  In the study by Andreas, et al, healthy adult chondrocytes, 
initially expanded in monolayer, were encapsulated in alginate beads in 
methodology comparable to the study presented here.  Alginate beads were 
exposed to conditioned media from cultured synovial fibroblasts from RA patients 
or normal controls, and further small molecule interventions were also performed.  
There is remarkable overlap between the differential gene expression profile of 
chondrocytes in RA fibroblast conditioned media in this publication and the class 
prediction gene cohort presented in this study. Additionally, the clustering of 
samples, including therapeutic interventions, is comparable to the original 
publication supporting the assertion made in this study that biologically relevant 
data distribution is preserved after z-score normalisation.   
5.4.5: Biological relevance of study 
Whilst functional and histo-morphological equivalence with native tissue may 
represent the ultimate goal for biological tissue engineering many studies often rely 
on a limited panel of established genes to define success.  This approach can 
neglect the complex gene interaction mechanisms diminishing the significance of 
the analysis (Haynes, Higdon et al. 2013). Whilst large transcriptome surveys and 
co-expression analysis are not practical in most cases the profiling of a validated 
gene signature for class prediction could be a systematic screening procedure to 
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demonstrate progression of a novel organo-typic culture method.  In other terms, 
the expression space within which these culture systems reside needs to be 
delimited.  Using a linear analogy differentiated tissue and dedifferentiated 
monolayer cells represented either extreme of a gene expression spectrum in this 
study; defining where along that line a novel culture system ‘sits’ by way of 
screening of modules of highly co-expressed genes may allow higher throughput 
testing of novel systems and provide rational regulatory targets for perturbation or 
therapeutic interventions.  
In this chapter a cohort of genes is defined that may represent a class prediction 
signature capable of discriminating between standard three-dimensional culture 
systems and monolayer and native tissue sample in the rat and human.  This 
signature contains a number of IL-6 family members and other chemokines with 
known musculoskeletal disease and development associations.  Reluctance to 
make more confident statements about the significance of this finding stems from 
the small number of samples relative to the whole study and, therefore, statistical 
concerns regarding bias.  This signature would require validation, either by qPCR 
or microarray, using the same three conditions across multiple culture time-points.  
Concomitant protein validation would also be required.    
The tissue-specific architecture of transcriptomes is highly conserved across 
mouse, rat and human studies (Prasad, Kumar et al. 2013), however, this was not 
unambiguously demonstrated for cartilage and tendon alone in this study.  The 
authors of this study noted that comparative studies of mouse, rat, and human 
transcriptomes in response to perturbations, were still missing.  This type of 
investigation would require the use of comparable tissue sources and identical 
experimental conditions.  The work presented in this chapter, to the author’s 
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knowledge, is the first to consider transcriptomic responses to perturbations 
arising both in cartilage and tendon.     
This study makes reference to the small number of relevant cartilage and tendon 
studies made available to researchers both for rats and humans.  Only through the 
permissive inclusion policy of this study was it possible to gather a sufficient 
number of data sets required for network co-expression analysis.  Clearly the use 
of matched tissue and experimental conditions for rat and human would be ideal, 
but this type of data is not currently available in public repositories. 
Little is understood of the comparability of rat gene regulatory networks relative to 
humans in complex disease models.  It is imperative, therefore, that there is 
community consensus on the nature of animal models for osteoarthritis or 
tendinopathy rather than small ‘first-in-field’ studies that are difficult to translate 
into complex human musculoskeletal disease.   
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Appendix 5.1  
 
 
Table SD5.1  Datasets used for rat cartilage and tendon meta-analysis.  Description of headings (L to R): i) Accession – code for access of array 
data from either ‘ArrayExpress’ or ‘Gene Expression Omnibus’.  Hyperlinks are provided for direct access; ii) Tissue – source tissue for samples.  
This includes sub-compartments of tissues which may have been isolated in each study, for example, cells, fascicles, layers by laser-capture micro-
dissection; iii) Source – body region from which tissue was derived.  For musculoskeletal tissues this can be quite variable; Donor details – sex, 
breed and age (or weight) for animal sources where provided; iv) Platform – Manufacturer | Platform | Version; v) Citation – chapter references.  
Where citations are not given these were not available from data source and were not found following database searches.  Not all datasets have been 
published; vi) Number of Arrays – the total number of arrays available from the study.  The number used after quality control is provided in 
parentheses if this differs.  This may not always equate to biological replicates.  Description– synopsis of study and associated caveats.  
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Accession 
 
Tissue (Source) Donor details 
 
Platform Citation 
(number) 
Number of 
arrays 
(arrays 
used) 
Description  
Dataset I 
(Chapter 2) 
Cartilage, tendon & fibroblasts.  
(Hip, Knee, Achilles, Tail and DFT 
and dermis.).  F344, ♂, 12 wks 
Illumina, RatRef-
12 v1.0 
Expression 
BeadChip 
NA 40 (36) Analysis of chondrocytes 
and tenocytes in three 
conditions – whole cartilage 
and tendon, monolayer and 
three-dimensional model 
cultures. Array no longer in 
production.  Four arrays 
removed at quality control.    
Dataset II 
(Chapter 3) 
Cartilage and tendon.  (Hip, Knee, 
Achilles and DFT).  Wistar, ♂, 
12wks 
Affymetrix, 
Genechip Gene 
ST 2.0  
NA 24 Analysis of matrix-free cells 
in three conditions – native, 
monolayer and three-
dimensional model cultures.   
E-MEXP-2672 Tendon (Tail).   Sprague Dawley 
(SD), E21 – 6wks 
 
Affymetrix 
GeneChip Rat 
Genome 230 2.0 
NA 9 Transcription profile of rat 
tail tendon at three 
developmental stages -  
embryonic day 21, 
week 3 and week 6 
post-natal.   
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E-GEOD-
42295 
Cartilage (Femoro-tibial joint) NA 
 
Affymetrix 
GeneChip Rat 
Genome 230 2.0 
(Appleton, 
Pitelka et al. 
2007) 
12 (11) Transcription profile of rat 
experimental model of 
osteo-arthritis.  Four 
conditions consisting of 
either surgical intervention 
or sham-operated and 
harvested at 2 or 8 weeks.   
n=12.  One sample did not 
pass quality control.   
E-GEOD-8077 
 
Cartilage (Femoro-tibial joint).  SD, 
♂, 300-325 g 
 
 
Affymetrix 
GeneChip Rat 
Genome 230 2.0 
(Appleton, 
Pitelka et al. 
2007) 
15 (14) Transcription profile of a 
rat experimental model of 
osteoarthritis.  Groups 
consist of surgical 
intervention (medial 
meniscotomy), contralateral 
limb cartilage, and sham-
operate cartilage.  Five 
samples from each group.   
n=10 
Linköping 
University, 
Sweden 
Tendon (Fascicle) Affymetrix Gene 
1.0 ST Array 
Eliasson, 
Andersson et 
al. (2012) 
18 Acknowledgment 
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Linköping 
University, 
Sweden 
Tendon (Fascicle) Rat Gene ST 1.1 
Affymetrix  
(Eliasson, 
Andersson et 
al. 2013) 
8  
E-GEOD-9537 Cartilage.  (Growth plate zones).   
SD, ♂, 42-46 days   
Affymetrix 
GeneChip Rat 
Genome 230 2.0 
(Zhang, 
Pritchard et 
al. 2008) 
8  Transcription profile of rat 
perichondral and reserve 
growth plates obtained by 
laser-capture micro-
dissection.  Four zones 
considered: perichondral, 
reserve, proliferative and 
hypertrophic.   
n=2 per zone using pooled 
RNA from three rats at 
either 42 or 46 days of age. 
E-GEOD-
47676 
Ligament (Medial collateral).  Wistar, 
♂, NA   
Affymetrix 
GeneChip Rat 
Genome 230 2.0 
(Chamberlain, 
Brounts et al. 
2011) 
9 
(3/condition
) 
Transcript profiling of early 
rat healing medial collateral 
ligament.  Three time 
points – intact and day 3 or 
day 7 post injury.   
E-GEOD-6119 Cartilage (Monolayer).   Wistar, ♂, Affymetrix 
GeneChip Rat 
(Gouze, 
Gouze et al. 
13 (11) Gene expression profiling 
of chondrocytes in 
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8weeks Genome 230 2.0 2006) monolayer under one of 
four conditions: passage 3 
control, plus IL-1beta, plus 
glucosamine, or 
combination of IL-1beta 
and glucosamine.   NA.  
Two arrays removed at 
quality control 
E-GEOD-
28958 
Cartilage.   SD, ♀, 12-14 weeks Affymetrix 
GeneChip Rat 
Gene 1.0 ST Array  
(Nam, Perera 
et al. 2011) 
12 (11) Gene expression analysis 
from arthritis model 
induced by mono-
iodoacetate injection.  
Three groups consisting of 
saline sham, and 5, 9 or 21 
days post-injection.   n=12.  
One sample removed at 
quality control.  
E-GEOD-
23432 
Cartilage.   SD, ♂, 1 week Affymetrix 
GeneChip Rat 
Genome 230 2.0 
(Chau, 
Forcinito et 
al. 2011) 
24  Micro-dissection of post-
natal rat growth plates.   
n=5.   
E-GEOD-
14402 
Cartilage.   Neonatal, 1day.   Affymetrix 
GeneChip Rat 
(Rockel, 
Bernier et al. 
8 Transcription profile of 
primary chondrocytes 
treated with TNF-alpha, 
DMSO, MEK1/2 inhibitor 
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Genome 230 2.0 2009) or TNF-alpha + MEK1/2 
inhbitor.   n=2 per 
condition 
E-GEOD-
30322 
Subchondral bone.  Femoro-tibial 
joint.  SD, 10 week old, ♂.   
Agilent Whole Rat 
Genome 
Microarray 4x44k 
G4131F 
(Zhang, Fang 
et al. 2012) 
30 (4) Medial meniscotomy and 
medial collateral ligament 
transection plus sham 
controls in time course 
study.  Normal cartilage 
controls used as part of 
preparatory study in this 
chapter. 
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Table SD5.2  Data sets used in meta-analysis of human microarrays from cartilage and tendon 
Accession 
 
Tissue 
(Source) 
Donor 
details 
Platform Citation Number of arrays 
(arrays used) 
Description 
E-GEOD-43923 Cartilage.   
Femoro-tibial 
joint.   
Human, NA 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
(Klinger, Beyer 
et al. 2013) 
6 (6) Articular and osteophytic cartilage obtained 
from knee joints following total knee 
arthroplasty.   Total of 15 donors was used   
E-GEOD-17368 Cartilage,  
Epiphyseal – 
extra digits.   
Human, NA 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
NA 9 (9) Passage post-natal epiphyseal cartilage up 
to passage 8.   No indication of number of 
donors or replicates.   
E-GEOD-6565 Cartilage.   
Distal femur.   
Human, 18-
Affymetrix 
GeneChip 
Human 
Genome U133 
(Funari, Day et 
al. 2007) 
5 (on this array) Transcription profile of femoral cartilage 
from 18-22 week foetal cartilage.   Other 
replicates performed on other arrays 
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22wks Plus 2.0 
E-GEOD-51812 Cartilage.   
Limb 
condensation
s.   Human, 
6-17 weeks 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
(Wu, 
Bluguermann et 
al. 2013) 
15 Identification of chondrocyte subsets 
during development.  Six replicates relate to 
foetal limb chondrogenic condensations, 
six to total limb cells, and three to 
chondrocytes from the articular region at 
17weeks.   n=7 
E-GEOD-40942 hfBMSCs, 
proximal 
tibial growth 
plate.   
Human, 22 
week 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
(van Gool, 
Emons et al. 
2012) 
10 Transcription profiling of human foetal 
mesenchymal stromal cells undergoing 
chondrogenic differentiation.   n=1 – cells 
for differentiation study came from one 
foetus; there are six  weekly time-points.  
Four further arrays reflect normal hyaline 
growth plate cartilage from adults. 
E-MEXP-2488 Cartilage.   
Articular.  
Human 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
(Minogue, 
Richardson et 
al. 2010) 
3 Comparison of articular cartilage to nucleus 
pulposus.    Three samples in this study 
refer to articular cartilage.  Samples relating 
to vertebral nuclear pulposus cartilage have 
been deliberately excluded.    
E-MEXP-2276 Cartilage.   
Growth plate.   
Affymetrix 
GeneChip 
(Schibler, 
Gibbs et al. 
11 Transcription profiling of primary 
chondrocytes from normal foetal cartilage 
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Human, 
foetal (18-
25.5 wks) 
♀/♂ 
Human 
Genome U133 
Plus 2.0 
2009) or from individuals with thanatophoric 
dysplasia.   n=11 
E-GEOD-12860 Cartilage.   
Femoral 
condyles.   
Human, 37-
74 years 
Affymetrix 
GeneChip 
Human 
Genome HG-
U133A 
(Andreas, 
Häupl et al. 
2009) 
20 Transcription profiling of chondrocyte 
response to anti-rheumatic drugs.  Passage 
two cells maintained in alginate bead 
culture.   n=6 – same donors as E-GEOD-
10024   
E-GEOD-10024 Cartilage.   
Femoral 
condyles.   
Human, 37-
74 years 
Affymetrix 
GeneChip 
Human 
Genome HG-
U133A 
(Andreas, 
Lübke et al. 
2008) 
6 Gene expression profile of human alginate 
cultured chondrocytes treated with 
supernatant from synovial fibroblasts from 
RA patients.   n=6.  Three stimulated 
donor chondrocytes were pooled for each 
array.   
E-GEOD-39795 Cartilage.   
Femoral 
condyles.   
Human, 23-
46yo, ♀/♂ 
Affymetrix 
GeneChip 
Human Gene 
1.0 ST  
(Grogan, Duffy 
et al. 2013) 
12 Expression profile analysis from cartilage 
zones.  Superficial, middle, deep are 
considered.  n=4 
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E-GEOD-43191 Cartilage.   
Femoral 
condyles.   
Human, 45-
82yo, ♀/♂ 
Affymetrix 
GeneChip 
Human Gene 
1.1 ST 
(Fernández-
Tajes, Soto-
Hermida et al. 
2014) 
23 Transcription profile of articular 
chondrocytes from individuals with 
osteoarthritis.  n=23  
E-GEOD-26051 Tendon.   
Various.   
Human, 32-
65yo, ♀/♂ 
Affymetrix 
GeneChip 
Human 
Genome U133 
Plus 2.0 
(Jelinsky, 
Rodeo et al. 
2011) 
46 Gene expression profiling of normal and 
lesional tendons from a variety of sites.   
n=46.  Various tendon sites harvested from 
spectrum of donors.  Reader is referred to 
sample descriptors in ArrayExpress.    
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Table SD5.3  Data sets used for consensus study using liver data sets 
Accession 
 
Tissue 
 
Platform Citation Number of arrays 
(arrays used) 
Description  
E-GEOD-15238 Liver.   
Human, 9-
12 weeks 
and 1.5-81 
years 
Affymetrix 
GeneChip 
Human 
Genome 
U133 Plus 2.0 
NA 13 (13) Embryonic and post-natal/adult livers.  
Total of 13 donors was used.     
E-GEOD-17548 Liver.   
Human, 
NA 
Affymetrix 
GeneChip 
Human 
Genome 
U133 Plus 2.0 
NA 30 (30) Tissue from cirrhosis and hepatocellular 
carcinoma.  30 donors.    
E-GEOD-47972 Liver.   
Human, 
NA 
Affymetrix 
GeneChip 
Human 
Genome 
NA 18 (18) Primary hepatocytes  
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U133 Plus 2.0 
E-GEOD-23343 Liver.   
Human, 
NA 
Affymetrix 
GeneChip 
Human 
Genome 
U133 Plus 2.0 
NA 17(17) Livers biopsies from control and type-II 
diabetes patients.  N=17 
E-GEOD-49541 Liver.   
Human, 
NA 
Affymetrix 
GeneChip 
Human 
Genome 
U133 Plus 2.0 
NA 72 (72) Tissue from patients with non-alcoholic fatty 
liver disease 
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Appendix 5.2 
 
R Codes 
 
Code assumes investigator has R Expression Sets for each 
gene expression profile, up-to-date R version and correct 
packages in R library 
 
Code applies weighted gene co-expression network analysis 
to Ensembl annotated meta-matrices from rat and human and 
outputs gene modules, network preservation statistics and 
module:trait associations.   
 
###################################################### 
#Create annotation file to annotate probes across 
species## 
###################################################### 
###Let's get the human orthologs of rat genes using 
biomaRt 
 
library(rat2302probe) 
 
    probes<-rat2302ENTREZID 
    mapped_probes<-mappedkeys(probes) 
    xx<-as.list(probes[mapped_probes]) 
    affy.ID<-names(xx) 
 
library(biomaRt) 
 
#Define your database 
##Ensembl does an independent mapping of array probe sequences 
to genomes.  If there is no clear match then the probe is not 
assigned to a gene. 
 
ensembl<-
useMart("ensembl",dataset="rnorvegicus_gene_ensembl") 
 listAttributes(ensembl) 
###cannot call attributes from multiple databases 
#get rat 
one<-
getBM(attributes=c("affy_rat230_2","ensembl_gene_id","entre
zgene","external_gene_id","description"),filters="affy_rat2
30_2",values=affy.ID,mart=ensembl) 
#get human 
two<-
getBM(attributes=c("ensembl_gene_id","hsapiens_homolog_ense
mbl_gene"),filters="affy_rat230_2",values=affy.ID,mart=ense
mbl) 
 annotation<-merge(one,two, by="ensembl_gene_id") 
 table(duplicated(annotation$hsapiens_homolog_ensembl_gene)) 
 
#FALSE  TRUE 
#12296  5472 
 
annotation2<-
annotation[!duplicated(annotation$hsapiens_homolog_ensembl_
gene),] 
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####Re-annotate human Entrez gene identifiers by Ensembl gene 
identifiers 
 
 ensembl<-useMart("ensembl",dataset="hsapiens_gene_ensembl") 
# use U133 plus 2 identifiers 
 
library(hgU133plus2.db) 
 
    probes<-hgu133plus2ENTREZID 
    mapped_probes<-mappedkeys(probes) 
    xx<-as.list(probes[mapped_probes]) 
    U133.ID<-names(xx) 
 
hsap<-
getBM(attributes=c("affy_hg_u133_plus_2","ensembl_gene_id","entr
ezgene","external_gene_id"),filters="affy_hg_u133_plus_2",values
=U133.ID,mart=ensembl) 
 table(duplicated(hsap$ensembl_gene_id)) 
 hsap2<-hsap[!duplicated(hsap$ensembl_gene_id),] 
 
 setwd("/Users/xxx/working_directory") 
 save("annotation2","hsap2", 
 file="Rat_to_Human_annotations.RData") 
 
#load function to move columns in large matrices 
########################## 
###Move columns around#### 
########################### 
 
moveMe <- function(data, tomove, where = "last", ba = NULL)  
 { 
    temp <- setdiff(names(data), tomove) 
    x <- switch( 
    where, 
    first = data[c(tomove, temp)], 
    last = data[c(temp, tomove)], 
    before =  
 { 
    if (is.null(ba)) stop("must specify ba column") 
if (length(ba) > 1) stop("ba must be a single character string") 
data[append(temp, values = tomove, after = (match(ba, temp)-1))] 
  } 
 ,after =  
 { 
    if (is.null(ba)) stop("must specify ba column") 
if (length(ba) > 1) stop("ba must be a single character 
string")data[append(temp, values = tomove, after = (match(ba, 
temp)))] 
 }) 
    x 
 } 
 
####################################################### 
#Merging R expression sets from multiple data sets##### 
####################################################### 
#load Loess normalised Esets 
#Esets prefixed with accession codes  
#setwd() 
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library(inSilicoMerging) 
 esets<-list(eset1,eset2,eset3….esetN) 
 merged<-merge(esets,method="GENENORM") 
detach("package:inSilicoMerging") 
#rm(esets) 
#plot PCA to visualize data  
library(limma) 
 plotMDS(exprs(merged),cex=0.5) 
 boxplot(exprs(merged),las=2) 
 
##Genenorm normalised data 
 data2<-exprs(merged) 
 write.csv(data2,"exprs_merged.csv") 
 data2<-read.csv("exprs_merged.csv") 
 colnames(data2)[1] <- c("EntrezID") 
 
################################# 
##Reannotate rat with human orthologs 
################################# 
setwd("/Users/xxx/working_directory") 
load("Rat_to_Human_annotations.RData") 
 
data<-merge(data2,annotation2,by.x="EntrezID",by.y="entrezgene") 
 data<-data[,-c(172:176)] 
 data3<-moveMe(data,c("EntrezID")) 
 data3<-moveMe(data3,c("hsapiens_homolog_ensembl_gene"),"first") 
 data3<-data3[,-172] 
 colnames(data3)[1]<-c("Ensembl") 
 rat.data<-data3 
 rm(data,data2,data3) 
 
########################################## 
##Human data############################## 
########################################### 
library(inSilicoMerging) 
 esets<-list(esetHuman1, esetHuman2, esetHumanN) 
 merged<-merge(esets,method="GENENORM") 
detach("package:inSilicoMerging") 
 
library(limma) 
 plotMDS(exprs(merged),cex=0.5) 
 data2<-exprs(merged) 
 write.csv(data2,"exprs_merged.csv") 
 data2<-read.csv("exprs_merged.csv") 
 colnames(data2)[1] <- c("EntrezID") 
 
########################################## 
##re-annotate human with Ensembl gene ids 
########################################### 
setwd("/Users/xxx/working_directory") 
load("Rat_to_Human_annotations.RData") 
 data<-merge(data2,hsap2,by.x="EntrezID",by.y="entrezgene") 
 data3<-moveMe(data,c("ensembl_gene_id"),"first") 
 data3<-data3[,-c(123:124)] 
 data3<-data3[,-2] 
 colnames(data3)[1]<-c("Ensembl") 
 human.data<-data3 
 
 
 save(rat.data,human.data, 
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 file="Gnorm_cross_spp_annotated_data.RData") 
 
################################################################# 
######Rat to human cartilage|tendon network consensus analysis### 
################################################################# 
library(WGCNA) 
setwd("/Users/xxx/working_directory") 
load("Gnorm_cross_spp_annotated_data.RData") 
#contains - rat.data – meta-matrix 
#contains - human.data – meta-matrix 
 
####Prepare Rat data 
 ArrayName=names(data.frame(rat.data[,-1])) 
 GeneName=rat.data$Ensembl 
 exprs.rat=data.frame(t(rat.data[,-1])) 
 names(exprs.rat)=rat.data[,1] 
 dimnames(exprs.rat)[[1]]=names(data.frame(rat.data[,-1])) 
##Prepare Human data 
 ArrayName=names(data.frame(human.data[,-1])) 
 GeneName=human.data$Ensembl 
 exprs.human=data.frame(t(human.data[,-1])) 
 names(exprs.human)=human.data[,1] 
 dimnames(exprs.human)[[1]]=names(data.frame(human.data[,-1])) 
####Intersect Rat data after filtering with Human data after 
filtering by Ensembl ID 
commonProbesA=intersect(colnames(exprs.rat), 
colnames(exprs.human)) 
length(commonProbesA) 
###Remove genes not found in both datasets 
 datExprRat = exprs.rat[,commonProbesA]   
###intersect data on Ensembl genes 
 datExprHuman = exprs.human[,commonProbesA] 
 
##Filter each data set 
###RAT#### 
 exprs.v=as.vector(apply(as.matrix(datExprRat),2,var,na.rm=T)) 
#calculate variance across the expression data  
 present=as.vector(apply(!is.na(as.matrix(datExprRat)),2,sum)) 
 keep=exprs.v>0.4 & present>=4 
 table(keep) 
 filt.rat=datExprRat[,keep] 
 
#####HUMAN 
exprs.v=as.vector(apply( 
as.matrix(datExprHuman),2,var,na.rm=T)) 
present=as.vector(apply(!is.na(as.matrix(datExprHuman)),2,sum)) 
 keep=exprs.v>0.4 & present>=4 
 table(keep) 
 filt.human<-datExprHuman[,keep] 
 
####Intersect Rat data after filtering with human data after 
filtering by Ensembl ID 
 commonProbesB=intersect(colnames(filt.rat), 
 colnames(filt.human)) 
 length(commonProbesB) 
#[1] 5278 
##Prepare another adjacency matrix with the new data 
 datExprRat=filt.rat[,commonProbesB];   
##note location of comma - we are dealing with columns not rows as 
the data is transposed 
 datExprHuman = filt.human[,commonProbesB] 
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####Prepare Liver Data and annotate as per rat and human meta 
matrices 
load("Gnorm_LIVER_annotated_data.RData") 
#humanLiver.data file created as for other human data 
 ArrayName=names(data.frame(humanLIVER.data[,-1])) 
 GeneName=humanLIVER.data$Ensembl 
 exprs.liver=data.frame(t(humanLIVER.data[,-1])) 
 names(exprs.liver)=humanLIVER.data[,1] 
dimnames(exprs.liver)[[1]]=names(data.frame(humanLIVER.data[,-
1])) 
###restrict liver data to the same genes being used for cartilage 
and tendon analysis 
 datExprLiver = exprs.liver[,commonProbesB] 
 save(datExprHuman,datExprRat,datExprLiver, 
 file="datExprRat_Human_Liver.RData") 
 
######################## 
#####PICK-UP POINT 1#### 
######################## 
library(WGCNA) 
setwd("/Users/xxx/working_directory") 
load("datExprRat_Human_Liver.RData") 
 
###Consensus modules ## 
##transpose data again; 
 t.rat<-t(datExprRat); 
 t.human<-t(datExprHuman); 
 options(stringsAsFactors=FALSE); 
 nSets=2; 
 setLabels=c("Rat","Human"); 
 shortLabels=c("RN","HS"); 
 
 multiExprA=vector(mode="list",length=nSets); 
 multiExprA[[1]]=list(data=as.data.frame(t(t.rat))); 
 names(multiExprA[[1]]$data)=colnames(datExprRat); 
 colnames(multiExprA[[1]]$data)=names(datExprRat); 
 
 multiExprA[[2]]=list(data=as.data.frame(t(t.human))); 
 names(multiExprA[[2]]$data)=colnames(datExprHuman); 
 colnames(multiExprA[[2]]$data)=names(datExprHuman); 
 
 
 
##Define the Eset dimensions 
 exprSize=checkSets(multiExprA) 
 nGenes=exprSize$nGenes 
 nSamples=exprSize$nSamples 
 
###NAMES#### 
#net_A <- human and rat consensus 
#multiExprA <- human and rat consensus 
#consMEsA <- human and rat consensus 
 
#net_B <- human only data 
#net_C <- rat only data 
 
#NETWORK CONSTRUCTION###### 
 net_A=blockwiseConsensusModules(
 multiExprA,power=7,minModuleSize=30,deepSplit=1, 
 pamRespectsDendro=FALSE,mergeCutHeight=0.25,numericLabels=TRUE,
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 minKMEtoStay=0,saveTOMs=FALSE,verbose=5 
 ) 
#names(net) 
 consME_A=net_A$multiMEs; 
 moduleLabels=net_A$colors; 
 moduleColors=labels2colors(moduleLabels) 
 consTree=net_A$dendrograms[[1]]; 
plotDendroAndColors( 
net_A$dendrograms[[1]],moduleColors[net_A$blockGenes[[1]]],"Cons
ensus\nModule 
Colors",dendroLabels=FALSE,hang=0.03,addGuide=TRUE,guideHang=0.0
5 
) 
 
save(net_A,consMEs_A,moduleColors,consTree,file="rat_human_consensus
.RData") 
rm(filt.rat,filt.human,commonProbesA,commonProbesB,t.human,t.rat,pre
sent,net,exprs.human,exprs.rat,exprs.v) 
collectGarbage() 
 
########################## 
#####PICK UP POINT 2###### 
########################## 
load("rat_to_human_consensus_net.RData") 
#re-calulate the consMEs to give them colour names 
 consMEsA<-multiSetMEs(multiExprA,universalColors=moduleColors); 
#Add the tendon trait to the eigengenes and order them by consensus 
hierarchical clustering; 
 MET<-consensusOrderMEs(consMEsA); 
#MET<-consensusOrderMEs(addTraitToMEs(consMEsC,tendon)); 
##Now call the function 'plotEigengeneNetworks' to perform the 
differential analysis 
 sizeGrWindow(8,10) 
 par(cex=0.9) 
 plotEigengeneNetworks( 
 MET,setLabels,marDendro=c(0,2,2,1), 
 marHeatmap=c(3,3,2,1),zlimPreservation=c(0.5,1),xLabelsAngle=90) 
 
 
###LOOK AT THE PROBES IN A MODULE 
#unique(colors) 
 modules =c("brown"); 
# Select module probes 
 setwd("/Users/xxx/working_directory") 
 probes = names(datExprHuman) 
 inModule = is.finite(match(moduleColors, modules)) 
 modProbes = probes[inModule] 
 head(modProbes) 
 module.x<-data.frame(Module=modProbes) 
#module<-merge(module.x,anno,by.x="Module",by.y="EntrezID") 
 write.csv(module.x,"Brown_module.csv",row.names=FALSE) 
 
########################## 
##Species-Specific Modules 
########################## 
 
########################## 
#Human Specific Modules ## 
########################## 
 
##require datExprHuman - has to have consensus-matched probes 
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##also repeat for datExprRat 
 net_B<-blockwiseModules( 
 datExprHuman,power=7,minModuleSize=30,deepSplit=1, 
 pamRespectsDendro = FALSE, mergeCutHeight = 0.2,  
 numericLabels = TRUE, minKMEtoStay = 0, saveTOMs = FALSE, 
 verbose = 5 
 ) 
 
 humanMEs=net_B$MEs; 
 humanLabels=net_B$colors; 
 humanColors=labels2colors(humanLabels) 
 humanTree=net_B$dendrograms[[1]] 
 plotDendroAndColors( 
humanTree,humanColors[net_B$blockGenes[[1]]],"Module 
Colors",dendroLabels=FALSE,hang=0.03,addGuide=TRUE,guideHang=0.0
5 
) 
 
save(net_B,humanMEs,humanLabels,humanColors,humanTree,file="human_se
t_specific.RData") 
 
########################## 
#####PICK UP POINT 3###### 
########################## 
load("human_set_specific.RData") 
###The consensus network analysis results are represented by the 
variables consMEs, moduleLabels, moduleColors, and consTree. We are 
now ready to relate the human cartilage|tendon modules to the 
consensus modules. We calculate the overlaps of each pair of 
cartilage|tendon-consensus modules, and use the Fisher’s exact test 
(also known as hypergeometric test) to assign a p-value to each of 
the pairwise overlaps. 
 
#Isoloate the module labels in the order they appear in the ordered 
module eigengenes 
 humanModuleLabels=substring(names(humanMEs),3); 
 consModuleLabels=substring(names(consME_A[[1]]$data),3) 
#Convert the numeric module labels to color labels 
 humanModules<-labels2colors(as.numeric(humanModuleLabels)); 
 consModules<-labels2colors(as.numeric(consModuleLabels)); 
#Numbers of affy and consensus modules 
 nHumanMods=length(humanModuleLabels); 
 nConsMods=length(consModuleLabels); 
##initialise tables of p-values and of the corresponding counts 
 pTable<-matrix(0,nrow=nHumanMods,ncol=nConsMods); 
 CountTbl<-matrix(0,nrow=nHumanMods,ncol=nConsMods); 
##Execute all pairwise comparisons 
 for(fmod in 1:nHumanMods) 
 for(cmod in 1:nConsMods) 
 { 
 humanMembers=(humanColors==humanModules[fmod]); 
 consMembers=(moduleColors==consModules[cmod]); 
pTable[fmod,cmod]=-log10(fisher.test(humanMembers,consMembers, 
alternative="greater")$p.value); 
 CountTbl[fmod,cmod]=sum( 
humanColors==humanModules[fmod]&moduleColors==consModules[cmod]) 
 } 
#To display the p-value and count tables in an informative way we 
create a color-coded table of the intersection counts.  The colours 
will indicate the p-value significance: 
#truncate the p values smaller than 10^{-50} to 10^{-50} 
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#marginal counts (really module sizes) 
 humanModTotals = apply(CountTbl,1,sum); 
 consModTotals = apply(CountTbl,2,sum); 
#Actual plotting 
 sizeGrWindow(12,7) 
 par(mfrow=c(1,1)) 
 par(cex=1.0) 
 par(mar=c(10,14,2.7,1)+0.3) 
#use the function labeledheatmap to produce the color-coded table 
 labeledHeatmap(Matrix=pTable, 
 xLabels=paste(" ",consModules), 
 yLabels=paste(" ",humanModules), 
 colorLabels=TRUE, 
 xSymbols=paste("Cons ",consModules,": ",consModTotals,sep=""), 
 ySymbols=paste("Cartilage|Tendon",humanModules,":", 
 humanModTotals,sep=""), 
 textMatrix=CountTbl, 
 colors=blueWhiteRed(100)[50:100], 
main="Correspondence of Human Cartilage|Tendon set-specific and 
Human:Rat consensus modules", 
 cex.text=1.0,cex.lab=1.0,setStdMargins=FALSE); 
 
###LOOK AT THE PROBES IN A MODULE 
#unique(colors) 
 modules =c("red"); 
# Select module probes 
 setwd("/Users/xxx/working_directory") 
 probes = names(datExprHuman) 
 inModule = is.finite(match(humanColors, modules)) 
 modProbes = probes[inModule] 
 head(modProbes) 
 module.x<-data.frame(Module=modProbes) 
#module<-merge(module.x,anno,by.x="Module",by.y="EntrezID") 
 write.csv(module.x,"module.csv",row.names=FALSE) 
 
########################## 
#Rat-Specific Modules##### 
########################## 
#Requires datExprRat 
 net_C<-blockwiseModules( 
 datExprRat,power=7,minModuleSize=30, 
 deepSplit=1,pamRespectsDendro=FALSE,  
 mergeCutHeight=0.2,numericLabels=TRUE,  
 minKMEtoStay=0,saveTOMs=FALSE,verbose=5 
 ) 
 
 RatMEs=net_C$MEs; 
 ratLabels=net_C$colors; 
 ratColors=labels2colors(ratLabels) 
 ratTree=net_C$dendrograms[[1]] 
 plotDendroAndColors( 
 ratTree,ratColors[net_C$blockGenes[[1]]], 
 "ModuleColors",dendroLabels=FALSE, 
 hang=0.03,addGuide=TRUE,guideHang=0.05 
 ) 
 
save(net_C,RatMEs,ratLabels,ratColors,ratTree,file="rat_set_specific
.RData") 
 
 
########################## 
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#####PICK UP POINT 4###### 
########################## 
load(file="rat_set_specific.RData") 
 
#Isoloate the module labels in the order they appear in the ordered 
module eigengenes 
 ratModuleLabels=substring(names(RatMEs),3); 
 consModuleLabels=substring(names(consME_A[[1]]$data),3) 
#Convert the numeric module labels to color labels 
 ratModules<-labels2colors(as.numeric(ratModuleLabels)); 
 consModules<-labels2colors(as.numeric(consModuleLabels)); 
#Numbers of affy and consensus modules 
 nRatMods=length(ratModuleLabels); 
 nConsMods=length(consModuleLabels); 
 
##initialise tables of p-values and of the corresponding counts 
 pTable<-matrix(0,nrow=nRatMods,ncol=nConsMods); 
 CountTbl<-matrix(0,nrow=nRatMods,ncol=nConsMods); 
 
##Execute all pairwise comparisons 
 for(fmod in 1:nRatMods) 
 for(cmod in 1:nConsMods) 
 { 
 ratMembers=(ratColors==ratModules[fmod]); 
 consMembers=(moduleColors==consModules[cmod]); 
pTable[fmod,cmod]=-
log10(fisher.test(ratMembers,consMembers,alternative="greater")$
p.value); 
CountTbl[fmod,cmod]=sum(ratColors==ratModules[fmod]& 
moduleColors==consModules[cmod]) 
 } 
 
 ratModTotals = apply(CountTbl,1,sum); 
 consModTotals = apply(CountTbl,2,sum); 
#Actual plotting 
 sizeGrWindow(12,7) 
 par(mfrow=c(1,1)) 
 par(cex=1.0) 
 par(mar=c(12,16,2.7,1)+0.3) 
#use the function labeledheatmap to produce the color-coded table 
 labeledHeatmap( 
 Matrix=pTable, 
 xLabels=paste(" ",consModules), 
 yLabels=paste(" ",ratModules), 
 colorLabels=TRUE, 
 xSymbols=paste("Cons ",consModules,": ",consModTotals,sep=""), 
 ySymbols=paste("Cartilage|Tendon", 
 ratModules,":",ratModTotals,sep=""), 
 textMatrix=CountTbl, 
 colors=blueWhiteRed(100)[50:100], 
main="Correspondence of Rat Cartilage|Tendon set-specific and 
Human:Rat consensus modules", 
 cex.text=1.0,cex.lab=1.0,setStdMargins=FALSE 
 ); 
 
###LOOK AT THE PROBES IN A MODULE 
#unique(colors) 
 modules =c("green"); 
# Select module probes 
 setwd("/Users/xxx/working_directory") 
 probes = names(datExprRat) 
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 inModule = is.finite(match(ratColors, modules)) 
 modProbes = probes[inModule] 
 head(modProbes) 
 module.x<-data.frame(Module=modProbes) 
#module<-merge(module.x,anno,by.x="Module",by.y="EntrezID") 
 write.csv(module.x,"Rat_green_module.csv",row.names=FALSE) 
 
 
##multiExpr set already created: 1=Rat; 2=Human - create a new one 
 
multiExpr2=list(A1=list(data=datExprRat), 
A2=list(data=datExprHuman)); 
 multiColor=list(A1=ratColors); 
 
######################################### 
####MODULE PRESERVATION################## 
######################################### 
 
#This function assesses how well a module in one study is preserved 
in another study 
 mp=modulePreservation( 
 multiExpr2,multiColor,referenceNetworks=1, 
 verbose=3,networkType="unsigned",nPermutations=30, 
 maxGoldModuleSize=100,maxModuleSize=400 
 ); 
 stats = mp$preservation$Z$ref.A1$inColumnsAlsoPresentIn.A2; 
stats2=mp$preservation$log.pBonf$ref.A1$inColumnsAlsoPresentIn.A
2; 
 
  
 modulesPreserved<data.frame( 
 stats$moduleSize, 
 stats$Zsummary.pres,stats2$log.p.Bonfsummary.pres 
 ); 
 rownames(modulesPreserved)<-rownames(stats); 
 
setwd("/Users/xxx/working_directory"); 
write.csv(stats,"Module_Preservation_Z_scores.csv"); 
rm(mp,stats,stats2,multiExpr2,multiColor,modulesPreserved) 
 
 
 
########################################################### 
## Module membership (kME) and its use in comparing networks 
########################################################### 
 
 MEList = moduleEigengenes(datExprRat,colors=ratColors) 
 MEs = MEList$eigengenes 
 colorsRat=names(table(ratColors)) 
 
 geneModuleMembership1 = signedKME(datExprRat, MEs) 
 colnames(geneModuleMembership1)= 
 paste("PC",colorsRat,".cor",sep="" 
 ); 
 MMPvalue1=corPvalueStudent( 
 as.matrix(geneModuleMembership1),dim(datExprRat)[[2]] 
 ); 
 colnames(MMPvalue1)=paste("PC",colorsRat,".pval",sep=""); 
 
 Gene = rownames(t(datExprRat)) 
 kMEtable1=cbind(Gene,Gene,ratColors) 
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 for (i in 1:length(colorsRat)) 
 kMEtable1=cbind( 
 kMEtable1,geneModuleMembership1[,i],MMPvalue1[,i] 
 ) 
 colnames(kMEtable1)= 
 c("PSID","Gene","Module",sort( 
 c(colnames(geneModuleMembership1),colnames(MMPvalue1)))) 
 
setwd("/Users/alanmueller/Desktop/Thesis/Chapter_4_MetaAnalysis/DATA
") 
write.csv(kMEtable1,"kMEtable1.csv",row.names=FALSE) 
#or 
#write.csv(kMEtable1,"Rat_modules_kME.csv",row.names=FALSE) 
 
#Now repeat for HUMAN, using the module assignments from A2 to 
determine kME values. 
# First calculate MEs for A2, since we haven't done that yet 
 
 PCs2A = moduleEigengenes( 
 datExprHuman, colors=ratColors 
 );  
 ME_2A = PCs2A$eigengenes; 
geneModuleMembership2=signedKME(datExprHuman,ME_2A); 
colnames(geneModuleMembership1) 
=paste("PC",colorsRat,".cor",sep=""); 
 MMPvalue2=corPvalueStudent( 
 as.matrix(geneModuleMembership2),dim(datExprHuman)[[2]] 
 );  
 colnames(MMPvalue2)=paste("PC",colorsRat,".pval",sep=""); 
 
 kMEtable2 = cbind(Gene,Gene,ratColors);  
 for (i in 1:length(colorsRat)) 
 kMEtable2=cbind( 
 kMEtable2,geneModuleMembership2[,i],MMPvalue2[,i] 
 )  
 colnames(kMEtable2)=colnames(kMEtable1) 
 write.csv(kMEtable2,"kMEtable_rat_human.csv",row.names=FALSE) 
 
##Now that we have kME values for both networks, there are a few 
additional ways in which we can compare the resulting networks.  The 
first thing we can do is plot the kME values of each gene in A1 
against the corresponding kME values of each gene in A2. Modules 
with points showing a high correlation are highly preserved. 
 
##all genes  
 par(mfrow=c(4,3)) 
 for (c in 1:length(colorsRat)) 
 { 
 verboseScatterplot( 
 geneModuleMembership2[,c],geneModuleMembership1[,c], 
 main=colorsRat[c], xlab="kME in Human",ylab="kME in Rat") 
 }  
 
##Using all genes allows one to include all positively and 
negatively correlated genes, but often also includes a lot of noise 
 
#subset of genes originally assigned to a given module 
 par(mfrow=c(4,3)) 
 for (c in 1:length(colorsRat)) 
 { 
 inMod = ratColors== colorsRat[c]  
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 verboseScatterplot(geneModuleMembership2[inMod,c], 
 geneModuleMembership1[inMod,c],main=colorsRat[c], 
 xlab="kME in Human",ylab="kME in Rat") 
 } 
 
##Using only in-module genes is a visual way of assessing hub gene 
conservation: if these genes show between-set correlation, then the 
genes in the upper right of the plot are likely to be common hub 
genes between data sets. (Hub genes are genes that show significant 
correlation with MEs and high within-module connectivity and will be 
discussed below.) 
#The second thing we can do is determine which genes are hubs in 
both networks by determine which genes have extremely high kME 
values in both networks. 
 topGenesKME=NULL; 
 for(c in 1:length(colorsRat)) 
 { 
 kMErank1=rank(-geneModuleMembership1[,c]) 
 kMErank2=rank(-geneModuleMembership2[,c]) 
 maxKMErank=rank(apply(cbind(kMErank1,kMErank2+.00001),1,max)) 
 topGenesKME=cbind(topGenesKME,Gene[maxKMErank<=20]) 
 } 
 colnames(topGenesKME)=colorsRat; 
 topGenesKME; 
 consensus.hubs<-as.data.frame(topGenesKME); 
write.csv(consensus.hubs,file="CONSENSUS_HUBS_rat_human.csv",row.nam
es=FALSE) 
 
##These genes represent the top 20 genes per module based on kME in 
both networks. 
 
 
############################################# 
##PHENOTYPIC DATA ASSOCIATIONS WITH SPECIES NETWORK MODULES 
############################################# 
###LOAD IN THE PHENOTYPIC DATA############### 
############################################# 
##Prepared binary matrix of sample membership of defined phenotypic 
groups – pData.csv for the species 
 
 setwd("/Users/xxx/working_directory") 
 traitData<-read.csv("pData.csv") 
 Traits=vector(mode="list",length=nSets) 
 for(set in 1:nSets) 
 { 
 setSamples=rownames(multiExprA[[set]]$data); 
 traitRows=match(setSamples,traitData$Sample); 
 Traits[[set]]=list(data=traitData[traitRows,-1]); 
 rownames(Traits[[set]]$data)=setSamples; 
 } 
 collectGarbage() 
 
################################################################ 
##Let's look at the phenotypic data for the rat modules######### 
################################################################ 
##require: datExprRat, pData 
 dim(datExprRat) 
#[1]  170 5278 
 traitData = read.csv("pData.csv") 
 allTraits = traitData 
 ratSamples<-rownames(datExprRat) 
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 traitRows<-match(ratSamples,allTraits$Sample) 
 datTraits<-allTraits[traitRows,-1] 
 rownames(datTraits)<-ratSamples 
 head(datTraits) 
 
#Recalculate MEs with color labels 
 nGenes = ncol(datExprRat) 
 nSamples = nrow(datExprRat) 
 MEs0 = moduleEigengenes(datExprRat,ratColors)$eigengenes 
 MEs = orderMEs(MEs0) 
 moduleTraitCor = cor(MEs, datTraits, use = "p"); 
 moduleTraitPvalue = corPvalueStudent(moduleTraitCor, nSamples) 
 textMatrix=paste(signif(moduleTraitCor,2), 
 "\n(",signif(moduleTraitPvalue,1),")", 
 sep = "")  
 dim(textMatrix) = dim(moduleTraitCor) 
 dev.new() 
 par(mar = c(6, 8.5, 3, 3)) 
 
 labeledHeatmap(Matrix = moduleTraitCor, 
             xLabels = names(datTraits), 
             yLabels = names(MEs), 
             ySymbols = names(MEs), 
             colorLabels = FALSE, 
             setStdMargins=FALSE, 
             cex.lab=0.8, 
             colors = blueWhiteRed(50), 
             textMatrix = textMatrix, 
             cex.text = 0.8, 
             zlim = c(-1,1), 
             main = paste("Module-trait relationships")) 
 
  
################################################################ 
##Let's look at the phenotypic data for the human modules######### 
################################################################ 
##require: datExprHuman, pData 
 dim(datExprHuman) 
#[1]  166 5278 
 traitData = read.csv("pData.csv") 
 allTraits = traitData 
 humanSamples<-rownames(datExprHuman) 
 traitRows<-match(humanSamples,allTraits$Sample) 
 datTraits<-allTraits[traitRows,-1]   
 rownames(datTraits)<-humanSamples  
 head(datTraits) 
 
#Recalculate MEs with color labels 
 nGenes = ncol(datExprHuman) 
 nSamples = nrow(datExprHuman) 
 
 MEs0 = moduleEigengenes(datExprHuman,humanColors)$eigengenes 
 MEs = orderMEs(MEs0) 
 
 moduleTraitCor = cor(MEs, datTraits, use = "p"); 
 moduleTraitPvalue = corPvalueStudent(moduleTraitCor, nSamples) 
 
 textMatrix=paste( 
 signif(moduleTraitCor, 2), 
 "\n(", signif(moduleTraitPvalue, 1), 
  ")", sep = "")  
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 dim(textMatrix) = dim(moduleTraitCor) 
 dev.new() 
 par(mar = c(6, 8.5, 3, 3)) 
 
 labeledHeatmap(Matrix = moduleTraitCor, 
             xLabels = names(datTraits), 
             yLabels = names(MEs), 
             ySymbols = names(MEs), 
             colorLabels = FALSE, 
             setStdMargins=FALSE, 
             cex.lab=0.6, 
             colors = blueWhiteRed(50), 
             textMatrix = textMatrix, 
             cex.text = 0.6, 
             zlim = c(-1,1), 
             main = paste("Module-trait relationships")) 
 
##plotting the MDS might help define the groups 
 
###Correlations with the phenotypic data are only moderate at best 
r=0.5 and this may reflect the very diverse data that we see.  As 
such we should consider the consensus data.   
 
 
###MODULE/TRAITS FOR CONSENSUS NETWORKS 
 
##CONSENSUS MODULES 
######Relating consensus modules to external microarray sample 
information  
 
##set up variables to contain the module_trait correlations – choose 
correct multiExpr for rat or human 
 exprSize=checkSets(multiExprA); 
 moduleTraitCor=list() 
 moduleTraitPvalue=list() 
 #caluculate the correlations 
 for(set in 1:nSets) 
 { 
 moduleTraitCor[[set]]=cor(
 consME_A[[set]]$data,Traits[[set]]$data,use="p"); 
moduleTraitPvalue[[set]]=corPvalueFisher(moduleTraitCor[[set]],e
xprSize$nSamples[set]); 
 } 
 
#We now display the module-trait relationships using a color-coded 
#table.  Print the correlations and the corresponding p-values, abd 
#colour-code the entries by the p-value significance. 
 
##convert the numerical labels to colors for labelling of modules in 
the plot 
MEColors<-labels2colors( 
as.numeric(substring(names(consME_A[[set]]$data),3))); 
 MEColorNames<-paste("ME",MEColors,sep=""); 
 sizeGrWindow(10,7) 
 
####################################################################
#Plot the module-trait relationship table for set number 1 (Rat) 
####################################################################
## 
 set=1 
 textMatrix=paste(signif( 
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 moduleTraitCor[[set]],2), 
 "\n(",signif(moduleTraitPvalue[[set]],1), 
 ")",sep=""); 
 dim(textMatrix)=dim(moduleTraitCor[[set]]) 
 par(mar=c(6,8.8,3,2.2)) 
 labeledHeatmap(Matrix=moduleTraitCor[[set]], 
    xLabels=names(Traits[[set]]$data), 
    yLabels=MEColorNames, 
    ySymbols=MEColorNames, 
    colorLabels=FALSE, 
    colors=blueWhiteRed(50), 
    textMatrix=textMatrix, 
    setStdMargins=FALSE, 
    cex.text=0.5, 
    zlim=c(-1,1), 
    main=paste( 
    "Module—traitrelation ships in", 
    setLabels[set])); 
       
####################################################################
#Plot the module-trait relationship table for set number 2 (Human) 
####################################################################
## 
 set=2 
 textMatrix=paste(signif(moduleTraitCor[[set]],2), 
 "\n(",signif(moduleTraitPvalue[[set]],1), 
 ")",sep=""); 
 dim(textMatrix)=dim(moduleTraitCor[[set]]) 
 par(mar=c(6,8.8,3,2.2)) 
 labeledHeatmap(Matrix=moduleTraitCor[[set]], 
    xLabels=names(Traits[[set]]$data), 
    yLabels=MEColorNames, 
    ySymbols=MEColorNames, 
    colorLabels=FALSE, 
    colors=blueWhiteRed(50), 
    textMatrix=textMatrix, 
    setStdMargins=FALSE, 
    cex.text=0.5, 
    zlim=c(-1,1), 
    main=paste( 
    "Module--trait relationships in", 
    setLabels[set])); 
     
 
###There are several ways of forming a measure of module-trait 
relationships that summarize the two sets into one measure.  We will 
form a very conservative one: for each module -trait pair we take 
the correlation that has the lower absolute value in the two sets if 
the two correlations have the same sign, and zero relationship if 
the two correlations have opposite signs: 
 
# Initialize matrices to hold the consensus correlation and p-value 
consensusCor=matrix(NA,nrow(moduleTraitCor[[1]]), 
ncol(moduleTraitCor[[1]])); 
consensusPvalue=matrix(NA,nrow(moduleTraitCor[[1]]), 
ncol(moduleTraitCor[[1]])); 
# Find consensus negative correlations 
 negative = moduleTraitCor[[1]] < 0 & moduleTraitCor[[2]] < 0; 
consensusCor[negative]=pmax(moduleTraitCor[[1]][negative], 
moduleTraitCor[[2]][negative]); 
consensusPvalue[negative]=pmax( 
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moduleTraitPvalue[[1]][negative], 
moduleTraitPvalue[[2]][negative]); 
# Find consensus positive correlations 
 positive = moduleTraitCor[[1]] > 0 & moduleTraitCor[[2]] > 0; 
consensusCor[positive]=pmin(moduleTraitCor[[1]][positive], 
moduleTraitCor[[2]][positive]); 
 consensusPvalue[positive]=pmax( 
moduleTraitPvalue[[1]][positive], 
moduleTraitPvalue[[2]][positive]); 
 
##we display the consensus module-trait relationships again using a 
color-coded table: 
 textMatrix=paste( 
 signif(consensusCor,2),"\n(", 
 signif(consensusPvalue,1),")",sep=""); 
 dim(textMatrix)=dim(moduleTraitCor[[set]]) 
 par(mar=c(6,8.8,3,2.2)); 
 labeledHeatmap(Matrix=consensusCor, 
    xLabels=names(Traits[[set]]$data), 
    yLabels=MEColorNames, 
    ySymbols=MEColorNames, 
    colorLabels=FALSE, 
    colors=blueWhiteRed(50), 
    textMatrix=textMatrix, 
    setStdMargins=FALSE, 
    cex.text=0.5, 
    zlim=c(-1,1), 
   main=paste( 
   "consensus module-trait relationships across\n", 
    paste(setLabels,collapse="and")) 
    ) 
 
############################################################# 
#REPEAT ANALYSIS USING LIVER META-MATRIX AGAINST HUMAN OR RAT 
#DATA######################################################## 
 
######Principal Component Analysis of complete merged data sets 
#used datExprHuman or datExprRat 
library(FactoMineR) 
 
 res.pca<-PCA(datExprHuman,graph=FALSE,axes=c(1,2)) 
 PC1 <- res.pca$ind$coord[,1] 
 PC2 <- res.pca$ind$coord[,2] 
##Select appropriate species groupings 
##Human  
condition<-c( 
rep("alginate",26), 
rep("Monolayer",9), 
rep("Foetal Normal",3), 
rep("FoetalDysplastic",8), 
rep("Tendon Non-lesional",23), 
rep("Tendon Lesional",23), 
rep("Cartilage",16), 
rep("Differentiating",6), 
rep("OA",23),rep("Cartilage",3), 
rep("OA",3), 
rep("Differentiating",15), 
rep("Foetal Normal",5), 
rep("Cartilage",3)) 
 
##Rat 
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 #condition<-c( 
 #rep("alginate",26), 
 #rep("Monolayer",9), 
 #rep("Foetal Normal",3), 
 #rep("Foetal Dysplastic",8), 
 #rep("Normal",23), 
 #rep("Perturbed",23), 
 #rep("Normal",16), 
 #rep("Differentiating",6), 
 #rep("Perturbed",23), 
 #rep("Normal",3), 
 #rep("Perturbed",3), 
 #rep("Differentiating",15), 
 #rep("Foetal Normal",5), 
 #rep("Normal",3)) 
 
 tissue<c( 
 rep("chondrocytes",46), 
 rep("tenocytes",46), 
 rep("chondrocytes",74)) 
 
 
 condition<-as.data.frame(condition) 
 tissue<-as.data.frame(tissue) 
 PCs <- data.frame(cbind(PC1,PC2,condition,tissue)) 
 PCA.comp1<-res.pca$eig[1,2] 
 PCA.comp2<-res.pca$eig[2,2] 
  
library(ggplot2) 
library(RColorBrewer) 
  
 mypalette<-brewer.pal(7,"Accent") 
mypalette<c("lightsteelblue1","goldenrod3","grey27","orange1","g
rey0","midnightblue","firebrick1") 
  
p2<-ggplot(PCs) 
 p2<p2+geom_point( 
 aes(PC1,PC2,color=condition,shape=tissue), 
 size=6,alpha=0.4)  
 +scale_colour_manual(values=mypalette) 
 +labs(list(x=sprintf("PC1(%.1f%%)",PCA.comp1), 
 y=sprintf("PC2(%.1f%%)",PCA.comp2))) 
 +theme_minimal(base_size=10,base_family="Helvetica") 
 +theme(legend.position="bottom",text=element_text(size=12), 
 plot.title=element_text(lineheight=.8)) 
+ggtitle("Human Cartilage|Tendon Meta-Set\nPrincipal Component 
Analysis") 
 +scale_shape_discrete(solid=T) 
p2 
 
####################################################################
#Export network topology to Cytoscape for visualization#############  
#################################################################### 
##Choose topological overlap matrix (TOM) for rat or human and 
replace as appropriate 
 
 TOM.human= TOMsimilarityFromExpr(datExprHuman, power = 7); 
 TOM.rat= TOMsimilarityFromExpr(datExprRat, power = 7); 
# Read in the annotation file 
 load("Rat_to_Human_annotations.RData") 
#Select modules 
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 modules =c("green");  ##create vector of modules 
c("green","yellow") 
#Select module probes 
 probes = names(datExprHuman) 
 inModule = is.finite(match(humanColors, modules)); 
 modProbes = probes[inModule]; 
modGenes=annotation2$external_gene_id[match(modProbes, 
annotation2$hsapiens_homolog_ensembl_gene)] 
# Select the corresponding Topological Overlap 
 modTOM = TOM.human[inModule, inModule] 
 dimnames(modTOM) = list(modProbes, modProbes) 
 
 cyt = exportNetworkToCytoscape( 
 modTOM, 
   edgeFile=paste("CytoscapeInput-edges", 
 paste(modules,collapse="-"),".txt", sep=""), 
   nodeFile = paste("CytoscapeInput-nodes-",  
 paste(modules, collapse="-"), ".txt", sep=""), 
   weighted = TRUE, 
   threshold = 0.02, 
   nodeNames = modProbes, 
   altNodeNames = modGenes, 
 nodeAttr = humanColors[inModule]) ##or NULL 
 
save(TOM.rat,TOM.human,file="TOM_for_CYTOSCAPE.RData") 
 
 
 
 
 
 
 
 
 
 
 
[END] 
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!
6 :  De-novo  sequenc ing  and labe l -
f ree  quant i f i ca t ion of  prote ins  
f rom car t i l age  and tendon ce l l s   
 
Abstract 
The complex anionic matrix surrounding chondrocytes and tenocytes in vivo poses 
considerable technical problems in mass spectrometry proteomic surveys of 
cartilage and tendon.  Highly abundant proteins dominate profiles, limit the depth 
of coverage and, therefore, can result in critical loss of data necessary for 
integration with transcriptomic data.  In parallel with a transcriptome profiling 
study a proteomic survey of matrix-depleted chondrocytes and tenocytes was 
undertaken using a tandem mass-spectrometry label-free quantification approach. 
The study returned a depth of coverage for proteins exceeding those found in 
contemporary publications considering cartilage and tendon. Moderate expression 
correlation was found with Affymetrix transcriptomic data, including functional 
annotations and pathway topology analysis.  Anti-correlated elements were also 
defined including the ROCK-inhibitor CHORDC1 revealing regulatory aspects 
the systems profiled.    
Three-dimensional culture systems were found to express high levels of proteins 
associated with oxidative phosphorylation and mitochondrial function.  Fibrin and 
alginate cultures presented 1390 overlapping proteins including chondrogenesis-
associated protein osteoactivin (GPNMB).  Signalling through the PI-3K/Akt and 
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PPAR peroxisome pathways were also predicted in alginate bead cultures from 
protein abundance.   
Given the role of oxidative stress in cartilage pathology and oxidative 
phosphorylation in stem cell differentiation and self-renewal this study contributes 
to a wider understanding of the response to three-dimensional model culture 
systems of cartilage and tendon cells.  Furthermore, peri-cellular matrix depletion 
aids the depth of coverage in both tendon and cartilage proteomic discovery 
studies.      
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6.1: Introduction 
 
6.1.1: General approaches in mass spectrometry  
Investigators face a trade-off in proteomics studies between achieving maximum 
depth, or coverage, of sample analysis and retaining the in situ complexity of the 
sample.  This complexity may relate to the large numbers of proteins present 
and/or the structural components, e.g. extra-cellular matrix, that introduces 
additional obstacles related to sample handling.  There is a loss of connectivity, or 
‘chain of evidence’, between the original sample and the final peptide profile 
wherever there is more than one protein present due to sample losses and 
sensitivity of detection. The ability to robustly define large numbers of proteins 
from peptide mass fingerprints derived from sample proteolysis has been a key 
break-through in high-throughput proteomics (Thiede, Höhenwarter et al. 2005).    
Once solubilized, protein fractions are complex mixtures within which the 
dynamic range of protein abundance is manifold (Bantscheff, Lemeer et al. 2012), 
from moles to attamoles. Complex protein mixtures cannot be analysed efficiently 
and some form of resolving process, or separation methodology, is required.  
Traditionally gel-electrophoresis was used to separate proteins by charge and/or 
mass; resolved protein bands could be cut out of the gel, digested and the resultant 
peptides analysed by mass spectrometry (MS).  
In the contemporary mass spectrometry work-flow MS instruments are coupled 
directly to high-performance liquid chromatography (LC) columns. The input to 
these columns is a peptide mixture derived from digestion of the original sample 
by an enzyme(s), for example trypsin.  Flow through the column(s) is retarded by 
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various fractionation methods (ion exchange, isoelectric focusing) thereby 
reducing the complexity of the peptide mixture before it elutes into the MS 
instrument.  The elution of peptides over time is a key feature in ensuring 
comparability between samples on the same run (Deutsch, Lam et al. 2008). Once 
eluted into the instrument the peptides are ionized in an instrument-dependent 
manner: either electrospray ionisation (ESI) or matrix-assisted laser desorption 
ionisation (MALDI).    
Tandem mass spectrometry, often referred to as MS/MS, now allows the high-
throughput analysis and identification of peptides.  Discovery surveys of the 
proteome are crudely referred to as ‘shot-gun’ proteomics indicating the often 
hypothesis-free nature of these profiling studies.  Intact ionised peptides that are 
injected into the instrument have an initial precursor ion scan, which results in a 
peak in the MS reading.  Dynamically, the instrument selects precursor peptides, 
these are isolated and then subjected to collision fragmentation; the numerous 
resultant fragment ions for each precursor peptide produce the tandem MS spectra 
raw data files.  This output leads on to the bioinformatics techniques, such as de 
novo sequencing, used to assimilate and infer the composition of the original 
protein mixture.    
6.1.2: Discovery projects: comprehensive proteome coverage and 
quantification in mass spectrometry 
Comprehensive proteome coverage is essential where different experimental 
variables are being considered to ensure adequate overlap in the profiles, however, 
a judgement on the completeness of coverage is not straightforward and may 
require preliminary studies to define optimal conditions for maximal protein 
discovery, i.e. coverage saturation.  This may require multiple technical, as well as 
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biological, replicates.  In reality comprehensive projects are likely to define 50-70% 
of the proteome predicted from gene models (Beck, Claassen et al. 2011).  Given 
the advances in liquid chromatography and improved sensitivity of MS 
instruments and data acquisition modern LC-MS systems have the capability to 
identify and quantify in the region of 5,000-10,000 proteins from a given sample 
(Bantscheff, Lemeer et al. 2012).  
Whether a protein is detectable is related to a number of technical and biological 
variables including: sample handling in a manner compatible with MS; solubility 
and digestion protocols; searches of databases with accurate annotation, and any 
additional post-translational modifications (PTMs) that can result in mismatches 
or false negatives if unidentified; finally, proteins may not be transcribed or 
translated within a particular condition.  It is pertinent to point out that in MS 
studies the absence of evidence for a protein’s presence is not evidence for its 
absence (Beck, Claassen et al. 2011).  Correlation between protein abundance and 
gene expression data is only moderate (Thiede, Höhenwarter et al. 2005) and this 
uncoupling between the transcriptome and proteome reflects the different 
processing rates of degradation and stability between the different levels of the 
biological hierarchy (Beck, Claassen et al. 2011, Payne 2015).  Additionally, the 
accurate and reproducible measurement of both mRNA and protein (de Sousa 
Abreu, Penalva et al. 2009), mRNA sequence signatures (Vogel, Abreu et al. 2010) 
and time-delay components (Wang, Wang et al. 2010) all contribute to the 
explanation for the variation between transcriptome and proteome profiles. 
There are a number of options for defining differential abundance between 
samples with each having critical advantages limitations. Those most commonly 
used involve either metabolic (e.g. SILAC) or chemical labeling (e.g. iTRAQ), 
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spiked standards (QconCAT) or label-free methods (e.g. spectral counts, relative 
intensity) (Bantscheff, Schirle et al. 2007, Bantscheff, Lemeer et al. 2012).  In this 
study only label-free relative intensity quantification is used where the direct mass 
spectrometric signal of a peptide precursor ion derived from a particular protein is 
compared to the equivalent in other samples and conditions.     
6.1.3: Key issues in cartilage and tendon proteomics 
Although not explicitly stated many of the issues arising in cartilage proteomics 
may be extrapolated to tendon samples. In general, all studies suffer from under-
representation of low abundance proteins due to the massive dynamic range in 
mixtures; high abundance proteins overwhelm the analysis and obscure other 
relevant, but less abundant components.  Pre-fractionation of samples, for 
example dialysis with molecular weight cut-off filters, differential extraction of 
cellular compartments (Rockstroh, Müller et al.) and/or the depletion of highly 
abundant proteins, e.g. serum albumin, hyaluron, globins etc., is critical to 
improving the depth, or coverage, of analysis (Wilson, Whitelock et al. 2009).  
Enrichment of low-abundance proteins can be achieved by equalization of protein 
abundance in a sample with diverse hexapeptides bound to silica beads; unbound 
abundant proteins, which have saturated binding sites on beads, are washed away, 
whilst low abundance proteins are concentrated, thereby reducing the dynamic 
range of the samples (Boschetti and Righetti 2008, Millioni, Tolin et al. 2011).   
6.1.4: Peri-cellular matrix  
As defined above proteomic surveys benefit from a reduction in the complexity of 
the samples.  In terms of reducing the complexity of samples from cartilage and 
tendon the peri-cellular matrix (PCM) (defined in Chapter 1) needs to be 
considered in addition to the general extra-cellular matrix.  Furthermore, the peri- 
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and extra-cellular matrix of monolayer and model culture systems needs to be 
considered if matrix-reduction strategies targeted at native tissues are used. 
Depletion of the PCM, beyond reducing the sample complexity, would reduce the 
highly anionic network surrounding the cell that can impede LC resolution, ensure 
changes in abundance are more comparable across samples, improve sensitivity of 
detection for low abundance proteins and remove the requirement for choatropic 
agents used to improve the solubility of collagenous samples.   
The peri-cellular matrix of the chondrocyte must be considered as an autonomous 
transducer of biochemical and biomechanical signals from out with the 
chondrocyte and is considered distinct from the extra-cellular or territorial matrix 
(Wilusz, Sanchez-Adams et al. 2014).  The PCM is a narrow cloak that aggregates a 
number of chondrocytes into a structure termed a ‘chondron’, first described by 
Bennighoff almost a century ago (Benninghoff 1925). Unlike the ECM the PCM is 
directly anchored to the plasma membrane (McLane, Chang et al. 2013) and 
extends variably, up to 20µm, from the cell surface.  The peri-cellular matrix of 
tenocytes has been previously discussed in this thesis (Ritty, Roth et al. 2003).  
The composition of the PCM is predominantly type VI collagen, but additionally 
aggrecan, hyaluron, perlecan, biglycan and type IX collagen are present; these 
create a capsular mesh within which the chondrocytes reside. In a proteomic 
analysis of the PCM Zhang, et al (2011) defined the presence of three type VI 
collagen chains, transforming growth factor-beta induced protein (TGF-βI), 
ADAM28 and latent-transforming growth factor beta-binding protein 2 (LTBP2) 
(Zhang, Jin et al. 2011).  As such, the PCM represents an enriched corona of large, 
negatively charged proteoglycans and collagen that would require to be depleted to 
further reduce the complexity of chondrocyte samples.   
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Using particle exclusion assays McLane, et al (2013) found that the PCM 
meshwork was variable in size. The high water content means that the PCM is not 
visible using phase-contrast microscopy, and is easily damaged by histochemical 
techniques (McLane, Chang et al. 2013).  
The various enzymes used to digest extra- and peri-cellular matrix have different 
specificities; dispase, for example, does not cleave type VI collagen (Kielty, Lees et 
al. 1993, Lee, Poole et al. 1997) and was used by Zhang, et al (2011) to 
differentially digest cartilage and retrieve chondrons (Zhang, Jin et al. 2011).  
Pronase effects, in contrast, are directed at proteoglycans in the extracellular 
matrix exposing the collagen fibrils rendering them more susceptible to 
subsequent collagenase digestion (Kuettner, Pauli et al. 1982).  In Kuettner, et al 
(1982) a final single-cell suspension is obtained by the inclusion of a 0.25% trypsin 
digest subsequent to pronase (0.1%) and collagenase (0.4%).  Others have used 
hyaluronidase to deplete peri-cellular hyaluron (Nishida, Knudson et al. 2003),  a 
major component of the PCM (McLane, Chang et al. 2013).   
6.1.5: Study Aims 
Although representing a critical interface between the cell and the extra-cellular 
matrix the PCM coats the cell surface in an anionic mesh, which was hypothesized 
to influence the complexity of the cartilage and tendon samples. 
In order to establish a coherent and comprehensive understanding of the changes 
in cellular protein abundance during environmental transitions to monolayer and 
three-dimensional model cultures a discovery survey of the chondrocyte and 
tenocyte proteome was undertaken using primary isolated cells, passage three cells 
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from monolayer and cells from three-dimensional cultures.  This was undertaken 
in parallel to a transcriptomic survey of the same conditions (Chapter 3).   
It was proposed that by depleting extra- and peri-cellular matrix components a 
greater coverage of the proteome would be possible and low abundance proteins 
would be identified, thereby extending the current understanding of protein 
expression in these tissues.  Furthermore, by performing the analysis in parallel 
with a gene expression study validation of differentially expressed elements would 
be possible across two high-throughput platforms and rational targets and markers 
could be identified using bioinformatics techniques.   
This study sought to establish an optimal peri-cellular depletion method, maximize 
cell yield from small tissue volumes, enrich low-abundance proteins and 
demonstrate consistent differential protein abundance across replicated samples.   
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6.2: Methods 
 
6.2.1: Preparatory studies to define optimal matrix-depletion protocol 
 
Sample origins 
Cartilage and tendon from eight week old, male Lewis rats (n=3, 289 ± 4 g) were 
obtained under the previously described conditions (section 2.2.1). Cartilage 
samples were derived from either pooled hip and knee cartilage or pooled 
shoulder cartilage.  Tendon samples were derived from tail tendon or pooled 
Achilles and deep flexor tendon samples from the fore- and hind-limb.  For 
preparatory studies isolated cells were defined as either native, monolayer or 
model culture as described in section 3.2.1 and Figure 3.2.  Monolayer, alginate 
and fibrin samples were prepared as before, with the exception of the addition of 
20.4 mM CaCl2 to reagents used to re-suspend lyophilized thrombin according to 
Wang, et al (1995) (Wang, Pins et al. 1995).   
Sample handling 
The preparation, handling and storage of samples was made with respect to 
minimizing loss of peptides, with glass and low-adsorption plastic tubes used in 
preference to standard plastics where possible (Kraut, Marcellin et al. 2009, 
Goebel-Stengel, Stengel et al. 2011) 
Peri-cellular matrix digestion protocols 
Tissue dissection was undertaken on sterilized glass Petri dishes.  Tissue was 
washed in warmed PBS; cartilage was ground using glass mortar and pestle; 
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tendon samples were minced as before. Tissue underwent one of two digestion 
protocols:  
a) Shoulder cartilage or tail tendon - standard 0.4% collagenase type II 
(Worthington, as before) for > 12 hours at 37 °C in media free of serum and 
phenol-red;  
b) Pooled hip and knee or Achilles and DDFT - ‘triple digest’ protocol, consisting 
of 60 minute sequential digests of: 0.1% (w/v) pronase E (protease from 
Streptomyces, > 3.5 U/mg, Sigma, #P8811), 0.4% collagenase type II, 5 U/mL 
hyaluronidase (400-1000U/mg Type I-S, from bovine testes, Sigma, #H3506). 
A third method consisting of 0.4% collagenase type II (> 12hrs) followed by 
0.25% trypsin (trypsin from bovine pancreas, >10,000 BAEE units/mg, Sigma, 
#T1426) (90mins) was also used as a development of the first protocol.  All 
enzymatic solutions were filter sterilized.  The triple digest protocol was also 
applied to cell pellets from monolayer and model cultures.  Each step was 
performed at 37 °C in a shaking incubator. Between each digest step samples were 
centrifuged at ~500 x g for eight minutes and the resultant supernatant was 
discarded.  After the final digest samples were washed and centrifuged in warmed, 
sterile PBS. Cell count, particle exclusion assay (below) and trypan-blue viability 
assays were performed on all samples. All protocols were otherwise performed in 
a cell-culture flow hood to maintain sterility and reduce keratin contamination.   
Protein extraction and resolution  
Isolated cells were washed twice in warmed PBS, passed through a 70 µm strainer 
to produce a single-cell suspension, pelleted, then re-suspended in 0.5 mL PBS and 
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EDTA-free protease inhibitor cocktail (cOmplete ULTRA Mini, Roche) and 
transferred to LoBind tubes (Eppendorf AG., Germany).  Protein samples were 
snap-frozen in liquid nitrogen and stored at -80 °C until required.  For each 
tenocytes and chondrocyte sample 103 and 104 cells were stored respectively.  
Samples were stored in Eppendorf LoBind tubes and snap frozen and stored at -
80 °C until required.  Samples were defrosted and sonicated on ice (10 Hz, 50% 
power), three times for each sample with > 1 minute intervals between sonication 
events.  Sonicated samples were passed through 0.22 µm cellulose acetate spin 
columns (Spin-X, CoStar, Corning) to removed cellular debris as per the 
manufacturer’s recommendations.  Total protein concentration was estimated by 
photometric analysis at 650nm (Multiskan™ Microplate Spectrophotometer, 
Thermo Scientific) using the Pierce™ 660 nm Protein Assay (Pierce, Thermo 
Scientific), following the manufacturer’s guidelines, against a bovine serum 
albumin standard curve (range 2000-25 mg/mL) based on a polynomial equation 
raised to the third order.    To concentrate low protein yields from native and 
model culture samples 10 µg were concentrated using an hydroxylated silica slurry 
(StrataClean Resin, Agilent Technologies Inc.) according to the manufacturer’s 
guidelines and re-suspended in standardize volumes of loading buffer for gel 
electrophoresis.   
Gel electrophoresis and staining  
Concentrated samples, including silica beads, were re-suspended in 20 µL Laemmli 
(2% SDS) buffer with dithiothreitol (DTT).  Samples were denatured by heating to 
95 °C for ten minutes then loaded onto 4-12% polyacrylamide gels (NuPAGE® 
Novex® 4-12% Bis-Tris Protein Gels, Life Technologies) and electrophoresed 
under 200 V for thirty minutes in Tris/SDS buffer (pH 8.3).  Molecular weight 
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standards were run in parallel (Novex® Sharp Pre-stained Protein Standard, as 
before).   Gels were washed three times in ultra-pure water and fixed in a 30% 
ethanol|10% acetic acid solution for thirty minutes.  Silver staining was 
undertaken using the Pierce™ Silver Staining Kit (as before). 
Particle exclusion assay    
To demonstrate the absence of PCM around digested cells a particle exclusion 
assay (McLane, Chang et al. 2013) was performed on samples from the preliminary 
analysis using 7 µm microspheres (Carboxyl Latex Beads, 4% w/v, Life 
Technologies) instead of sheep erythrocytes.  Briefly, following digestion protocol 
cells were washed, pelleted and re-suspended in PBS.  Equal volumes (10 µL) of a 
cell suspension and microspheres were mixed and vizualised on a haemocytometer 
under a light microscope.  As the presence of the PCM excludes particles from 
abutting the cell, following digestion particles were anticipated to be in close 
apposition with the cell.   
6.2.2: LC-MS/MS and label-free quantification  
 
Study design and sample preparation  
Study design was comparable to that described in section 3.2.1.  Native, monolayer 
and three-dimensional cultures (n = 24, four biological replicates per condition, 
two tissues) were prepared in parallel with the microarray samples; proteomic 
samples were derived from independent biological replicates.  All samples, tissue, 
monolayer or model cultures all underwent digestion protocols to deplete extra- 
and peri-cellular matrix as described in 3.2.1 and Figure 3.2.  After digestion cells 
were washed once more in PBS, counted, pelleted and re-suspended in 1 mL 
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sterile PBS aliquots with the addition of protease inhibitors. Samples were stored 
at -80 °C in Protein LoBind tubes.  
Samples were thawed and held on ice for sonication. Chondrocyte cell suspensions 
were sonicated first in aliquots required to obtain 2.5 x105 cells (equivalent to 50 
µg protein at 200 pg/cell). Each aliquot was mixed on a vortex mixer and 
sonicated 3 x 10 s at 30% amplitude (delivered from a 3 mm probe of a Sonics 
Vibra Cell™, Jencons Scientific Ltd, UK) with 50 s rest time between pulses.  The 
probe was not washed between aliquots of the same sample but between samples. 
Sonicated samples were held on ice.   
Tryptic digestion 
For chondrocytes, a volume of sample equivalent to ~50 µg protein was added to 
10 µL of Strataclean Resin beads (as before) and the beads mixed for 1 min using 
a vortex mixer. The samples were centrifuged at 2,000 rpm for 2 min and 
supernatant removed and retained. For the native chondrocytes 1.25 mL of sample 
was added in the first round of mixing, followed by consecutive binding with a 
further 1.25 mL of sample. The beads were washed with 1 mL of 25 mM 
ammonium bicarbonate (AmBic) and re-suspended in 80 mL of 25 mM AmBic. 
Five millilitres of 1% (w/v) Rapigest (Waters, UK) was added to the samples 
which were heated for 10 min at 80 °C on a heating block with intermittent mixing 
(400 rpm/15 s on/off). Five millilitres of 9.2 mg/mL DTT was added and after 
brief mixing the samples were heated at 60 °C for 10 min. For the alkylation step 
5 mL of 33 mg/mL iodoacetamide was added and the samples held at room 
temperature in the dark for 30 min. Five millilitres of trypsin (0.2 mg/ mL in 50 
mM acetic acid; Promega Gold) was added and the sample tubes placed in a rotary 
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mixer at 37 °C. After 2 hrs the same amount of trypsin was added to the sample 
tubes, which were incubated overnight. 
The samples were pulse centrifuged and 1 mL of trifluoroacetic acid (TFA) added. 
Of the mixed digest 0.5 mL was spotted onto pH paper to confirm acidity. The 
samples were incubated in a heating block at 37 °C with intermittent mixing 
followed by centrifugation for 30 min at 7 °C. The supernatant digests were 
transferred to 0.5 mL low-bind tubes (as before) and centrifuged for a further 30 
min. 10 mL of each sample was transferred to total recovery vials for MS analysis. 
An SDS-PAGE gel of the digest was run and was clear of bands.  
For tenocytes, the maximum number of cells used for all samples was standardised 
to the native tenocyte sample with the smallest number of cells (130,000, ~26 µg 
protein).  Samples were processed as described above for chondrocytes.   
High resolution LC-MS/MS analysis 
One millilitre of digest (chondrocytes – 500 ng protein equivalent, ~ 250 ng for 
the tenocytes) was injected on-column and chromatographed over a 2 hr gradient 
using a method whereby following a survey scan at 70,000 resolution the top ten 
most abundant peptide ions are fragmented and measured at high resolution 
(35,000) in the Orbitrap analyser to a mass accuracy of 0.01 Da. Each replicate, 
n=12 per cell type, was eluted with 30 minutes wash stages/blank runs between 
conditions (native, monolayer, model cultures).  Chondrocyte and tenocyte 
samples were run on separate days.    
All peptide separations were carried out using an UltiMate® 3000 Nano LC system 
(Dionex, Thermo Fisher Scientific). For each analysis the sample was loaded onto 
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a trap column (Acclaim PepMap 100 Dionex, 2 cm x 75 µm inner diameter, C18, 3 
µm, 100 Å pore size) at 5 µL/min with an aqueous solution containing 0.1% (v/v) 
TFA and 2% (v/v) acetonitrile. After 3 min, the trap column was set in-line with 
an analytical column (Easy-Spray PepMap® RSLC 15cm x 75µm inner diameter, 
C18, 2µm, 100Å) (Dionex). Peptide elution was performed by applying a mixture of 
solvents A and B. Solvent A was high performance LC (HPLC) grade water with 
0.1% (v/v) formic acid, and solvent B was HPLC grade acetonitrile 80% (v/v) 
with 0.1% (v/v) formic acid. Separations were performed by applying a linear 
gradient of 3.8% to 50% solvent B over 95 min at 300 nL/min followed by a 
washing step (5 min at 99% solvent B) and an equilibration step (15 min at 3.8% 
solvent B).  
Mass spectroscopy 
Mass spectrometry was undertaken using a hybrid quadripole-Orbitrap mass 
spectrometer (Q Exactive™, Thermo Scientific) (Michalski, Damoc et al. 2011) 
operated in data dependent positive (ESI+) mode to automatically switch between 
full scan MS and MS/MS acquisition. Survey full scan MS spectra (m/z 300-2000) 
were acquired in the Orbitrap with 70,000 resolution (m/z 200) after accumulation 
of ions to 1x106 target value based on predictive automatic gain control (AGC) 
values from the previous full scan. Dynamic exclusion was set to 20 s. The ten 
most intense multiply charged ions (z ≥ 2) were sequentially isolated and 
fragmented in the octopole collision cell by higher energy collisional dissociation 
(HCD) with a fixed injection time of 120 ms and 35,000 resolution. Typical mass 
spectrometric conditions were as follows: spray voltage, 1.9 kV, no sheath or 
auxillary gas flow; heated capillary temperature, 250 °C; normalised HCD collision 
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energy 30%. The MS/MS ion selection threshold was set to 1 x 104 counts and a 2 
m/z isolation width was set. 
6.2.3: Bioinformatics  
All bioinformatics analysis was undertaken using raw data files (.XML).  Analysis 
of raw data, including de novo sequencing alignment, normalisation, peptide and 
protein identification, and label-free relative quantification was undertaken using 
the PEAKS software, under license (PEAKS®, version 7, Bioinformatics Solutions 
Inc., Waterloo, Canada).     
Tandem mass spectra were used for peptide identification using database 
dependent and independent methods.  Database dependent methods used query 
matching of experimental mass spectra against theoretical peptides generated from 
the Rattus norvegicus (UniProtKB, http://www.uniprot.org/taxonomy/10116) 
reference proteome sequence database (accessed June, 2014) containing 27,344 
entries (Magrane and Consortium 2011).   Both canonical and isoform sequence 
data was queried.   
The following search parameters were used: a) peptide mass tolerance, 10 ppm; b) 
fragment ion mass tolerance, 0.01 Da; c) peptide charge 1+,2+ and 3+; d) trypsin 
was selected as the specific cleavage agent; e) one missed cleavage was permitted.  
Permissible amino modifications were defined as, carbamidomethylation (fixed) 
and oxidation of methionine (variable).  Peptide sequences were also defined 
directly from MS/MS spectra by de novo sequencing. A database decoy-fusion 
method was used in PEAKS® and FDR was set at < 1%.  
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Protein identification, homology searching, PTM and mutations 
For all protein identifications using software modules within PEAKS® – de novo 
sequence, homology searching and post-translational modification/mutation 
analysis – the same filtering parameters were in place.  The false discovery rate was 
set at 0.1%, peptide score ≥ 25, protein score ≥ 20, ≥ 2 unique peptides and an 
average local confidence of ≥ 80% for de novo-only peptides.   
Label-free relative quantification and differential abundance 
Label-free relative quantification was undertaken using the PEAKS Q® 
quantification software based upon the peptide ratios derived from mass spectra 
peak areas.  The concomitant protein ratios were calculated from the top three 
unique peptide peak areas for a particular protein confidently detected in multiple 
samples from the same group.  Peptide features across multiple samples were 
aligned using a combinatorial model for feature matching including a high 
performance retention time alignment algorithm (Lin, He et al. 2013).   
Label-free quantification was undertaken within tissue groups and across all 
conditions or pairwise combinations of conditions as for the microarray studies. 
For all conditions the same parameters were used.  As chondrocyte and tenocyte 
studies were not performed in series these studies were not comparable.  Feature 
detection was performed separately on each sample, but relative intensities of 
peptide features were only calculated where features were detected in multiple 
samples.  To ensure stringency peptide features had to be present in four out of 
twelve samples (i.e. one condition).  For a protein to be called as significantly 
different between native, monolayer or model cultures a -10logP-score of 20 (the 
weighted sum of the –log10 P-scores of the supporting peptides and equivalent to 
a p-value of 0.01) and a fold change > 1 was set.  All other values were left as 
 471 
defaults.  Monolayer culture samples were used as the reference samples to centre 
the retention time alignment.  The total ion current (TIC) of the samples was used 
to calculate the normalisation factors; this was multiplied with the area of each 
feature for the calculation of a sample or group ratio.   
PEAKS Q® does not provide a confidence value for each log2 ratio for 
differentially abundant proteins.  To evaluate whether there was statistical evidence 
for differential abundance of identified proteins between groups the log2 ratios 
were exported to R and analysed using Limma (Smyth 2005), as before, section 
2.2.4.  The false discovery rate was determined by the Benjamini-Hochberg 
method (as before) and adjusted p-values were set at p < 0.05, log2 fold-change > 
1.4, and B statistic (log odds ratio) > 0 set as filtering thresholds for differential 
abundance as used previously (see Chapters 2 and 3).  Only proteins that passed 
this two-step filtering were considered to be differentially abundant between 
samples.    
Correlation of gene expression and protein abundance 
For the native to monolayer comparison Uniprot accession codes from proteins 
with differential expression were converted to Entrez identifiers and common 
gene symbols so that they were comparable with the Affymetrix gene expression 
data (Chapter 3).  These protein lists were then matched to the filtered, 
differentially expressed genes.  Duplicate entries were removed. The log2 fold-
change values were plotted and the Pearson’s product-moment correlation and 
95% confidence interval (CI) calculated for all elements and also for those which 
were only positively correlated.   
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General bioinformatics 
The use of bioinformatics tools for gene ontology functional annotation 
(DAVID), re-annotation (R packages), pathway topology analysis (SPIA), and 
graphical tools has all been described in Chapters 2 and 3.  Ingenuity® Pathway 
Analysis predictions of upstream regulators were based upon pairwise 
comparisons of filtered proteins with significant differential abundance.   
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6.3: Results 
 
6.3.1: Preparatory studies 
Preliminary studies sought to optimise protocols maximising cell harvests and 
protein yield for proteomics and to reduce the complexity of the samples by 
matrix depletion. In initial investigations total cell numbers harvested from 
cartilage were higher using the triple digest protocol of sequential pronase, 
collagenase and hyaluronidase (2.1 x106 ± 6.93 x105) compared to the extended 
collagenase digest alone (9.7 x105 ± 4.7x104), p = 0.02, but samples for each 
technique arose from different tissue locations.  The mean cell harvest from 
collagenase-digested tendon was 5.93 x105 ± 4.2x104 cells; comparison with the 
triple digest protocol was not possible due to the consistent finding of large 
cellular aggregates or ‘rafts’ associated with undigested fibrillar material that did 
not dissociate with gentle agitation.   
Total protein extracts were highly variable between replicates and were not 
significantly different between digest protocols. The protein profiles of native cells 
after each digestion protocol were compared to total protein extracts for 
monolayer and model cultures, Figure 6.1 and 6.2.  
To reduce the inter-sample variability in cell counts and total protein extracted the 
methodology was repeated and standardised for tissue source, tissue volume and 
cell numbers for protein extraction with respect to different matrix depletion 
protocols.  Additionally, to reduce the presence of undigested fibrillar material and 
cell aggregation a 90 minute 0.25% trypsin digest was performed after 20 hour 
0.4% collagenase type II digestion. Cartilage from the hip and knee from two rats 
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(249 ±35 g) were harvested and pooled (0.23 ± 7x10-3 g); tendon was pooled from 
DDFT and Achilles (0.14 ± 2.4 x10-2 g) and tissue digested using one of the two 
described protocols. 
Total protein was extracted from cell pellets of tenocytes (104) and chondrocytes 
(105) derived from each digestion protocol. Silver-stained PAGE is shown in 
Figure 6.3.  In general total protein yields were higher for extended collagenase 
and trypsin digested tissue (range: 64-69 µg/mL) compared to the shorter triple 
digest protocol (range: 47-55 µg/mL) on two replicates.  Total cell numbers were 
also greater in the longer digest period.     
In particle exclusion assays micro-beads were found in close apposition with cells 
liberated from tissue by either digestion protocol (Figure 6.4) indicating that in 
isolated cells the peri-cellular matrix was depleted rapidly.  Cell viability testing 
with trypan blue found that < 10% of cells stained positive in either methodology.   
Given that an extended digestion protocol consisting of sequential collagenase 
type II (0.4%) and trypsin (0.25%) resulted in improved cell harvests and was 
more practical for handling large numbers of samples this was elected as the most 
appropriate method for matrix depletion.   
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Monolayer chondrocytes 
Alginate chondrocytes 
Figure 6.1:  
CHONDROCYTES: Trans-illuminated, silver-stained, 4-12% polyacrylamide gel loaded with 10μg total protein resolved by electrophoresis.  Images show 
resolved proteins from either i) native chondrocytes ii) chondrocytes from monolayer at passage three, or iii) chondrocytes from alginate following either a 
standard collagenase digest (native chondrocytes) or an extended serial digest protocol, all samples (figure legend).  Native samples do not show the same 
complexity as samples from monolayer and alginate cultures.  Differential banding is evident between conditions, however, between the two digestion 
protocols shown for native samples there are few differential bands except at ~30kDa where a lower MW band is found in collagenase digested 
chondrocytes.  Within each condition there was reasonable reproducibility between biological replicates (n=3).  Monolayer and alginate culture samples were 
run on the same gel and efficiency of  the development of  silver-staining accounts for the over-exposure of  the monolayer samples.   
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Figure 6.2:  
TENOCYTES: Trans-illuminated, silver-stained, 4-12% polyacrylamide gel loaded with 10μg total protein resolved by electrophoresis.  Images 
show resolved proteins from either i) native tenocytes ii) tenocytes from monolayer at passage three, or iii) tenocytes from fibrin following either 
a standard collagenase digest (native tenocytes) or an extended serial digest protocol, all samples (figure legend).  Native samples do not show 
the same complexity as samples from monolayer and fibrin cultures.  Differential banding is evident between conditions, however, between the 
two digestion protocols shown for native samples there are few differential bands other than at ~30kDa as found in Figure 6.1.  Within each 
condition there was reasonable reproducibility between biological replicates (n=3).   
Triple digest 
Collagenase digest 
Molecular weight marker 
Figure legend 
Native tenocytes 
Monolayer tenocytes 
Fibrin tenocytes 
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Figure 6.3:  
Trans-illuminated, silver-stained, 4-12% polyacrylamide gel loaded with 10μg total protein resolved by electrophoresis. Samples represent two 
biological replicates.  Images show resolved proteins from either native chondrocytes (105 cells) or tenocytes (104 cells) following either a 0.4% 
collagenase type II/0.25% trypsin sequential digest (12 hours, plus 90 minutes) or a serial digest protocol (4x90 minutes, see Methods), figure 
legend.  Following extended digestion with collagenase and trypsin native chondrocytes and tenocytes show comparable protein bands.  In 
contrast chondrocytes following a shorter digestion protocol using multiple enzymes displayed differential banding patterns, for example at 
~15kDa.  Tenocytes derived from digestion using a shorter, serial digest protocol resulted in poor total protein yields. Using standardised cell 
numbers rather than relying on estimated protein concentration resulted in improved reproducibility between biological samples.     
Serial multi-enzyme digest 
Collagenase/Trypsin digest 
Molecular weight marker 
Native chondrocytes  
Native tenocytes  
Figure legend 
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A:  Chrondrocyte (x40) 
following:  
a) 0.1% pronase;  
b)0.4% collagenase;   
c) 50 U/mL hyaluronidase;  
d)0.25% trypsin, in 90mins 
sequential digests 
B:  Chondrocyte (x40) 
following  
a)  0.4% collagenase, 20hrs  
b) 0.25% trypsin, 90 min 
digest  
Figure 6.4: Particle exclusion assays permit the visualisation of  the translucent peri-cellular 
matrix (PCM) which surrounds both chondrocytes and tenocytes.  Where the PCM is present 
small particles are unable to abut the cells creating the impression of  a translucent corona.  
Using 7 µm (scale bars) latex micro-beads the presence of  the PCM after either a multi-
enzyme serial digest (A) or a two-stage (B) digestion technique could not be inferred as beads 
(arrows) were all closely associated with isolated cells, even following the first 90 minute 
digest.      
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6.3.2: Shot-gun proteomics study with label-free quantification 
 
Proteomics sample statistics 
The wet weight of cartilage and tendon harvested from samples (n = 12) was not 
significantly different (p = 0.06), however, significantly greater numbers of cells 
were isolated from cartilage (6.3x105 ± 1.5x105) relative to tendon (3.1x105 ± 
1.7x105), p = 3.5x10-5.  There was no statistical difference between the wet-weight 
of the cartilage or tendon tissue harvested for the microarray (Chapter 3) or 
proteomic samples.  
Base-peak ion chromatograms 
Representative base-peak ion chromatograms are presented in Figure 6.5 
(chondrocytes) and Figure 6.6 (tenocytes) derived from separate LC runs.  These 
demonstrated good qualitative comparisons between samples within an 
experimental group in terms of relative signal intensity and retention time. The 
chromatograms are scaled to the most abundant ions and demonstrate a large 
number of peaks across all samples over the whole period of analysis (two hours).  
A contaminant peak, possibly associated with protease inhibitors, was sharply 
defined at the end of each run (data not shown) and was most evident in samples 
where greater sample volumes were required for equivalent protein concentrations, 
i.e. native and model culture systems (data not shown).   
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 Figure 6.6:  Tenocytes Representative base-peak LC-MS ion 
chromatograms plotting the relative 
abundance/intensity of  the base 
peak in each spectrum (y-axis) over 
retention time (x-axis).   Peak 
annotations indicate the time (top 
value) and mass-to-charge ratio (m/z) 
(bottom value). The chromatogram is 
scaled to the most abundant ion.   
 
Vertical grid lines are provided to 
highlight common peaks and their 
differences across conditions.   
 
From top-bottom (Figure legend): A 
– Native tenocytes; B – fibrin 
tenocytes; C – monolayer tenocytes; 
D – native tenocytes (alternative 
replicate).    
Native tenocytes 
Monolayer tenocytes 
3D culture tenocytes 
Legend 
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Figure 6.6:  Tenocytes 
Representative base-peak LC-MS ion 
chromatograms plotting the relative 
abundance/intensity of  the base 
peak in each spectrum (y-axis) over 
retention time (x-axis).   Peak 
annotations indicate the time (top 
value) and mass-to-charge ratio (m/z) 
(bottom value). The chromatogram is 
scaled to the most abundant ion.   
 
Vertical grid lines are provided to 
highlight common peaks and their 
differences across conditions.   
 
From top-bottom (Figure legend): A 
– Native tenocytes; B – fibrin 
tenocytes; C – monolayer tenocytes; 
D – native tenocytes (alternative 
replicate).    
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Monolayer tenocytes 
3D culture tenocytes 
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MS/MS qualitative analysis and protein identification  
The total number of MS/MS spectra and peptide spectral matches to the rat 
Uniprot database are presented in Table 6.1.  In general there was considerable 
qualitative overlap between cells from the same condition, i.e. comparable proteins 
were identified.  Protein groups represent collections of ambiguous (shared) 
peptides assigned to multiple proteins as a result of sequence similarities in the 
Emsembl protein database.    
NATIVE CELLS     
For native cells 2206 (1591 protein groups) and 1872 (1302 protein groups) were 
defined for chondrocytes and tenocytes respectively.  This related to the 
identification of 540 (chondrocytes) and 237 (tenocytes) unique proteins between 
the native cells.  
MONOLAYER 
From passage three cells there were 2419 (chondrocytes) and 2154 (tenocytes) 
identified from 1762 and 1581 protein groups respectively.  As expected there 
were fewer proteins unique to either chondrocytes (386) or tenocytes (191) in the 
monolayer condition as compared to either native cells or three-dimensional 
culture conditions.   
MODEL CULTURES 
For model cultures 2597 (1875 protein groups) and 2441 (1762 protein groups) 
were defined for alginate and fibrin cultures respectively.  This related to 1959 
(alginate) and 1839 (fibrin) unique proteins of which 1390 were confidently 
identified in both alginate and fibrin model cultures.  Relative to fibrin cultures 
there were 569 unique elements found in alginate cultures; conversely 449 unique 
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elements were found in fibrin cultures. Complete protein identification lists are 
found in SD6.    
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 Condition MS 
Scans 
MS/MS 
Scans 
Identified Peptide 
Spectrum Matches 
Groups 
(SPIDER) 
Proteins 
(SPIDER) 
 
De novo only Without 
duplicate 
proteins 
Unique to 
condition  
Native chondrocytes  
 
44147 93267 53453 1591 (1632) 2206 (2258) 4743 1695 540 
Native tenocytes 49389 82174 43751 1302 (1326) 1872 (1904) 2973 1392 237 
Monolayer chondrocytes 41212 100689 66593 1762 2419 5302 1827 386 
Monolayer tenocytes  41967 98476 61254 1581 2154 5818 1632 191 
Alginate model cultures  46200    89925 58430 1875 2597 3537 1959 569 
Fibrin model cultures  40775 100605 62067 1762 1441 7737 1839 449 
Table 6.1: Qualitative assessment of  mass spectrometry data – database search parameters were the same for all analyses.  Filtering settings 
common to all conditions:  peptide FDR<0.1%; peptide -10logP score ≥25, protein -10logP score ≥20; proteins unique peptides≥2, de novo 
average local confidence ≥80%.  Homology search results from SPIDER algorithm in PEAKS shown in parentheses.  Unique to condition 
refers to a comparison of  identifiers between chondrocytes and tenocytes from native, monolayer or model culture groups.     
 
Table 6.2: Differential abundance statistics across a) chondrocyte study, b) tenocyte study.  Available study proteins – total number identified 
across all analysis at thresholds set in Methods.  Total differential abundance – remaining after statistical threshold filtering.  Only unique 
identifiers are retained for further functional analysis.  Higher/Lower – relative abundance in stated pairwise comparison.   
Comparison Available study proteins Total differential abundance Filtered (Unique) Higher Lower  
Native > Monolayer 1421   1031 937 158 780 
Monolayer > Alginate - 756 630 428 203 
Alginate > Native - 838 718 553 165 
a. 
Native > Monolayer 1402  926 835 72 763 
Monolayer > Fibrin - 884 806 384 422 
Fibrin > Native - 988 895 819 76 
b. 
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6.3.3: Label-free relative quantification  
 
Dimensionality reduction  
Principal component analysis of log2 ratios from either chondrocyte or tenocyte 
studies demonstrated strong clustering into three conditional groups: native cells, 
monolayer at passage three, and model cultures, Figure 6.7.  There was strong 
intra-condition correlation in relative protein abundance (>0.9) for each sample.   
Following filtering for differential abundance, samples were assessed by 
unsupervised hierarchical clustering, Figure 6.8 and 6.9.  Both chondrocyte and 
tenocyte studies clustered by condition.  For chondrocytes there was co-clustering 
between native chondrocytes and alginate cultures; native tenocytes co-clustered 
with monolayer tenocytes with fibrin constructs within a separate clade.  
Gene Ontology functional annotations 
Uniprot accession codes were re-annotated with unique Entrez gene identifiers 
and used to functionally annotate those proteins with significant differential 
abundance, Figure 6.8 and 6.9.   
Proteins more abundant in native chondrocytes were associated with biological 
process terms relating to ‘carbohydrate metabolic process’, ‘regulation of biological 
quality’ and ‘positive regulation of bone resorption’. 
Monolayer cells were abundant in proteins associated with ‘actin filament-based 
process’ and ‘cellular metabolic process’.  Three-dimensional model cultures were 
found to be enriched for terms associated with ‘oxidation reduction’ and 
‘generation of precursor metabolites and energy’.   
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Figure 6 .7 : P r inc ipa l 
Component Analysis –  
  
A: Chondrocytes:  
Plot based upon proteins 
with a log ratio >1 (fold-
change >2) using PEAKS Q 
software.  Correlations 
between samples within a 
condition (see figure legend) 
were all >0.9.  Conditions 
show strong clustering with 
~89% of  the data variation 
described by the first two 
principal components.   
 
 
 
 
 
 
 
 
 
 
 
B: Tenocytes -   
D a t a s o u r c e a s f o r 
chondrocytes.  First two 
p r i nc ip a l componen t s 
describe more than 90% of  
the variation in the data.  As 
with the chondrocyte data 
conditions cluster robustly 
into ‘native’, ‘monolayer’ 
and ‘fibrin’ groups.    
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Figure 6.8 : Heatmap – chondrocyte proteins defined as having significant differential 
abundance by PEAKS Q software (log2 ratios).  Conditions (columns) show distinct 
changes in protein abundance (rows).  Five groups are defined by a vertical line 
bisecting clades (row dendrogram) and proteins within these groups are functionally 
annotated using DAVID (FDR<0.01) – CC: Cellular component; BP: Biological 
process; MF: Metabolic function; KEGG – canonical pathway annotations.  Higher 
abundance is show red, lower by green (colour key) – heatmap is scaled by row.   
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Figure 6.9 : Heatmap – tenocyte proteins defined as having significant 
differential abundance by PEAKS Q software (log2 ratios).  Conditions 
(columns) show distinct changes in protein abundance (rows).  Three 
groups are defined by a line bisecting clades (row dendrogram) and 
proteins within these groups are functionally annotated using DAVID 
(FDR<0.01) – CC: Cellular component; BP: Biological process; MF: 
Metabolic function; KEGG – canonical pathway annotations. Higher 
abundance is show red, lower by green (colour key) – heatmap is scaled 
by row.    
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Differential abundance 
 
CHONDROCYTES: 
After filtering and the removal of duplicate entries there were 937 proteins 
considered to be differentially abundant between native and monolayer 
chondrocytes, Table 6.2a.  For native cells the most highly abundant proteins 
were dominated by erythrocyte-associated proteins: HBA, HBB, NOS2, LGALS5. 
Proteins related to extracellular matrix interactions including cartilage oligomeric 
matrix protein (COMP), chondroadherin (CHAD), integrin-binding sialoprotein 
(IBSP) and the collagens type II, alpha 1, and type XI, alpha 2, were more 
abundant in native chondrocytes.  Proteins with known osteoarthritis associations 
were also more abundant: 14-3-3 epsilon (YWHAE), inositol triphosphate 
receptor, type 2 (ITPR2) and tartrate-resistant acid phosphatase type 5 (ACP5).   
Monolayer chondrocytes at passage three were more abundant in proteins 
associated with actin filament-based processes, ACTN1, ITGB1 and debrin, and 
collagen fibril organization– annexin 2, collagen type III and V, and TGF-β2.  The 
proteins thrombospondin 2 and 4, the mesoderm development candidate 2 
(MESDC2), follistatin-like 2 (FSTL2) and CCN-family protein CCN2/connective 
tissue growth factor were also more abundant in monolayer culture than in native 
chondrocytes.  Full differential abundance lists for all pairwise comparisons are 
provided in SD6.  
Chondrocytes in alginate demonstrated higher relative abundance of 
chondrogenesis-associated proteins including the DCC (deleted in colorectal 
cancer) ligand netrin 1 (NTN1), transmembrane glycoprotein NMB/osteoactivin 
(GPNMB), and ADP-ribosyl cyclase 2 (encoded by bone marrow stromal cell 
antigen, BST1).  Other notable proteins were associated with oxidation-reduction 
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(COX2, MAOA, TRAP1, SOD2) and nitrogen compound metabolic processes 
(CHI3L1, STAT3).  
TENOCYTES: 
There were 835 proteins that were found to be differentially abundant between 
native tenocytes and monolayer, Table 6.2b.  Native tenocytes were represented 
by higher abundance of proteins associated with biological adhesion, cartilage 
oligomeric matrix protein, and the lysosomal integral membrane protein/LIMP2, 
encoded by SCARB2.  Other lysosome-associated proteins, LAMP1 and LAMP2, 
were also more abundant.  Proteins associated with lipid biosynthetic process, 
prostacyclin synthase (PTGIS) and the regulator of phosphatidylinositol levels 
phosphatidate cytidylyltransferase 2, encoded by CDS2, were found at higher 
levels in native tenocytes. 
In monolayer tenocytes proteins involved with the regulation of cytoskeletal 
organization and microtubule dynamics were more abundant including the 
integrin-linked kinase (ILK) and stathmin 1 (STMN1).  Actin filament-based 
processes were defined by the high abundance of debrin 1 (DBN1), integrin beta 1 
(fibronectin receptor beta) and myosin, light chain 6 in passage three tenocytes.   
As found with chondrocytes MAPK1 and MAPK3 mitogen activated protein 
kinases, associated with regulation of gene expression, were more abundant in this 
monolayer condition.   
Associated with tenocytes in fibrin culture was the higher expression the Bmp-
antagonist gremlin 1 (GREM1) and osteoactivin (GPNMB) relative to native 
tenocytes.  As with alginate cultures ‘oxidative phosphorylation’ was a significantly 
enriched functional annotation and was related to the higher abundance of PTGS1 
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and 2, MAOA and LEPREL1. The MSC marker THY-1/CD90, the fibronectin 
receptor integrin beta 1 and transforming growth factor, beta induced (TGF-βI), 
and catenin, beta 1 (CTNNB1) were all found at higher levels in fibrin constructs.  
The overlap of differentially abundant proteins between the chondrocyte and 
tenocyte studies is presented in Figure 6.10.  Tenocytes and chondrocytes shared 
differential abundance of 501 proteins in the comparison between native cells and 
monolayer.  Fewer proteins were common to both cell types when the comparison 
between native cells and those in model cultures was made, 304 proteins.  This is 
consistent with the divergence of alginate and fibrin cultures shown in the 
Affymetrix gene expression profiles in Chapter 3.     
Pathway topology analysis  
Over-representation analysis of KEGG pathways is provided in Figure 6.8 and 
6.9.  Using Entrez gene identifiers pathway topology analysis was used to define 
significantly perturbed pathways, Figure 6.11 and 6.12.  For native to monolayer 
transitions the ‘focal adhesion’ and ‘regulation of actin cytoskeleton’ pathways 
were predicted to be activated for both chondrocytes and tenocytes, SD6.16 - 
6.17.  For chondrocytes the PI-3K-signalling pathway was shown to be perturbed 
in all comparisons with activation predicted in both native and monolayer cells.   
In the monolayer to model culture transition for both cell types the ‘Parkinson’s 
disease’ and ‘Alzheimer’s disease’ pathways were predicted to be inhibited, 
however, there was conflicting evidence for the activation status of other pathways 
with ‘focal adhesion’ predicted to be activated in chondrocytes, whilst inhibited for 
tenocytes.  For alginate cultures the ‘HIF1 signaling’ pathway was activated and 
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‘PI-3K signaling’ inhibited; in comparison for fibrin cultures the ‘Jak-STAT’ 
pathway was predicted to be activated along with ‘regulation of actin cytoskeleton’.   
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A B
C D
Native Chondrocytes to Monolayer
Native Tenocytes to Monolayer
Native Chondrocytes to Alginate
Native Tenocytes to Fibrin
Euler Diagram of Differentially Abundant Proteins
A:C - Common to monolayer and 
alginate comparisons from native 
chondrocytes (n=516): 
•  Gene Ontology annotation  
BP: mRNA processing | Cellular 
metabolic process | Carboxylic acid 
metabolic process | Translational 
elongation  
B:D - Common to monolayer 
and fibrin comparisons from 
native tenocytes (n=505): 
•  Gene Ontology annotation  
BP: Translational elongation | 
O x i d a t i o n r e d u c t i o n | 
Gene r a t i on o f  p r ecu r so r 
metabolites and energy | Protein 
fo ld ing |Ca rboxy l i c a c i d 
metabolic process 
A:B - Common to monolayer from 
native cells (n=501): 
•  Gene Ontology annotation  
BP: Translation elongation | Cellular 
protein metabolic process | Amino 
acid activation | Actin filament-based 
process  
C:D - Common to model cultures 
from native cells (n=304): 
•  Gene Ontology annotation  
B P : O x i d a t i o n r e d u c t i o n | 
Generation of  precursor metabolites 
and energy | Oxoacid metabolic 
process | Lipid catabolic process  
Figure 6.10 – Euler diagram showing shared proteins for each comparison across chondrocyte and 
tenocyte studies (figure legend).  Common proteins are annotated by biological process terms using 
DAVID.  A:C represents proteins common to both comparisons in chondrocytes; likewise, B:D shows 
proteins common to tenocyte comparisons.  Across chondrocyte and tenocyte studies gene ontology 
studies show enrichment for biological process annotations found when studies are considered 
independently. There is greater overlap in proteins between native to monolayer comparisons (A:B) 
than between native to model culture comparisons (C:D); this concurs with the  greater overlap of  
differentially expressed genes from monolayer and a divergence in profile for model conditions shown 
by the Affymetrix data in Chapter 3.       
718 
933 829 
895 
Native chondrocytes to monolayer  
Native tenoocytes to monolayer  
Native chondrocytes to alginate  
Native tenoocytes to fibrin  
Figure legend 
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•  ECM-receptor interaction:  
     Comp, Chad, Col2a1, Col11a2, Ibsp, Spp1  
•  Multicellular organismal homeostasis: 
     Gpx1, Acp5, Coro1a; 
•  Macromolecule localization:  
     Hgs, Adfp, Myo6, Ywhae   
•  Notable:  
     Alpl, Ptgs2, Itpr2, S100a1 
Figure 6.11: Functional annotation of  key proteins with significant differential abundance - chondrocytes.  Associated terms relate to gene 
ontology groups from which representative proteins were collected.  Terms are not always significant due to small numbers of  proteins but 
provide summary functional annotations for proteins with strong evidence for differential abundance.  Central schematic (figure legend) 
indicates the different pairwise comparisons; associated with each are the KEGG canonical signalling pathways are the most significantly 
perturbed pathways and their predicted status: (+) activated, (-) inhibited.   
•  Nitrogen compound metabolic process: Chi3l1, Sept9, Stat3 
•  Oxidation reduction: Cox2, Ogdh, Maoa 
•  Fatty acid beta-oxidation: Crat, Decr1, Hsd17b4 
•  Cartilage development: Ctgf, Mapk3, Tgfb2 
•  Bone resorption: Tpp1, Xdh, Ctnnb1 
•  Notable: Ntn1, Gpnmb, Stat1,4 and 6, Icam1, Bst1  
| KEGG 
+ Focal Adhesion  
+ ECM-receptor interaction 
+ PI3K signalling pathway 
  
- Parkinson’s disease 
- Alzheimer’s disease  
- Huntingdon’s disease 
| KEGG 
+ Parkinson’s disease  
+ HIF1 signalling pathway 
  
- Alzheimer’s disease  
- Huntingdon’s disease 
- PI3K signalling pathway  
•  Actin filament-based process:  
    Actn1, Itgb1, Dbn1 
•  Gene expression:  
    Ctnnb1, Edf1, Ccar1 
•  Regulation of  translation:  
    Mapk1, Mapk3, Eif4e 
•  Collagen fibril organisation: 
    Anxa2, Col3a1, Col5a1, Col5a2, Tgfb2 
•  Notable: Thbs2, Thbs4, Gsk3b, Fstl2, Mesdc2 
| KEGG 
+ Focal Adhesion  
+ Regulation of  actin cytoskeleton 
+ PI3K signalling pathway 
  
- Prion diseases 
- HIF1 signalling pathway  
• •
Native chondrocytes 
Monolayer chondrocytes 
3D culture chondrocytes 
Figure legend 
•• •
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•  Transport:  
     Adfp, Kdelr1, Sdhd 
•  Generation of  precursor metabolites and energy: 
Atp5f1, Nd2, Sod2 
•  Lipid biosynthetic process:   
     Cyb5r3, Ptgis, Ccds2   
•  Biological adhesion:  
     Comp, Mfge8, Scarb2 
•  Translation elongation:   Cnn1, Myl6, Dbn1 
•  Oxidation reduction:   Ptgs1, Ptgs2, Maoa, Leprel1 
•  Carbohydrate metabolic process:  Bgn, Slc3a2, Hk2 
•  Response to oxidative stress:  ApoE, Mmp14, Map2K1 
•  Cell differentiation:    Thy1, Itgb1, Tgfbi, Ctnnb1, Stat3 
•  Actin filament-based process:  
     Cnn1, Myl6, Dbn1 
•  Regulation of  cytoskeletal organisation: 
     Cfl1, Stmn1,  Lima1 
•  Oxidation reduction: Plod1-3, Sod1, Txn1  
•  Monosaccharide metabolic process:   
     Cryab, Mdh1, Fabp5  
•  Extracellular matrix:  
     Col3a1, Col5a1, Fn1, Mmp3, Ctgf, Ccdc80, Spp1 
| KEGG 
+ Focal Adhesion  
+ Regulation of  actin cytoskeleton 
+ Parkinson’s disease  
| KEGG 
+ Huntingdon’s disease 
+ Prion diseases 
  
- Parkinson’s disease 
- Alzheimer’s disease  
- Focal adhesion 
| KEGG 
+ Regulation of  actin cytoskeleton 
+ Jak-STAT signalling pathway 
  
- Parkinson’s disease  
- Alzheimer’s disease  
- Huntingdon’s disease 
- Prion diseases 
- ErbB signalling pathway 
•
Native tenocytes 
Monolayer tenocytes 
3D culture tenocytes 
Legend 
•
•• •
Figure 6.12: Functional annotation of  key proteins with significant differential abundance - tenocytes.  Associated terms relate to gene 
ontology groups from which representative proteins were collected.  Terms are not always significant due to small numbers of  proteins but 
provide summary functional annotations for proteins with strong evidence for differential abundance.  Central schematic (figure legend) 
indicates the different pairwise comparisons; associated with each are the KEGG canonical signalling pathways are the most significantly 
perturbed pathways and their predicted status: (+) activated, (-) inhibited.   
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6.3.4: Moderate correlation between gene and proteomic expression 
data  
For the native chondrocyte to dedifferentiated chondrocyte transition there were 
320 elements matched across the two datasets.  Overall these elements were 
moderately correlated, r = 0.56 (tdf = 318, p < 2.2e-16, 95% CI: 0.48-0.63), Figure 
6.13; when only those elements with matched fold-change direction were 
considered this was improved, r = 0.88 (tdf = 240, p < 2.2e-16, 95% CI: 0.79-0.87).  
There were 42 elements more highly expressed in native chondrocytes that shared 
directional change in both gene expression and protein abundance surveys.  These 
included known chondrogenic markers including collagen type 2 (COL2A1) and 
collagen type IX, chondroadherin (CHAD), integrin-binding sialoprotein (IBSP), 
matrix metalloproteinase MMP3, HAPLN1 (link protein), PRG4 (lubricin), in 
addition to more novel cartilage-associated proteins: calcium channel ITPR2 
(inositol 1,4,5-trisphosphate receptor, type 2), and products associated with matrix 
mineralization, SPP1/osteopontin. Others had no known association with 
cartilage: dynamin (DNM1), serine protease inhibitor SERPINB1A, and 
glutathione-S-transferase.   
For elements with higher expression in monolayer chondrocytes there were 200 
that shared directional change.  The following were noted: carbonic anhydrase 
CAR9, COL5A2, transgelin (TAGLN), the lectin LGALS1, thrombospondin 2 
(THBS2), stathmin (STMN1). The only element with high anti-correlated 
expression was CHORDC1/morgana protein (Cysteine And Histidine-Rich 
Domain (CHORD) Containing 1).  
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For the equivalent transition for tenocytes there were 231 elements with were 
found in both datasets with moderate correlation in effect size, r = 0.41, (tdf = 329, p 
< 1.2e-10, 95% CI: 0.29-0.51), Figure 6.14.  There were 13 elements found to be 
more highly expressed in native tenocytes relative to monolayer including, 
superoxide dismutase 2 (SOD2), serine (or cysteine) peptidase inhibitor, clade E, 
member 2 (SERPINE2), perilipin 2 (PLIN2) and prostaglandin I2 (prostacyclin) 
synthase (PTGIS).  In monolayer, there were 175 elements found to be common 
to both analyses and shared directional change.  Those with the highest correlation 
included: integrin, alpha 11 (ITGA11), neural cell adhesion molecule 1 (NCAM1), 
coiled-coil domain containing 80 (CCDC80) and Thy-1 cell surface antigen 
(THY1/CD90).  For tenocytes CHORDC1 was also highly anti-correlated.    
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Differentially Expressed Elements Common to Microarray and Proteomic Studies
 Native Chondrocytes vs. Monolayer Chondrocytes
HBA1 
CHAD 
CLEC3A 
NOS2 
F13A1 
LOC287167  
LCP1 
HBB-B1 
SERPINB1A 
ACE 
IBSP 
LGALS 
TAGLN 
GRB14 
CHORDC1 
Figure 6.13: Correlation scatterplot – chondrocytes.  Relative abundance (log2 fold 
change) of  proteins (x-axis) in native to monolayer transition for chondrocytes is plotted 
against differential expression (log2 fold-change) for genes (y-axis) from the Affymetrix 
data.  Dark data points indicate correlated elements (shared direction of  fold change); 
light points indicate anti-correlated (no match) elements.  Only the most highly 
correlated are labeled.  CHORDC1 is found as an anti-correlated protein in both 
chondrocytes and tenocytes.  Annotated lists are found in SD6.   
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ITGA11 
NCAM1 
SOD2 
SERPINE2 
PLIN2 
SLC2A1 
 
CHORDC1 
Figure 6.14: Correlation scatterplot –tenocytes.  Relative abundance (log2 fold 
change) of  proteins (x-axis) in native to monolayer transition for tenocytes is plotted 
against differential expression (log2 fold-change) for genes (y-axis) from the 
Affymetrix data.  Dark data points indicate correlated elements (shared direction of  
fold change); light points indicate anti-correlated (no match) elements.  Only the most 
highly correlated are labeled.  Few gene and proteins from native tenocytes are found 
in both data sets; the majority of  elements arise from monolayer data.  Annotated lists 
are found in SD6.   
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6.3.5: Oxidative phosphorylation associated proteins are robustly 
expressed in three-dimensional cultures 
Transcriptome profiling had found elevated levels of pro-inflammatory 
chemokines in three-dimensional cultures.  Considering the protein abundance of 
these cultures found proteins strongly associated with the KEGG canonical 
signalling pathway ‘oxidative phosphorylation’ (Figure 6.8) in the alginate to 
native chondrocyte comparison, Figure 6.15.  Proteins associated with 
mitochondrial dynamics, optic atrophy 1 (OPA1, C-M-T disease 1A) and 
cytochrome C subunits were more abundant in alginate cultures than either native 
or monolayer chondrocytes.  Fibrin cultures shared comparable annotation for 
oxidative phosphorylation.   
6.3.6: Common upstream regulators predicted to relate to PPAR and 
PI-3K signaling in alginate cultures  
Analysis of alginate and native chondrocyte protein profiles using Ingenuity® 
Pathway Analysis defined the most significant canonical pathways as 
‘mitochondrial dysfunction’, ‘oxidative phosphorylation’ and ‘EIF2 signalling’.  
Upstream regulators were predicted for the protein profile and these including 
small molecule agonist of PPARα signalling, pirinixic acid (z-score = 2.19, p = 
4.1e-14, 258 proteins were downstream targets of 17 regulators) Table 6.3, and 
transcription factors associated with PPARα and PI-3K signalling, Figure 6.16. 
The signal transducer and activator of transcription 3 protein (STAT3) was 
consistently associated with predicted mechanistic networks. In this analysis 
STAT3 is more highly abundant in alginate beads than in native cells; this was 
consistent with Illumina and Affymetrix gene expression analysis.   
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Figure 6.15 – Heatmap of  log2 ratios for chondrocyte 
conditions using proteins enriched for the KEGG 
canonical signalling pathway ‘oxidative phosphorylation’.  
Consistent with an understanding of  glycolytic pathways 
being the main ATP source in chondrocytes from 
cartilage oxidative phosphorylation associated proteins are 
highly abundant in chondrocytes from alginate cultures.     
Native chondrocytes 
Monolayer chondrocytes 
Alginate chondrocytes 
Condition  
P
ro
tein
s 
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Figure 6.16 – Predicted upstream regulators 
and mechanistic network defined by IPA for 
alginate relative to native chondrocytes.  
 
A: In the predicted mechanistic network the 
agonist of  PPAR signalling, pirinixic acid, is 
predicted to be associated with the following 
downstream targets 
 
B:  Mechanistic network overlaid with proteins 
found to be differentially abundant between 
chondrocytes in alginate culture and native 
chondrocytes (see figure legend for colour 
key).  Of  the predicted upstream regulators 
STAT3 was more abundant in alginate beads.  
Using IPA it was predicted that the profile of  
protein abundance was consistent with 
inhibition of  PPAR signalling in native 
chondrocytes and TNF-mediated signalling in 
alginate cultures.  Proteins with known 
associations with upstream regulators found to 
be more abundant in alginate beads included 
CNN2/CTGF, SERPINE2 and CTNNB1.  
Functional annotations associated with all 
proteins in the network included ‘development 
of  cardiovascular system’ (activated, 
p=2.1e-19) and ‘differentiation of  connective 
tissue’ (inhibited, p=3.73e-20).   
B. 
A. 
 503 
Comparison Pirinixic acid D3T 
Native to monolayer -4.43 (p=1.23e-11) -6.04 (p=2.23e-37) 
Monolayer to alginate 3.37  (p=1.23e-23) 4.69 (p=3.4e-27) 
Alginate to native 2.19 (p=4.8e-14) Not represented 
Native to monolayer -5.05 (p=2.02e-12) -7.3 (p=6.52e-40) 
Monolayer to fibrin 1.4 (p=2.81e-16) 1.9 (p=5.9e-20) 
Fibrin to native 3.06 (p=4.5e-14) 6.01 (p=2.24e-29) 
C
ho
nd
ro
cy
te
s 
T
en
oc
yt
es
 
Table 6.3: Chemical reagents (columns) used by Ingenuity Pathway Analysis as 
proxy regulators of  signalling pathways based upon differentially abundant proteins 
in A) chondrocytes and B) tenocyte comparisons (rows).  Cells represent activation 
z-score and overlap p-value.  The actions of  the PPAR-alpha agonist pirinixic acid 
and the anti-oxidant 1,2 dithiol-3-thione (D3T) are both shown to be consistent 
with the protein abundance profiles in monolayer and three-dimensional cultures 
(excluding alginate to native chondrocyte comparison).   
A. 
B. 
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6.4: Discussion 
 
6.4.1: Study design and limitations 
In a review of cartilage proteomic surveys Hsueh, et al (2014) found that between 
14 and 814 proteins could be identified, depending on the methods used and 
whether whole tissue or in vitro chondrocytes were profiled (Hsueh, Önnerfjord et 
al. 2014).  Relative to these studies the profiling of matrix-depleted native cells in 
this study resulted in higher numbers of differentially abundant proteins, greater 
than 1800 across both chondrocytes and tenocytes.  This exemplifies the trade-off 
between the depth of coverage achieved with mass spectrometry and the accurate 
representation of the native state.  Additional levels of statistical analysis and post-
hoc filtering were employed to ensure that only the most robust changes were 
retained for differential abundance analysis.  The large number of confidently 
identified and differentially abundant proteins permitted the use of over-
representation analysis for functional annotation and pathway topology analysis 
methods and facilitated significant descriptors to be derived from them.   
This study was unusual in that it surveyed both gene expression and protein 
abundance in parallel with sample collection and culture periods temporally 
matched.  Consistent sample handling, awareness of cell culture media 
contaminants (phenol red), application of multiple wash phases, use of glass and 
low-affinity plastic storage tubes, the depletion of abundant, anionic matrix and 
local technical expertise were all practices that may have contributed to the 
identification of large numbers of proteins and the high intra-sample correlation in 
proteomic profiles.   
 505 
The principal limitation was the number of cells available for analysis, especially 
for native tenocytes and three-dimensional culture samples.  Although 
methodologies exist for the co-extraction of RNA and protein the low cell yield 
from samples in the preliminary study indicated that paired biological replicates 
would not be possible.  Furthermore, for the same wet weight, tendon consistently 
yielded fewer cells than cartilage and required special attention to ensure optimal 
digestion of fibrillar material (Ritty, Roth et al. 2003).  Sample handling in this 
study was not optimal with cells frozen as suspensions in PBS with protease 
inhibitors rather than as cell pellets.  This did influence the concentration of 
protein that was loaded on the LC for tenocytes, but did not ultimately appear to 
have adversely influenced the number of proteins identified with comparable 
numbers identified in both native cell groups.   
The depletion of extra- and peri-cellular matrix (PCM) results in a loss of 
information relating to proteins with key roles in cartilage and tendon 
homeostasis, for example integrins and other plasma membrane proteins 
(Iliopoulos, Gkretsi et al. 2010), though some were represented in this analysis.  
An assumption of PCM depletion was based upon a particle-exclusion test, which 
although cheap and quick to perform limited assessment to individual cells tested 
from aliquots in preliminary studies, i.e. it gave no indication as to the overall 
sample reduction in PCM components for the final analysis.  Validation of type VI 
collagen depletion by Western blotting or loss of Alcian blue staining for 
polysulphated proteoglycans would have provided more robust qualitative 
indicators of PCM depletion.  The low fold-changes associated with extra-cellular 
matrix proteins and the lack of ECM-associated annotations from differentially 
 506 
abundant proteins would suggest that depletion approach was effective, however 
all three collagen type VI alpha chains were found to be differentially abundant.        
This study utilized the linear Bayes moderated t-test within Limma (Smyth 2005) 
applied to the gene expression data to provide a comparable way of filtering the 
data and providing a confidence value to the identification of differentially 
abundant proteins.  This approach is now relatively commonly used in the 
proteomics literature (Katayama, Paczesny et al. 2009, Ting, Cowley et al. 2009, 
Schwämmle, León et al. 2013, Wanner, Subbaiah et al. 2013) and, as such, is a 
valid methodology within this context.  Absolute or labeled-relative quantification 
would be an obvious step to validate differential abundance in proteins of interest.    
6.4.2: Oxidative phosphorylation in three dimensional culture systems 
Given the considerable overlap in protein surveys from different cells sources and 
conditions there is confidence in the significantly enriched functional annotations 
presented. ‘Oxidative phosphorylation’ and ‘oxidation-reduction’ were the 
consistent descriptors for three-dimensional model cultures as compared to ‘actin 
filament-based processes’ for monolayer cultures.  In tandem with these findings 
across all comparisons canonical signalling pathways associated with 
neurodegenerative conditions were strongly enriched and shown to have 
differential, although conflicted, activation status. Furthermore, proteins associated 
with metabolic processes – carbohydrate and fatty acid metabolism  - abounded.   
How these findings are interpreted is conditional upon the view taken of the 
nature of cells in three-dimensional cultures, i.e. whether they represent a 
regenerative, re-differentiating population, or the representation of a degenerative 
state.  These findings also have relevance to the use of mesenchymal stem cells for 
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cartilage directed-differentiation studies or defining populations of adult tissue 
stem-cells.  On this basis the relevance of oxidative phosphorylation (OXPHOS) 
to musculoskeletal biology should be considered.   
OXPHOS is the metabolic process of ATP synthesis in mitochondria at the 
expense of respired oxygen.  Redox reactions, where electrons are transferred 
from donors (NADH from the citric acid cycle) to acceptors, for example oxygen 
(terminal acceptor), along the electron transport chain release energy used to 
reform ATP from ADP.  The addition of a phosphate group to ADP is driven by 
proton gradients created by the harnessing of energy released in the electron 
transport chain to drive proton pumps (Alberts, Bray et al. 1998).  The terminal 
electron acceptor in the respiratory chain is oxygen, which with the addition of 
four electron and two protons forms water.  Although this is efficient a small 
number of electrons will partially reduce oxygen, with the addition of only one or 
two electrons, to produce harmful reactive oxygen species superoxide and 
peroxide.  
In both the gene and protein surveys of native, monolayer and model culture 
conditions over-representation and pathway topology analysis have implicated the 
KEGG canonical pathways for the neurodegenerative diseases: Parkinson’s, 
Huntington’s and Alzheimer’s.  Initially this does not seem intuitive to the 
understanding of musculoskeletal cell biology, however, given the considerable 
evidence supporting mitochondrial dysfunction in these three conditions (Correia, 
Santos et al. 2012, Johri and Beal 2012) the annotation of these proteomics data 
set with neurodegenerative pathways is a consequence of the component proteins 
having associations with mitochondrial homeostasis and/or dysfunction.  This 
would indicate the importance of OXPHOS and redox balance for homeostatic 
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mechanisms in chondrocytes and tenocytes.  For example, this study presents 
evidence for high abundance of proteins associated with mitochondrial dynamics 
and fission/fusion, OPA1 (optic atrophy 1) in model cultures and MFN2, 
mitofusin-2, (associated with Charcot-Marie-Tooth type 2A) in fibrin cultures.   
OXPHOS in chondrogenesis and regeneration       
The process of OXPHOS has relevance to the condensation and differentiation of 
chondrocytes.  Using a bioluminescent monitoring system Kwon, et al (2012) 
found that ATP oscillations were dependent on glycolysis, oxidative 
phosphorylation and Ca2+ levels, and were synchronized by gap junctions across 
chondrocytes during condensation (Kwon, Ohmiya et al. 2012).  This 
condensation was retarded by blockade of the ATP oscillations. The authors 
concluded that this type of synchronized oscillatory activity during condensation 
would be relevant to the periodic secretion of adhesion molecules and ECM 
during condensation.   
Chondrocytes are known to reside in hypoxic conditions (Pfander and Gelse 
2007), have few mitochondria, and generate the majority of their ATP (> 90%) by 
anaerobic glycolysis rather than OXPHOS (Otte 1991, Martin, Martini et al. 2012) 
yet hypoxia is also known to promote maintenance of stem cells, including MSCs, 
and these are more reliant on glycolysis than OXPHOS.  This may be a 
mechanism for the prevention of oxidative stress-induced senescence occurring by 
OXPHOS under normoxia (Ito and Suda 2014).  It is not clear from the data 
arising in this study whether OXPHOS activity is a response to culture conditions 
alone and/or represents changes in the differentiation status of cells in three-
dimensional cultures.  Under normoxic conditions mesenchymal stem cells have 
been shown to significantly reduce oxygen consumption when differentiating 
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towards a chondrocytic phenotype in pellet cultures, in contrast to osteoblastic 
differentiation (Pattappa, Heywood et al. 2011).  The dedifferentiated 
chondrocyte, in contrast, shows an increased reliance on OXPHOS with 
increasing periods of time in culture (Heywood and Lee 2008), with expansion 
under hypoxic and low-glucose conditions enhancing the subsequent 
differentiation capacity of monolayer-expanded cells in pellet culture (Heywood, 
Nalesso et al. 2014).   
Additionally, PI-3K/Akt/mTOR has a ‘nutrient sensing’ activity in response to 
glucose and amino acids.  In the maintenance of stem cell pools equilibrium in 
metabolic pathways is required where mitochondria in stem cells are relatively 
quiescent and the reliance is on glycolytic pathways.  A change to oxidative 
phosphorylation is associated with impaired stem cell function and differentiation 
(Ito and Suda 2014).  Where the redox rheostat is finely balanced to maintain self-
renewal and inhibit differentiation comparable mechanisms may be relevant in 
dedifferentiation/re-differentiation mechanisms for musculoskeletal cells.   
PI-3K/Akt signalling and OXPHOS 
In Chapter 3 pathway topology analysis of the gene expression profiles of the 
same conditions implicated PI-3K/Akt signalling pathway as the over-arching 
regulatory mechanism.  In the proteomic profiles this remained a significantly 
perturbed pathway for chondrocytes, but the predicted activation statuses were 
contradictory.  The role of PI-3K/Akt signalling is not at odds with findings of 
oxidative phosphorylation pathways in the proteomic survey.  The production of 
ROS is enhanced by PI-3K/Akt signalling through the repression of FOXO-
mediated responses (Ito and Suda 2014). As discussed in Chapter 3 oxidative 
stress appears to inhibit IGF1 induction of matrix synthesis by failing to activate 
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Akt by phosphorylation (Yin, Park et al. 2009) via PTEN (Iwasa, Hayashi et al. 
2014).   
OXPHOS, oxidative stress and OA 
In Chapter 3 and 5 the high expression of chemokines in model cultures was 
presented.  In this proteomic survey few are represented in the differential 
abundance analysis – this is perhaps unsurprising given that IL-6, for example, is 
largely secreted and found at high levels in culture media (Tsuchida, Beekhuizen et 
al. 2012).  The question arises as to whether oxidative stress induced by OXPHOS 
promotes a pro-inflammatory cytokine signature or whether cytokine release is 
within the re-differentiation mechanism of cells in model culture.  Recently Cao 
and colleagues (2013) found that mitochondria in cultured murine chondrocytes, 
and in situ within transgenic mice, responded to IL-1β or TNFα with ‘super-oxide 
flashes’ 2-5 fold more frequently than in quiescent chondrocytes (Cao, Zhang et al. 
2013) 
There is evidence associating mitochondrial dysfunction and oxidative stress with 
chondropathies and age-related degeneration in general.  The density of 
mitochondria decreases with increasing depth from the surface of articular 
cartilage in line with an understanding of decreasing oxygen tension from ~5% to 
< 1% from the superficial to deep layers (Blanco, Rego et al. 2011, Cao, Zhang et 
al. 2013).  Osteoarthritis is associated with the elevated production of ROS by 
chondrocytes and inhibition of respiratory chain complexes III or V reduces ROS 
levels, but inhibition results in the induction of pro-inflammatory cytokine 
production (Blanco, Rego et al. 2011).   
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Expression of superoxide dismutase 2 (mitochondrial), SOD2, is significantly 
decreased in OA chondrocytes and cartilage (Blanco, Rego et al. 2011).  Using an 
MS time-of-flight approach to 2D DIGE resolved proteins from human articular 
chondrocytes (HACS) Ruiz-Romero, et al (2009) defined a significant decrease in 
the levels of SOD2 in osteoarthritis HACS, with a concomitant higher expression 
of ROS and TRAP1, a heat-shock protein 90 family-member with ROS 
antagonistic activity (Ruiz-Romero, Calamia et al. 2009); further work found 
TRAP1 protein to be more highly expressed under hypoxic conditions (Ruiz-
Romero, Calamia et al. 2010) and may act as a molecular switch between 
OXPHOS and glycolysis (Yoshida, Tsutsumi et al. 2013).  In this study SOD2 is 
highly abundant in alginate and fibrin cultures relative to native cells and TRAP1 is 
expressed at higher levels in alginate cultures in normoxic conditions relative to 
native cells, but not in fibrin cultures.   This would imply an anti-oxidant response 
is present in alginate-encapsulated chondrocytes and does not necessarily indicate 
that there is a redox imbalance.   
Summary  
On the basis of protein abundance, results presented in this study indicate that 
oxidative phosphorylation contributes to ATP synthesis in model cultures.  The 
considerable qualitative overlap in confidently identified proteins in both fibrin 
and alginate cultures suggest that this is common to both systems.  
Given the evidence for mitochondrial dysfunction in cartilage pathology and a 
potential role in cellular differentiation and self-renewal of stem cells the metabolic 
profile of cells in organo-typic cultures should be validated and standardised.  
Recent studies indicate dynamic activity in chondrocytes in terms of ATP 
production and super-oxide concentrations.  This temporal dynamic should also 
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be considered in model culture systems.  If alginate cultures represent a superoxide 
and pro-inflammatory soup they may represent a better model of osteoarthritis 
than of the physiological state. 
6.4.3: Proteomic and gene expression correlations  
As outlined in the introduction the correlation between mRNA and protein levels 
is poorly correlated representing as it does early and late stages of an observed 
regulatory event with no appreciation of the complex modulation occurring 
concurrently (Payne 2015).  Tian, et al (2004) reported that differential expression 
analysis of mRNA would account for no more than 40% of the variation in 
protein expression; this uncoupling of the two expression profiles highlighting the 
importance of post-translational regulatory mechanisms (Tian, Stepaniants et al. 
2004).  
Moderate correlation is shown between differentially expressed elements from 
proteomics and transcriptomic studies from the same experimental groups using 
the same study design and methods.  It is worth considering this objectively – 
firstly, the veracity of these findings could be accepted and the conclusion made 
that the identification and correlation of the same proteins in chondrocytes and 
tenocytes indicated some equivalence in processes.  The alternative view is that 
there is bias in the lists of identified proteins, as a consequence of the nature of 
tryptic digestion and peptide behavior in the MS, and so, also bias in the 
differential abundance findings.  Further validation of correlations between gene 
and protein levels of the serine protease inhibitors SERPINE1 and SERPINB1A, 
IBSP and SOD2 in native chondrocytes or tenocytes by qPCR and Western 
blotting would be required.  Consideration of parallel miRNA studies, 
metabolomics, protein phosphorylation status and the definition of dynamic 
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cellular localization in association with gene and protein expression profiling 
would assist interpretation of future experiments i.e. whole cell modeling (Karr, 
Sanghvi et al. 2012), however, integration of multiple data sources and not 
defining correlation ‘correctness’ should be the focus of future research (Payne 
2015).  
Utility of anti-correlated mRNA and protein expression  
Even given the appreciation of the discordant relationship between gene and 
protein expression there is still utility in this type of correlation analysis.  Anti-
correlated elements (where the fold-change direction is not shared in mRNA and 
protein expression profiling) are of interest as they may disclose additional 
information representing post-translational regulatory mechanisms (Tian, 
Stepaniants et al. 2004), e.g. miRNA.  Payne (2014) notes that these differences are 
fundamentally related to regulatory mechanisms rather than measurement errors 
(Payne 2015).  Here the highly anti-correlated expression of morgana 
protein/CHORDC1/Chp-1, a ROCK inhibitor (Ferretti, Palumbo et al. 2010) and 
HSP90 interacting protein (Wu, Luo et al. 2005), is reported between mRNA and 
protein expression in chondrocytes and tenocytes in the native to monolayer 
comparison.  In both scenarios high mRNA expression in native cells is associated 
with low protein abundance.  There are no publications investigating the role of 
CHORDC1 in cartilage or tendon physiology and so it should be considered in a 
wider context.   Recently the proto-oncogene activity of morgana protein has been 
associated with PTEN destabilization, through the inhibition of ROCK (Rho 
family of GTPases), promoting PI-3K/Akt signalling (Fusella, Ferretti et al. 2014). 
Modulation of ROCK is well described as being relevant to the differentiation 
status of chondrocytes and to cartilage function.  Inhibition of ROCK has effects 
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on SOX9 activation and the suppresses dedifferentiation in chondrocytes (Woods 
and Beier 2006, Matsumoto, Furumatsu et al. 2012).  Mechnotransduction through 
RhoA/ROCK is also a key modulator of CNN2/CTGF and TGFβ-Smad 
signaling with inhibitors of ROCK inhibiting CNN2/CTGF expression (Chaqour 
and Goppelt-Struebe 2006). Therefore, although the correlation of expression 
changes between mRNA and protein may provide some level of validation of 
findings the anti-correlated elements are also sources of further complexity in our 
wider understanding of cartilage physiology.  In this case there is rationale for the 
further investigation of CHORDC1 mRNA and protein expression in relation to a 
mechanistic network involving PI-3K/Akt, RhoA/ROCK, CCN-family and 
TGFβ-Smad signaling in chondrocyte differentiation status.        
6.4.4:  PPAR signalling  
A predicted role for peroxisome proliferator-activated receptor (PPAR) signalling 
in native chondrocytes is introduced for the first time in this thesis.  Using the 
PPARα agonist pirinxic acid as a proxy for activation of this pathway Ingenuity® 
Pathway Analysis predicted inhibition where the protein profile was associated 
with high abundance in native cells compared to monolayer; there was predicted 
activation in both monolayer and three-dimensional cultures for both 
chondrocytes and tenocytes. With Ingenuity® analysis the activation of PPAR 
signalling follows the prediction of D3T-mediated effects.  D3T is an anti-oxidant, 
which stabilizes the NRF2 transcription factor involved in responses to oxidative 
stress (Kwak, Itoh et al. 2001).   
Peroxisomes are membrane-bound vesicles for the storage and degradation of 
reactive chemicals and hydrogen peroxide.  They contain oxidative enzymes and a 
major function is the breakdown of long chain fatty acids by beta-oxidation 
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(Alberts, Bray et al. 1998).  Peroxisome proliferator-activated receptors were 
identified as ligand-inducible transcription factors that induced peroxisome 
proliferation (Dreyer, Krey et al. 1992).  PPAR isotypes (α, β/δ, or γ isotypes) 
have different gene targets and distinct tissue distributions (Gorniak 2014) with 
roles in lipid metabolism, inflammation, insulin sensitivity, metabolism (Ahmadian, 
Suh et al. 2013) and mitochondrial biogenesis, acting in heterodimer partnership 
with retinoid X receptor-α (RXRα) 
With respect to cartilage research the focus has been on the PPARγ transcription 
factor; most recently PPARγ knock-out mice have been shown to develop 
spontaneous osteoarthritis (Vasheghani, Monemdjou et al. 2013) and impaired 
endochondral ossification (Monemdjou, Vasheghani et al. 2012)  suggesting that 
PPARγ is a critical regulator of cartilage health and development.  A PPARγ 
agonist, given orally to mice, was demonstrated to diminish the severity of 
collagen-induced arthritis (Tomita, Kakiuchi et al. 2006).  In an in vivo study of rat 
chondrocytes encapsulated in alginate beads, however, the application of various 
PPAR agonists was shown to inhibit the TGF-β1 stimulating effects on 
prostaglandin synthesis suggesting deleterious effects of some PPAR agonists 
(Poleni, Bianchi et al. 2007).   
Although separately oxidative stress, mitochondrial dysfunction and PPAR 
signalling have all been investigated in cartilage, as described above, an integrated 
understanding of these mechanisms in cartilage physiology is not apparent in the 
literature.  Given the supporting evidence there is a rationale for further research 
relating to the contribution of PPAR-signalling in cartilage homeostasis and 
disease.  
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6.4.5: Summary  
A proteomic discovery profiling study of chondrocytes and tenocytes, employing a 
label-free relative quantification approach, demonstrated moderate associations 
with a gene expression study performed in parallel.  This was in line with current 
understanding of the expected correlation between mRNA and protein in 
expression studies.  Functional annotation, pathway topology analysis and 
prediction of upstream regulators was comparable across chondrocyte and 
tenocyte studies implicating oxidative phosphorylation, oxidative stress and PPAR 
signalling as mechanisms involved within in vitro culture systems.  These findings 
were broadly in line with those found within the Affymetrix gene expression 
studies.  Further validation focused on validating the metabolic activity of cells in 
three-dimensional cultures is required.   
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7 :  Explora t ion of  in tegra t ion  
s t ra teg ies  for  proteomic  and 
t ranscr ip tomic  data  se ts   
 
 
Abstract 
Omics data integration poses considerable technical and conceptual challenges.  
The principle motivation is a deeper understanding of the mechanistic 
relationships between the components comprising a living system and describing 
that through mathematical or relational models.   
Conflicting pathway analysis and upstream regulators across transcriptomic and 
proteomic data sets prompted exploration of tools for omics integration to define 
consensus pathways and regulators.  It was proposed that rationalization of the 
key regulators in de- and re-differentiation would yield a targetable mechanistic 
network.  Data from two transcriptomic and one proteomic study were integrated 
on three levels: i) union of discrete elements, ii) by functional annotations and, iii) 
by mechanistic networks derived from common upstream regulators.  
Integration of mechanistic networks defined a protein-protein interaction network 
centred on the predicted reciprocal mediation by TGFβ and PDGF-BB.  
Common downstream targets and intermediate regulators were identified for both 
cartilage and tendon from mechanistic networks including CCN2/connective 
tissue growth factor and SMAD7 in TGF-β1-regulated networks.   
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To fully utilize the multi-level omics data available in this thesis data imputation 
and quantitative integration methods should be explored.  Simple statistical 
strategies for imputation of missing data may be appropriate, whilst multivariate 
projection-based approaches could be employed to integrate quantitative data 
from gene and protein profiling studies.          
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7.1: Introduction  
 
7.1.1: Motivations for multi-omics data integration 
Data discovery and data exploitation are the two challenges that comprise data 
integration and are central to the principal goals of systems biology research, i) 
defining the components of the living systems, and ii) understanding the 
dysfunction of the system arising from the interaction of these components 
(Gomez-Cabrero, Abugessaisa et al. 2014).  The hallmark responses to changes in 
conditions are captured within the gene response and this response may then be 
subsequently profiled at multiple levels in the biological hierarchy (proteome, 
metabolome, methylome).  Data integration assumes that each of the functional 
levels of the biological hierarchy are inter-related and that consideration of all 
elements of these levels as a whole system will decipher the complexity of living 
organisms. By integrating these levels profiling becomes more comprehensive and 
a more robust understanding of the active processes may become reliably 
described (Sass, Buettner et al. 2013).     
As presented in Chapter 6 the correlation of effect sizes between transcriptomic 
and proteomic studies is only moderate as a consequence of a number of 
intermediary events for which information is unavailable, e.g. half-life and kinetic 
data, post-transcriptional modifications influencing activation status, and temporal 
information.  Furthermore, conflicting pathway prediction and inconsistencies in 
functional annotation of data sets prompts further exploration of the data sets to 
determine a consensus systems account of the responses of chondrocytes and 
tenocytes to culture conditions.  Integration of transcriptomic and proteomic data 
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can provide another level of data analysis and identify changes in the samples not 
apparent from independent analysis alone (Haider and Pal 2013).   
Being able to integrate data from these different levels would encourage a more 
robust understanding of the key regulatory mechanisms at play in the de- and re-
differentiation transitions associated with organotypic cultures for culture and 
tendon.  It was hypothesised that use of omics integration strategies would 
facilitate the development of unified protein-protein network for de- and re-
differentiation establishing a testable model for future analysis.  It was proposed 
that these techniques would generate a consensus understanding of the novel data 
sets generated in this thesis and rationalise conflicts in predicted pathways and 
core regulators.    
7.1.2: Challenges of integration 
 
“Know less, faster”.  Prof. Harvey Blanch 
 
As the cost of per unit of measurement using omics technologies has decreases the 
data generated has increased.  This has led to numerous challenges not least of 
which is the outpacing of resource allocation for processing and integration by the 
data generated (Palsson and Zengler 2010). Although the hurdles to omics 
integration are significant, a number of web-based (e.g. 3Omics, (Kuo, Tian et al. 
2013))  and open-source software tools (R packages, Cytoscape) have recently 
become available to support this type of investigation, in addition to public 
repositories and consortia-based projects (Cabrero, Abugessaisa et al. 2014). There 
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are a number of general approaches that may be used for integration, each varying 
in complexity.   
Union of the data elements represents the most straightforward approach and 
creates a reference data set, however this considers only absolute matches of 
elements (or features) and does not represent overlapping functional descriptors 
of the data or deal with missing data.  The second approach deals with extracting 
common functional annotations for both data sets, for example, enrichment 
analysis for gene ontology biological process terms or signaling pathways.  
Topological network approaches (see Chapters 4 and 5), meta-analysis merging of 
individual domain datasets and correlations, estimation of missing data, multiple 
regression analysis, clustering approaches and dynamic modeling represent more 
complex techniques to omics integration (Haider and Pal 2013).    
The methods employed to integrate the data depend on several factors, including: 
a) an understanding of the source of the data and its limitations; b) an awareness 
of the differences in expression between the two domains and why they may not 
correlate; c) a clear objective for the analysis; d) and whether the combined model 
may be extrapolated or represents a collective behaviour of a group of cells within 
a tissue and not the system in general (Haider and Pal 2013).   
Core to the consideration of high-throughput, multi-dimensional data is the 
question of whether the data arising is derived from direct measurement of the 
biological features or as a consequence of the experimental condition, and/or bias 
and artefacts.  Unsupervised analysis, such as clustering, model-based and 
projection-based methods, are exploratory statistical approaches that allow 
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reduction of dimensionality, and noise, and allows data to be visualized in a 
smaller subspace by graphical representations (Yao, Coquery et al. 2012).    
7.1.3: Multivariate data analysis methods 
Researchers have used a number of multi-variate analysis approaches to integrate 
highly dimensional data from diverse data sources.  These ‘projection-based’ 
methods, principal component analysis (PCA) being the classical example, 
integrate the data through the projection of each data set into smaller subspace to 
maximize the covariance between data sets (Günther, Shin et al. 2014).  This 
allows the key players to be identified.  In addition to PCA projection-based 
methods include independent PCA (Yao, Coquery et al. 2012), partial least squares 
regression (PLS) (Lê Cao, Boitard et al. 2011), canonical correlation analysis (CCA) 
(González, Déjean et al. 2008).  Unlike PCA these methods have the capacity to 
integrate two types of data sets.  They are also widely implemented in R packages, 
e.g. mixOmics (Lê Cao, González et al. 2009).   
Using a modification of co-inertia analysis Meng, et al (2014) integrated 
transcriptomic and proteomic data from multiple cancerous cell lines from a 
variety of tissues (omicade4 R package) (Meng, Kuster et al. 2014).  This 
strategy had the advantage of not requiring mapping or filtering the different data 
sets to intersect on common features across more than two data sets.  The 
methodology provides graphical representation of the relationships between the 
data sets, but requires the multiple data sets to arise from the same individuals.   
7.1.4: Project Aims   
Using the transcriptomic and proteomic data sets arising from Chapters 2, 3 and 
6 several integration strategies were explored, i) union of data set elements, ii) 
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extraction of common feature annotations, iii) derivation of common upstream 
regulators and development of mechanistic networks.  Here the intention is to 
define common regulatory mechanisms for de- and re-differentiation and consider 
how these are associated with current understanding of disease mechanisms.  
Furthermore, by defining the common regulatory mechanisms this may focus 
efforts in the research and development of organo-typic culture systems.   
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7.2: Methods 
 
7.2.1 Extraction of common features and functional annotations 
 
Union of discrete elements 
All differential expressed genes and proteins were converted to unique Entrez gene 
identifiers and common elements were extracted for each pairwise comparison.  
Overlaps between each data set are presented as Euler plots.   
RAMONA 
 
To integrate multi-level data in terms of gene ontology functional annotation the 
RAMONA web application was used (http://icb.helmholtz-muenchen.de/ramona) 
(Sass, Buettner et al. 2014) an implementation of the multi-level ontology analysis 
(MONA) method (Sass, Buettner et al. 2013).  Briefly, Entrez identifiers for the rat 
arising from differential expression analysis for either transcriptomic or proteomic 
data was used as the input to a model-based Bayesian approach to infer term 
probabilities (P).  Different pair-wise comparisons were considered in turn.  The 
output from RAMONA contained some redundant annotations.  In order to limit 
descriptors to unique terms REVIGO was employed (as before, Chapter 2) to filter 
on semantic similarity.  Gene ontology terms with a term probability of P > 0.5 
were used as the input to REVIGO.  Presented terms had a probability of > 0.5 
(RAMONA) and threshold dispensability score < 0.3 (REVIGO).  All results are 
available in SD7.  
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7.2.2: Defining common upstream regulators and developing 
mechanistic networks 
 
Topological network approaches implemented within Ingenuity® Pathway Analysis 
were used as previously described (2.2.5) on individual data sets to ascertain the 
common upstream regulators, create mechanistic networks and annotate canonical 
pathways.  Analysis for common regulators was run on the Ingenuity® knowledge 
base issued November 2014. Mechanistic networks were derived by connecting sets 
of upstream regulators within the IPA knowledge base that could elicit the gene or 
protein expression profiles provided from the data sets.  Known downstream 
targets of the regulators within the differential expression data set could be added to 
the network.  Nodes (genes) were added to mechanistic networks to provide a cell-
specific context as defined in the text, for example TNMD and COL2A1 for tendon 
and cartilage respectively. 
  
 535 
7.3: Results 
 
7.3.1: Union of discrete elements 
 
Using only universal Entrez annotations and removing duplicate entries there were 
few data set elements that were found to be common to all three data sets, Figure 
7.1 – 7.4.  The greatest overlap between transcriptomic and proteomic data sets was 
for the cartilage to monolayer chondrocyte comparison (130 features) and the 
fewest were found for the comparison between monolayer tenocytes and fibrin 
constructs (41 features).  Despite the Illumina transcriptomic data arising from a 
different experimental protocol the number of features overlapping with the 
proteomic data was comparable between the Affymetrix and Illumina 
transcriptomic data sets.  Given the low numbers of features that were consistently 
identified across all data sets union of unique elements was not considered an 
adequate method for integrating multi-omics data sets.      
 
7.3.2: Integrated gene ontology functional annotations using RAMONA 
 
CHONDROCYTES 
Dedifferentiation in chondrocytes, following integration of biological process gene 
ontology terms across data sets, was associated with the terms: ‘protein transport’, 
‘ossification’, ‘I-kappaB kinase/NF-kappaB signaling’, ‘Wnt-signaling pathway’, 
‘oxidation-reduction process’ and included development-associated terms 
‘regulation of cell morphogenesis’, ‘cardiovascular system development’ and 
‘anatomical structure morphogenesis’, Figure 7.1.  Enriched KEGG pathways 
using gene ontology across all datasets were: ‘RNA transport’, ‘Wnt-signaling 
pathway’ and ‘osteoclast differentiation’.   
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For the re-differentiation transition (monolayer to alginate beads), Figure 7.2, 
functional annotation across all studies was associated with mitochondrial 
associated terms - ‘response to oxidative stress’, ‘oxidation-reduction process’, 
‘proton transport’, ‘electron transport chain’.  Other terms included: ‘muscle 
structure development’, ‘collagen fibril organisation’ and ‘integrin-mediated 
signaling pathway’.  Enriched KEGG pathways related to the canonical pathways 
‘proteosome’, ‘RNA transport’, and ‘oxidative phosphorylation’.  
TENOCYTES 
In the dedifferentiation transition from native tenocytes to monolayer functional 
annotation across data sets was associated with: ‘oxidation-reduction process’, 
‘ossification’, ‘muscle structure development’, ‘actin filament-based process’ and 
‘connective tissue development’, Figure 7.3.  KEGG canonical pathways enriched 
in this analysis related to ‘RNA transport’, ‘ribosome’, ‘Wnt-signaling pathway’ and 
‘axon guidance’.   
The transition to tenogenic fibrin constructs from monolayer was annotated with 
‘response to wounding’, ‘ECM organization’, ‘oxidation-reduction process’ and 
‘cellular response to glucose starvation’, Figure 7.4.  Additionally, ‘phospholipid 
biosynthetic process’ and ‘cellular response to cytokine stimulus’ were notable.  
Enriched KEGG pathways were comparable to those found for chondrocyte 
redifferentiation – ‘aminoacyl-tRNA biosynthesis’, ‘proteosome’, ‘Parkinson’s 
disease’ and ‘oxidative phosphorylation’.   
These unified annotations were consistent with findings presented for each data set 
independently.   Data contributing to cross data set functional annotation analysis is 
found in SD7.   
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Commonly enriched KEGG pathways using RAMONA: RNA transport; Wnt-signaling pathway, 
osteoclast differentiation 
 
 
Figure 7.1: Union of  Entrez identifiers from transcriptomic and proteomic analysis for the transition 
from native chondrocytes to monolayer chondrocytes.  Euler plot shows the number of  Entrez 
gene identifiers shared between data sets once duplicates have been removed. Term probabilities (P) as 
defined by RAMONA are divided into those >0.5 and those >0.9.   
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Commonly enriched KEGG pathways using RAMONA:  Proteosome, Protein processing in the 
endoplasmic reticulum; lysosome, RNA transport, oxidative phosphorylation and valine, leucine, and 
isoleucine degradation. No significant enrichment of  KEGG pathways was found for cross-
transcriptome analysis using RAMONA.   
  
Figure 7.2: Union of  Entrez identifiers from transcriptomic and proteomic analysis for the transition 
from monolayer chondrocytes to alginate cultures.  Euler plot shows the number of  Entrez gene 
identifiers shared between data sets once duplicates have been removed. Term probabilities (P) as 
defined by RAMONA are divided into those >0.5 and those >0.9.   
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Commonly enriched KEGG pathways using RAMONA: RNA transport, ribosome, Wnt-signaling 
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Figure 7.3: Union of  Entrez identifiers from transcriptomic and proteomic analysis for the 
transition from native tenocytes to monolayer cultures.  Euler plot shows the number of  Entrez 
gene identifiers shared between data sets once duplicates have been removed. Term probabilities (P) 
as defined by RAMONA are divided into those >0.5 and those >0.9.   
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Commonly enriched KEGG pathways using RAMONA: Protein processing in endoplasmic reticulum; 
Aminoacyl-tRNA biosynthesis; proteosome; Parkinson’s disease; oxidative phosphorylation; insulin 
signaling pathway.  No significant enrichment of  KEGG pathways was found for cross-transcriptome 
analysis using RAMONA.   
 
Figure 7.4: Union of  Entrez identifiers from transcriptomic and proteomic analysis for the transition 
from monolayer tenocytes to fibrin cultures.  Euler plot shows the number of  Entrez gene identifiers 
shared between data sets once duplicates have been removed. Term probabilities (P) as defined by 
RAMONA are divided into those >0.5 and those >0.9.   
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7.3.3 Common upstream regulators define de- and re-differentiation 
mechanistic networks  
Integration by intersection of discrete elements or functional ontologies fails to 
provide a mechanistic understanding of the data or make use of quantitative data.  
By defining upstream regulators common to de- or re-differentiation conditions for 
chondrocytes or tenocytes it may be possible to define a targetable mechanistic 
network. Using Ingenuity® Pathway Analysis the upstream master regulators, 
consistent with differential expression profiles, were predicted. Regulators that were 
consistently changed across a transition and cell-type were considered.  Mechanistic 
networks were created for common regulators.  These networks were derived from 
known protein-protein interactions and evidence from the curated IPA knowledge 
base.     
Dedifferentiation is associated with a TGF-β1 network  
In general, for the transition to monolayer from native cells TGF-β1 was predicted 
to be a common upstream regulator (Table 7.1).  Mechanistic networks derived 
from differential expression lists predicted TGF-β1 to be inhibited in the native 
context i.e. genes or proteins found to have higher expression in native cartilage or 
tendon were consistent with a predicted inhibition of TGF-β1 regulated networks.  
Activation status was variable across data sets with low z-score in the Affymetrix 
chondrocyte data set, however, TGF-β1 had significantly lower expression in native 
chondrocytes and tenocytes compared to monolayer consistent with IPA prediction.    
SMAD7 and CCN2 are common downstream targets 
For both chondrocyte and tenocyte dedifferentiation TGF-β1 mechanistic networks 
SMAD7 was predicted as an intermediate regulator and down-stream target of 
TGF-β1.  SMAD7 was down-regulated in native cartilage and chondrocytes in both 
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Illumina and Affymetrix gene expression data sets and in native tenocytes in the 
Affymetrix data set.  Across transcriptomic and proteome profiling studies the CCN 
family member CCN2/connective tissue growth factor (CTGF) also showed lower 
expression in native cells relative to monolayer and was a down-stream target of 
TGF-β1 and SMAD7, which was predicted to inhibit CCN2 expression.   
A dedifferentiation mechanistic network was developed comprising the predicted 
upstream regulators, consistent with the provided expression profiles, and their 
downstream targets.   Quantitative expression profiles were overlain for each data 
set and comparison, Figures 7.5-7.7.  A unified dedifferentiation model was 
prepared based upon the common intermediate regulators and down-stream 
effectors frequently found in the differential expression analysis, including CCN2 
and THY-1, Figures 7.8-7.9.  A global protein-protein interaction network 
(STRING) of this proposed dedifferentiation mechanistic network was found to be 
highly enriched for interaction and functional annotations related to cartilage 
development and condensation, Figure 7.10, consistent with predictions from the 
IPA knowledge base.        
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Cell type Data source Upstream 
regulator 
Activation  
z-score 
Overlap  
p-value 
DE genes  
available 
Chondrocytes Illumina TP53 
TGFB1 
MYC 
-3.68 
-2.59 
4.08 
9e-32 
2.04e-26 
1.9e-18 
435 (14) 
679 (23) 
515 (19) 
Chondrocytes Affymetrix TGFB1 
TNF 
PDGFBB 
-0.52 
5.48 
3.64 
3.2e-25 
1.14e-24 
2.4e-23 
726 (19) 
663 (17) 
477 (18) 
Chondrocytes Proteomics MYC 
NFE2L2 
TGFB1 
-4.71 
-6.56 
-4.2 
7.2e-61 
1.1e-30 
1.5e-23 
393 (18) 
198 (8) 
384 (18) 
Tenocytes Illumina TGFB1 
HRAS 
KRAS 
-1.04 
-0.285 
-2.27 
1e-23 
1.2e-20 
1.3e-16 
319 (18) 
325 (19) 
306 (17) 
Tenocytes 
 
Affymetrix TNF 
PDGFBB 
TGFB1 
6.63 
3.86 
-2.2 
3.7e-50 
4.7e-39 
3.9e-38 
692 (17) 
549 (23) 
685 (20) 
Tenocytes 
 
Proteomics MYC 
NFE2L2 
TGFB1 
-4.35 
-6.8 
-6.8 
6.7e-62 
1.04e-25 
2.1e-19 
399 (13) 
392 (17) 
437 (19) 
Table 7.1: Top upstream regulators predicted using Ingenuity Pathway Analysis knowledge base from 
differential expression/abundance for the native to monolayer comparison across three data sources 
and two cell types.  Small molecules and other chemicals predicted by IPA are not included.  The 
activation z-score indicates the predicted activation status of  the mechanistic network (negative values 
indicating inhibition).  Only genes with available mechanistic networks are shown.  DE genes available 
indicates those genes in the differential lists that are known down-stream targets of  a number of  master 
regulators (defined in parentheses).  TGFB1 is consistently predicted to to be inhibited for gene profiles 
more highly expressed in native tendon or cartilage, i.e. dedifferentiation is associated with active TGFB1 
regulation.   
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Figure 7.5: Ingenuity mechanistic network formed from Affymetrix (A) or Illumina (B) gene expression data 
for native chondrocyte to monolayer transition derived from TGF-β1 network.  SMAD7 was found to be a 
common downstream regulator within the TGF-β1  mechanistic network – expression was significantly lower 
in native chondrocytes relative to monolayer (figure legend). Only those genes with direct up- or down-
stream associations with SMAD7 are shown and annotated with gene symbols.  Added nodes: SOX9.   
A. Affymetrix 
B.  Illumina 
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Figure 7.6: Ingenuity mechanistic network formed from Affymetrix (A) or Illumina (B) data for native 
tenocyte to monolayer transition derived from TGF-β1  network.  In native tenocytes IL-1B was more highly 
expressed than in monolayer – it was predicted to have an inhibitor effect (figure legend) on SMAD7, SCX 
and RUNX2, which all had lower expression in native tenocytes than in monolayer.  SMAD7 was not 
differentially expressed in Illumina data – Ingenuity predicted activation which contradicted the findings in 
the other data sets where SMAD7 was down-regulated in native tissue.  Added node: TNMD (B.).   
A. Affymetrix 
B. Illumina 
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Figure 7.7A: Detail of  mechanistic network for proteomics data for native chondrocytes to monolayer 
comparisons.  Inhibitor of  TGF beta and BMP signalling, SMAD7, was a common intermediate regulator 
in the TGFB1 mechanistic network and is shown to have inhibitory effects on CNN2/CTGF, SERPINE1 
and COL3A1 when active (figure legend).  Nodes in green indicate proteins with lower abundance in native 
chondrocytes. Gene symbols are used for node annotation.   
Figure 7.7B: Detail of  mechanistic network for proteomics data for native tenocytes to monolayer 
cultures comparisons.  JUN was a common intermediate regulator for differentially abundant proteins. 
Added nodes: TNMD and SCX.  In both proteomics analysis SMAD7 is predicted as activated (figure 
legend).  Nodes in green represent proteins with lower expression in native tenocytes relative to monolayer.  
Gene symbols are used for node annotation.   
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Figure 7.8A: Model network to unify findings from Figures 7.5-7.7. Network derived from prediction of  Tgf-
β1 as a core upstream regulator associated with native cartilage transition to monolayer.  Predicted intermediate 
regulators and tendon markers are overlain with differential expression values from A) Affymetrix.  Reduction in 
expression of  Smad7  and Thy-1 in native cells is consistent feature of  dedifferentiation in transcriptomic data 
(figure legend). CP – canonical pathways; Functional annotation p<0.001.  
A. Low High Log2 fold-change 
B. 
Figure 7.8B: Model network to unify findings from Figures 7.5-7.7. Network derived from prediction of  Tgf-
β1 as a core upstream regulator associated with native cartilage transition to monolayer.  Predicted intermediate 
regulators and tendon markers are overlain with differential expression values from B) Illumina.  Reduction in 
expression of  Smad7  and Thy-1 in native cells is consistent feature of  dedifferentiation in transcriptomic data 
(figure legend). CP – canonical pathways; Functional annotation p<0.001.  
Low High Log2 fold-change 
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C. 
Low High Log2 fold-change 
Figure 7.8C: Model network to unify findings from Figures 7.5-7.7. Network derived from prediction of  Tgf-
β1 as a core upstream regulator associated with native cartilage transition to monolayer.  Predicted intermediate 
regulators and tendon markers are overlain with differential abundance values from C) proteomic relative 
quantification study.  Reduction in abundance of  Ctgf, Tgfβ2, Stat3 and Thy-1 in native cells is a feature of  
dedifferentiation in proteomic data (figure legend). CP – canonical pathways; Functional annotation p<0.001.  
Figure 7.9A: Model network to unify findings from Figures 7.5-7.7.  Network derived from prediction of  
Tgf-β1 as a core upstream regulator of  expression changes associated with native tenocyte transition to 
monolayer.  Predicted intermediate regulators and tendon markers are overlain with differential expression 
values from A) Affymetrix.  Reduction in expression of  Ctgf, Scx, Smad7, and Thy-1 in native cells is 
feature of   dedifferentiation in Affymetrix data.      
A. 
Low High Log2 fold-change 
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B. Low High Log2 fold-change 
Figure 7.9B: Model network to unify findings from Figures 7.5-7.7.  Network derived from prediction of  
Tgf-β1 as a core upstream regulator of  expression changes associated with native tenocyte transition to 
monolayer.  Predicted intermediate regulators and tendon markers are overlain with differential expression 
values from B) Illumina.  Reduction in expression of  Ctgf, Tgf-β2, Cepbp and Thy-1 in native cells is 
feature of   dedifferentiation in this model.      
C. Low High Log2 fold-change 
Figure 7.9C: Model network to unify findings from Figures 7.5-7.7.  Network derived from prediction of  
Tgf-β1 as a core upstream regulator of  expression changes associated with native tenocyte transition to 
monolayer.  Predicted intermediate regulators and tendon markers are overlain with differential abundance 
values from C) proteomic relative quantification study.  Reduction in abundance of  Ctgf, Stat3 and Thy-1 in 
native cells is feature of   dedifferentiation in proteomic studies – see also Figure 7.8C.      
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Figure 7.10: Protein-protein 
interaction network derived 
f r o m  S T R I N G  f o r 
dedifferentiation mechanistic 
network.  Network considers 
both cartilage and tendon 
m a r k e r s ( C O L 2 A 1 a n d 
TNMD).  Modes of  actions for 
proteins are indicated in the 
network and are defined in the 
figure legend.  Interaction 
network was found to be 
enriched (p = 3.4 e-12) with 45 
interactions observed on 15 
proteins.    
Activation 
Inhibition 
Binding 
Phenotype 
Catalysis 
PTM 
Reaction 
Expression 
Figure legend  
KEGG Pathways # of  Proteins FDR 
Rheumatoid arthritis 5 9.2e-7 
TNF signaling pathway 5 2.8e-6 
Osteoclast differentiation 5 5.6e-6 
Table A: KEGG pathways 
associated with proposed 
dedifferentiation network with 
associated false discovery rate 
(FDR) and the number (#) of  
proteins associated with the 
term 
Table A: 
Biological Process Terms # of  Proteins FDR 
Regulation of  cartilage 
development 
5 3.1e-6 
Response to TGFbeta 6 1.2e-5 
Cartilage condensation 4 5.6e-6 
Table B: 
Table B: Biological process 
ontology terms associated with 
proposed dedifferentiation 
network with associated false 
discovery rate (FDR) and the 
number (#) of  proteins 
associated with the term 
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7.3.4: Re-differentiation transition from monolayer is associated with 
PDGF BB mediated network 
The monolayer to three-dimensional construct transitions were predicted to be 
associated with the inhibition of PDGF BB, TNF and IL-1B in gene expression 
studies, and with TGF-β1 activation in proteomics studies for both chondrocytes 
and tenocytes (Table 7.2).  Mechanistic networks were prepared for the highest 
scoring regulators for chondrocytes (PDGF BB) and tenocytes (TNF) and with 
focused components of the networks shown for IL-6 (chondrocytes) and IL-1B 
(tenocytes) in Figures 7.11-7.12. In proteomics studies JUN was a common 
intermediate regulator in the TGF-β1 network for both chondrocytes and tenocytes 
and the down-stream differentially abundant targets are presented in Figure 7.13.     
Transcriptomic- and proteomic-derived mechanistic networks regulated by PDGF 
BB and TNF overlapped with a number of intermediate regulators previously 
described for dedifferentiation including FOS, ApoE, IL-6, JUN, and EGR1.   
To define whether these de- and re-differentiation transitions could be unified in a 
single mechanistic network a model was prepared as before using PDGF BB as the 
common upstream regulator and including downstream targets present in both de- 
and re-differentiation networks and differentially expressed genes or proteins 
frequently identified as targets across the data sets, Figures 7.14– 7.19.  Protein-
protein interactions, Figure 7.20, were not significantly enriched, however KEGG 
pathways were comparable to the dedifferentiation network.  Functional 
annotations were associated with ECM organization and anatomical structure 
morphogenesis.   
     
 552 
SERPINE1 and SERPINE2 show reciprocal expression across data sets 
The serine protease inhibitors and chaperones SERPINE1 and SERPINE2 were 
found to be common downstream targets of predicted regulators across data sets.  
In the model networks presented in Figures 7.14 and 7.15-7.19 reciprocal 
expression patterns were noted with SERPINE2 showing higher gene and protein 
expression in native and three-dimensional conditions for both chondrocytes and 
tenocytes, whilst SERPINE1 expression was higher in monolayer for both cell 
types.  
 
Cell type Data source Upstream 
regulator 
Activation  
z-score 
Overlap  
p-value 
DE genes  
available 
Chondrocytes Illumina PDGF BB 
TNF 
IL1B 
-6.13 
-4.85 
-5.88 
1.2e-28 
5.3e-26 
3.4e-17 
220 (23) 
276 (16) 
222 (12) 
Chondrocytes Affymetrix TP53 
PDGF BB 
IL1B 
-0.11 
-4.78 
-6.2 
1.1e-32 
4.6e-30 
5.3e-22 
512 (24) 
335 (20) 
352 (13) 
Chondrocytes Proteomics MYC 
TP53 
TGFB1 
2.5 
1.23 
5.5 
3.9e-40 
2.5e-33 
5.8e-17 
279 (17) 
272 (18) 
254 (16) 
Tenocytes Illumina MYC 
TNF 
PDGF BB 
-0.58 
-2.3 
-2.5 
1.6e-13 
1.5e-07 
3.9e-07 
165 (16) 
211 (16) 
172 (13) 
Tenocytes 
 
Affymetrix TNF 
IL1B 
PDGF BB 
-6.9 
-6.84 
-6.85 
1.94e-56 
1.95e-56 
1.04e-48 
266 (15) 
250 (11) 
211 (16) 
Tenocytes 
 
Proteomics MYC 
APP 
TGFB1 
-0.56 
-2.29 
2.6 
5.8e-42 
9.1e-30 
7.13e-19 
380 (16) 
340 (18) 
401 (18) 
Table 7.2: Top upstream regulators predicted using Ingenuity Pathway Analysis knowledge base from 
differential expression/abundance for the monolayer to three-dimensional construct comparison 
across three data sources and two cell types.  Small molecules and other chemicals predicted by IPA are 
not included.  The activation z-score indicates the predicted activation status of  the mechanistic 
network.  Only genes with available mechanistic networks are shown.  DE genes available indicates 
those genes in the differential lists that are known down-stream targets of  a number of  mechanistic 
regulators (defined in parentheses).  For the transcriptomic data PDGF BB is commonly inhibited; for 
tenocytes TNF scored higher in both data sets.  For the proteomics data results were more variable, 
however, in both cases TGFB1 mechanistic network was predicted to be activated, the inverse of  the 
native to monolayer comparison.   
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Figure 7.11: Mechanistic network derived from downstream targets of  Pdgf  bb to show genes with direct 
interactions with IL-6. Nodes overlaid with differential expression data from A: Affymetrix, B: Illumina 
monolayer to alginate comparison. In both gene expression studies lower expression of  Il-6, TLR2 and CXCL2 
is found in monolayer culture relative to alginate beads under the predicted influence of  regulators shown in blue 
(figure legend). PI3K antagonist LY294002 is shown as activated.     
A. Affymetrix 
B. Illumina 
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Figure 7.12: Mechanistic network derived from downstream targets of  TNF to show genes with direct 
interactions with IL-1B. Nodes overlaid with differential expression data from A: Affymetrix, B: Illumina 
monolayer tenocytes to fibrin comparison. In both gene expression studies lower expression of  CXCL2 and 
ApoE is found in monolayer culture relative to fibrin cultures under the predicted influence of  regulators shown 
in blue (figure legend).   Added nodes: TNMD, SOX9 
A. Affymetrix  
B.  Illumina 
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Figure 7.13: Mechanistic network derived from downstream targets of  TGF-β1 to show proteins with 
direct interactions with Jun. Nodes overlaid with differential expression data from A: monolayer 
chondrocytes to alginate, B: monolayer tenocytes to fibrin cultures. In both protein abundance studies 
lower levels of  ICAM1 and IGF2R are found in monolayer cultures relative to the three-dimensional 
culture condition (figure legend).   
A.  Chondrocytes 
B. Tenocytes 
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A: Affymetrix: native chondrocytes to monolayer  
B. Affymetrix: monolayer chondrocytes to alginate 
Figure 7.14: Model developed from upstream regulators IL-6, PDGF-bb and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Higher expression of  IL-1b and 
COL2A1 in native chondrocytes with GREM1, SERPINE1 and COL3A1 more robustly expressed in monolayer 
cultures (figure legend); B: The re-differentiation transition finds a reciprocal relationship in the expression of  
SERPINE1 and SERPINE2; further alginate cultures show higher expression of  GPNMB, CHI3L1 and ApoE 
relative to monolayer.   
Low High 
Log2 fold-change 
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A: Illumina: native chondrocytes to monolayer  
B. Illumina: monolayer chondrocytes to alginate 
Figure 7.15: Model developed from upstream regulators IL-6, PDGF-bb and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Higher expression of  ApoE and 
COL2A1 in native chondrocytes with SERPINE1, GPNMB and TGFB2 more robustly expressed in monolayer 
cultures (figure legend); B: The re-differentiation transition finds a pro-inflammatory response with higher 
expression of  IL-6, CXCL2 and PTGS2 in alginate cultures.  Monolayer shows lower expression of  CHI3L1 and 
ApoE relative to alginate indicating some restitution of  the native expression profile.   
Low High 
Log2 fold-change 
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A: Proteomics: native chondrocytes to monolayer  
B. Proteomics: monolayer chondrocytes to alginate 
Figure 7.16: Model developed from upstream regulators IL-6, PDGF-bb and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Higher expression of  Col2a1, 
Serpine2 and Ptgs2 in native chondrocytes with Serpine1, Ctgf  and Tgfb2 more robustly expressed in monolayer 
cultures (figure legend); B: The re-differentiation transition finds the reciprocal relationship between Serpine1 
and Serpine2 demonstrable in the protein profile of  chondrocytes.   
Low High 
Log2 fold-change 
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A: Affymetrix: native tenocytes to monolayer  
B. Affymetrix: monolayer tenocytes to fibrin constructs 
Figure 7.17: Model developed from upstream regulators IL-6, PDGF-BB and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Higher expression of  key regulators 
PDGF BB, IL-6 and IL-1b in native tenocytes (figure legend); B: The re-differentiation transition finds lower 
expression of  IL-6, SERPINE2, BMP2 and ATF3 in monolayer relative to fibrin constructs suggestive of  an 
expression profile consistent with some restitution of  a differentiated state.   
Low High 
Log2 fold-change 
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A: Illumina: native tenocytes to monolayer  
B. Illumina: monolayer tenocytes to fibrin constructs 
Figure 7.18: Model developed from upstream regulators IL-6, PDGF-BB and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Higher expression of  ApoE and 
FOS in native tenocytes is associated with reduced expression of  CTGF and GREM1 relative to monolayer 
(figure legend); B: The re-differentiation transition finds lower expression SERPINE2 and GREM1 in 
monolayer relative to alginate.   
Low High 
Log2 fold-change 
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A: Proteomics: native tenocytes to monolayer  
B. Proteomics: monolayer tenocytes to fibrin constructs 
Figure 7.19: Model developed from upstream regulators IL-6, PDGF-bb and IL-1b and genes/proteins with 
common differential expression across both cartilage and tendon studies. A: Reciprocal expression of  SERPIN 
proteins was evident in dedifferentiation with higher abundance of  SERPINE2 in native tenocytes (figure 
legend); B: The higher expression of  FSTL1, CTGF and COL3A1 was evident in monolayer with lower 
expression of  SERPINE2 relative to fibrin.   
Low High 
Log2 fold-change 
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F i g u r e 7 . 2 0 : P r o p o s e d 
universal mechanistic network 
for de- and re-differentiation. 
Protein-protein interaction 
n e t w o r k d e r i v e d f r o m 
STRING. Modes of  actions for 
proteins are indicated in the 
network and are defined in the 
figure legend.  Interaction 
network was not found to be 
enriched with 74 interactions 
observed on 21 proteins.    
Activation 
Inhibition 
Binding 
Phenotype 
Catalysis 
PTM 
Reaction 
Expression 
Figure legend  
KEGG Pathways # of  Proteins FDR 
TNF signaling pathway 6 2.5e-7 
Rheumatoid arthritis 5 6.1e-6 
Osteoclast differentiation 4 1.9e-3 
Table A: KEGG pathways 
associated with proposed 
dedifferentiation network with 
associated false discovery rate 
(FDR) and the number (#) of  
proteins associated with the 
term 
Table A: 
Biological Process Terms # of  Proteins FDR 
Response to mechanical 
stimulus 
9 1.1e-9 
Extracellular matrix 
organisation 
8 8.04e-7 
Anatomical structure 
morphogenesis 
12 1.2e-5 
Table B: 
Table B: Biological process 
ontology terms associated with 
proposed dedifferentiation 
network with associated false 
discovery rate (FDR) and the 
number (#) of  proteins 
associated with the term 
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7.4: Discussion  
 
7.4.1: Union of data sets and functional annotations 
There was variable overlap between data sets in terms of commonly differentially 
represented genes and proteins.  Only a fraction of genes expressed in either the 
Illumina or Affymetrix studies were represented in the proteomics studies.  
Additionally, across all studies there were consistently very few common elements.  
For transcriptomic data this not unexpected (Manoli, Gretz et al. 2006).  Using only 
these common elements to integrate functional annotations would encourage 
erroneous and biased descriptors of the data. The integrated annotations presented 
here represent a consensus across two data sets using the MONA algorithm (Sass, 
Buettner et al. 2013, Sass, Buettner et al. 2014), which uses a Bayesian approach to 
determine marginal posteriors for the gene ontology terms.  This allowed the 
simultaneous assessment of data sets arising from both mRNA and protein studies.  
Integrated biological process functional annotations across transcriptomic and 
proteomic data sets demonstrated general concordance with findings previously 
presented.  In particular the relevance of metabolic changes associated with 
oxidation-reduction, carbohydrate and phospholipid biosynthetic processes were 
prominent.  A number of development-associated terms relating to muscle 
structure, vasculature, and cardiovascular development and cell morphogenesis were 
found across data sets.  Muscle-associated functional annotations were not 
restricted to tendon-derived data sets.  The application of this omics integration 
technique also highlighted Wnt- and NF-κB signalling, which although evident in 
the differential expression analysis in individual data sets, have not been consistently 
identified as significant gene ontology annotations.   
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The actions of Il-6-mediated signaling have been discussed in Chapter 5.  
Discussion here focuses on TGF-β-mediated mechanisms related to 
dedifferentiation. 
7.4.2: Shared upstream regulators guide mechanistic networks 
Union of elements or ontology-based approaches do not provide a mechanistic 
insight into the system under investigation; neither do they directly make use of the 
quantitative data.  In order to explore whether common mechanisms were 
regulating the dedifferentiation or redifferentiation phenotypes Ingenuity Pathway 
Analysis was used to define upstream regulators shared between chondrocytes and 
tenocytes.  Using known protein-protein interaction databases it was possible to 
demonstrate a highly enriched TGF-β centric network associated with 
dedifferentiation.  Further Ingenuity analysis of the redifferentiation transition 
predicted a reciprocal relationship between TGF-beta activation in monolayer and 
PDGF activation in three-dimensional cultures.  
SMAD7 as a mediator of differentiation status 
In musculoskeletal tissues TGF-βs are diverse regulators of differentiation steering 
developmental programs such as cell-fate decisions between cartilage and tendon 
(Lorda-Diez, Montero et al. 2009), chondrogenic condensation and proliferation 
(Finnson, Chi et al. 2012) and are key regulators of disease.  In a mechanical 
disruption osteoarthritis model high concentrations of TGF-β1 were found in 
subchondral bone (Zhen, Wen et al. 2013).  In this study transgenic activation of 
TGF-β1 expression induced osteoarthritis, whilst knock-out of the TGF–β type II 
receptor in subchondral MSCs mitigated these effects.  As such the TGF-β-family 
 565 
includes rational targets for regenerative interventions e.g. gene-based therapy 
(Madry and Cucchiarini 2013, Zhen and Cao 2014).  
That TGF-β-mediated signalling is predicted as a master upstream regulator of the 
gene and protein responses seen in de- and re-differentiation is unsurprising given 
the considerable complexity of ligand-receptor interactions and plasticity of TGF-β-
signalling processes (Schmierer and Hill 2007, Cellière, Fengos et al. 2011).  These 
data sets provide no indication of the temporal nature of the signal (whether 
transient, sustained or oscillatory) that would define more accurately the differences 
in cellular response observed across the different culture conditions.  Furthermore, 
a number of contextual determinants, for example factors regulating signal 
transduction (ligand isoforms), transcription factors that bind to SMAD proteins, 
and the epigenetic status of the cell, all modulate the TGF-β signaling effects 
(Massagué 2012).  Consequently, analysis of isolated and static gene expression 
profiles alone cannot provide a consistent understanding of the underlying 
mechanism when trying to establish the differentiation status of a cell.  In brief, the 
binary nature of pathway predictions in this study (activated versus inactivated) 
resulted in conflicted reports of pathway involvement.  This calls into question the 
reproducibility of pathway predictions and the relevance of predicted intermediate 
regulators.   
Although conflict exists there is still likely to be strong concordance in the 
biological process involved.  With this in mind integration in this chapter considered 
only common regulators identified across multiple data sets and focused only on 
downstream effectors that appeared in two or more data sets from the same cell 
type.   Whilst a cautious approach it is qualified by evidence in the literature 
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indicating the poor reproducibility of ‘biosignature’ approaches to defining 
phenotypes arising from small data sets (Azuaje, Zheng et al. 2011).       
This analysis sought to focus on the TGF-β-antagonist SMAD7 for which there was 
evidence of differential expression in dedifferentiation in both chondrocyte and 
tenocyte analysis across two platforms.  Additionally, it was associated with a 
number of common downstream targets, including CCN2/CTGF and SERPINE1.    
SMAD7 can inhibit both BMP (R-SMADS 1/5/8) and TGF-β (R-SMAD 2/3) 
signaling by competitively binding receptor R-SMADS (Nakao, Afrakhte et al. 1997, 
Massagué, Seoane et al. 2005), and through ubiquitin-mediated degradation of 
activated TGF-β receptor complex in association with SMURF2 (Kavsak, 
Rasmussen et al. 2000).  It is implicated in multiple physiological and 
pathophysiological contexts including embryonic development, fibrosis, 
tumourigenesis and inflammation (Zhu, Chen et al. 2011) consistent with TGF-β-
signaling pathways.  Two adenoviral over-expression studies of SMAD7 (from the 
same group) have been shown to be chondroprotective in osteoarthritis models 
(Scharstuhl, Vitters et al. 2003, Blaney Davidson, Vitters et al. 2006).   
SMAD7 influences differentiation and proliferation in chondrocytes 
Effects of SMAD7 on chondrocyte phenotype have been previously established.  
SMAD7 is expressed in developing growth plates (Sakou, Onishi et al. 1999).  In 
SMAD7 knock-out mice defects in terminal chondrocyte maturation are found with 
reduced shortened hypertrophic zones in a study of endochondral ossification 
(Estrada, Wang et al. 2013). Elevated levels of HIF1α were also found in the 
proliferative zones of SMAD7-/- mice suggesting an impact on the hypoxic stress 
response in developing cartilage. Further evidence for the effects of SMAD7 on the 
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differentiation status of chondrocytes comes from adenoviral over-expression of 
SMAD7 severely inhibited Mekel’s cartilage development in mice (Ito, Bringas et al. 
2002) whilst SMAD7-associated inhibition of differentiation and proliferation of 
osteoblasts has also been reported (Yano, Inoue et al. 2012).   
Recent work in β-islet cell differentiation in the pancreas (see Chapter 1) has 
demonstrated that reversal of dedifferentiation may be achieved through TGF-β 
inhibition; Blum, et al (2014) presented evidence indicating that an ALK5/TGF-βR1 
inhibitor was able to rescue dedifferentiated β-cells and inhibit cytokine-induced β-
cell stress (Blum, Roose et al. 2014).  Furthermore, enhanced expression of SMAD7 
promotes β-cell proliferation in vivo (Xiao, Gaffar et al. 2014), and this proliferation 
in response to β-cell loss may require an initial transition through a dedifferentiation 
state (El-Gohary, Tulachan et al. 2014).    
In summary, SMAD7 modulation of TGF-β signalling in dedifferentiation of 
chondroyctes, and tenocytes, is predicted in bioinformatics analysis and 
demonstrated in differential expression studies.  TGF-β signalling is implicated both 
in cartilage disease and development.  Evidence indicates that the developmental 
paradigm is recapitulated in osteoarthritis (Tchetina 2011).  It is, therefore, exigent 
that a better understanding of the dedifferentiation mechanism it developed. In 
particular defining whether the resulting loss of functional phenotype is firstly, 
associated with cartilage degeneration, secondly, a regenerative mechanism that may 
be harnessed.    
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7.4.3: SERPINE1, an ALK5 target, shows reciprocal expression with 
SERPINE2 between native, monolayer and three-dimensional 
cultures 
The model networks for de- and re-differentiation data from mRNA and protein 
studies show the reciprocal expression of two SERPIN family E-clade members, 
SERPINE1/PAI-1 (plasminogen activator inhibitor 1) and SERPINE2/PN-1 (glial-
derived nexin).  The latter shows higher expression in the native and three-
dimensional conditions, whilst the former shows up-regulation in monolayer.  
Although previously defined exclusively as serine protease inhibitors most SERPIN-
family members are often chaperones with diverse roles (Heit, Jackson et al. 2013). 
TGF-β signaling induces SERPINE1 expression through the co-operative binding 
of R-SMADs and AP-1 (Fos/Jun heterodimer) to the promoter (Zhang, Feng et al. 
1998, Guo, Inoki et al. 2005). The concomitant protein PAI-1, a secreted 
glycoprotein, is the inhibitor of urokinase plasminogen activator (uPA) and tissue 
plasminogen (tPA), which are required for the conversion of plasminogen to 
plasmin, a potent proteolytic enzyme (Małgorzewicz, Skrzypczak-Jankun et al. 2013) 
that activates a number of MMP family members with roles in ECM remodeling.  
As such PAI-1 titrates ECM degradation permitting the accumulation of ECM 
components at injury sites.  Although primarily an inhibitor of fibrinolysis it is also 
associated with a number of pathological processes especially fibro-proliferative 
disorders, renal fibrosis, atherosclerosis, vascular thrombosis and rheumatoid 
arthritis under the influence of TGFβ1; these activated genes SERPINE1 and 
CCN2 (see below) are also ROS-dependent (Samarakoon, Overstreet et al. 2013).   
SERPINE2/PN-1 functions are less well understood, however, it has been shown 
to inhibit a number of serine proteases including thrombin and urokinase; 
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expression in astrocytes, endothelial cells and fibroblasts is reported and is 
associated with the ECM.  It is also defined as a substrate for MMP9.  It is the only 
SERPIN found at physiological levels in the brain (Sappino, Madani et al. 1993). 
Recent evidence associated SERPINE2 expression with pro-neoplastic properties 
(Bergeron, Lemieux et al. 2010, Wang, Wang et al. 2014) including increased ECM 
deposition (Buchholz, Biebl et al. 2003).  SERPINE2 risk alleles associated with 
chronic obstructive pulmonary disorder (COPD) are widely reported (Demeo, 
Mariani et al. 2006, Zhu, Warren et al. 2007). Additionally, SERPINE2 has also 
been shown to have antagonistic effects on Hedgehog signaling (Vaillant, Michos et 
al. 2007, McKee, Xu et al. 2012). Whether modulation of SERPIN E protease 
inhibitors is relevant to the differentiation status of model cultures has not been 
determined, however it may be related to modulation of the forming ECM in these 
model cultures.     
7.4.4: CCN2/CTGF, a differentiation regulator and pro-fibrosis 
mediator, is associated with dedifferentiation 
Evidence is presented for the higher expression of the CCN family member 
CCN2/CTGF, connective tissues growth factor, in dedifferentiated chondrocytes 
and tenocytes at the gene and protein level. In Chapter 1 the relevance of CCN-
family members to the ECM is highlighted.  
CCN family members are immediate-early growth-responsive genes (with the 
exception of CCN3/NOV) with roles in cell proliferation, differentiation, 
embryogenesis and wound healing.  Dysregulated expression is extensively 
associated with a number of fibro-degenerative and fibro-proliferative conditions 
including ECM deposition in atherosclerosis, lung and kidney fibrosis, scleroderma 
and muscular dystrophies (Oemar and Lüscher 1997, Leask, Parapuram et al. 2009, 
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Morales, Gutierrez et al. 2013).  CCN2 also shows osteoarthritis-associated pro-
inflammatory effects (Wang, Qiu et al. 2013); intense CCN2 staining by IHC and 
ISH is evident in proliferative chondrocytes in moderate to severe osteoarthritis 
(Omoto, Nishida et al. 2004).  The presence of CCN2 proteolytic fragments in the 
media of femoral head explants of normal cartilage is reported (Wilson, Whitelock 
et al. 2009)  and this increases in the presence of IL-1 (Wilson, Belluoccio et al. 
2008).   
CCN2 is a cysteine-rich secreted protein with a high amino-acid homology with 
other CCN family members.  CCN proteins have a modular structure consisting of 
four-conserved modules: insulin-like growth factor binding protein-like (IGFBP) 
module, b) Williebrand factor type C (VWC) module; c) thrombospondin (TSP) 
type I repeat, and d) C-terminal module with ECM protein, growth factor and 
integrin binding potentials (Takigawa 2013).  The C-terminal module is homologous 
to slit (Oemar and Lüscher 1997) (see Chapter 1 and 2) associated with axonal 
guidance and tendon development in Drosophila (Schweitzer, Zelzer et al. 2010).  
Notably, CCN2 mRNA is induced by TGF-β, but not by PDGF, EDGF, or bFGF  
(Igarashi, Okochi et al. 1993); a TGF-β responsive consensus sequence has been 
identified in the CCN2 promoter region (Grotendorst, Okochi et al. 1996).  
CCN2 in endochondral ossification 
Early research considered CCN2 exclusively in the context of TGF-β1 mediated 
fibrotic conditions; further work demonstrated the pro-hypertrophic effects of 
CCN2 on growth-plate chondrocytes (Nakanishi, Nishida et al. 2000). Comparable 
promotion of differentiated status was subsequently found on osteoclasts and 
vascular endothelial cells defining CCN2 as ‘ecogenin’ or endochondral ossification 
genetic factor for its manifold effects on the proliferation and differentiation of 
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growth-plate chondrocytes, osteoblasts and endothelial cells (Ivkovic, Yoon et al. 
2003, Takigawa 2013).  
Transgenic mice generated to over-express CCN2/lacZ fusion gene under the 
control of the COL2A1 promoter were found to be, relative to the wild-type, larger, 
with longer tibia, there was evidence of enhance chondrocyte proliferation and 
increased proteoglycan and collagen type II accumulation in the proliferative and 
resting zones (Tomita, Hattori et al. 2013).  
CCN2 in differentiation status 
There is normally restricted expression of CCN2 in the adult (usually hepatic stellate 
cells and kidney mesangial cells) and the induction of CCN2 expression by TGF-β 
is generally restricted to cells of mesenchymal origin (Leask, Parapuram et al. 2009).  
CCN2 may be self-regulating in mesenchymal cells by the sustaining particular 
actions of TGF-β (Grotendorst 1997) probably through mediating levels of SMAD7 
(Qi, Chen et al. 2007, Sobral, Montan et al. 2011, van Rooyen, Schäfer et al. 2013). 
These reports are consistent with findings in this study of chondrocytes and 
tenocytes in monolayer demonstrating a TGFβ-CCN2 mediated regulatory network 
with elevated SMAD7 likely to represent a modulatory influence.     
It is not clear how the higher expression of CCN2 should be interpreted in the 
context of dedifferentiation as evidence relates both to musculoskeletal 
developmental stages and fibroblast proliferation mechanisms.  In gain of function 
studies investigating signaling mechanisms regulating cartilage and tendon 
differentiation, local application of TGF-β loaded micro-beads to the 
undifferentiated inter-digital mesenchyme in avian limb buds promotes the 
expression of CCN2, followed by SOX9 and BMPR1b genes; this is contrasted in 
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the digit tip, where chondrogenesis is inhibited and TGF-β application results in 
over-expression of scleraxis (SSCX) driving a tendon phenotype (Lorda-Diez, 
Montero et al. 2014).   
CCN2 has also been demonstrated to differentiate mesenchymal stem cells into 
fibroblasts (Lee, Shah et al. 2010) with enhanced expression of collagen type I and 
tenascin-C; treated cells had an attenuated capacity for tri-lineage differentiation 
potential into osteogenic, chondrogenic or adipogenic cells.   
The reported evidence gives conflicting accounts of the differentiation effects of 
CCN2 and these effects may be cell-restricted.  A definitive understanding of the 
actions of CCN2 on the differentiation status of chondrocytes and tenocytes in 
monolayer culture is not possible from these data sets alone.     
CCN2 in energy production  
Proliferation and differentiation may appear as mutually exclusive mechanisms but 
CCN2 promotes both in chondrocyte development. The findings presented in this 
chapter, of enhanced CCN2 mRNA and protein expression in monolayer and 
subsequent reductions in re-differentiation, are not at odds with the apparently 
“contradictory” (Kubota and Takigawa 2015) actions of CCN2 on chondrocyte 
proliferation and dedifferentiation. In work considering the regulatory effects of 
CCN2 on energy metabolism in chondrocytes Maeda-Uematsu, and co-workers, 
(2014) found that CCN2-null mice had an generalised reduction in the level of 
glycolytic metabolites and intracellular ATP relative to wild-type (WT) controls 
(Maeda-Uematsu, Kubota et al. 2014).  Recovery of intracellular ATP levels in 
chondrocytes from CCN2-null cells was achieved through the addition of 
exogenous CCN2.  Conversely ATP levels were reduced in wild-type cells using an 
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siRNA directed at CCN2 transcripts. The authors concluded that CCN2-mediated 
ATP regulation was likely to be mediated via the anaerobic pathway.  These findings 
may explain the alterations in CCN2 expression in monolayer and model culture 
systems parallel to metabolic changes; elevation of CCN2 expression in rapidly 
proliferating chondrocytes and tenocytes in monolayer culture may be associated 
with the increased energy demands consistent with findings in the work of Maeda-
Uematsu, et al (2014).   
CCN2 and integrin-signaling  
A consideration of CCN2 and integrin-mediated signaling concludes this discussion.  
As define in Chapter 1 the CCN-family have core roles in the transduction of extra-
cellular signals into the cell via integrin-mediated signaling (Leask and Abraham 
2006).  The roles of integrins in cartilage homeostasis and disease have also been 
described (Loeser 2014).  The C-terminal domain of CCN2 is known to interact 
directly with fibronectin through integrin alpha5-beta1 (Hoshijima, Hattori et al. 
2006).  Concentration-dependent increases in the expression of IL-6 in 
chondrocytes induced by CCN2 is attenuated by an alpha5-beta1 integrin 
neutralising antibody in a study of synovial fibroblasts from osteoarthritic joints 
(Liu, Hsu et al. 2012).  Given the relevance of CCN2 to interactions with integrins 
and the modulatory effect on chondrocytes further exploration of the relationship 
of this mechanism to de- and re-differentiation, and the development of organo-
typic cultures is required.    
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7.4.5: Future work  
 
Quantitative integration of data 
To fully realize the potential of multiomics analysis a systematic integration 
methodology is required that also allows exploration and comparison of the 
different strata of quantitative omics data.  Time constraints prevented exploration 
and implementation of these methods.   As previously outlined a number of multi-
variate statistical integration methods have been utilised by researchers to integrate 
quantitative multi-omics data. Of these approaches projection-based methods have 
been widely used and are also available as open-source software packages in the R 
language.  The omnicade4 package implements a multiple co-inertia analysis 
(MCIA) approach to integrate greater than two omics data sets, a previous limitation 
of other methods (Meng, Kuster et al. 2014).  This type of analysis was initially 
applied to ecology data to couple two (DolÉDec and Chessel 1994) or more (Bady, 
Dolédec et al. 2004) tables for the simultaneous ordination of data from a large 
number of environmental sites and populations.  The MCIA method allows the 
projection of several data sets into the same dimensional space and on the same 
scale.  This allows the exploration of diverse data features and the definition of co-
relationships between usually highly dimensional omics data sets.   
These methods still assume a common biological origin for the multi-omics data 
sets, i.e. the same tissue source or cell lines are assayed multiple times, and 
consequently this serves to limit analysis that may be undertaken with data available 
in this thesis.  Given the narrow genetic background of the inbred rat strain used for 
the Affymetrix and proteomic data sets application of co-inertia analysis should be a 
valid quantitative integration strategy.  Specifically this exploration would be used to 
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define co-relationships between the transcriptomic and proteomic data and assess 
the concordance between them.  This is especially useful given than the proteomic 
analysis of cartilage and tendon data is not directly comparable.  Given that this 
approach also doesn’t require intersection of common feature annotations depth of 
coverage is retained potentially enhancing the power of pathway analysis.  The 
potential for feature selection using MCIA also confers the possibility of an 
alternative in silico strategy for validation three-dimensional culture gene signatures.    
Dealing with missing data    
It is evident from the poor overlap of features across all three data sets that there is 
considerable loss of data points, which may bias and limit the understanding of the 
system.  This is particularly an issue for proteomics data due to issues of sensitivity 
and range discussed in Chapter 6.  Data points may be missing at random, 
however, many are missing as a result of non-random effects, e.g. qualitative 
changes between groups or annotation problems.  Often in proteomics studies 
undetected proteins in surveys are assigned ‘zero’ values.  Methods are required to 
impute or model this missing data (Aittokallio 2010, Li, Nie et al. 2011).   
Basic statistical imputation was performed for missing qPCR data (section 2.2.7), 
however, further exploration of missing data points for transcriptomic and 
proteomic profiling studies has not been undertaken.  Exploration of the degree of 
loss with technical replicates would be useful, but the use of imputation methods 
may be considered as cost-efficient as additional replicates (Aittokallio 2010).  
Several approaches have been used for microarray data: K-nearest neighbours, 
Bayesian PCA, and least squares regression.  Notably relatively simple imputation 
methods, such as using mean values, may work as well as more complex approaches 
(de Souto, Jaskowiak et al. 2015).  At present these strategies require 
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implementation prior to downstream analysis in independent data sets.  A pipeline 
for the imputation of missing data and subsequent omics integration should be 
developed to fully exploit the data arising from these studies. 
7.4.6: Summary statements 
The aim of this chapter was to integrate data from two transcriptomic and one 
proteomic data set with view to proposing a regulatory network to model three-
dimensional organotypic culture systems and validate in future work.  Clearly the 
postulated mechanistic networks do not include all elements of the system, but the 
objective was to deconstruct the mRNA and protein data represented in the 
different experiments, not to the point of abstraction, rather into a pragmatic 
mechanism that could be reasonably validated in the laboratory.  
Two key themes emerge from an understanding of the components of the model 
networks presented in this chapter relating to the TGF-β signaling pathway and its 
involvement at the beginning and the end – in development and disease.  This is 
derived from, firstly, the association with musculoskeletal developmental 
phenotypes (Havis, Bonnin et al. 2014, Lorda-Diez, Montero et al. 2014), the 
second with pro-fibrotic pathological mechanisms related to dysregulation of matrix 
turnover.  For example TGF-β1, CCN2 and SERPINE1 are all co-expressed in a 
ureter-obstruction model of kidney fibrosis (Samarakoon, Dobberfuhl et al. 2013).   
The contributory studies in this chapter consider whole tissue and matrix-depleted 
chondrocytes and tenocytes – these models do not consider the matrix roles in the 
sequestration and activation of TGF-β signaling. There is no supporting evidence 
regarding the temporal nature of this TGF-β signal (Cellière, Fengos et al. 2011).   It 
is proposed that to define the prevailing nature of dedifferentiated musculoskeletal 
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cells, or their re-differentiation, requires further research aimed at collecting 
dynamic quantitative and systematic data with levels of down-stream targets such as 
CTGF, SMAD7 and SERPINE1 defined in parallel.  In particular, development of 
cell-specific (Zi, Chapnick et al. 2012), and culture-specific, mathematical models 
for TGF-β signaling are required  as the unified mechanism proposed assumes a 
common trajectory for both chondrocytes and tenocytes in culture.    
To fully utilize the multi-level omics data available in this thesis data imputation and 
integration methods should be explored.  Simple statistical strategies for imputation 
of missing data may be appropriate, whilst multivariate projection-based approaches 
should be employed to integrate quantitative data from gene and protein profiling 
studies.          
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8 :  Genera l  Discuss ion 
 
8.1: Project objectives revisited 
 
Statements of intent 
In this thesis a systems biology approach was employed to explore the three-
dimensional culture phenotype and relate this to whole tissue and standard monolayer 
culture.  As defined at the outset monolayer culture has existed as the pre-eminent 
approach for in vitro modeling for cartilage and tendon.  The limitations of this strategy 
have been clear for many years and novel organotypic culture systems have been 
devised to overcome these limitations.  Despite this, a paradigm shift from two- to 
three-dimensional culture systems has not occurred.  At the time of writing no 
systematic investigation of three-dimensional models of cartilage or tendon has been 
undertaken.  Furthermore, these model culture methods are commonplace within the 
field of musculoskeletal research in spite of the fact that the gene and protein profiles of 
these models have not been fully characterized.   
It was asserted in the introduction that without validated and standardised organotypic 
models expedient translation of bioengineered tissue from the laboratory to the clinics 
would not be possible within the current regulatory frameworks.  It was also stated that 
the majority of studies utilized narrow definitions of differentiated status when 
qualifying progress in cartilage and tendon tissue engineering.  To fully realize the 
potential of in vitro systems, maximize the use of rare clinical specimens, and reduce the 
use of animal models there is a need for global characterization of organo-typic models 
and systematic comparisons with the in vivo environment.  Systems biology methods, 
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such as those presented in this thesis, are well-suited to complex integration of data and 
may be used to generate predictive models for functional validation.         
Associated with each chapter specific observations have been presented and specific 
discussion statements built upon these; associated recommendations for further 
validation and development of the results were also defined.  In this final discussion the 
principal themes of the study as a whole are considered; additionally the contribution to 
musculoskeletal research is outlined and a road map for further work is provided.   
The key project objectives were defined in Chapter 1 and these are revisited here in 
three sections.  Novels findings and their impact are reflected upon relative to these 
objectives; general concerns arising across all studies are considered, and future research 
and methodologies are presented.   
8.2: The de- and re-differentiated phenotypes.   
 
Objective 1: To define dedifferentiation and re-differentiation to mark-out 
the phenotypic boundaries within which cartilage and tendon cells function 
The terms de- and re-differentiation are used in cartilage and tendon research with no 
mechanistic definition.  Additionally there is no standard phenotype against which to 
benchmark novel findings and progress in bioengineering.  Progress is defined through 
the analysis of a limited spectrum of well-described differentially expressed genes and 
proteins, but inter-experimental comparisons are difficult and rarely are findings 
interrogated against other studies in the field.  By creating a reference gene expression 
profile for native cartilage and tendon, dedifferentiated chondrocytes and tenocytes, and 
three-dimensional culture systems a baseline catalogue is created against which further 
developments may be referred.       
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Regenerative medicine has the goal of replacing lost or damaged cells.  Approaches to 
achieve this include reprogramming, dedifferentiation or transdifferentiation; of these 
dedifferentiation represents a proliferative, less differentiated phenotype (Jopling, Boue 
et al. 2011).  In the mammal, recent work has found dedifferentiation occurs in 
regenerative (Porrello, Mahmoud et al. 2011) and degenerative contexts (Szibor, Pöling 
et al. 2014).  It may be a prerequisite to the replacement of lost cells (El-Gohary, 
Tulachan et al. 2014).  Dedifferentiation is recognised in chondrocytes (Schulze-Tanzil 
2009) and tenocytes (Yao, Bestwick et al. 2006) as a ‘side-effect’ of monolayer culture.  
Dedifferentiation as a mechanism in osteoarthritis is inconsistently referred to (Young, 
Smith et al. 2005) and its contribution to tendinopathy is unknown.  In order to 
investigate dedifferentiation as a contributory process to a loss of function or 
degenerative phenotype, or even a regenerative mechanism, in adult cartilage and 
tendon there must be adequate reference points.   
8.2.1: Dedifferentiation in monolayer represents a proliferative ‘pre-differentiated’ 
phenotype 
To initially explore a sematic association with dedifferentiation in regenerative contexts 
(Kragl, Knapp et al. 2009) qualitative definitions of dedifferentiation in monolayer were 
made: i) quiescent cells proliferate, ii) there is loss or reduced expression of the 
functional synthetic profile, iii) increased expression of markers of a pre-differentiated 
phenotype, iv) and markers are lineage restricted and not indicative of reversion to a 
pluripotent state, i.e. embryonic stem cell.   
Across two gene expression profiling studies there was evidence that chondrocytes and 
tenocytes were proliferative and expression of functional hallmarks were reduced (Tnmd, 
Col2a1) (2.3.3 and 3.3.3) in line with current understanding.  This study contributes to 
this by demonstrating increases in the expression of mesenchymal markers and markers 
 591 
of cartilage and tendon development (including Scx and Mkx) in monolayer-expanded 
cells. There was no evidence for a reversion to a pluripotent state as defined by the 
expression of markers associated with embryonic or induced pluripotent stem cells.  
Furthermore, the higher expression of homeobox genes, associated with developmental 
positioning (Pitx1), was robustly expressed in monolayer.  Finally, evidence of preserved 
expression of homeobox genes associated with topographical anatomy was described 
for adult cartilage and tendon (section 2.3.9).      
In purely sematic terms there is reasonable concordance with the qualitative definitions.  
This thesis proposes that chondrocytes and tenocytes in monolayer culture have a 
phenotype consistent with a proliferative ‘pre-differentiated’ musculoskeletal cell that 
may have position- and lineage-restricted potential.  In other words, the simple act of 
placing cells in monolayer culture induces phenotypic changes reminiscent of pre-
differentiated state.  This notion challenges studies defining the presence of adult tissue 
progenitor cells based exclusively on the expression of marker genes in monolayer.     
Recent evidence suggests that cartilage and tendon precursor cells are not defined by the 
isolated expression of Sox9 or Scx alone, rather combinations of expression patterns are 
evident in precursor tenocytes depending on the developmental proximity to nascent 
cartilage (Sugimoto, Takimoto et al. 2013) (section 1.5).  Evidence of the expression of 
Scx in both chondrocytes and tenocytes at passage three (section 3.3.3) lends credence 
to the hypothesis that they show common heritage and respond in a comparable way in 
vitro.  This has implications for our understanding of chondrocyte and tenocyte cell 
biology and how we exploit these cells in tissue engineering.  Firstly, these adult-derived, 
terminally differentiated cells are plastic and have potential to express developmental 
markers.  Secondly, by expressing developmental markers dedifferentiated cells may be 
in a permissive state that may be manipulated for regenerative purposes through the 
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correct biochemical and biomechanical cues.  Thirdly, this study provides reference 
markers against which gene expression profiles from disease states may be compared to 
in order to make inferences about underlying pathophysiological mechanisms, i.e. is loss 
of function by dedifferentiation a mechanism in chronic cartilage degeneration?  
8.2.2: Tissue-derived stem cells in monolayer cultures: dedifferentiated cells 
by any other name? 
Evidence of the multi-potentiality of tissue-derived stem cells has long relied on 
qualitative colourimetric assays (Alcian blue and Oil Red O staining for chondrogenic 
and adipogenic differentiation potential respectively) and limited panels of genes are 
assessed by qPCR.  There is no published comparison between the transcriptome and 
proteome of putative tissue-derived stem cells that have undergone directed 
differentiation studies and mature tissue.  Methods for isolating tissue progenitor 
populations from tendon (Bi, Ehirchiou et al. 2007), for example, are not dissimilar to 
those used in this thesis to derive tenocytes for monolayer culture.  In both scenarios  
cultures start with very low seeding densities.   Furthermore, there is no standardization 
in these techniques or comparison of putative tissue-progenitor cells between 
laboratories (Prockop 2009).   
The markers for musculoskeletal progenitors were frequently evident in the gene 
expression surveys in this thesis.  For example, Worthley, et al (2015) recently defined a 
novel nestin-negative (BMSC marker) skeletal stem cell population, 
osteochondroreticular (OCR) cells, in a cell-tracking experiment based upon the 
expression of the BMP antagonist Grem1 (Gremlin 1) (Worthley, Churchill et al. 2015).  
Consistently Grem1 has been identified as significantly differentially expressed in three-
dimensional culture systems from both chondrocytes and tenocytes (sections 2.3.2, 
3.3.2, 6.3.3, and SD2/3).  This may indicate that common regulatory mechanisms that 
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are in play in the de- to re-differentiation transition are common to differentiation 
pathways for resident adult progenitor cells.      
Markers for musculoskeletal progenitor cells are diverse and inconsistent in the 
literature and are over-represented in differential gene expression analysis of 
proliferating chondrocytes and tenocytes in this thesis.  A critical area for development 
of the findings in this study would be global gene and protein profiling of mesenchymal 
stem cells relative to cartilage stem/progenitor cells (Jiang and Tuan 2015), cells 
undergoing directed differentiation towards a chondrocytic phenotype, three-
dimensional culture systems and monolayer (dedifferentiated) cells.  Without more 
subtle descriptors the phenotypes of musculoskeletal cells in diverse environmental 
conditions cannot be adequately resolved and concerns should be raised where adult 
stem cell markers are reported to be present in cells that have undergone periods of 
monolayer expansion.   
 
8.2.3: Gene expression convergence challenges continued use of 
monolayer to model chondrocyte and tenocyte phenotypes 
Convergence of gene expression profiles in monolayer culture has been shown in cells 
from multiple tissue sources (Prasad, Kumar et al. 2013).  In two independent 
comparative studies convergence of chondrocytes and tenocyte gene expression profiles 
were found (sections 2.3.2 and 3.3.2). The fundamental question arising from this 
finding is whether the use of monolayer culture is defensible for the study of 
chondrocytes or tenocytes given that monolayer culture is physiologically uninformative 
(Haycock 2011).  Clearly there are limitations to the use of whole tissue, but universal 
acceptance of three-dimensional culture systems, and a move away from monolayer 
culture studies, is restrained by a lack of commercially available ‘bio-inspired’ materials 
that could be used in a flexible, reproducible and affordable manner to facilitate 
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seamless in vitro to in vivo translation of research (Prestwich 2007). Despite the 
importance of monolayer culture this study identifies that a critical obstacle to 
development of rational organotypic models is a dearth of integrated mRNA expression 
and protein abundance studies and a reliance on underpowered studies defining changes 
in a limited number of established markers as the sole deliverable output of a study.  A 
deeper understanding of the nature of organotypic cultures and the protein regulatory 
networks that govern the phenotype would facilitate translational research.  The 
contributions to this end are detailed further in the succeeding sections.        
8.2.4: Three-dimensional cultures do not restitute native expression 
profiles 
For three-dimensional cultures to represent adequate models of tissue a stable 
phenotype is required with gene and protein profiles consistent with (or comparable to) 
the tissue under investigation.  To achieve this would entail integration of biophysical 
and biochemical signals dynamically (Spanoudes, Gaspar et al. 2014).  In contribution to 
this goal mRNA and protein profiling evidence in this thesis demonstrates that 
established three-dimensional culture models for chondrocytes (De Ceuninck, Lesur et 
al. 2004) and tenocytes (Kapacee, Richardson et al. 2008) fail to restitute 
dedifferentiated cells to a cartilage or tendon phenotype respectively.  
For alginate culture, in particular, there is evidence of elevated expression of cytokines 
(sections 2.3.2 and 3.3.2), a shift to oxidative phosphorylation (section 6.3.5) and 
evidence of reduced cell viability with time (section 2.3.8).  Alginate cultures in both rat 
and human gene expression studies had more extreme expression of markers of 
inflammation than cartilage samples derived from human osteoarthritis or rat surgical 
models of osteoarthritis (section 5.3.9).    
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8.2.5: Gene signature classifies three-dimensional cultures 
Implicit in the title of this study was the requirement that the analysis of large 
expression profiling studies would have a practical output in relation to tissue 
engineering rather than creation of reference gene and protein lists alone.  A thirteen 
gene signature with enriched protein-protein interactions confidently identified alginate 
cultures separate from native or monolayer samples (section 5.3.10).  The results of the 
microarray meta-analysis may facilitate a systems approach to organotypic model 
development by defining whether gene expression changes associated with a novel 
intervention, e.g. novel cell scaffold, are more comparable to a standardised model 
systems or a native phenotype.  The validation of a standard phenotype in these culture 
systems would establish a control condition against which these interventions could be 
compared.  It could also encourage the reduction of animal tissue harvesting for these 
studies. This study also established that the gene signature differed between human and 
rodent studies with possible implications related to the translation of findings in rodent 
musculoskeletal studies to human disease.  
8.2.6: Matrix-depletion facilitates deeper exploration of cartilage and 
tendon proteome 
Improving the depth of proteome coverage usually requires additional fractionation or 
depletion steps to deal with the vast dynamic range in protein abundance.  High 
resolution LC-MS has improved this in recent years, however, this is still challenging for 
cartilage and tendon due to the highly anionic extra-cellular matrix.  In this thesis a 
simple protocol is outlined to deplete chondrocytes and tenocytes of extra- and peri-
cellular matrix resulting in a greater depth of coverage than found previous discovery 
publications (Hsueh, Önnerfjord et al. 2014), (section 6.3.2).  This opens the potential 
of detecting low abundance, regulatory proteins – for example, gremlin 1, catenin beta 1 
and MAP kinases were all identified in tenocytes in monolayer or fibrin cultures.  
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Beyond validation of individual targets the natural progression for this analysis would be 
to systematically build-up the proteome from component studies.  In Deshmuhk, et al 
(2015) comparable problems associated with skeletal muscle discovery analysis were 
overcome by combining uniquely identified proteins from C2C12 cultured myotubes 
and whole muscle to define 10, 218 proteins (Deshmukh, Murgia et al. 2015).  Stepwise 
discovery analysis of fractionated and cultured samples, in addition to whole tissue, 
would aid a more comprehensive understanding of the cartilage and tendon proteome.      
8.3:  Dealing with complex and heterogeneous data 
sets   
 
Objective 2: Define cross-species responses to homeostatic perturbations 
by cartilage and tendon through integration of gene-expression data 
 
8.3.1: Cross-species comparison of transcriptome networks yields novel 
insights  
In order to challenge the conclusions drawn from gene expression surveys of de- and 
re-differentiated cell profiles were considered with respect to other published data sets.  
The dearth of quality microarray data sets profiling cartilage or tendon in the rat 
required a permissive study inclusion policy in order to apply co-expression analysis 
methods to explore the global transcriptome network.  Using a data merging approach 
resulted in a complex and heterogenous matrix of samples and expression data.  The 
same methods were applied to human cartilage and tendon data and a comparison of 
the global transcriptome network architecture was undertaken to define common 
functional sub-networks that had a strong statistical association with particular 
phenotypes. 
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Modules within the rat transcriptome network corroborated the gene ontology 
functional annotations described in Chapter 2 and 3 with gene modules from 170 
arrays describing immune system processes, cell cycle and metabolic activity, and 
skeletal system development.  From the rat network a highly interconnected sub-
network of genes with known osteoarthritis associations were found (section 5.3.7).  
These were strongly associated with a normal cartilage phenotype and strongly 
negatively correlated with perturbed samples from rat models of osteoarthritis.  Within 
this sub-network genes with no known osteoarthritis association were found – it is 
proposed that these genes may have relevance to a further understanding of the 
pathophysiology of osteoarthritis in model species.  The impact on our understanding 
of human disease is discussed below.      
8.3.2: Informing complex human disease from rodent models – thesis 
findings have practical relevance to researchers  
The ultimate deliverable output of this study should be findings that allow some 
inference to be made with regard to human musculoskeletal disease – either to explore 
further regulatory networks that may be perturbed in the disease state, to refine disease 
models, and encourage development of regenerative strategies.  As has been asserted in 
earlier statements rat in vitro models of cartilage and tendon homeostasis are 
physiologically imperfect and so it becomes difficult to untangle what may be usefully 
extrapolated to human research, what is species-specific, and what is artefact.  In this 
thesis it is demonstrated that, using the available gene expression data sets for rat and 
human, there are co-expression network modules associated with normal cartilage gene 
expression profiles in the rat that are not replicated in human studies (section 5.3.7).  
The reasons for this have been described elsewhere, but it highlights a core issue of a 
network approach using data from rodent in vivo and in vitro models.  The lack of normal 
expression profiles for human cartilage and tendon make it difficult to compare 
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transcriptome networks; the absence of evidence for a given gene module in a co-
expression network from human data is not evidence for its absence.   
There is considerable controversy centred on the relevance of rodent models to human 
disease, most notably in inflammation (Seok, Warren et al. 2013, Takao and Miyakawa 
2015).  Primarily these studies have focused on the correlation of gene expression 
profiles between mice and human expression studies.  In this thesis low, but positive, 
correlations of gene expression rank were found between species (section 5.3.4) for 
cartilage and tendon derived studies.  It is also demonstrated that the overall 
transcriptomic structure is highly conserved between rat and human networks (section 
5.3.5).  This is consistent with a recent re-evaluation of mouse ENCODE data 
demonstrating that gene expression across species (mouse and human) clusters by tissue 
and not by species (Gilad and Mizrahi-Man 2015).  The converse had been published by 
the ENCODE consortium (Lin, Lin et al. 2014), but supporting earlier statements in 
this thesis calling for disclosure of microarray sample batching in public repositories, 
batch effects in the ENCODE data had not been resolved.      
Findings presented in this thesis have a practical impact for musculoskeletal researchers 
interested in developing bioengineered cartilage and tendon. For future studies to make 
further headway efforts should be made to at a community level to rationalize models, 
optimise laboratory methods/parameters, and curate gene orthologs across rodent and 
human studies not least because of the wider impact on the veracity of translational 
research in science policy and knock-on effects on funding.  Further development of the 
co-expression analysis study presented in this thesis should bear the controversies, 
discussed above, in mind.  For example, rodent and human expression profiles both 
consider inflammatory osteoarthritis, but activation of such pathways occur on vastly 
different time-scales.  More careful matching of expression studies across species, and 
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dealing with batch effects where possible, is more likely to yield informative results than 
loose amalgams of tissue, cell and disease profiles (Shay, Lederer et al. 2015).    
8.3.3: Ontologies fail to provide depth of functional annotation 
The use of gene ontology functional annotations was a core data-mining tool in the 
collection of studies presented within this thesis.  The presence of highly enriched 
annotations for immune functions in native cartilage, and muscle transcripts in tendon, 
from differentially expressed genes prompted exploration of methods to determine how 
these profiles compared to those from other studies.  The possible methodological and 
anatomical reasons for this have been discussed in Chapter 2.  Further consideration of 
the relevance of gene ontology annotations to a systems understanding is warranted.  
Throughout this thesis annotations using developmental terminology are evident: 
‘anatomical structure morphogenesis’, ‘tissue morphogenesis’, ‘regulation of cell 
differentiation’ (sections 2.3.4, 3.3.4, and 7.3.1) are found to be associated with 
dedifferentiation in monolayer and re-differentiation in three-dimensional culture 
systems.  Enriched terms such as these contribute positively to a hypothesis of 
constrained plasticity of isolated chondrocytes and tenocytes.  However, alongside these 
numerous incongruous annotations are evident; the most obvious example of this was 
the significant number of annotations associated with neurodegenerative disorders used 
to annotate enriched KEGG pathways in the proteomic profiles of monolayer and 
three-dimensional cultures (section 6.3.3).  A further example was the annotation of 
dedifferentiated chondrocytes with ‘tendon development’ annotation (section 3.3.4), but 
this was not apparent for the equivalent tenocyte analysis.  Disparity across knowledge 
bases was also evident with PI-3K signalling pathway shown to be the predominant 
pathway in de- and re-differentiation (section 3.3.7) yet described as hepatic stellate cell 
activation by Ingenuity Pathway Analysis.  With respect to the cross-species analysis 
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presented in this thesis assumptions are also made with regard to the equivalence of 
annotations.   
These concerns with ontologies in musculoskeletal research may be considered as 
arising from several broad issues: i) heterogenous cell populations (especially for native 
tissues) obfuscate accurate annotation of the cell population of interest, ii) functional 
annotations are inconsistent across knowledge bases, iii) annotations are biased and are 
not stage-, condition-, or tissue-specific, iv) and annotations are subject to researcher 
bias.   
Nehrt, et al (2011) used gene ontology annotations to refute the ortholog conjecture, 
that orthologous genes share greater functional similarity that paralogous genes (Nehrt, 
Clark et al. 2011).  Although this has now been challenged within the context of 
comparative genomics it revealed issues within the gene ontological annotations, in 
particular the ‘open world assumption’ that the absence of a GO functional annotation 
for a gene does not indicate absence of that function, rather it reflects artifacts created 
by the methods of collection of molecular biology data.  This has been described as a 
‘global ascertainment bias’ in that certain types of experiments tend to be performed in 
certain model species resulting in very unequal representation of certain biological and 
molecular functions between rodent and human annotations.  In particular biological 
process terms for development and cell differentiation are over-represented in the 
mouse relative to human annotations (Thomas, Wood et al. 2012).  These issues are 
compounded in tissues for which there are few gene ontology annotations, i.e. tendon.  
Consequently, an understanding of how GO annotations are derived should inform the 
corroborative process for the data presented in this thesis, in particular comparative 
profiling of development stages of cartilage and tendon with de- and re-differentiated 
cells should be considered.      
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8.3.4: Deconvolution of data from heterogenous samples may yield further 
insights into cartilage and tendon 
Gene expression profiles derived from cartilage and tendon represent the average signal 
for a heterogenous tissue.  The relative proportions of each cell type can vary 
considerably, especially when derived from small tissue samples collected by manual 
dissection.  This can confound downstream analysis, not only through functional 
annotations (described above), but also through the misidentification of candidate 
biomarkers.   
To disentangle the expression signals requires the use of deconvolution algorithms; 
these can serve as cost-effective tools to rationalise the component cell profiles, which 
would otherwise require specialist resources, e.g., micro-dissection, cell sorting.  Flexible 
frameworks, such as the CellMix R package (Gaujoux and Seoighe 2013) facilitate the 
implementation of these methods, but require auxiliary data sets to define cell 
proportions.  Only recently a novel implementation of latent variable analysis in R, 
CellCODE, has been shown to be able to assign differentially expressed genes to cell-
types based upon data structure alone and without specific knowledge of the data set 
(Chikina, Zaslavsky et al. 2015).  Further analysis of expression data from whole 
cartilage and tendon would benefit from the application of deconvolution strategies to 
retrieve cell-specific profiles.      
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8.4: Challenges of data integration 
 
Objective 3:  Integrate gene expression and protein abundance data to 
rationalize validation targets and derive mechanistic networks.  
 
8.4.1: Summary of integration approaches employed  
The data accumulated in this collection of studies represents a rich resource to be 
exploited further.  However, discussion of each study in isolation has limited relevance 
to a wider systems understanding of the response of chondrocytes and tenocytes to 
environmental perturbations.  Through integration of data from snapshot profiles at 
different levels of the biological hierarchy a consistent and comprehensive narrative may 
emerge.   
A number of data integration strategies were employed in this thesis.  To aggregate data 
from multiple diverse microarray gene expression profiles data was merged by 
intersecting on common gene identifiers and applying a global normalization method to 
create a single matrix.  The structure of the transcriptome network could then be 
determined through the use of a weighted gene co-expression network analysis (sections 
4.3.1 and 5.3.3).  The utility of this approach was clear, however, small data sets 
demonstrated unstable network structures and in this context the confidence with which 
regulatory hub genes could be identified was marginal; this was exemplified by the 
equivocal impact of siRNA knock-down of the Lzts2 gene on expression of markers of 
differentiation status in chondrocytes (section 4.3.7).  Despite the strong statistical 
associations supporting the choice of module and hub gene in an individual data set this 
study highlighted the necessity for interrogation of multiple data sets to define 
consensus modules.   
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To determine a comprehensive functional annotation of the biological processes likely 
to be involved in de- and re-differentiation a novel model-based Bayesian method was 
used (Sass, Buettner et al. 2014).  This approach considers each data set as a noisy 
representation of a common underlying gene response.  This permitted the integration 
of functional annotations from a number of biological levels, simultaneously dealing 
with redundant terms and issues of multiple testing.  This application did summarise 
dedifferentiation by the terms ‘ossification’, ‘oxidation-reduction process’ and the 
KEGG Wnt-signalling pathway.  The limitation of this approach, in addition to 
ontology concerns discussed above, is that only two different levels may be considered 
and makes no use of quantitative data.   
The third method used to integrate data from transcriptomic and proteomic data sets 
aimed to infer the common upstream transcriptional regulators that resulted in the 
observed expression profiles from each data set.  This analysis made use of causal 
analytic algorithms included within Ingenuity Pathway Analysis.  Upstream regulators 
are predicted that are consistent with regulation of the observed gene expression profile 
through direct or indirect relationships.  Mechanistic networks are hypothesis networks 
built upon identified upstream regulators by connecting the regulators considered to be 
acting through the same signalling mechanism (Krämer, Green et al. 2014).    
This technique demonstrated the reciprocal activation and inhibition predicted for the 
master regulators TGF-β1 and PDGF BB in de- and re-differentiation.  Furthermore, a 
highly enriched protein-protein interaction network was evident for dedifferentiation 
derived from Ingenuity mechanistic hypothesis networks.  Through this SMAD7 and 
CTGF were identified as common downstream targets in the dedifferentiated 
phenotype (section 7.3.2).  For redifferentiation, mechanistic networks were centred on 
JUN. FOS, BMP2, GREM1 and IL-1B and IL-6.  By performing this analysis over 
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several studies and two tissue sources it was possible to define a consensus network.  
This meets the goal of devising a mechanistic network for de- and re-differentiation and 
sub-setting a target group for further wet-lab validation and input to models.   
Although this method allowed qualitative comparisons to be made across independent 
data sets, e.g. TGF-β1 activation is predicted in monolayer in all data sets (section 
7.3.2), this approach again does not utilize the quantitative data.  Missing nodes in a 
regulatory cascade are given statistical predictions for their activation or inhibition.  This 
allowed the inclusion of targets not shown to be differentially expressed, but were 
relevant to the tissue under investigation.   
Clearly the observed gene expression profile may be modulated by a number of 
different regulators and it cannot be known a priori which of these predominates.  
Although each of these hypothesis networks has a statistical score associated with it they 
are a function of the observed gene expression profile.  The absence of nodes and the 
strict cut-off defined in Ingenuity could have implications on the reproducibility of 
these networks.  
8.4.2: Pathways and mechanistic networks 
This study reports the contribution of a number of signalling pathways as being 
involved monolayer and three-dimensional culture phenotypes including Wnt-, NF-kB, 
PI-3K/Akt (section 3.3.7), PPAR (section 6.3.6), IL-6 (section 5.3.8) and TGF-β 
(section 7.3.2)-signalling.  These have all been implicated in development and/or disease 
mechanisms in chondrocyte and tenocyte or defined by in vitro studies.  The finding of 
multiple signalling pathways in this study is not contradictory rather it demonstrates the 
requirement of integration across multiple data sets and the levels of the biological 
hierarchy.   
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By defining the consensus upstream regulators associated with mRNA and protein 
profiles in this study it was possible to propose a unified mechanistic network for the 
observed chondrocyte and tenocyte phenotypes. Crucially the proposed network is 
static and incomplete; it requires both an assessment of sufficiency (whether it describes 
the behavior of the system within a specified range of tolerance) and a test of realism 
(whether this is the correct mechanism) (Boogerd, Bruggeman et al. 2013).  In line with 
current opinion development of this TGF-β mediated model would require a more 
quantitative and systematic approach, not least mathematical modeling of temporal 
signals (Zi, Chapnick et al. 2012).  Time course analysis would be an integral component 
of further expression profiling.     
The future challenge from these, and other, expression data sets is the reverse 
engineering of gene regulatory networks (GRN) from gene expression data.  In using 
co-expression network analysis functional sub-networks were isolated and these are 
useful for exploring emerging functional properties of groups of genes in the system, 
but they do not represent or infer causal relationships (Emmert-Streib, Glazko et al. 
2012).  Likewise, Ingenuity Mechanistic Networks are useful exploratory tools, but are 
hypothesis networks defined by the knowledge base and number of input genes from a 
data set.  They also have a tendency to ‘over-fit’ networks, for example TGF-β1 was 
defined as the upstream regulator of over 700 genes in one analysis of Affymetrix 
expression data (section 7.3.3).  In addition to being ‘scale-free’ (Barabási and Oltvai 
2004) gene regulatory networks are parsimonious in design, i.e. sparse (Leclerc 2008).  
This was an emerging issue in Chapter 5 where a complex and heterogenous network 
was developed and was insufficiently sparse.  There are a number of available strategies 
for inferring regulatory networks from gene expression surveys.  These include 
correlation-based methods (WGCNA), mutual information (ARACNE) and Boolean 
 606 
and Bayesian network methods (Liu 2015). Future work would focus on inferring 
regulatory networks from gene expression data arising from these studies.   
Data, data everywhere 
Data constraints were a core issue in this thesis.  Issues of cost, platform obsolescence, 
quality control and missing data all arose with microarray gene expression profiling 
studies in this thesis.  To overcome limitations in the data arising from novel 
experimental work, and to place gene expression profiles in a wider context, methods of 
gene expression data integration were considered by data merging approaches.  Many 
practical concerns were evident including the poor quality of many expression profiles 
submitted to public repositories, difficulty in handling data from multiple microarray 
platforms, the dearth of available cartilage and tendon profiles, the minimal sequence 
and target overlap between probes from different platform technologies and the 
problems associated with handling noisy and heterogenous data.   
Although some guidelines for microarray meta-analysis and data integration have been 
suggested (Ramasamy, Mondry et al. 2008) there is no standard procedure for dealing 
with diverse expression data.  Diversity of the data is a function of the plethora of 
commercial products and lack of standardization across the musculoskeletal research 
community with respect to disease models and laboratory methods.  Although the 
methodologies used in this thesis require refinement, in terms of inclusion criteria and 
the focusing of research questions, they represent the first attempt to describe 
regulatory sub-networks associated with native cartilage and tendon as well as three-
dimensional culture systems.  
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8.5: Project objectives redefined 
An understanding of dedifferentiation as a regenerative mechanism must develop with 
respect to other regenerative models, i.e. stem cells (Maden 2013).  A body of evidence 
defines the presence of tissue-resident stem cells in the tendon (Bi, Ehirchiou et al. 
2007, Lui and Chan 2011) and chondro-progenitors in the superficial zone of articular 
cartilage (Candela, Yasuhara et al. 2014).  Numerous studies have considered the 
directed differentiation of MSCs (often from bone-marrow or adipose tissue) towards a 
chondrocytic phenotype (Boeuf and Richter 2010) with view to autologous sources of 
stem cells for cartilage repair.  The findings of developmental marker expression in 
monolayer cells in this study would have benefitted from analysis in a wider context, for 
example, transcriptomic profiling alongside differentiating MSCs or comparisons 
relative to the monolayer culture methodologies used for deriving tendon-derived stem 
cells.  This would facilitate a narrower definition of dedifferentiation by delineating the 
extent of any developmental phenotype.  Elucidation of a restricted de-/re-
differentiation regulatory network would be a valuable contribution to the modeling of 
novel organotypic culture systems and informing regenerative musculoskeletal 
interventions.    
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